[{"path":"https://www.serdarbalci.com/jsurvival/CLAUDE.html","id":null,"dir":"","previous_headings":"","what":"CLAUDE.md","title":"CLAUDE.md","text":"file provides guidance Claude Code (claude.ai/code) working code repository.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/CLAUDE.html","id":"project-overview","dir":"","previous_headings":"","what":"Project Overview","title":"CLAUDE.md","text":"jsurvival, jamovi module survival analysis part ClinicoPath statistical analysis suite. provides survival analysis functions natural language summaries, Kaplan-Meier plots, Cox regression, various survival-related calculations medical research.","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/CLAUDE.html","id":"package-development-workflow","dir":"","previous_headings":"Development Commands","what":"Package Development Workflow","title":"CLAUDE.md","text":"","code":"# Documentation and building devtools::document()          # Generate documentation from roxygen comments devtools::check()            # Run R CMD check  devtools::build()            # Build package devtools::install()          # Install package locally  # Website documentation pkgdown::build_site()        # Build documentation website locally"},{"path":"https://www.serdarbalci.com/jsurvival/CLAUDE.html","id":"testing","dir":"","previous_headings":"Development Commands","what":"Testing","title":"CLAUDE.md","text":"formal test suite currently exists add testing: usethis::use_testthat() usethis::use_test(\"function-name\")","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/CLAUDE.html","id":"jamovi-module-structure","dir":"","previous_headings":"Architecture","what":"jamovi Module Structure","title":"CLAUDE.md","text":"R functions: Located /R/ paired .h.R (header/options) .b.R (body/implementation) files jamovi configuration: YAML files /jamovi/ define module interface menu structure singlearm: Single arm survival analysis survival: Univariate survival analysis Cox regression survivalcont: Survival analysis continuous variables cut-offs multisurvival: Multivariable Cox regression oddsratio: Odds ratio calculations binary outcomes timeinterval: Time interval calculations","code":""},{"path":"https://www.serdarbalci.com/jsurvival/CLAUDE.html","id":"key-dependencies","dir":"","previous_headings":"Architecture","what":"Key Dependencies","title":"CLAUDE.md","text":"Core: jmvcore (jamovi framework), R6 (class system) Survival analysis: survival, survminer, finalfit, rms, KMunicate Data manipulation: dplyr, tidyr, purrr, janitor Visualization: ggplot2, scales","code":""},{"path":"https://www.serdarbalci.com/jsurvival/CLAUDE.html","id":"file-patterns","dir":"","previous_headings":"Architecture","what":"File Patterns","title":"CLAUDE.md","text":"Analysis functions: {name}.h.R (options/header) + {name}.b.R (implementation) jamovi config: {name}..yaml (analysis), {name}.r.yaml (results), {name}.u.yaml (UI) Documentation: Roxygen2 comments markdown support","code":""},{"path":"https://www.serdarbalci.com/jsurvival/CLAUDE.html","id":"cicd-and-automation","dir":"","previous_headings":"","what":"CI/CD and Automation","title":"CLAUDE.md","text":"GitHub Actions: Runs R CMD check multiple platforms, skips “WIP” commits Documentation: Auto-deployed https://www.serdarbalci.com/jsurvival/ via pkgdown Package checking: Multi-platform testing (macOS, Windows, Ubuntu)","code":""},{"path":"https://www.serdarbalci.com/jsurvival/CLAUDE.html","id":"development-notes","dir":"","previous_headings":"","what":"Development Notes","title":"CLAUDE.md","text":"Uses devtools workflow roxygen2 documentation formal testing framework - consider adding testthat exported functions proper roxygen documentation Follow existing code patterns new analyses (header + body structure) Version managed DESCRIPTION file (currently 0.0.3.21)","code":""},{"path":"https://www.serdarbalci.com/jsurvival/LICENSE.html","id":null,"dir":"","previous_headings":"","what":"GNU General Public License","title":"GNU General Public License","text":"Version 2, June 1991Copyright © 1989, 1991 Free Software Foundation, Inc.,51 Franklin Street, Fifth Floor, Boston, MA 02110-1301 USA Everyone permitted copy distribute verbatim copies license document, changing allowed.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/LICENSE.html","id":"preamble","dir":"","previous_headings":"","what":"Preamble","title":"GNU General Public License","text":"licenses software designed take away freedom share change . contrast, GNU General Public License intended guarantee freedom share change free software–make sure software free users. General Public License applies Free Software Foundation’s software program whose authors commit using . (Free Software Foundation software covered GNU Lesser General Public License instead.) can apply programs, . speak free software, referring freedom, price. General Public Licenses designed make sure freedom distribute copies free software (charge service wish), receive source code can get want , can change software use pieces new free programs; know can things. protect rights, need make restrictions forbid anyone deny rights ask surrender rights. restrictions translate certain responsibilities distribute copies software, modify . example, distribute copies program, whether gratis fee, must give recipients rights . must make sure , , receive can get source code. must show terms know rights. protect rights two steps: (1) copyright software, (2) offer license gives legal permission copy, distribute /modify software. Also, author’s protection , want make certain everyone understands warranty free software. software modified someone else passed , want recipients know original, problems introduced others reflect original authors’ reputations. Finally, free program threatened constantly software patents. wish avoid danger redistributors free program individually obtain patent licenses, effect making program proprietary. prevent , made clear patent must licensed everyone’s free use licensed . precise terms conditions copying, distribution modification follow.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/LICENSE.html","id":"terms-and-conditions-for-copying-distribution-and-modification","dir":"","previous_headings":"","what":"TERMS AND CONDITIONS FOR COPYING, DISTRIBUTION AND MODIFICATION","title":"GNU General Public License","text":"0. License applies program work contains notice placed copyright holder saying may distributed terms General Public License. “Program”, , refers program work, “work based Program” means either Program derivative work copyright law: say, work containing Program portion , either verbatim modifications /translated another language. (Hereinafter, translation included without limitation term “modification”.) licensee addressed “”. Activities copying, distribution modification covered License; outside scope. act running Program restricted, output Program covered contents constitute work based Program (independent made running Program). Whether true depends Program . 1. may copy distribute verbatim copies Program’s source code receive , medium, provided conspicuously appropriately publish copy appropriate copyright notice disclaimer warranty; keep intact notices refer License absence warranty; give recipients Program copy License along Program. may charge fee physical act transferring copy, may option offer warranty protection exchange fee. 2. may modify copy copies Program portion , thus forming work based Program, copy distribute modifications work terms Section 1 , provided also meet conditions: ) must cause modified files carry prominent notices stating changed files date change. b) must cause work distribute publish, whole part contains derived Program part thereof, licensed whole charge third parties terms License. c) modified program normally reads commands interactively run, must cause , started running interactive use ordinary way, print display announcement including appropriate copyright notice notice warranty (else, saying provide warranty) users may redistribute program conditions, telling user view copy License. (Exception: Program interactive normally print announcement, work based Program required print announcement.) requirements apply modified work whole. identifiable sections work derived Program, can reasonably considered independent separate works , License, terms, apply sections distribute separate works. distribute sections part whole work based Program, distribution whole must terms License, whose permissions licensees extend entire whole, thus every part regardless wrote . Thus, intent section claim rights contest rights work written entirely ; rather, intent exercise right control distribution derivative collective works based Program. addition, mere aggregation another work based Program Program (work based Program) volume storage distribution medium bring work scope License. 3. may copy distribute Program (work based , Section 2) object code executable form terms Sections 1 2 provided also one following: ) Accompany complete corresponding machine-readable source code, must distributed terms Sections 1 2 medium customarily used software interchange; , b) Accompany written offer, valid least three years, give third party, charge cost physically performing source distribution, complete machine-readable copy corresponding source code, distributed terms Sections 1 2 medium customarily used software interchange; , c) Accompany information received offer distribute corresponding source code. (alternative allowed noncommercial distribution received program object code executable form offer, accord Subsection b .) source code work means preferred form work making modifications . executable work, complete source code means source code modules contains, plus associated interface definition files, plus scripts used control compilation installation executable. However, special exception, source code distributed need include anything normally distributed (either source binary form) major components (compiler, kernel, ) operating system executable runs, unless component accompanies executable. distribution executable object code made offering access copy designated place, offering equivalent access copy source code place counts distribution source code, even though third parties compelled copy source along object code. 4. may copy, modify, sublicense, distribute Program except expressly provided License. attempt otherwise copy, modify, sublicense distribute Program void, automatically terminate rights License. However, parties received copies, rights, License licenses terminated long parties remain full compliance. 5. required accept License, since signed . However, nothing else grants permission modify distribute Program derivative works. actions prohibited law accept License. Therefore, modifying distributing Program (work based Program), indicate acceptance License , terms conditions copying, distributing modifying Program works based . 6. time redistribute Program (work based Program), recipient automatically receives license original licensor copy, distribute modify Program subject terms conditions. may impose restrictions recipients’ exercise rights granted herein. responsible enforcing compliance third parties License. 7. , consequence court judgment allegation patent infringement reason (limited patent issues), conditions imposed (whether court order, agreement otherwise) contradict conditions License, excuse conditions License. distribute satisfy simultaneously obligations License pertinent obligations, consequence may distribute Program . example, patent license permit royalty-free redistribution Program receive copies directly indirectly , way satisfy License refrain entirely distribution Program. portion section held invalid unenforceable particular circumstance, balance section intended apply section whole intended apply circumstances. purpose section induce infringe patents property right claims contest validity claims; section sole purpose protecting integrity free software distribution system, implemented public license practices. Many people made generous contributions wide range software distributed system reliance consistent application system; author/donor decide willing distribute software system licensee impose choice. section intended make thoroughly clear believed consequence rest License. 8. distribution /use Program restricted certain countries either patents copyrighted interfaces, original copyright holder places Program License may add explicit geographical distribution limitation excluding countries, distribution permitted among countries thus excluded. case, License incorporates limitation written body License. 9. Free Software Foundation may publish revised /new versions General Public License time time. new versions similar spirit present version, may differ detail address new problems concerns. version given distinguishing version number. Program specifies version number License applies “later version”, option following terms conditions either version later version published Free Software Foundation. Program specify version number License, may choose version ever published Free Software Foundation. 10. wish incorporate parts Program free programs whose distribution conditions different, write author ask permission. software copyrighted Free Software Foundation, write Free Software Foundation; sometimes make exceptions . decision guided two goals preserving free status derivatives free software promoting sharing reuse software generally.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/LICENSE.html","id":"no-warranty","dir":"","previous_headings":"","what":"NO WARRANTY","title":"GNU General Public License","text":"11. PROGRAM LICENSED FREE CHARGE, WARRANTY PROGRAM, EXTENT PERMITTED APPLICABLE LAW. EXCEPT OTHERWISE STATED WRITING COPYRIGHT HOLDERS /PARTIES PROVIDE PROGRAM “” WITHOUT WARRANTY KIND, EITHER EXPRESSED IMPLIED, INCLUDING, LIMITED , IMPLIED WARRANTIES MERCHANTABILITY FITNESS PARTICULAR PURPOSE. ENTIRE RISK QUALITY PERFORMANCE PROGRAM . PROGRAM PROVE DEFECTIVE, ASSUME COST NECESSARY SERVICING, REPAIR CORRECTION. 12. EVENT UNLESS REQUIRED APPLICABLE LAW AGREED WRITING COPYRIGHT HOLDER, PARTY MAY MODIFY /REDISTRIBUTE PROGRAM PERMITTED , LIABLE DAMAGES, INCLUDING GENERAL, SPECIAL, INCIDENTAL CONSEQUENTIAL DAMAGES ARISING USE INABILITY USE PROGRAM (INCLUDING LIMITED LOSS DATA DATA RENDERED INACCURATE LOSSES SUSTAINED THIRD PARTIES FAILURE PROGRAM OPERATE PROGRAMS), EVEN HOLDER PARTY ADVISED POSSIBILITY DAMAGES. END TERMS CONDITIONS","code":""},{"path":"https://www.serdarbalci.com/jsurvival/LICENSE.html","id":"how-to-apply-these-terms-to-your-new-programs","dir":"","previous_headings":"","what":"How to Apply These Terms to Your New Programs","title":"GNU General Public License","text":"develop new program, want greatest possible use public, best way achieve make free software everyone can redistribute change terms. , attach following notices program. safest attach start source file effectively convey exclusion warranty; file least “copyright” line pointer full notice found. Also add information contact electronic paper mail. program interactive, make output short notice like starts interactive mode: hypothetical commands show w show c show appropriate parts General Public License. course, commands use may called something show w show c; even mouse-clicks menu items–whatever suits program. also get employer (work programmer) school, , sign “copyright disclaimer” program, necessary. sample; alter names: General Public License permit incorporating program proprietary programs. program subroutine library, may consider useful permit linking proprietary applications library. want , use GNU Lesser General Public License instead License.","code":"<one line to give the program's name and a brief idea of what it does.> Copyright (C) <year>  <name of author>  This program is free software; you can redistribute it and/or modify it under the terms of the GNU General Public License as published by the Free Software Foundation; either version 2 of the License, or (at your option) any later version.  This program is distributed in the hope that it will be useful, but WITHOUT ANY WARRANTY; without even the implied warranty of MERCHANTABILITY or FITNESS FOR A PARTICULAR PURPOSE.  See the GNU General Public License for more details.  You should have received a copy of the GNU General Public License along with this program; if not, write to the Free Software Foundation, Inc., 51 Franklin Street, Fifth Floor, Boston, MA 02110-1301 USA. Gnomovision version 69, Copyright (C) year name of author Gnomovision comes with ABSOLUTELY NO WARRANTY; for details type `show w'. This is free software, and you are welcome to redistribute it under certain conditions; type `show c' for details. Yoyodyne, Inc., hereby disclaims all copyright interest in the program `Gnomovision' (which makes passes at compilers) written by James Hacker.  <signature of Ty Coon>, 1 April 1989 Ty Coon, President of Vice"},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-introduction.html","id":"introduction","dir":"Articles","previous_headings":"","what":"Introduction","title":"jSurvival 01: Introduction to Survival Analysis for Pathologists","text":"jsurvival provides comprehensive survival analysis tools specifically designed clinical research oncology studies. module offers user-friendly interfaces time--event analysis, basic Kaplan-Meier curves advanced competing risks multivariate Cox regression models. Learning Objectives: Master fundamental survival analysis concepts methods Learn Kaplan-Meier survival curve construction interpretation Apply Cox proportional hazards regression multivariable analysis Understand competing risks analysis complex clinical scenarios Implement molecular biomarker survival analysis workflows Create publication-ready survival plots tables","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-introduction.html","id":"module-overview","dir":"Articles","previous_headings":"Introduction","what":"Module Overview","title":"jSurvival 01: Introduction to Survival Analysis for Pathologists","text":"jsurvival encompasses four main areas survival analysis:","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-introduction.html","id":"basic-survival-analysis","dir":"Articles","previous_headings":"Introduction > Module Overview","what":"1. Basic Survival Analysis","title":"jSurvival 01: Introduction to Survival Analysis for Pathologists","text":"Kaplan-Meier Curves: Non-parametric survival estimation Log-rank Tests: Compare survival groups Median Survival: Time--event summary statistics Confidence Intervals: Uncertainty quantification survival estimates","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-introduction.html","id":"regression-models","dir":"Articles","previous_headings":"Introduction > Module Overview","what":"2. Regression Models","title":"jSurvival 01: Introduction to Survival Analysis for Pathologists","text":"Cox Proportional Hazards: Multivariable time--event modeling Stratified Cox Models: Account non-proportional hazards Time-dependent Covariates: Dynamic risk factor modeling Model Diagnostics: Assumption testing validation","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-introduction.html","id":"advanced-methods","dir":"Articles","previous_headings":"Introduction > Module Overview","what":"3. Advanced Methods","title":"jSurvival 01: Introduction to Survival Analysis for Pathologists","text":"Competing Risks: Multiple event types analysis Multistate Models: Disease progression modeling Parametric Survival: Weibull, exponential, distributions Frailty Models: Unobserved heterogeneity modeling","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-introduction.html","id":"clinical-applications","dir":"Articles","previous_headings":"Introduction > Module Overview","what":"4. Clinical Applications","title":"jSurvival 01: Introduction to Survival Analysis for Pathologists","text":"Biomarker Analysis: Molecular predictor evaluation Treatment Comparisons: Therapeutic intervention assessment Prognostic Models: Risk stratification tools Real-World Evidence: Population-based survival studies","code":"library(jsurvival) library(survival) library(dplyr)"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-introduction.html","id":"sample-data-overview","dir":"Articles","previous_headings":"Getting Started","what":"Sample Data Overview","title":"jSurvival 01: Introduction to Survival Analysis for Pathologists","text":"","code":"# Load molecular pathology survival data data(ihc_molecular_comprehensive)  # Survival data structure cat(\"Survival dataset dimensions:\", nrow(ihc_molecular_comprehensive), \"×\", ncol(ihc_molecular_comprehensive), \"\\n\")  # Key survival variables survival_vars <- c(\"Overall_Survival_Months\", \"Death_Event\", \"PFS_Months\", \"Progression_Event\") cat(\"Survival variables:\", paste(survival_vars, collapse = \", \"), \"\\n\")  # Molecular biomarkers for stratification biomarker_vars <- c(\"EGFR_Mutation\", \"MSI_Status\", \"HER2_IHC\", \"PD_L1_TPS\") cat(\"Biomarker variables:\", paste(biomarker_vars, collapse = \", \"), \"\\n\")  # Basic survival summary survival_summary <- ihc_molecular_comprehensive %>%   summarise(     n = n(),     median_os = median(Overall_Survival_Months),     death_rate = round(mean(Death_Event) * 100, 1),     median_pfs = median(PFS_Months),     progression_rate = round(mean(Progression_Event) * 100, 1)   )  cat(\"\\nSurvival Summary:\\n\") cat(\"Patients:\", survival_summary$n, \"\\n\") cat(\"Median OS:\", survival_summary$median_os, \"months\\n\") cat(\"Death rate:\", survival_summary$death_rate, \"%\\n\") cat(\"Median PFS:\", survival_summary$median_pfs, \"months\\n\") cat(\"Progression rate:\", survival_summary$progression_rate, \"%\\n\")"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-introduction.html","id":"kaplan-meier-survival-analysis","dir":"Articles","previous_headings":"Core Survival Analysis","what":"1. Kaplan-Meier Survival Analysis","title":"jSurvival 01: Introduction to Survival Analysis for Pathologists","text":"Foundation survival analysis time--event data.","code":"# Kaplan-Meier Analysis Example # In jamovi: jsurvival > Survival Analysis  cat(\"Kaplan-Meier Survival Analysis\\n\") cat(\"==============================\\n\\n\")  if(requireNamespace(\"survival\", quietly = TRUE)) {   library(survival)      # Create survival object   surv_obj <- Surv(ihc_molecular_comprehensive$Overall_Survival_Months,                    ihc_molecular_comprehensive$Death_Event)      # Overall survival curve   km_overall <- survfit(surv_obj ~ 1, data = ihc_molecular_comprehensive)      cat(\"Overall Survival Analysis:\\n\")   print(summary(km_overall, times = c(12, 24, 36, 60))$table)      # Survival by EGFR mutation status   km_egfr <- survfit(surv_obj ~ EGFR_Mutation, data = ihc_molecular_comprehensive)      cat(\"\\nSurvival by EGFR Status:\\n\")   egfr_summary <- summary(km_egfr)$table   print(egfr_summary)      # Log-rank test   logrank_egfr <- survdiff(surv_obj ~ EGFR_Mutation, data = ihc_molecular_comprehensive)   p_value <- 1 - pchisq(logrank_egfr$chisq, 1)      cat(\"\\nLog-rank test p-value:\", round(p_value, 4), \"\\n\")      if(p_value < 0.05) {     cat(\"Conclusion: Significant difference in survival by EGFR status\\n\")   } else {     cat(\"Conclusion: No significant difference in survival by EGFR status\\n\")   } }"},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-introduction.html","id":"cox-proportional-hazards-regression","dir":"Articles","previous_headings":"Core Survival Analysis","what":"2. Cox Proportional Hazards Regression","title":"jSurvival 01: Introduction to Survival Analysis for Pathologists","text":"Multivariable analysis accounting multiple prognostic factors.","code":"# Cox Regression Analysis Example # In jamovi: jsurvival > Cox Diagnostics  cat(\"\\nCox Proportional Hazards Regression\\n\") cat(\"===================================\\n\\n\")  if(requireNamespace(\"survival\", quietly = TRUE)) {   # Multivariable Cox model   cox_model <- coxph(Surv(Overall_Survival_Months, Death_Event) ~                       EGFR_Mutation + MSI_Status + Age + Grade + Tumor_Mutational_Burden,                      data = ihc_molecular_comprehensive)      cat(\"Cox Regression Results:\\n\")   cox_summary <- summary(cox_model)   print(cox_summary$coefficients[, c(\"coef\", \"exp(coef)\", \"Pr(>|z|)\")])      # Model performance   cat(\"\\nModel Performance:\\n\")   cat(\"Concordance:\", round(cox_summary$concordance[1], 3), \"\\n\")   cat(\"R-squared:\", round(cox_summary$rsq[1], 3), \"\\n\")   cat(\"Likelihood ratio test p-value:\", round(cox_summary$logtest[3], 4), \"\\n\")      # Hazard ratios with confidence intervals   cat(\"\\nHazard Ratios (95% CI):\\n\")   hr_ci <- exp(confint(cox_model))   hr_estimates <- exp(cox_model$coefficients)      for(i in 1:length(hr_estimates)) {     var_name <- names(hr_estimates)[i]     hr <- round(hr_estimates[i], 2)     ci_lower <- round(hr_ci[i, 1], 2)     ci_upper <- round(hr_ci[i, 2], 2)     p_val <- round(cox_summary$coefficients[i, \"Pr(>|z|)\"], 3)          cat(paste0(var_name, \": HR = \", hr, \" (\", ci_lower, \"-\", ci_upper, \"), p = \", p_val, \"\\n\"))   } }"},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-introduction.html","id":"competing-risks-analysis","dir":"Articles","previous_headings":"Core Survival Analysis","what":"3. Competing Risks Analysis","title":"jSurvival 01: Introduction to Survival Analysis for Pathologists","text":"Handle situations multiple types events can occur.","code":"# Competing Risks Analysis Example # In jamovi: jsurvival > Competing Survival  cat(\"\\nCompeting Risks Analysis\\n\") cat(\"=======================\\n\\n\")  # Create competing events data # Death from disease vs death from other causes competing_data <- ihc_molecular_comprehensive %>%   mutate(     # Simulate competing events     death_cause = case_when(       Death_Event == 0 ~ \"Alive\",       Death_Event == 1 & Grade == 3 ~ \"Disease\",       Death_Event == 1 & Age > 75 ~ \"Other\",       Death_Event == 1 ~ sample(c(\"Disease\", \"Other\"), 1, prob = c(0.7, 0.3)),       TRUE ~ \"Alive\"     ),          # Competing event indicator     event_type = case_when(       death_cause == \"Disease\" ~ 1,       death_cause == \"Other\" ~ 2,       TRUE ~ 0     )   )  # Competing risks summary competing_summary <- competing_data %>%   group_by(death_cause) %>%   summarise(     n = n(),     percentage = round(n() / nrow(competing_data) * 100, 1),     median_time = median(Overall_Survival_Months),     .groups = 'drop'   )  cat(\"Competing Events Summary:\\n\") print(competing_summary)  # Event rates by biomarker status biomarker_events <- competing_data %>%   group_by(EGFR_Mutation, death_cause) %>%   summarise(n = n(), .groups = 'drop') %>%   group_by(EGFR_Mutation) %>%   mutate(percentage = round(n / sum(n) * 100, 1))  cat(\"\\nEvent Rates by EGFR Status:\\n\") print(biomarker_events)  # Clinical interpretation disease_death_rate <- mean(competing_data$death_cause == \"Disease\") * 100 cat(\"\\nClinical Interpretation:\\n\") cat(\"Disease-specific death rate:\", round(disease_death_rate, 1), \"%\\n\")  if(disease_death_rate > 50) {   cat(\"Conclusion: Disease is the predominant cause of death\\n\") } else {   cat(\"Conclusion: Competing causes of death are significant\\n\") }"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-introduction.html","id":"molecular-stratification","dir":"Articles","previous_headings":"Biomarker Survival Analysis","what":"Molecular Stratification","title":"jSurvival 01: Introduction to Survival Analysis for Pathologists","text":"Evaluate prognostic impact molecular biomarkers.","code":"cat(\"Molecular Biomarker Survival Analysis\\n\") cat(\"====================================\\n\\n\")  # Multiple biomarker analysis biomarkers <- c(\"EGFR_Mutation\", \"MSI_Status\", \"HER2_IHC\")  for(biomarker in biomarkers) {   cat(paste0(\"Survival Analysis for \", biomarker, \":\\n\"))   cat(paste0(rep(\"-\", nchar(biomarker) + 25), collapse = \"\"), \"\\n\")      # Create survival object   surv_obj <- Surv(ihc_molecular_comprehensive$Overall_Survival_Months,                    ihc_molecular_comprehensive$Death_Event)      # Survival by biomarker   formula_str <- paste(\"surv_obj ~\", biomarker)   km_biomarker <- survfit(as.formula(formula_str), data = ihc_molecular_comprehensive)      # Summary statistics   biomarker_summary <- summary(km_biomarker)$table   print(biomarker_summary)      # Log-rank test   logrank_test <- survdiff(as.formula(formula_str), data = ihc_molecular_comprehensive)   p_value <- 1 - pchisq(logrank_test$chisq, length(unique(ihc_molecular_comprehensive[[biomarker]])) - 1)      cat(\"Log-rank test p-value:\", round(p_value, 4), \"\\n\")      if(p_value < 0.05) {     cat(\"Result: Significant prognostic biomarker\\n\")   } else {     cat(\"Result: Not a significant prognostic biomarker\\n\")   }   cat(\"\\n\") }"},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-introduction.html","id":"continuous-biomarker-analysis","dir":"Articles","previous_headings":"Biomarker Survival Analysis","what":"Continuous Biomarker Analysis","title":"jSurvival 01: Introduction to Survival Analysis for Pathologists","text":"Evaluate continuous biomarkers like PD-L1 expression tumor mutational burden.","code":"cat(\"Continuous Biomarker Analysis\\n\") cat(\"=============================\\n\\n\")  # PD-L1 TPS analysis pdl1_quartiles <- quantile(ihc_molecular_comprehensive$PD_L1_TPS,                            probs = c(0, 0.25, 0.5, 0.75, 1.0))  ihc_with_quartiles <- ihc_molecular_comprehensive %>%   mutate(     PD_L1_Quartile = cut(PD_L1_TPS,                          breaks = pdl1_quartiles,                         labels = c(\"Q1 (Low)\", \"Q2\", \"Q3\", \"Q4 (High)\"),                         include.lowest = TRUE),          PD_L1_Clinical = case_when(       PD_L1_TPS < 1 ~ \"Negative (<1%)\",       PD_L1_TPS < 50 ~ \"Low Positive (1-49%)\",       TRUE ~ \"High Positive (≥50%)\"     )   )  cat(\"PD-L1 TPS Distribution:\\n\") pdl1_dist <- table(ihc_with_quartiles$PD_L1_Clinical) print(pdl1_dist)  # Survival by PD-L1 clinical categories if(requireNamespace(\"survival\", quietly = TRUE)) {   surv_obj <- Surv(ihc_with_quartiles$Overall_Survival_Months,                    ihc_with_quartiles$Death_Event)      km_pdl1 <- survfit(surv_obj ~ PD_L1_Clinical, data = ihc_with_quartiles)      cat(\"\\nSurvival by PD-L1 Expression Level:\\n\")   pdl1_summary <- summary(km_pdl1)$table   print(pdl1_summary)      # Test for trend   logrank_pdl1 <- survdiff(surv_obj ~ PD_L1_Clinical, data = ihc_with_quartiles)   p_value_pdl1 <- 1 - pchisq(logrank_pdl1$chisq, 2)      cat(\"Log-rank test p-value:\", round(p_value_pdl1, 4), \"\\n\")      # Tumor mutational burden analysis   tmb_median <- median(ihc_molecular_comprehensive$Tumor_Mutational_Burden)   tmb_high <- ihc_molecular_comprehensive$Tumor_Mutational_Burden >= tmb_median      cat(\"\\nTumor Mutational Burden Analysis:\\n\")   cat(\"Median TMB:\", tmb_median, \"mutations/Mb\\n\")   cat(\"TMB-High cases:\", sum(tmb_high), \"(\", round(mean(tmb_high) * 100, 1), \"%)\\n\")      # TMB survival analysis   km_tmb <- survfit(surv_obj ~ tmb_high, data = ihc_molecular_comprehensive)   tmb_summary <- summary(km_tmb)$table      cat(\"Survival by TMB Status:\\n\")   print(tmb_summary) }"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-introduction.html","id":"multivariable-prognostic-models","dir":"Articles","previous_headings":"Advanced Applications","what":"Multivariable Prognostic Models","title":"jSurvival 01: Introduction to Survival Analysis for Pathologists","text":"Develop comprehensive prognostic models incorporating multiple biomarkers.","code":"cat(\"Multivariable Prognostic Model Development\\n\") cat(\"=========================================\\n\\n\")  if(requireNamespace(\"survival\", quietly = TRUE)) {   # Comprehensive prognostic model   prog_model <- coxph(Surv(Overall_Survival_Months, Death_Event) ~                        Age + Grade +                        EGFR_Mutation + MSI_Status +                        PD_L1_TPS + Tumor_Mutational_Burden,                       data = ihc_molecular_comprehensive)      # Model summary   prog_summary <- summary(prog_model)      cat(\"Comprehensive Prognostic Model:\\n\")   print(prog_summary$coefficients[, c(\"coef\", \"exp(coef)\", \"Pr(>|z|)\")])      # Model performance metrics   cat(\"\\nModel Performance:\\n\")   cat(\"Concordance index:\", round(prog_summary$concordance[1], 3), \"\\n\")   cat(\"Standard error:\", round(prog_summary$concordance[2], 3), \"\\n\")      # Risk score calculation   risk_scores <- predict(prog_model, type = \"risk\")   risk_tertiles <- cut(risk_scores,                        breaks = quantile(risk_scores, probs = c(0, 1/3, 2/3, 1)),                       labels = c(\"Low Risk\", \"Intermediate Risk\", \"High Risk\"),                       include.lowest = TRUE)      # Risk group validation   risk_validation <- ihc_molecular_comprehensive %>%     mutate(Risk_Group = risk_tertiles) %>%     group_by(Risk_Group) %>%     summarise(       n = n(),       events = sum(Death_Event),       event_rate = round(mean(Death_Event) * 100, 1),       median_survival = median(Overall_Survival_Months),       .groups = 'drop'     )      cat(\"\\nRisk Group Validation:\\n\")   print(risk_validation)      # Test risk stratification   surv_risk <- Surv(ihc_molecular_comprehensive$Overall_Survival_Months,                     ihc_molecular_comprehensive$Death_Event)      km_risk <- survfit(surv_risk ~ risk_tertiles)   logrank_risk <- survdiff(surv_risk ~ risk_tertiles)   p_value_risk <- 1 - pchisq(logrank_risk$chisq, 2)      cat(\"Risk stratification p-value:\", round(p_value_risk, 4), \"\\n\")      if(p_value_risk < 0.001) {     cat(\"Conclusion: Excellent risk stratification achieved\\n\")   } else if(p_value_risk < 0.05) {     cat(\"Conclusion: Significant risk stratification achieved\\n\")   } else {     cat(\"Conclusion: Risk stratification needs improvement\\n\")   } }"},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-introduction.html","id":"integration-with-other-modules","dir":"Articles","previous_headings":"","what":"Integration with Other Modules","title":"jSurvival 01: Introduction to Survival Analysis for Pathologists","text":"jsurvival works seamlessly ClinicoPath modules:","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-introduction.html","id":"connection-to-clinicopathdescriptives","dir":"Articles","previous_headings":"Integration with Other Modules","what":"Connection to ClinicoPathDescriptives","title":"jSurvival 01: Introduction to Survival Analysis for Pathologists","text":"Baseline characteristics inform survival model covariates Quality metrics validate survival endpoint reliability Descriptive statistics support survival study design","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-introduction.html","id":"connection-to-meddecide","dir":"Articles","previous_headings":"Integration with Other Modules","what":"Connection to meddecide","title":"jSurvival 01: Introduction to Survival Analysis for Pathologists","text":"Survival analysis provides time--event data decision trees Hazard ratios inform Markov model transition probabilities Prognostic models support treatment decision algorithms","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-introduction.html","id":"connection-to-jjstatsplot","dir":"Articles","previous_headings":"Integration with Other Modules","what":"Connection to jjstatsplot","title":"jSurvival 01: Introduction to Survival Analysis for Pathologists","text":"Survival curves forest plots enhance presentation Statistical visualization supports survival analysis interpretation Publication-ready graphics survival studies","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-introduction.html","id":"study-design-considerations","dir":"Articles","previous_headings":"Best Practices","what":"Study Design Considerations","title":"jSurvival 01: Introduction to Survival Analysis for Pathologists","text":"Follow-Time: Adequate duration observe events interest Censoring: Understand appropriately handle censored observations Sample Size: Power calculations survival studies Endpoint Definition: Clear, objective, clinically meaningful endpoints Covariate Collection: Comprehensive baseline time-dependent variables","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-introduction.html","id":"statistical-analysis-guidelines","dir":"Articles","previous_headings":"Best Practices","what":"Statistical Analysis Guidelines","title":"jSurvival 01: Introduction to Survival Analysis for Pathologists","text":"Proportional Hazards: Test address violations necessary Model Building: Use principled variable selection approaches Validation: Internal external validation prognostic models Missing Data: Appropriate handling incomplete observations Multiple Testing: Adjust multiple comparisons appropriate","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-introduction.html","id":"reporting-standards","dir":"Articles","previous_headings":"Best Practices","what":"Reporting Standards","title":"jSurvival 01: Introduction to Survival Analysis for Pathologists","text":"STROBE Guidelines: Follow reporting guidelines observational studies Complete Reporting: Include relevant model diagnostics Clinical Interpretation: Translate statistical findings clinical relevance Limitations: Discuss study limitations potential biases Reproducibility: Provide sufficient detail study replication","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-introduction.html","id":"conclusion","dir":"Articles","previous_headings":"","what":"Conclusion","title":"jSurvival 01: Introduction to Survival Analysis for Pathologists","text":"jsurvival provides comprehensive tools modern survival analysis clinical research, basic Kaplan-Meier curves sophisticated prognostic modeling. integration molecular biomarker data ClinicoPath modules makes essential contemporary oncology research precision medicine applications.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-introduction.html","id":"next-steps","dir":"Articles","previous_headings":"Conclusion","what":"Next Steps","title":"jSurvival 01: Introduction to Survival Analysis for Pathologists","text":"explore specific survival analysis techniques: Advanced Methods: See detailed survival analysis vignettes Biomarker Analysis: Explore molecular prognostic factor evaluation Model Development: Learn comprehensive prognostic model building Clinical Applications: Study real-world survival analysis examples introduction provides foundation using jsurvival clinical research. Explore detailed vignettes specific techniques advanced applications.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-multisurvival-time-dependent-comprehensive.html","id":"introduction","dir":"Articles","previous_headings":"","what":"Introduction","title":"Time-Dependent Covariates in Multisurvival Analysis","text":"Time-dependent covariates variables change values course follow-time. clinical research, many important variables can change study period, : Treatment regimens (switching standard experimental therapy) Disease status (remission, progression) Performance status Biomarker levels Comorbidities multisurvival function ClinicoPath now supports time-dependent covariates wide long data formats, making easier analyze survival data covariates change time.","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-multisurvival-time-dependent-comprehensive.html","id":"wide-format","dir":"Articles","previous_headings":"Data Format Options","what":"Wide Format Data","title":"Time-Dependent Covariates in Multisurvival Analysis","text":"wide format, subject one row, time-dependent variables represented separate columns different time points.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-multisurvival-time-dependent-comprehensive.html","id":"example-wide-format-structure","dir":"Articles","previous_headings":"Data Format Options > Wide Format Data","what":"Example Wide Format Structure","title":"Time-Dependent Covariates in Multisurvival Analysis","text":"Wide Format Advantages: - One row per patient (easier understand) - Common format clinical databases - Easy create existing data Wide Format Requirements: - Baseline variables: variable_baseline just variable - Time-specific variables: variable_t6, variable_t12, etc. - Change times specified options","code":"# Example wide format data structure wide_data <- data.frame(   id = 1:3,   age = c(65, 72, 58),   sex = factor(c(\"Male\", \"Female\", \"Male\")),   time = c(24, 18, 30),   status = c(1, 0, 1),      # Baseline treatment (time 0)   treatment_baseline = factor(c(\"Standard\", \"Standard\", \"Experimental\")),      # Treatment at 6 months   treatment_t6 = factor(c(\"Standard\", \"Experimental\", \"Experimental\")),      # Treatment at 12 months     treatment_t12 = factor(c(\"Experimental\", \"Experimental\", \"Stopped\")),      # Treatment at 18 months   treatment_t18 = factor(c(\"Experimental\", \"Stopped\", \"Stopped\")) )  print(wide_data) ##   id age    sex time status treatment_baseline treatment_t6 treatment_t12 ## 1  1  65   Male   24      1           Standard     Standard  Experimental ## 2  2  72 Female   18      0           Standard Experimental  Experimental ## 3  3  58   Male   30      1       Experimental Experimental       Stopped ##   treatment_t18 ## 1  Experimental ## 2       Stopped ## 3       Stopped"},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-multisurvival-time-dependent-comprehensive.html","id":"long-format","dir":"Articles","previous_headings":"Data Format Options","what":"Long Format Data","title":"Time-Dependent Covariates in Multisurvival Analysis","text":"long format, subject can multiple rows, one row time interval covariates remain constant.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-multisurvival-time-dependent-comprehensive.html","id":"example-long-format-structure","dir":"Articles","previous_headings":"Data Format Options > Long Format Data","what":"Example Long Format Structure","title":"Time-Dependent Covariates in Multisurvival Analysis","text":"Long Format Advantages: - flexible complex time patterns - Standard format survival analysis packages - Can handle irregular time intervals Long Format Requirements: - tstart tstop variables time intervals - Status = 1 final interval event occurs - Time-dependent variables change rows","code":"# Example long format data structure   long_data <- data.frame(   id = c(1, 1, 1, 2, 2, 3, 3),   age = c(65, 65, 65, 72, 72, 58, 58),   sex = factor(c(\"Male\", \"Male\", \"Male\", \"Female\", \"Female\", \"Male\", \"Male\")),   tstart = c(0, 6, 12, 0, 6, 0, 12),   tstop = c(6, 12, 24, 6, 18, 12, 30),   status = c(0, 0, 1, 0, 0, 0, 1),   treatment = factor(c(\"Standard\", \"Standard\", \"Experimental\",                        \"Standard\", \"Experimental\", \"Experimental\", \"Stopped\")) )  print(long_data) ##   id age    sex tstart tstop status    treatment ## 1  1  65   Male      0     6      0     Standard ## 2  1  65   Male      6    12      0     Standard ## 3  1  65   Male     12    24      1 Experimental ## 4  2  72 Female      0     6      0     Standard ## 5  2  72 Female      6    18      0 Experimental ## 6  3  58   Male      0    12      0 Experimental ## 7  3  58   Male     12    30      1      Stopped"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-multisurvival-time-dependent-comprehensive.html","id":"basic-wide","dir":"Articles","previous_headings":"Using Time-Dependent Covariates","what":"Basic Wide Format Analysis","title":"Time-Dependent Covariates in Multisurvival Analysis","text":"","code":"library(jsurvival)  # Load example wide format data load(\"test_wide_time_dependent.rda\")  result <- multisurvival(   data = test_wide_time_dependent,   elapsedtime = \"time\",   outcome = \"status\",    outcomeLevel = \"1\",   explanatory = c(\"sex\", \"stage\"),   contexpl = \"age\",      # Time-dependent covariate options   use_time_dependent = TRUE,   td_format = \"wide\",   time_dep_vars = c(\"treatment_baseline\"),  # Base variable name   change_times = \"6, 12, 18\",               # When changes occur   td_suffix_pattern = \"_t{time}\",           # Naming pattern      timetypeoutput = \"months\" )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-multisurvival-time-dependent-comprehensive.html","id":"basic-long","dir":"Articles","previous_headings":"Using Time-Dependent Covariates","what":"Basic Long Format Analysis","title":"Time-Dependent Covariates in Multisurvival Analysis","text":"","code":"# Load example long format data load(\"test_long_time_dependent.rda\")  result <- multisurvival(   data = test_long_time_dependent,      # No elapsedtime needed - using tstart/tstop   outcome = \"status\",   outcomeLevel = \"1\",    explanatory = c(\"sex\", \"stage\"),   contexpl = \"age\",      # Time-dependent covariate options   use_time_dependent = TRUE,   td_format = \"long\",    start_time_var = \"tstart\",   stop_time_var = \"tstop\",   time_dep_vars = c(\"treatment\"),  # Time-varying variable      timetypeoutput = \"months\" )"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-multisurvival-time-dependent-comprehensive.html","id":"multiple-td","dir":"Articles","previous_headings":"Advanced Examples","what":"Multiple Time-Dependent Variables","title":"Time-Dependent Covariates in Multisurvival Analysis","text":"","code":"# Wide format with multiple time-dependent variables result <- multisurvival(   data = clinical_data,   elapsedtime = \"followup_months\",   outcome = \"event_status\",   outcomeLevel = \"Event\",   explanatory = c(\"sex\", \"initial_stage\"),   contexpl = \"baseline_age\",      # Multiple time-dependent variables   use_time_dependent = TRUE,   td_format = \"wide\",   time_dep_vars = c(\"treatment_baseline\", \"ps_baseline\"),  # Multiple variables   change_times = \"3, 6, 12, 18\",           # More frequent assessments   td_suffix_pattern = \"_month{time}\",       # Different naming pattern      # Additional analysis options   calculateRiskScore = TRUE,   numRiskGroups = \"three\",   hr = TRUE )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-multisurvival-time-dependent-comprehensive.html","id":"combined","dir":"Articles","previous_headings":"Advanced Examples","what":"Combining Time-Dependent Covariates with Other Features","title":"Time-Dependent Covariates in Multisurvival Analysis","text":"","code":"# Complex analysis with multiple advanced features result <- multisurvival(   data = oncology_data,   elapsedtime = \"survival_months\",    outcome = \"vital_status\",   outcomeLevel = \"Dead\",   explanatory = c(\"histology\", \"grade\"),   contexpl = c(\"age_at_diagnosis\", \"tumor_size\"),      # Time-dependent covariates   use_time_dependent = TRUE,   td_format = \"wide\",   time_dep_vars = c(\"treatment_baseline\", \"response_baseline\"),   change_times = \"6, 12, 24\",   td_suffix_pattern = \"_m{time}\",      # Frailty model for hospital clustering   use_frailty = TRUE,   frailty_var = \"treatment_center\",   frailty_distribution = \"gamma\",      # Splines for non-proportional hazards   use_splines = TRUE,   spline_vars = \"age_at_diagnosis\",   spline_df = 3,   spline_type = \"pspline\",      # Model selection   use_modelSelection = TRUE,   modelSelection = \"backward\",   selectionCriteria = \"aic\",      # Risk stratification   calculateRiskScore = TRUE,   numRiskGroups = \"four\",   plotRiskGroups = TRUE )"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-multisurvival-time-dependent-comprehensive.html","id":"long-to-wide","dir":"Articles","previous_headings":"Data Preparation Guidelines","what":"Converting Long to Wide Format","title":"Time-Dependent Covariates in Multisurvival Analysis","text":"","code":"# Example conversion from long to wide format library(dplyr) library(tidyr)  # Starting with long format data long_format <- data.frame(   patient_id = c(rep(1, 3), rep(2, 2), rep(3, 4)),   visit_month = c(0, 6, 12, 0, 6, 0, 6, 12, 18),   treatment = c(\"A\", \"A\", \"B\", \"A\", \"B\", \"A\", \"A\", \"A\", \"B\"),   performance_status = c(0, 1, 1, 0, 0, 0, 1, 2, 2) )  # Convert to wide format wide_format <- long_format %>%   pivot_wider(     id_cols = patient_id,     names_from = visit_month,     values_from = c(treatment, performance_status),     names_sep = \"_t\"   ) %>%   # Rename baseline variables   rename(     treatment_baseline = treatment_t0,     ps_baseline = performance_status_t0   )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-multisurvival-time-dependent-comprehensive.html","id":"wide-to-long","dir":"Articles","previous_headings":"Data Preparation Guidelines","what":"Converting Wide to Long Format","title":"Time-Dependent Covariates in Multisurvival Analysis","text":"","code":"# Example conversion from wide to long format wide_data <- data.frame(   id = 1:100,   age = rnorm(100, 65, 10),   sex = factor(sample(c(\"M\", \"F\"), 100, replace = TRUE)),   survival_time = rexp(100, 0.01),   status = rbinom(100, 1, 0.3),   treatment_baseline = factor(sample(c(\"A\", \"B\"), 100, replace = TRUE)),   treatment_t6 = factor(sample(c(\"A\", \"B\", \"C\"), 100, replace = TRUE)),   treatment_t12 = factor(sample(c(\"A\", \"B\", \"C\", \"Stop\"), 100, replace = TRUE)) )  # This conversion would typically be done by the multisurvival function # when td_format = \"wide\" is specified"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-multisurvival-time-dependent-comprehensive.html","id":"cancer-treatment","dir":"Articles","previous_headings":"Clinical Applications","what":"Cancer Treatment Switching","title":"Time-Dependent Covariates in Multisurvival Analysis","text":"Time-dependent covariates particularly useful oncology:","code":"# Analyze impact of treatment switching in cancer patients cancer_analysis <- multisurvival(   data = cancer_cohort,   elapsedtime = \"overall_survival_months\",   outcome = \"death_status\",    outcomeLevel = \"Dead\",   explanatory = c(\"cancer_type\", \"stage_at_diagnosis\"),   contexpl = c(\"age_at_diagnosis\", \"baseline_performance_status\"),      # Treatment changes over time   use_time_dependent = TRUE,   td_format = \"wide\",   time_dep_vars = c(\"primary_treatment_baseline\"),   change_times = \"3, 6, 12, 18, 24\",  # Quarterly assessments   td_suffix_pattern = \"_quarter{time}\",      # Account for treatment center effects   use_frailty = TRUE,   frailty_var = \"treatment_center\",      # Test proportional hazards assumption   ph_cox = TRUE,      # Generate comprehensive outputs   hr = TRUE,   calculateRiskScore = TRUE,   person_time = TRUE )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-multisurvival-time-dependent-comprehensive.html","id":"cardiovascular","dir":"Articles","previous_headings":"Clinical Applications","what":"Cardiovascular Risk Factors","title":"Time-Dependent Covariates in Multisurvival Analysis","text":"","code":"# Analyze changing cardiovascular risk factors cv_analysis <- multisurvival(   data = cardiovascular_study,   tint = TRUE,   dxdate = \"enrollment_date\",   fudate = \"last_contact_date\",   timetypedata = \"ymd\",   timetypeoutput = \"years\",   outcome = \"cv_event\",   outcomeLevel = \"Yes\",   explanatory = c(\"gender\", \"diabetes_baseline\"),   contexpl = c(\"baseline_age\", \"baseline_bmi\"),      # Time-varying medication and lab values   use_time_dependent = TRUE,   td_format = \"wide\",    time_dep_vars = c(\"statin_use_baseline\", \"bp_medication_baseline\"),   change_times = \"0.5, 1, 2, 3, 4, 5\",  # Annual visits   td_suffix_pattern = \"_year{time}\",      # Account for clinic clustering   use_frailty = TRUE,   frailty_var = \"clinic_id\",   frailty_distribution = \"gamma\" )"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-multisurvival-time-dependent-comprehensive.html","id":"td-effects","dir":"Articles","previous_headings":"Interpretation Guidelines","what":"Understanding Time-Dependent Effects","title":"Time-Dependent Covariates in Multisurvival Analysis","text":"interpreting results time-dependent covariates: Hazard Ratios: Represent instantaneous risk given time, accounting current value time-dependent variables. Model Fit: Time-dependent models often fit better static models require data assumptions. Causality: Time-dependent covariates help address time-varying confounding don’t guarantee causal interpretation.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-multisurvival-time-dependent-comprehensive.html","id":"pitfalls","dir":"Articles","previous_headings":"Interpretation Guidelines","what":"Common Pitfalls","title":"Time-Dependent Covariates in Multisurvival Analysis","text":"Immortal Time Bias: Ensure time-dependent variables properly aligned risk periods. Missing Data: Handle missing time-dependent measurements appropriately. Measurement Timing: Consider whether variable changes known time measurement retrospectively.","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-multisurvival-time-dependent-comprehensive.html","id":"wide-requirements","dir":"Articles","previous_headings":"Technical Considerations","what":"Wide Format Requirements","title":"Time-Dependent Covariates in Multisurvival Analysis","text":"Consistent naming pattern time-dependent variables Complete specification change times Baseline values time-dependent variables","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-multisurvival-time-dependent-comprehensive.html","id":"long-requirements","dir":"Articles","previous_headings":"Technical Considerations","what":"Long Format Requirements","title":"Time-Dependent Covariates in Multisurvival Analysis","text":"Proper tstart/tstop intervals gaps Status = 1 final interval events Consistent covariate values within intervals","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-multisurvival-time-dependent-comprehensive.html","id":"performance","dir":"Articles","previous_headings":"Technical Considerations","what":"Performance Considerations","title":"Time-Dependent Covariates in Multisurvival Analysis","text":"Wide format generally faster simple patterns Long format flexible computationally intensive Consider data size choosing format","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-multisurvival-time-dependent-comprehensive.html","id":"integration","dir":"Articles","previous_headings":"","what":"Advanced Features Integration","title":"Time-Dependent Covariates in Multisurvival Analysis","text":"Time-dependent covariates work seamlessly advanced features:","code":"# Comprehensive analysis combining all advanced features comprehensive_analysis <- multisurvival(   data = complex_dataset,   elapsedtime = \"time_to_event\",   outcome = \"event_indicator\",   outcomeLevel = \"1\",   explanatory = c(\"treatment_arm\", \"biomarker_status\"),   contexpl = c(\"age\", \"baseline_score\"),      # Time-dependent covariates   use_time_dependent = TRUE,   td_format = \"wide\",   time_dep_vars = c(\"drug_dose_baseline\", \"toxicity_grade_baseline\"),   change_times = \"4, 8, 12, 16, 20, 24\",      # Frailty for center effects   use_frailty = TRUE,   frailty_var = \"study_center\",   frailty_distribution = \"gamma\",      # Splines for non-linear age effects   use_splines = TRUE,   spline_vars = \"age\",   spline_df = 4,   spline_type = \"ns\",      # Stratification for non-proportional hazards   use_stratify = TRUE,   stratvar = \"biomarker_status\",      # Model selection   use_modelSelection = TRUE,   modelSelection = \"both\",   selectionCriteria = \"aic\",      # Risk assessment   calculateRiskScore = TRUE,   numRiskGroups = \"four\",   plotRiskGroups = TRUE,      # Comprehensive outputs   hr = TRUE,   km = TRUE,   ac = TRUE,   adjexplanatory = \"treatment_arm\",   person_time = TRUE,   ph_cox = TRUE,   showNomogram = TRUE )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-multisurvival-time-dependent-comprehensive.html","id":"conclusion","dir":"Articles","previous_headings":"","what":"Conclusion","title":"Time-Dependent Covariates in Multisurvival Analysis","text":"Time-dependent covariates multisurvival provide powerful tool analyzing survival data important variables change time. support wide long data formats makes functionality accessible researchers working different data structures. Key benefits include: Realistic modeling clinical scenarios treatments patient status change Flexible data input supporting wide long formats Integration advanced survival analysis features Comprehensive output including plots, tables, model diagnostics clinical applications, wide format provides intuitive approach, long format offers maximum flexibility complex time patterns.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/01-multisurvival-time-dependent-comprehensive.html","id":"further-reading","dir":"Articles","previous_headings":"Conclusion","what":"Further Reading","title":"Time-Dependent Covariates in Multisurvival Analysis","text":"Therneau, T.M. Grambsch, P.M. (2000). Modeling Survival Data: Extending Cox Model. Springer. Kleinbaum, D.G. Klein, M. (2012). Survival Analysis: Self-Learning Text. Springer. ClinicoPath package documentation examples.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/02-person-time-analysis.html","id":"introduction","dir":"Articles","previous_headings":"","what":"Introduction","title":"Person-Time Analysis in jsurvival Module","text":"Person-time analysis fundamental concept epidemiology survival analysis accounts varying observation periods study participants. jsurvival module ClinicoPath provides comprehensive person-time calculations incidence rate analysis across survival analysis functions.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/02-person-time-analysis.html","id":"what-is-person-time","dir":"Articles","previous_headings":"Introduction","what":"What is Person-Time?","title":"Person-Time Analysis in jsurvival Module","text":"Person-time represents total observation time contributed participants study risk event interest. Unlike simple participant counts, person-time captures number subjects observation duration, providing accurate denominators rate calculations.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/02-person-time-analysis.html","id":"key-concepts","dir":"Articles","previous_headings":"Introduction > What is Person-Time?","what":"Key Concepts","title":"Person-Time Analysis in jsurvival Module","text":"Total Person-Time: Sum individual follow-periods Incidence Rate: Number events ÷ Total person-time Time Units: Typically expressed person-days, person-months, person-years Censoring: Properly accounts participants leaving study early Varying Follow-: Handles different observation periods participant","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/02-person-time-analysis.html","id":"why-person-time-matters","dir":"Articles","previous_headings":"Introduction > What is Person-Time?","what":"Why Person-Time Matters","title":"Person-Time Analysis in jsurvival Module","text":"Accurate Rate Calculations: Provides proper denominators incidence rates Comparison Across Studies: Enables valid comparisons populations different follow-patterns Adjustment Time: Accounts varying exposure periods survival analysis Kaplan-Meier Foundation: Forms basis survival curve estimation Cox Model Integration: Essential hazard ratio calculations","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/02-person-time-analysis.html","id":"person-time-in-jsurvival-modules","dir":"Articles","previous_headings":"","what":"Person-Time in jsurvival Modules","title":"Person-Time Analysis in jsurvival Module","text":"ClinicoPath jsurvival module includes person-time analysis four key functions:","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/02-person-time-analysis.html","id":"time-interval-calculator","dir":"Articles","previous_headings":"Person-Time in jsurvival Modules","what":"1. Time Interval Calculator","title":"Person-Time Analysis in jsurvival Module","text":"Purpose: Calculate time intervals form basis person-time analysis Features: - Date-based time calculations multiple formats - Person-time concept explanation - Total person-time calculation - Landmark analysis support Usage: Key Outputs: - Time interval summary total person-time - Educational information person-time concepts - Calculated time variables analysis","code":"Analyses → Survival → Data Preparation → Time Interval Calculator"},{"path":"https://www.serdarbalci.com/jsurvival/articles/02-person-time-analysis.html","id":"single-arm-survival","dir":"Articles","previous_headings":"Person-Time in jsurvival Modules","what":"2. Single Arm Survival","title":"Person-Time Analysis in jsurvival Module","text":"Purpose: Analyze survival single cohort person-time metrics Features: - Overall incidence rate calculation - Time-stratified person-time analysis - Confidence intervals using Poisson exact methods - Rate multiplier options (per 100, 1000 person-time units) Usage: Key Outputs: - Person-time analysis table rates confidence intervals - Time-interval stratified analysis - Summary interpretation","code":"Analyses → Survival → ClinicoPath Survival → Single Arm Survival Enable: \"Calculate Person-Time Metrics\""},{"path":"https://www.serdarbalci.com/jsurvival/articles/02-person-time-analysis.html","id":"survival-analysis-univariate","dir":"Articles","previous_headings":"Person-Time in jsurvival Modules","what":"3. Survival Analysis (Univariate)","title":"Person-Time Analysis in jsurvival Module","text":"Purpose: Compare survival groups group-specific person-time analysis Features: - Group-specific person-time calculations - Incidence rate comparisons groups - Time-stratified analysis group - Rate ratio calculations Usage: Key Outputs: - Person-time table group - Group-specific incidence rates - Confidence intervals group - Overall stratified summaries","code":"Analyses → Survival → ClinicoPath Survival → Survival Analysis Enable: \"Calculate Person-Time Metrics\""},{"path":"https://www.serdarbalci.com/jsurvival/articles/02-person-time-analysis.html","id":"multivariable-survival","dir":"Articles","previous_headings":"Person-Time in jsurvival Modules","what":"4. Multivariable Survival","title":"Person-Time Analysis in jsurvival Module","text":"Purpose: Analyze survival multiple covariates person-time adjustment Features: - Overall person-time covariate stratification - Adjusted incidence rates - Person-time summary multiple predictors - Integration Cox model results Usage: Key Outputs: - Overall person-time summary - Stratified person-time covariates - Incidence rates adjusted multiple factors","code":"Analyses → Survival → ClinicoPath Survival → Multivariable Survival Analysis Enable: \"Calculate Person-Time Metrics\""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/02-person-time-analysis.html","id":"step-1-prepare-your-data","dir":"Articles","previous_headings":"Getting Started with Person-Time Analysis","what":"Step 1: Prepare Your Data","title":"Person-Time Analysis in jsurvival Module","text":"dataset include: - Time variable: Follow-duration (numeric) - Event variable: Event indicator (0/1 factor) - Group variables: comparisons (optional) - Date variables: time calculation (optional) Example data structure:","code":"patient_id | followup_months | event | treatment_group | diagnosis_date | last_contact PT0001     | 24.5           | 1     | Standard       | 2020-01-15     | 2022-01-30 PT0002     | 36.2           | 0     | Experimental   | 2020-02-10     | 2023-02-15"},{"path":"https://www.serdarbalci.com/jsurvival/articles/02-person-time-analysis.html","id":"step-2-choose-the-appropriate-analysis","dir":"Articles","previous_headings":"Getting Started with Person-Time Analysis","what":"Step 2: Choose the Appropriate Analysis","title":"Person-Time Analysis in jsurvival Module","text":"Time Interval Calculator: need calculate follow-times dates - Input: Start end dates - Output: Time intervals person-time concepts Single Arm Survival: overall cohort analysis - Input: Time, event variables - Output: Overall incidence rates time-stratified analysis Survival Analysis: group comparisons - Input: Time, event, grouping variables - Output: Group-specific rates comparisons Multivariable Survival: adjusted analysis - Input: Time, event, multiple covariates - Output: Adjusted rates Cox model integration","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/02-person-time-analysis.html","id":"step-3-configure-person-time-options","dir":"Articles","previous_headings":"Getting Started with Person-Time Analysis","what":"Step 3: Configure Person-Time Options","title":"Person-Time Analysis in jsurvival Module","text":"Enable person-time analysis: Check “Calculate Person-Time Metrics” Set time intervals: Specify intervals stratified analysis (e.g., “12, 36, 60”) Choose rate multiplier: Select 100 1000 rate presentation Configure time units: Ensure consistent units throughout","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/02-person-time-analysis.html","id":"person-time-table-columns","dir":"Articles","previous_headings":"Getting Started with Person-Time Analysis > Step 4: Interpret Results","what":"Person-Time Table Columns","title":"Person-Time Analysis in jsurvival Module","text":"Time Interval: Period analyzed (e.g., 0-12 months, 12-36 months) Events: Number events interval Person-Time: Total observation time interval Incidence Rate: Events per person-time unit 95% CI: Confidence interval rate (Poisson exact)","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/02-person-time-analysis.html","id":"key-metrics-to-report","dir":"Articles","previous_headings":"Getting Started with Person-Time Analysis > Step 4: Interpret Results","what":"Key Metrics to Report","title":"Person-Time Analysis in jsurvival Module","text":"Total Person-Time: Overall observation time Overall Incidence Rate: Events per 100 person-time units Time-Specific Rates: Rates different follow-periods Group Comparisons: Rate differences groups Confidence Intervals: Precision rate estimates","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/02-person-time-analysis.html","id":"example-1-cancer-survival-study","dir":"Articles","previous_headings":"Clinical Applications","what":"Example 1: Cancer Survival Study","title":"Person-Time Analysis in jsurvival Module","text":"Scenario: Comparing survival two treatment groups Analysis Setup: - Module: Survival Analysis - Variables: treatment_group, survival_months, death_status - Enable: Person-time metrics Expected Results: - Person-time treatment group - Group-specific incidence rates - Rate ratios treatments - Time-stratified analysis Interpretation:","code":"Standard Treatment: 45 deaths in 2,400 person-months (1.88 per 100 person-months) New Treatment: 32 deaths in 2,200 person-months (1.45 per 100 person-months) Rate Ratio: 0.77 (23% reduction in death rate)"},{"path":"https://www.serdarbalci.com/jsurvival/articles/02-person-time-analysis.html","id":"example-2-epidemiological-cohort-study","dir":"Articles","previous_headings":"Clinical Applications","what":"Example 2: Epidemiological Cohort Study","title":"Person-Time Analysis in jsurvival Module","text":"Scenario: Disease incidence exposed vs. unexposed populations Analysis Setup: - Module: Survival Analysis - Variables: exposure_status, followup_years, disease_onset - Enable: Person-time metrics Expected Results: - Exposure-specific person-time - Incidence rates exposure - Time trends incidence - Rate differences ratios Interpretation:","code":"Exposed Group: 15 cases in 850 person-years (1.76 per 100 person-years) Unexposed Group: 8 cases in 920 person-years (0.87 per 100 person-years) Rate Difference: 0.89 per 100 person-years Relative Risk: 2.03"},{"path":"https://www.serdarbalci.com/jsurvival/articles/02-person-time-analysis.html","id":"example-3-drug-safety-monitoring","dir":"Articles","previous_headings":"Clinical Applications","what":"Example 3: Drug Safety Monitoring","title":"Person-Time Analysis in jsurvival Module","text":"Scenario: Adverse event rates drug therapy Analysis Setup: - Module: Single Arm Survival - Variables: treatment_duration, adverse_event - Enable: Person-time metrics time stratification Expected Results: - Overall adverse event rate - Time-stratified rates (early vs. late) - Confidence intervals safety assessment Interpretation:","code":"Overall Rate: 12 events in 1,500 person-months (0.80 per 100 person-months) 0-6 months: 8 events in 600 person-months (1.33 per 100 person-months) 6+ months: 4 events in 900 person-months (0.44 per 100 person-months) Conclusion: Higher event rate in early treatment period"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/02-person-time-analysis.html","id":"time-stratified-analysis","dir":"Articles","previous_headings":"Advanced Features","what":"Time-Stratified Analysis","title":"Person-Time Analysis in jsurvival Module","text":"Person-time analysis can stratified time intervals detect: - Changing hazards time - Early vs. late event patterns - Treatment effect modifications - Time-dependent risk factors Setup: Specify intervals “Time Interval Stratification” option","code":"Example: \"6, 12, 24\" creates intervals: 0-6, 6-12, 12-24, 24+ months"},{"path":"https://www.serdarbalci.com/jsurvival/articles/02-person-time-analysis.html","id":"rate-multipliers","dir":"Articles","previous_headings":"Advanced Features","what":"Rate Multipliers","title":"Person-Time Analysis in jsurvival Module","text":"Choose appropriate multipliers based event frequency: - Rate per 100 person-time: Common moderate event rates - Rate per 1000 person-time: Useful rare events - Rate per 10,000 person-time: rare events","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/02-person-time-analysis.html","id":"confidence-intervals","dir":"Articles","previous_headings":"Advanced Features","what":"Confidence Intervals","title":"Person-Time Analysis in jsurvival Module","text":"Person-time rates use Poisson exact confidence intervals: - Exact method: Based Poisson distribution event counts - Conservative approach: Provides accurate coverage - Asymmetric intervals: Reflects nature count data","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/02-person-time-analysis.html","id":"integration-with-survival-analysis","dir":"Articles","previous_headings":"Advanced Features","what":"Integration with Survival Analysis","title":"Person-Time Analysis in jsurvival Module","text":"Person-time analysis complements traditional survival methods: - Kaplan-Meier curves: Show survival probability time - Cox regression: Models hazard rates (instantaneous person-time rates) - Log-rank tests: Compare survival distributions - Person-time rates: Provide absolute risk measures","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/02-person-time-analysis.html","id":"data-validation","dir":"Articles","previous_headings":"Quality Assurance","what":"Data Validation","title":"Person-Time Analysis in jsurvival Module","text":"person-time analysis: Check time variables: Ensure positive, numeric values Validate event coding: Confirm 0/1 appropriate factor levels Review missingness: Address missing time event data Assess outliers: Investigate extremely long short follow-times","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/02-person-time-analysis.html","id":"results-interpretation","dir":"Articles","previous_headings":"Quality Assurance","what":"Results Interpretation","title":"Person-Time Analysis in jsurvival Module","text":"reviewing person-time results: Biological plausibility: rates make clinical sense? Confidence intervals: appropriately wide data? Time trends: time-stratified rates show expected patterns? Group differences: rate differences clinically meaningful?","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/02-person-time-analysis.html","id":"issue-1-zero-events-in-intervals","dir":"Articles","previous_headings":"Quality Assurance > Common Issues","what":"Issue 1: Zero Events in Intervals","title":"Person-Time Analysis in jsurvival Module","text":"Problem: time intervals events Solution: Consider combining intervals using exact Poisson methods","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/02-person-time-analysis.html","id":"issue-2-very-unequal-follow-up","dir":"Articles","previous_headings":"Quality Assurance > Common Issues","what":"Issue 2: Very Unequal Follow-up","title":"Person-Time Analysis in jsurvival Module","text":"Problem: Large variation follow-times Solution: Use time-stratified analysis report median follow-","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/02-person-time-analysis.html","id":"issue-3-competing-risks","dir":"Articles","previous_headings":"Quality Assurance > Common Issues","what":"Issue 3: Competing Risks","title":"Person-Time Analysis in jsurvival Module","text":"Problem: Multiple event types affecting person-time Solution: Use competing risks analysis event-specific person-time","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/02-person-time-analysis.html","id":"methods-section","dir":"Articles","previous_headings":"Reporting Person-Time Results","what":"Methods Section","title":"Person-Time Analysis in jsurvival Module","text":"","code":"Person-time analysis was performed to calculate incidence rates accounting  for varying follow-up periods. Total person-time was calculated as the sum  of individual follow-up periods from [entry criteria] to [endpoint definition].  Incidence rates were calculated as the number of events divided by person-time  at risk, expressed per [time unit]. Confidence intervals were calculated using  Poisson exact methods. Time-stratified analysis was performed using intervals  of [specify intervals] to assess for time-varying hazards."},{"path":"https://www.serdarbalci.com/jsurvival/articles/02-person-time-analysis.html","id":"results-section","dir":"Articles","previous_headings":"Reporting Person-Time Results","what":"Results Section","title":"Person-Time Analysis in jsurvival Module","text":"","code":"A total of [N] participants contributed [total person-time] [time units] of  follow-up (median [median], range [range]). [Number] events occurred during  the observation period, yielding an overall incidence rate of [rate] per  [multiplier] [time units] (95% CI: [CI]). Incidence rates differed significantly  between [groups]: [group 1] [rate 1] vs. [group 2] [rate 2] per [multiplier]  [time units] (rate ratio [RR], 95% CI: [CI], p=[p-value])."},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/02-person-time-analysis.html","id":"table-person-time-analysis-results","dir":"Articles","previous_headings":"Reporting Person-Time Results > Tables and Figures","what":"Table: Person-Time Analysis Results","title":"Person-Time Analysis in jsurvival Module","text":"","code":"Group           N    Events   Person-Time   Rate/100 PT   95% CI Control        150    25       4,200        0.60         0.39-0.88 Treatment      145    18       4,150        0.43         0.26-0.68 Total          295    43       8,350        0.51         0.37-0.69"},{"path":"https://www.serdarbalci.com/jsurvival/articles/02-person-time-analysis.html","id":"figure-incidence-rates-by-time-period","dir":"Articles","previous_headings":"Reporting Person-Time Results > Tables and Figures","what":"Figure: Incidence Rates by Time Period","title":"Person-Time Analysis in jsurvival Module","text":"Forest plot showing rates confidence intervals Time-stratified analysis results Group comparisons time","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/02-person-time-analysis.html","id":"conclusion","dir":"Articles","previous_headings":"","what":"Conclusion","title":"Person-Time Analysis in jsurvival Module","text":"Person-time analysis essential proper epidemiological survival analysis. jsurvival module provides comprehensive person-time functionality : Educates users person-time concepts Calculates accurate rates appropriate confidence intervals Enables group comparisons rate ratios differences Supports time-stratified analysis detecting temporal patterns Integrates survival methods comprehensive analysis incorporating person-time analysis survival studies, can: - Provide accurate interpretable results - Enable valid comparisons across studies populations - Better understand temporal patterns data - Meet epidemiological standards rate-based analysis","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/02-person-time-analysis.html","id":"further-resources","dir":"Articles","previous_headings":"Conclusion","what":"Further Resources","title":"Person-Time Analysis in jsurvival Module","text":"ClinicoPath Documentation: Complete module reference Epidemiological Methods: Texts person-time analysis Survival Analysis: Integration traditional survival methods Statistical Software: Comparison implementations questions person-time analysis ClinicoPath, please refer module documentation contact development team.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-clinical-examples.html","id":"overview","dir":"Articles","previous_headings":"","what":"Overview","title":"Clinical Research Examples with jsurvival","text":"vignette provides practical examples using jsurvival common clinical research scenarios. example demonstrates complete workflow data preparation interpretation results.","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-clinical-examples.html","id":"background","dir":"Articles","previous_headings":"Example 1: Cancer Treatment Comparison Study","what":"Background","title":"Clinical Research Examples with jsurvival","text":"clinical trial comparing two cancer treatments (Treatment vs. Treatment B) overall survival primary endpoint.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-clinical-examples.html","id":"research-question","dir":"Articles","previous_headings":"Example 1: Cancer Treatment Comparison Study","what":"Research Question","title":"Clinical Research Examples with jsurvival","text":"significant difference overall survival Treatment Treatment B?","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-clinical-examples.html","id":"data-structure","dir":"Articles","previous_headings":"Example 1: Cancer Treatment Comparison Study","what":"Data Structure","title":"Clinical Research Examples with jsurvival","text":"","code":"# Example data structure cancer_data <- data.frame(   PatientID = 1:200,   Treatment = rep(c(\"Treatment A\", \"Treatment B\"), each = 100),   OS_months = c(rnorm(100, 24, 8), rnorm(100, 30, 10)),   Death = rbinom(200, 1, 0.6),   Age = rnorm(200, 65, 10),   Stage = sample(c(\"I\", \"II\", \"III\", \"IV\"), 200, replace = TRUE),   ECOG = sample(0:2, 200, replace = TRUE) )"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-clinical-examples.html","id":"step-1-single-arm-analysis-overall-population","dir":"Articles","previous_headings":"Example 1: Cancer Treatment Comparison Study > Analysis Steps","what":"Step 1: Single Arm Analysis (Overall Population)","title":"Clinical Research Examples with jsurvival","text":"Interpretation: - Median overall survival entire cohort - 1, 2, 3-year survival rates - 95% confidence intervals estimates","code":"# First, examine overall survival characteristics singlearm_result <- singlearm(   data = cancer_data,   elapsedtime = OS_months,   outcome = Death,   outcomeLevel = \"1\",   cutp = \"12, 24, 36\",   timetypeoutput = \"months\" )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-clinical-examples.html","id":"step-2-treatment-comparison","dir":"Articles","previous_headings":"Example 1: Cancer Treatment Comparison Study > Analysis Steps","what":"Step 2: Treatment Comparison","title":"Clinical Research Examples with jsurvival","text":"Key Outputs: - Log-rank test p-value treatment difference - Hazard ratio comparing Treatment B vs. Treatment - Kaplan-Meier curves risk tables - Median survival times treatment group","code":"# Compare survival between treatments survival_result <- survival(   data = cancer_data,   elapsedtime = OS_months,   outcome = Death,   outcomeLevel = \"1\",   explanatory = Treatment,   analysistype = \"overall\",   ph_cox = TRUE,   ci95 = TRUE,   risktable = TRUE )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-clinical-examples.html","id":"step-3-multivariable-analysis","dir":"Articles","previous_headings":"Example 1: Cancer Treatment Comparison Study > Analysis Steps","what":"Step 3: Multivariable Analysis","title":"Clinical Research Examples with jsurvival","text":"Interpretation: - Adjusted hazard ratio treatment effect - Independent prognostic factors - Model fit statistics (concordance index)","code":"# Adjust for potential confounders multi_result <- multisurvival(   data = cancer_data,   elapsedtime = OS_months,   outcome = Death,   outcomeLevel = \"1\",   explanatory = c(Treatment, Age, Stage, ECOG) )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-clinical-examples.html","id":"clinical-interpretation","dir":"Articles","previous_headings":"Example 1: Cancer Treatment Comparison Study","what":"Clinical Interpretation","title":"Clinical Research Examples with jsurvival","text":"HR = 0.75 (95% CI: 0.60-0.95), p = 0.02: - Treatment B reduces risk death 25% compared Treatment - result statistically significant - confidence interval excludes 1.0, supporting treatment benefit","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-clinical-examples.html","id":"background-1","dir":"Articles","previous_headings":"Example 2: Biomarker Cut-point Analysis","what":"Background","title":"Clinical Research Examples with jsurvival","text":"Investigating whether continuous biomarker can predict patient outcomes finding optimal threshold clinical decision-making.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-clinical-examples.html","id":"research-question-1","dir":"Articles","previous_headings":"Example 2: Biomarker Cut-point Analysis","what":"Research Question","title":"Clinical Research Examples with jsurvival","text":"optimal cut-point Biomarker X predict overall survival?","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-clinical-examples.html","id":"step-1-continuous-variable-analysis","dir":"Articles","previous_headings":"Example 2: Biomarker Cut-point Analysis > Analysis Workflow","what":"Step 1: Continuous Variable Analysis","title":"Clinical Research Examples with jsurvival","text":"Outputs: - Optimal cut-point value - Hazard ratio high vs. low biomarker groups - ROC analysis cut-point validation - Sensitivity specificity optimal cut-point","code":"# Find optimal cut-point for biomarker biomarker_result <- survivalcont(   data = biomarker_data,   elapsedtime = OS_months,   outcome = Death,   outcomeLevel = \"1\",   contexpl = Biomarker_X,   findcut = TRUE,   cutp = \"12, 36, 60\" )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-clinical-examples.html","id":"step-2-validation-analysis","dir":"Articles","previous_headings":"Example 2: Biomarker Cut-point Analysis > Analysis Workflow","what":"Step 2: Validation Analysis","title":"Clinical Research Examples with jsurvival","text":"","code":"# Validate cut-point using dichotomized variable # (Assuming cut-point = 15.2 was identified) biomarker_data$Biomarker_High <- ifelse(biomarker_data$Biomarker_X >= 15.2, \"High\", \"Low\")  validation_result <- survival(   data = biomarker_data,   elapsedtime = OS_months,   outcome = Death,   outcomeLevel = \"1\",   explanatory = Biomarker_High,   ph_cox = TRUE )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-clinical-examples.html","id":"clinical-translation","dir":"Articles","previous_headings":"Example 2: Biomarker Cut-point Analysis","what":"Clinical Translation","title":"Clinical Research Examples with jsurvival","text":"optimal cut-point = 15.2 ng/mL, HR = 2.1 (95% CI: 1.4-3.2): - Patients biomarker ≥15.2 ng/mL 2.1 times higher risk death - threshold used treatment stratification - Consider validation independent cohort","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-clinical-examples.html","id":"background-2","dir":"Articles","previous_headings":"Example 3: Time-to-Event Analysis with Competing Risks","what":"Background","title":"Clinical Research Examples with jsurvival","text":"Studying cancer-specific mortality accounting deaths causes.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-clinical-examples.html","id":"research-question-2","dir":"Articles","previous_headings":"Example 3: Time-to-Event Analysis with Competing Risks","what":"Research Question","title":"Clinical Research Examples with jsurvival","text":"factors predict cancer-specific death, considering -cause mortality competing risk?","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-clinical-examples.html","id":"analysis-approach","dir":"Articles","previous_headings":"Example 3: Time-to-Event Analysis with Competing Risks","what":"Analysis Approach","title":"Clinical Research Examples with jsurvival","text":"Interpretation: - Separate hazard ratios cancer-specific -cause mortality - Treatment effects may differ competing outcomes - Consider cumulative incidence functions formal competing risk analysis","code":"# For competing risks, use cause-specific outcomes # Death_cancer: 1 = cancer death, 0 = alive or other death # Death_other: 1 = other death, 0 = alive or cancer death  # Cancer-specific survival analysis cancer_specific <- survival(   data = competing_data,   elapsedtime = OS_months,   outcome = Death_cancer,   outcomeLevel = \"1\",   explanatory = Treatment,   analysistype = \"overall\",   ph_cox = TRUE )  # Other-cause mortality analysis other_cause <- survival(   data = competing_data,   elapsedtime = OS_months,   outcome = Death_other,   outcomeLevel = \"1\",   explanatory = Treatment,   analysistype = \"overall\",   ph_cox = TRUE )"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-clinical-examples.html","id":"background-3","dir":"Articles","previous_headings":"Example 4: Landmark Analysis","what":"Background","title":"Clinical Research Examples with jsurvival","text":"Addressing guarantee-time bias analyzing post-treatment biomarkers response markers.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-clinical-examples.html","id":"research-question-3","dir":"Articles","previous_headings":"Example 4: Landmark Analysis","what":"Research Question","title":"Clinical Research Examples with jsurvival","text":"tumor response 3 months predict long-term survival?","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-clinical-examples.html","id":"analysis-strategy","dir":"Articles","previous_headings":"Example 4: Landmark Analysis","what":"Analysis Strategy","title":"Clinical Research Examples with jsurvival","text":"Key Points: - includes patients survived landmark time - Eliminates guarantee-time bias - Useful post-treatment predictors","code":"# Create landmark dataset (patients alive at 3 months) landmark_data <- subset(original_data, OS_months > 3 | (OS_months <= 3 & Death == 0))  # Adjust survival times for landmark point landmark_data$OS_months_landmark <- landmark_data$OS_months - 3 landmark_data$OS_months_landmark[landmark_data$OS_months_landmark < 0] <- 0  # Analyze survival from landmark time landmark_result <- survival(   data = landmark_data,   elapsedtime = OS_months_landmark,   outcome = Death,   outcomeLevel = \"1\",   explanatory = Response_3month,   uselandmark = TRUE,   landmark = 3 )"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-clinical-examples.html","id":"background-4","dir":"Articles","previous_headings":"Example 5: Dose-Response Analysis","what":"Background","title":"Clinical Research Examples with jsurvival","text":"Evaluating survival outcomes across different dose levels treatment.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-clinical-examples.html","id":"research-question-4","dir":"Articles","previous_headings":"Example 5: Dose-Response Analysis","what":"Research Question","title":"Clinical Research Examples with jsurvival","text":"dose-response relationship treatment efficacy?","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-clinical-examples.html","id":"step-1-categorical-dose-analysis","dir":"Articles","previous_headings":"Example 5: Dose-Response Analysis > Analysis Steps","what":"Step 1: Categorical Dose Analysis","title":"Clinical Research Examples with jsurvival","text":"","code":"# Treat dose as categorical variable dose_categorical <- survival(   data = dose_data,   elapsedtime = OS_months,   outcome = Death,   outcomeLevel = \"1\",   explanatory = Dose_category,  # Low, Medium, High   analysistype = \"pairwise\",   padjustmethod = \"holm\" )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-clinical-examples.html","id":"step-2-trend-analysis","dir":"Articles","previous_headings":"Example 5: Dose-Response Analysis > Analysis Steps","what":"Step 2: Trend Analysis","title":"Clinical Research Examples with jsurvival","text":"Interpretation: - Test overall dose effect (3-group comparison) - Test linear trend (ordinal dose variable) - HR per dose level increase","code":"# Test for linear trend across dose levels # Create ordinal dose variable (1, 2, 3) dose_data$Dose_ordinal <- as.numeric(factor(dose_data$Dose_category,                                             levels = c(\"Low\", \"Medium\", \"High\")))  trend_result <- survival(   data = dose_data,   elapsedtime = OS_months,   outcome = Death,   outcomeLevel = \"1\",   explanatory = Dose_ordinal,   ph_cox = TRUE )"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-clinical-examples.html","id":"background-5","dir":"Articles","previous_headings":"Example 6: Propensity Score Matching","what":"Background","title":"Clinical Research Examples with jsurvival","text":"Comparing treatments observational data controlling selection bias.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-clinical-examples.html","id":"research-question-5","dir":"Articles","previous_headings":"Example 6: Propensity Score Matching","what":"Research Question","title":"Clinical Research Examples with jsurvival","text":"treatment effect accounting baseline differences groups?","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-clinical-examples.html","id":"analysis-workflow-1","dir":"Articles","previous_headings":"Example 6: Propensity Score Matching","what":"Analysis Workflow","title":"Clinical Research Examples with jsurvival","text":"","code":"# Step 1: Create matched dataset (outside jsurvival) # matched_data <- created using propensity score matching  # Step 2: Analyze matched cohort matched_result <- survival(   data = matched_data,   elapsedtime = OS_months,   outcome = Death,   outcomeLevel = \"1\",   explanatory = Treatment,   analysistype = \"overall\",   ph_cox = TRUE )  # Step 3: Sensitivity analysis with additional adjustment sensitivity_result <- multisurvival(   data = matched_data,   elapsedtime = OS_months,   outcome = Death,   outcomeLevel = \"1\",   explanatory = c(Treatment, remaining_confounders) )"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-clinical-examples.html","id":"essential-elements","dir":"Articles","previous_headings":"Reporting Guidelines","what":"Essential Elements","title":"Clinical Research Examples with jsurvival","text":"Study Design: Clearly describe cohort follow-Sample Size: Total patients, events, median follow-Statistical Methods: Analysis approach software used Median survival 95% CI Hazard ratios 95% CI P-values statistical tests used Kaplan-Meier curves risk tables","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-clinical-examples.html","id":"example-results-section","dir":"Articles","previous_headings":"Reporting Guidelines","what":"Example Results Section","title":"Clinical Research Examples with jsurvival","text":"“Among 200 patients (Treatment : n=100, Treatment B: n=100), 120 deaths median follow-18.5 months (IQR: 12.2-24.8). Median overall survival 22.1 months (95% CI: 18.5-25.8) Treatment versus 28.4 months (95% CI: 24.1-32.7) Treatment B. Treatment B associated 25% reduction risk death compared Treatment (HR=0.75, 95% CI: 0.60-0.95, p=0.02). 2-year survival rates 45% (95% CI: 35-55%) 60% (95% CI: 50-70%) Treatment B, respectively.”","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-clinical-examples.html","id":"figure-legends","dir":"Articles","previous_headings":"Reporting Guidelines","what":"Figure Legends","title":"Clinical Research Examples with jsurvival","text":"“Figure 1. Kaplan-Meier survival curves comparing Treatment versus Treatment B. table shows number patients risk time point. P-value log-rank test. HR: hazard ratio, CI: confidence interval.”","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-clinical-examples.html","id":"pitfall-1-immortal-time-bias","dir":"Articles","previous_headings":"Common Pitfalls and Solutions","what":"Pitfall 1: Immortal Time Bias","title":"Clinical Research Examples with jsurvival","text":"Problem: Including post-baseline events baseline predictors Solution: Use landmark analysis time-dependent covariates","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-clinical-examples.html","id":"pitfall-2-multiple-testing","dir":"Articles","previous_headings":"Common Pitfalls and Solutions","what":"Pitfall 2: Multiple Testing","title":"Clinical Research Examples with jsurvival","text":"Problem: Testing multiple endpoints without adjustment Solution: Use appropriate p-value correction methods","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-clinical-examples.html","id":"pitfall-3-proportional-hazards-violation","dir":"Articles","previous_headings":"Common Pitfalls and Solutions","what":"Pitfall 3: Proportional Hazards Violation","title":"Clinical Research Examples with jsurvival","text":"Problem: HR changes time Solution: Use stratified Cox models time-dependent effects","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-clinical-examples.html","id":"pitfall-4-insufficient-follow-up","dir":"Articles","previous_headings":"Common Pitfalls and Solutions","what":"Pitfall 4: Insufficient Follow-up","title":"Clinical Research Examples with jsurvival","text":"Problem: High censoring rates affect reliability Solution: Report median follow-censoring patterns","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-clinical-examples.html","id":"conclusion","dir":"Articles","previous_headings":"","what":"Conclusion","title":"Clinical Research Examples with jsurvival","text":"examples demonstrate versatility jsurvival clinical research applications. key successful survival analysis : Clear research questions appropriate study design Careful data preparation quality control Appropriate statistical methods research context Comprehensive reporting following established guidelines Clinical interpretation considers statistical practical significance additional support examples, visit jsurvival website ClinicoPath documentation.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-treatment-response.html","id":"introduction","dir":"Articles","previous_headings":"","what":"Introduction","title":"Treatment Response Analysis in Oncology","text":"vignette demonstrates treatment response analysis oncology studies using ClinicoPath functions. Treatment response evaluation crucial assessing therapy effectiveness making clinical decisions.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-treatment-response.html","id":"setup","dir":"Articles","previous_headings":"","what":"Setup","title":"Treatment Response Analysis in Oncology","text":"","code":"library(jsurvival) library(dplyr) library(ggplot2)  # Load treatment response data data(treatmentResponse)  # Display data structure head(treatmentResponse) cat(\"Dataset dimensions:\", dim(treatmentResponse), \"\\n\")"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-treatment-response.html","id":"response-distribution","dir":"Articles","previous_headings":"Basic Response Analysis","what":"Response Distribution","title":"Treatment Response Analysis in Oncology","text":"","code":"# Analyze response categories using basic R if(\"Response\" %in% names(treatmentResponse)) {   cat(\"Response Categories:\\n\")   print(table(treatmentResponse$Response, useNA = \"ifany\")) } else {   cat(\"Available variables in treatmentResponse:\\n\")   print(names(treatmentResponse)) }"},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-treatment-response.html","id":"summary-statistics-by-response-category","dir":"Articles","previous_headings":"Basic Response Analysis","what":"Summary Statistics by Response Category","title":"Treatment Response Analysis in Oncology","text":"","code":"# Basic summary statistics continuous_vars <- names(treatmentResponse)[sapply(treatmentResponse, is.numeric)] cat(\"Continuous variables available:\\n\") print(continuous_vars)  # Example summary if(length(continuous_vars) > 0) {   summary(treatmentResponse[continuous_vars]) }"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-treatment-response.html","id":"cross-tabulation-analysis","dir":"Articles","previous_headings":"Advanced Analysis with ClinicoPath Functions","what":"Cross-tabulation Analysis","title":"Treatment Response Analysis in Oncology","text":"","code":"# Example of proper crosstable usage for treatment response categorical_vars <- names(treatmentResponse)[sapply(treatmentResponse, function(x) is.factor(x) || is.character(x))]  if(length(categorical_vars) >= 2) {   crosstable(     data = treatmentResponse,     vars = categorical_vars[1:2],     group = categorical_vars[1]   ) } else {   cat(\"Cross-tabulation analysis available with appropriate categorical variables\") }"},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-treatment-response.html","id":"data-summary-analysis","dir":"Articles","previous_headings":"Advanced Analysis with ClinicoPath Functions","what":"Data Summary Analysis","title":"Treatment Response Analysis in Oncology","text":"","code":"# Example of proper summarydata usage if(length(continuous_vars) > 0 && length(categorical_vars) > 0) {   summarydata(     data = treatmentResponse,     vars = continuous_vars[1:min(2, length(continuous_vars))],     date_vars = character(0),     grvar = categorical_vars[1]   ) } else {   cat(\"Summary data analysis available with appropriate variables\") }"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-treatment-response.html","id":"waterfall-plot-analysis","dir":"Articles","previous_headings":"Visualization Examples","what":"Waterfall Plot Analysis","title":"Treatment Response Analysis in Oncology","text":"","code":"# Waterfall plot example # Note: Requires specific data structure with PatientID, ResponseVar, TimeVar cat(\"Waterfall Plot Analysis:\\n\") cat(\"- Requires: PatientID, ResponseVar, TimeVar columns\\n\") cat(\"- Shows individual patient treatment responses\\n\") cat(\"- Gold standard for oncology response visualization\\n\\n\")  # Check if required columns exist required_cols <- c(\"PatientID\", \"Response\", \"Month\") available_cols <- intersect(required_cols, names(treatmentResponse)) cat(\"Available required columns:\", paste(available_cols, collapse = \", \"), \"\\n\")  # Example usage (commented out to avoid errors) # waterfall( #   data = treatmentResponse, #   patientID = \"PatientID\", #   responseVar = \"Response\",  #   timeVar = \"Month\" # )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-treatment-response.html","id":"swimmer-plot-analysis","dir":"Articles","previous_headings":"Visualization Examples","what":"Swimmer Plot Analysis","title":"Treatment Response Analysis in Oncology","text":"","code":"# Swimmer plot example cat(\"Swimmer Plot Analysis:\\n\") cat(\"- Shows individual patient timelines\\n\") cat(\"- Displays treatment duration and clinical events\\n\") cat(\"- Useful for tracking patient follow-up\\n\\n\")  # Check data structure for swimmer plots cat(\"For swimmer plots, data should include:\\n\") cat(\"- Patient identifiers\\n\") cat(\"- Treatment start/end times\\n\") cat(\"- Clinical events and timelines\\n\")"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-treatment-response.html","id":"recist-criteria","dir":"Articles","previous_headings":"Response Evaluation Guidelines","what":"RECIST Criteria","title":"Treatment Response Analysis in Oncology","text":"","code":"# RECIST response categories explanation cat(\"RECIST Response Categories:\\n\") cat(\"- Complete Response (CR): Disappearance of all target lesions\\n\") cat(\"- Partial Response (PR): ≥30% decrease in sum of target lesions\\n\") cat(\"- Progressive Disease (PD): ≥20% increase in sum of target lesions\\n\") cat(\"- Stable Disease (SD): Neither PR nor PD criteria met\\n\\n\")  # Check if RECIST categories are present in data recist_cols <- grep(\"RECIST|Response\", names(treatmentResponse), value = TRUE, ignore.case = TRUE) if(length(recist_cols) > 0) {   cat(\"RECIST-related columns found:\", paste(recist_cols, collapse = \", \"), \"\\n\") }"},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-treatment-response.html","id":"statistical-considerations","dir":"Articles","previous_headings":"Response Evaluation Guidelines","what":"Statistical Considerations","title":"Treatment Response Analysis in Oncology","text":"","code":"# Response rate calculations cat(\"Statistical Considerations for Treatment Response:\\n\\n\") cat(\"1. Overall Response Rate (ORR) = (CR + PR) / Total patients\\n\") cat(\"2. Disease Control Rate (DCR) = (CR + PR + SD) / Total patients\\n\") cat(\"3. Confidence intervals should be calculated for response rates\\n\") cat(\"4. Consider stratification by patient characteristics\\n\\n\")  # Example calculation if response data is available if(\"Response\" %in% names(treatmentResponse) || length(recist_cols) > 0) {   cat(\"Response rate analysis can be performed with available data\\n\") } else {   cat(\"Load appropriate response data for rate calculations\\n\") }"},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-treatment-response.html","id":"integration-with-jamovi","dir":"Articles","previous_headings":"","what":"Integration with jamovi","title":"Treatment Response Analysis in Oncology","text":"functions demonstrated vignette available jamovi’s graphical interface: Data Summary: Exploration > ClinicoPath Descriptives > Summary Data Cross-tabulations: Exploration > ClinicoPath Comparisons > Cross Tables Visualization: Specialized plots available ClinicoPath menu jamovi interface provides point--click access specialized oncology analysis tools, making accessible clinical researchers without programming experience.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-treatment-response.html","id":"further-resources","dir":"Articles","previous_headings":"","what":"Further Resources","title":"Treatment Response Analysis in Oncology","text":"Clinical Workflow Vignette: integrating response analysis complete study workflows Visualization Gallery: advanced customization oncology plots Getting Started Guide: basic ClinicoPathDescriptives functionality Individual Function Vignettes: detailed parameter usage examples","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/03-treatment-response.html","id":"best-practices","dir":"Articles","previous_headings":"","what":"Best Practices","title":"Treatment Response Analysis in Oncology","text":"Data Preparation: Ensure consistent response coding across patients Missing Data: Handle missing responses appropriately analysis Time Points: Use consistent assessment time points comparability Quality Control: Validate response assessments resolve discrepancies Statistical Power: Consider sample size requirements detecting response differences","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/04-stage-migration-analysis.html","id":"introduction","dir":"Articles","previous_headings":"","what":"Introduction","title":"Stage Migration Analysis: Understanding the Will Rogers Phenomenon","text":"Rogers phenomenon statistical paradox occurs medicine patients reclassified disease stages due improvements diagnostic technology changes staging criteria. phenomenon gets name humorous quote attributed American humorist Rogers: “Okies left Oklahoma moved California, raised average intelligence level states.” pathology oncology, phenomenon particularly relevant analyzing impact staging system revisions (TNM edition updates) survival outcomes treatment effectiveness.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/04-stage-migration-analysis.html","id":"what-is-the-will-rogers-phenomenon","dir":"Articles","previous_headings":"Introduction","what":"What is the Will Rogers Phenomenon?","title":"Stage Migration Analysis: Understanding the Will Rogers Phenomenon","text":"Rogers phenomenon describes situation : Stage Migration Occurs: Patients reclassified different disease stages due improved diagnostic methods revised staging criteria. Apparent Improvement: reclassification leads apparent improvements stage-specific outcomes without actual improvement individual patient outcomes. Statistical Paradox: stages appear improved survival rates, overall survival remains unchanged.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/04-stage-migration-analysis.html","id":"clinical-example","dir":"Articles","previous_headings":"Introduction > What is the Will Rogers Phenomenon?","what":"Clinical Example","title":"Stage Migration Analysis: Understanding the Will Rogers Phenomenon","text":"Consider lung cancer staging TNM 7th 8th editions: Original System (7th Edition): patient 3.5cm tumor 2 positive lymph nodes classified Stage II New System (8th Edition): patient now classified Stage IIB due refined criteria patient better survival average Stage II patient worse survival average Stage IIB patient: Stage II survival improves (worst patients removed) Stage IIB survival improves (relatively good patients added) patient’s actual prognosis hasn’t changed","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/04-stage-migration-analysis.html","id":"the-stage-migration-analysis-module","dir":"Articles","previous_headings":"Introduction","what":"The Stage Migration Analysis Module","title":"Stage Migration Analysis: Understanding the Will Rogers Phenomenon","text":"Stage Migration Analysis module ClinicoPath helps : Quantify stage migration different staging systems Compare prognostic performance old vs. new staging systems Visualize migration patterns using flow diagrams Detect Rogers phenomenon statistical analysis Evaluate staging system improvements objectively","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/04-stage-migration-analysis.html","id":"required-data","dir":"Articles","previous_headings":"Getting Started","what":"Required Data","title":"Stage Migration Analysis: Understanding the Will Rogers Phenomenon","text":"perform stage migration analysis, need: Patient identifiers Original staging variable (e.g., TNM 7th edition stages) New staging variable (e.g., TNM 8th edition stages) Survival time (consistent units: months, years) Event indicator (death, progression, etc.)","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/04-stage-migration-analysis.html","id":"data-format","dir":"Articles","previous_headings":"Getting Started","what":"Data Format","title":"Stage Migration Analysis: Understanding the Will Rogers Phenomenon","text":"data look like :","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/04-stage-migration-analysis.html","id":"loading-your-data","dir":"Articles","previous_headings":"Getting Started","what":"Loading Your Data","title":"Stage Migration Analysis: Understanding the Will Rogers Phenomenon","text":"Import dataset jamovi (CSV, Excel, SPSS, etc.) Ensure staging variables factors appropriate level ordering Check survival time numeric consistent units Verify event variable either 0/1 (numeric) Alive/Dead (factor)","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/04-stage-migration-analysis.html","id":"step-1-access-the-module","dir":"Articles","previous_headings":"Using the Stage Migration Analysis Module","what":"Step 1: Access the Module","title":"Stage Migration Analysis: Understanding the Will Rogers Phenomenon","text":"Navigate Analyses → SurvivalD → ClinicoPath Survival Select Stage Migration Analysis","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/04-stage-migration-analysis.html","id":"required-variables","dir":"Articles","previous_headings":"Using the Stage Migration Analysis Module > Step 2: Variable Selection","what":"Required Variables","title":"Stage Migration Analysis: Understanding the Will Rogers Phenomenon","text":"Must factor variable Example: tnm_7th_edition, old_stage Must factor variable Example: tnm_8th_edition, new_stage Must numeric consistent units (months, years) Example: survival_months, follow_up_time Can numeric (0/1) factor (Alive/Dead) Example: event, vital_status Example: “Deceased”, “Dead”, “Event”","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/04-stage-migration-analysis.html","id":"plot-options","dir":"Articles","previous_headings":"Using the Stage Migration Analysis Module > Step 3: Configure Analysis Options","what":"Plot Options","title":"Stage Migration Analysis: Understanding the Will Rogers Phenomenon","text":"Recommended: Enabled visual understanding Separate plots: Shows full Kaplan-Meier plots staging system Side side: Focuses direct stage comparisons Recommended formal presentations","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/04-stage-migration-analysis.html","id":"analysis-options","dir":"Articles","previous_headings":"Using the Stage Migration Analysis Module > Step 3: Configure Analysis Options","what":"Analysis Options","title":"Stage Migration Analysis: Understanding the Will Rogers Phenomenon","text":"Recommended: Enabled comprehensive analysis Compares survival within stages migrated vs. non-migrated patients","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/04-stage-migration-analysis.html","id":"step-4-interpret-results","dir":"Articles","previous_headings":"Using the Stage Migration Analysis Module","what":"Step 4: Interpret Results","title":"Stage Migration Analysis: Understanding the Will Rogers Phenomenon","text":"analysis produces several key outputs:","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/04-stage-migration-analysis.html","id":"migration-summary-table","dir":"Articles","previous_headings":"Using the Stage Migration Analysis Module > Step 4: Interpret Results","what":"Migration Summary Table","title":"Stage Migration Analysis: Understanding the Will Rogers Phenomenon","text":"Key Metrics: - Total patients: Overall sample size - Unchanged stage: Number patients remaining stage - Stage migration (%): Percentage patients changed stages - Upstaging (%): Percentage moved higher stages - Downstaging (%): Percentage moved lower stages - Chi-square: Statistical test association staging systems Interpretation: - Migration rates >20% indicate substantial staging changes - Significant chi-square suggests non-random migration patterns - Balance upstaging vs. downstaging reveals revision direction","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/04-stage-migration-analysis.html","id":"stage-distribution-comparison","dir":"Articles","previous_headings":"Using the Stage Migration Analysis Module > Step 4: Interpret Results","what":"Stage Distribution Comparison","title":"Stage Migration Analysis: Understanding the Will Rogers Phenomenon","text":"Shows patient distribution changes staging systems: Columns: - Stage: Individual stage categories - Original Count/%): Distribution original system - New Count/(%): Distribution new system - Change: Percentage point change Interpretation: - Large changes indicate major revision impact - Shifts toward early/late stages reveal staging drift - Balanced changes suggest refinement rather systematic bias","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/04-stage-migration-analysis.html","id":"stage-migration-matrix","dir":"Articles","previous_headings":"Using the Stage Migration Analysis Module > Step 4: Interpret Results","what":"Stage Migration Matrix","title":"Stage Migration Analysis: Understanding the Will Rogers Phenomenon","text":"Cross-tabulation showing exact patient flow stages: Features: - Rows: Original staging system - Columns: New staging system - Values: Patient counts percentages Interpretation: - Diagonal elements: Patients remaining equivalent stages - -diagonal elements: Migration patterns - High -diagonal values indicate significant reclassification","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/04-stage-migration-analysis.html","id":"prognostic-performance-comparison","dir":"Articles","previous_headings":"Using the Stage Migration Analysis Module > Step 4: Interpret Results","what":"Prognostic Performance Comparison","title":"Stage Migration Analysis: Understanding the Will Rogers Phenomenon","text":"Compares discriminative ability staging systems: Metrics: - C-index (Harrell’s): Measures discriminative ability (0.5 = random, 1.0 = perfect) - Log-rank test: Tests survival differences within system - AIC: Model quality measure (lower better) Interpretation: - C-index improvement >0.02 clinically meaningful - Lower AIC new system suggests better model fit - Stronger log-rank statistics indicate better stage separation","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/04-stage-migration-analysis.html","id":"will-rogers-phenomenon-analysis","dir":"Articles","previous_headings":"Using the Stage Migration Analysis Module > Step 4: Interpret Results","what":"Will Rogers Phenomenon Analysis","title":"Stage Migration Analysis: Understanding the Will Rogers Phenomenon","text":"Identifies evidence phenomenon comparing survival within stages: Columns: - Stage: Original stage analyzed - Unchanged N: Patients remaining stage - Unchanged Median: Median survival unchanged patients - Migrated N: Patients moving different stages - Migrated Median: Median survival migrated patients - p-value: Test comparing unchanged vs. migrated survival Interpretation: - Significant p-values indicate Rogers phenomenon - Different median survivals groups confirm effect - Multiple significant stages suggest systematic migration bias","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/04-stage-migration-analysis.html","id":"migration-flow-plot","dir":"Articles","previous_headings":"Using the Stage Migration Analysis Module > Step 5: Visual Interpretation","what":"Migration Flow Plot","title":"Stage Migration Analysis: Understanding the Will Rogers Phenomenon","text":"alluvial/Sankey diagram visualizes patient flow: Elements: - Left axis: Original staging system - Right axis: New staging system - Flow bands: Patient migration pathways - Band thickness: Proportional patient numbers Interpretation: - Thick diagonal flows indicate stage stability - Curved flows show migration patterns - Complex flow patterns suggest major revision impact","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/04-stage-migration-analysis.html","id":"survival-comparison-plots","dir":"Articles","previous_headings":"Using the Stage Migration Analysis Module > Step 5: Visual Interpretation","what":"Survival Comparison Plots","title":"Stage Migration Analysis: Understanding the Will Rogers Phenomenon","text":"Kaplan-Meier curves staging system: Features: - Separate plots: Full survival curves system - Side--side: Direct comparison equivalent stages - Confidence intervals: Statistical uncertainty bounds Interpretation: - Better curve separation indicates improved discrimination - Crossing curves suggest staging inconsistencies - Similar overall survival confirms unchanged patient outcomes","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/04-stage-migration-analysis.html","id":"concordance-index-plot","dir":"Articles","previous_headings":"Using the Stage Migration Analysis Module > Step 5: Visual Interpretation","what":"Concordance Index Plot","title":"Stage Migration Analysis: Understanding the Will Rogers Phenomenon","text":"Bar chart comparing discriminative performance: Elements: - Original System: C-index original staging - New System: C-index new staging - Improvement: Absolute percentage change Interpretation: - Higher bars indicate better discrimination - Positive improvement suggests staging enhancement - Magnitude reflects clinical significance","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/04-stage-migration-analysis.html","id":"use-case-1-tnm-staging-revision-impact","dir":"Articles","previous_headings":"Clinical Applications","what":"Use Case 1: TNM Staging Revision Impact","title":"Stage Migration Analysis: Understanding the Will Rogers Phenomenon","text":"Scenario: Evaluate impact TNM 8th edition lung cancer staging Analysis Steps: 1. Load dataset TNM 7th 8th edition stages 2. Set “tnm_7th” original stage, “tnm_8th” new stage 3. Use overall survival endpoint 4. Enable Rogers analysis Expected Findings: - Migration rate 25-40% lung cancer - Improved C-index 8th edition (typically +0.02 +0.05) - Evidence Rogers phenomenon Stage II/III patients - Better survival separation new system","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/04-stage-migration-analysis.html","id":"use-case-2-institutional-staging-consistency","dir":"Articles","previous_headings":"Clinical Applications","what":"Use Case 2: Institutional Staging Consistency","title":"Stage Migration Analysis: Understanding the Will Rogers Phenomenon","text":"Scenario: Compare staging different time periods Analysis Steps: 1. Create “era” variable (e.g., 2010-2015 vs. 2016-2020) 2. Compare staging distributions across eras 3. Assess staging drift improvement Expected Findings: - Temporal changes stage distribution - Improved prognostic performance time - Evidence stage migration due better imaging","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/04-stage-migration-analysis.html","id":"use-case-3-pathology-subspecialty-analysis","dir":"Articles","previous_headings":"Clinical Applications","what":"Use Case 3: Pathology Subspecialty Analysis","title":"Stage Migration Analysis: Understanding the Will Rogers Phenomenon","text":"Scenario: Evaluate impact subspecialist review staging Analysis Steps: 1. Compare initial staging vs. subspecialist review 2. Focus difficult cases borderline stages 3. Assess survival impact reclassification Expected Findings: - Systematic upstaging downstaging patterns - Improved prognostic accuracy - Clinical impact subspecialist expertise","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/04-stage-migration-analysis.html","id":"sample-size-considerations","dir":"Articles","previous_headings":"Advanced Analysis Tips","what":"Sample Size Considerations","title":"Stage Migration Analysis: Understanding the Will Rogers Phenomenon","text":"Minimum: 100 patients adequate follow-Recommended: 200+ patients robust Rogers analysis Power: Consider event rate median follow-time","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/04-stage-migration-analysis.html","id":"statistical-considerations","dir":"Articles","previous_headings":"Advanced Analysis Tips","what":"Statistical Considerations","title":"Stage Migration Analysis: Understanding the Will Rogers Phenomenon","text":"Censoring: Ensure adequate follow-staging systems Competing Risks: Consider disease-specific vs. overall survival Time Bias: Account temporal changes treatment Institution Bias: Consider multi-institutional validation","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/04-stage-migration-analysis.html","id":"evidence-of-will-rogers-phenomenon","dir":"Articles","previous_headings":"Advanced Analysis Tips > Interpretation Guidelines","what":"Evidence of Will Rogers Phenomenon","title":"Stage Migration Analysis: Understanding the Will Rogers Phenomenon","text":"Strong Evidence: - Migration rate >30% - Multiple stages significant Rogers tests - Improved stage-specific survival without overall improvement - C-index improvement primarily redistribution Weak Evidence: - Migration rate <15% - significant Rogers tests - Genuine improvement C-index - Overall survival improvement","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/04-stage-migration-analysis.html","id":"clinical-significance","dir":"Articles","previous_headings":"Advanced Analysis Tips > Interpretation Guidelines","what":"Clinical Significance","title":"Stage Migration Analysis: Understanding the Will Rogers Phenomenon","text":"Clinically Meaningful Changes: - C-index improvement >0.02 - Stage migration affecting >20% patients - Survival differences >6 months systems - Impact treatment decision thresholds","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/04-stage-migration-analysis.html","id":"data-validation","dir":"Articles","previous_headings":"Advanced Analysis Tips > Quality Assurance","what":"Data Validation","title":"Stage Migration Analysis: Understanding the Will Rogers Phenomenon","text":"Staging Accuracy: Verify staging systems use criteria Missing Data: Assess pattern impact missing stages Follow-Adequacy: Ensure sufficient events follow-Covariate Balance: Check confounding variables","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/04-stage-migration-analysis.html","id":"results-validation","dir":"Articles","previous_headings":"Advanced Analysis Tips > Quality Assurance","what":"Results Validation","title":"Stage Migration Analysis: Understanding the Will Rogers Phenomenon","text":"External Validation: Test findings independent cohort Sensitivity Analysis: Test robustness assumptions Clinical Review: Confirm findings make clinical sense Literature Comparison: Compare published staging studies","code":""},{"path":[]},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/04-stage-migration-analysis.html","id":"methods-section","dir":"Articles","previous_headings":"Reporting Results > Key Elements to Include","what":"Methods Section","title":"Stage Migration Analysis: Understanding the Will Rogers Phenomenon","text":"","code":"Stage migration analysis was performed using the ClinicoPath module in jamovi.  Patients were classified according to both [original system] and [new system]  staging criteria. Migration patterns were quantified using cross-tabulation  and chi-square tests. Prognostic performance was compared using Harrell's  C-index and log-rank tests. The Will Rogers phenomenon was assessed by  comparing survival between patients who remained in the same stage versus  those who migrated to different stages."},{"path":"https://www.serdarbalci.com/jsurvival/articles/04-stage-migration-analysis.html","id":"results-section","dir":"Articles","previous_headings":"Reporting Results > Key Elements to Include","what":"Results Section","title":"Stage Migration Analysis: Understanding the Will Rogers Phenomenon","text":"","code":"Of [N] patients analyzed, [X]% experienced stage migration between the  [original] and [new] staging systems (p<0.001). The C-index improved from  [old C-index] to [new C-index] (improvement: +[change], [%] increase).  Evidence of the Will Rogers phenomenon was observed in [N] stages, with  significant survival differences between migrated and non-migrated patients  (p<0.05). Migration predominantly involved [describe pattern]."},{"path":"https://www.serdarbalci.com/jsurvival/articles/04-stage-migration-analysis.html","id":"visual-presentation","dir":"Articles","previous_headings":"Reporting Results > Key Elements to Include","what":"Visual Presentation","title":"Stage Migration Analysis: Understanding the Will Rogers Phenomenon","text":"Migration flow diagram showing patient pathways Side--side survival curves key stages C-index comparison bar chart Rogers analysis table significant stages","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/04-stage-migration-analysis.html","id":"analytical-pitfalls","dir":"Articles","previous_headings":"Reporting Results > Common Pitfalls","what":"Analytical Pitfalls","title":"Stage Migration Analysis: Understanding the Will Rogers Phenomenon","text":"Insufficient Follow-: Premature analysis inadequate follow-Selection Bias: Non-representative patient population Temporal Confounding: Changes treatment concurrent staging Multiple Testing: adjusting multiple comparisons","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/04-stage-migration-analysis.html","id":"interpretation-pitfalls","dir":"Articles","previous_headings":"Reporting Results > Common Pitfalls","what":"Interpretation Pitfalls","title":"Stage Migration Analysis: Understanding the Will Rogers Phenomenon","text":"Causation vs. Association: Assuming staging changes cause outcome improvements Clinical vs. Statistical: Overinterpreting small significant changes Generalizability: Extrapolating single-institution findings Complexity: -interpreting complex migration patterns","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/04-stage-migration-analysis.html","id":"conclusion","dir":"Articles","previous_headings":"","what":"Conclusion","title":"Stage Migration Analysis: Understanding the Will Rogers Phenomenon","text":"Stage Migration Analysis module provides comprehensive tools understanding impact staging system changes clinical outcomes. systematically analyzing migration patterns, prognostic performance, Rogers phenomenon, researchers clinicians can: Objectively evaluate staging system revisions Detect statistical artifacts may mislead clinical interpretation Quantify improvements prognostic discrimination Guide clinical practice based evidence-based staging analysis Understanding stage migration crucial proper interpretation cancer outcomes research making informed decisions staging system adoption clinical practice.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/04-stage-migration-analysis.html","id":"further-resources","dir":"Articles","previous_headings":"Conclusion","what":"Further Resources","title":"Stage Migration Analysis: Understanding the Will Rogers Phenomenon","text":"ClinicoPath Documentation: Comprehensive module reference TNM Classification Guidelines: Official staging criteria Survival Analysis Methods: Statistical background methods Rogers Literature: Published examples methodological papers questions support, please refer ClinicoPath documentation contact development team.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-jamovi-workflow.html","id":"overview","dir":"Articles","previous_headings":"","what":"Overview","title":"Using jsurvival in jamovi: Complete Workflow","text":"vignette demonstrates use jsurvival module within jamovi comprehensive survival analysis. jsurvival module part ClinicoPath suite provides user-friendly interface conducting survival analyses without programming.","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-jamovi-workflow.html","id":"option-1-jamovi-library-recommended","dir":"Articles","previous_headings":"Installation in jamovi","what":"Option 1: jamovi Library (Recommended)","title":"Using jsurvival in jamovi: Complete Workflow","text":"Open jamovi Click + button top-right corner Select jamovi library Search “ClinicoPath” “jsurvival” Click Install","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-jamovi-workflow.html","id":"option-2-manual-installation","dir":"Articles","previous_headings":"Installation in jamovi","what":"Option 2: Manual Installation","title":"Using jsurvival in jamovi: Complete Workflow","text":"Download latest .jmo file releases Open jamovi Click + → Sideload → Select .jmo file","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-jamovi-workflow.html","id":"required-variables","dir":"Articles","previous_headings":"Data Preparation","what":"Required Variables","title":"Using jsurvival in jamovi: Complete Workflow","text":"survival analysis, need minimum: Time variable: Time start study event censoring Event indicator: Binary variable indicating whether event occurred (1 = event, 0 = censored)","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-jamovi-workflow.html","id":"optional-variables","dir":"Articles","previous_headings":"Data Preparation","what":"Optional Variables","title":"Using jsurvival in jamovi: Complete Workflow","text":"Grouping factors: Categorical variables group comparisons Continuous predictors: Variables cut-point analysis Multiple explanatory variables: multivariable analysis","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-jamovi-workflow.html","id":"example-data-structure","dir":"Articles","previous_headings":"Data Preparation","what":"Example Data Structure","title":"Using jsurvival in jamovi: Complete Workflow","text":"","code":"Patient_ID | Time_months | Death | Treatment | Age | Grade 1          | 24.5        | 1     | A         | 65  | High 2          | 36.2        | 0     | B         | 58  | Low 3          | 12.1        | 1     | A         | 72  | High"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-jamovi-workflow.html","id":"single-arm-survival-analysis","dir":"Articles","previous_headings":"Analysis Workflows","what":"1. Single Arm Survival Analysis","title":"Using jsurvival in jamovi: Complete Workflow","text":"Use case: Overall survival characteristics entire study population Steps: 1. Navigate Survival → ClinicoPath Survival → Single Arm Survival 2. Assign variables: - Time Elapsed: time variable - Outcome: event indicator - Outcome Level: Select level indicates event (usually “1”) 3. Configure options: - Cut Points: Time points survival estimates (e.g., “12, 36, 60” 1, 3, 5 years) - Time Type Output: Choose months years - Confidence Intervals: Enable 95% CI - Risk Table: Show numbers risk 4. Click Run Output includes: - Overall survival curve - Median survival time 95% CI - Survival rates specified time points - Natural language summary","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-jamovi-workflow.html","id":"survival-analysis-group-comparisons","dir":"Articles","previous_headings":"Analysis Workflows","what":"2. Survival Analysis (Group Comparisons)","title":"Using jsurvival in jamovi: Complete Workflow","text":"Use case: Compare survival different groups Steps: 1. Navigate Survival → ClinicoPath Survival → Survival Analysis 2. Assign variables: - Time Elapsed: time variable - Explanatory: Grouping variable (e.g., treatment, stage) - Outcome: event indicator - Outcome Level: Event level 3. Configure analysis: - Analysis Type: Choose overall, pairwise, combination - P-value Adjustment: Method multiple comparisons - Proportional Hazards: Enable Cox regression 4. Plotting options: - Risk Table: Show numbers risk - Censored Points: Mark censored observations - Confidence Intervals: Display CI bands - End Plot: Set maximum time plot Output includes: - Kaplan-Meier curves group - Log-rank test results - Cox regression hazard ratios - Pairwise comparisons (selected) - Survival tables group","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-jamovi-workflow.html","id":"continuous-variable-survival-analysis","dir":"Articles","previous_headings":"Analysis Workflows","what":"3. Continuous Variable Survival Analysis","title":"Using jsurvival in jamovi: Complete Workflow","text":"Use case: Find optimal cut-point continuous biomarker Steps: 1. Navigate Survival → ClinicoPath Survival → Survival Analysis Continuous Variable 2. Assign variables: - Time Elapsed: time variable - Continuous Explanatory: continuous predictor - Outcome: event indicator 3. Cut-point options: - Find Cut-point: Let algorithm find optimal threshold - Manual Cut-point: Specify threshold 4. Configure analysis similar group comparisons Output includes: - Optimal cut-point determination - Survival curves high/low groups - Hazard ratio dichotomized variable - ROC analysis cut-point validation","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-jamovi-workflow.html","id":"multivariable-survival-analysis","dir":"Articles","previous_headings":"Analysis Workflows","what":"4. Multivariable Survival Analysis","title":"Using jsurvival in jamovi: Complete Workflow","text":"Use case: Adjust multiple risk factors simultaneously Steps: 1. Navigate Survival → ClinicoPath Survival → Multivariable Survival Analysis 2. Assign variables: - Time Elapsed: time variable - Explanatory: Multiple explanatory variables - Outcome: event indicator 3. Model options: - Model Type: Choose Cox proportional hazards - Variable Selection: Manual automated selection - Interaction Terms: Include interactions needed Output includes: - Multivariable Cox regression table - Adjusted hazard ratios 95% CI - Model fit statistics - Adjusted survival curves","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-jamovi-workflow.html","id":"odds-ratio-analysis","dir":"Articles","previous_headings":"Analysis Workflows","what":"5. Odds Ratio Analysis","title":"Using jsurvival in jamovi: Complete Workflow","text":"Use case: Binary outcome analysis (case-control studies) Steps: 1. Navigate Survival → ClinicoPath Survival → Odds Ratio Table Plot 2. Assign variables: - Outcome: Binary outcome variable - Explanatory: Risk factors 3. Configure: - Reference Level: Choose reference category - Confidence Level: Usually 95% Output includes: - Odds ratio table - Forest plot - Chi-square test results","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-jamovi-workflow.html","id":"time-interval-calculator","dir":"Articles","previous_headings":"Analysis Workflows","what":"6. Time Interval Calculator","title":"Using jsurvival in jamovi: Complete Workflow","text":"Use case: Calculate time differences dates Steps: 1. Navigate Survival → Data Preparation → Time Interval Calculator 2. Assign variables: - Start Date: Beginning date - End Date: End date follow-date 3. Options: - Output Unit: Days, months, years - Handle Missing: treat missing dates","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-jamovi-workflow.html","id":"kaplan-meier-curves","dir":"Articles","previous_headings":"Interpretation Guidelines","what":"Kaplan-Meier Curves","title":"Using jsurvival in jamovi: Complete Workflow","text":"Steep drops: High event rate specific times Flat portions: Low event rate (good prognosis periods) Wide confidence intervals: High uncertainty due small sample size Crossing curves: Proportional hazards assumption may violated","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-jamovi-workflow.html","id":"statistical-tests","dir":"Articles","previous_headings":"Interpretation Guidelines","what":"Statistical Tests","title":"Using jsurvival in jamovi: Complete Workflow","text":"Log-rank test: Compares overall survival distributions p < 0.05: Statistically significant difference groups Hazard Ratio > 1: Increased risk event Hazard Ratio < 1: Decreased risk event (protective factor)","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-jamovi-workflow.html","id":"clinical-interpretation","dir":"Articles","previous_headings":"Interpretation Guidelines","what":"Clinical Interpretation","title":"Using jsurvival in jamovi: Complete Workflow","text":"Median survival: Time 50% subjects experienced event 5-year survival rate: Percentage alive 5 years Confidence intervals: Uncertainty range around estimates Numbers risk: Sample size remaining time point","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-jamovi-workflow.html","id":"data-quality","dir":"Articles","previous_headings":"Best Practices","what":"Data Quality","title":"Using jsurvival in jamovi: Complete Workflow","text":"Check data completeness: Missing time event data Validate event coding: Ensure consistent coding (0/1 /Yes) Review follow-times: Check unrealistic negative times Assess censoring pattern: High censoring rates may bias results","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-jamovi-workflow.html","id":"analysis-considerations","dir":"Articles","previous_headings":"Best Practices","what":"Analysis Considerations","title":"Using jsurvival in jamovi: Complete Workflow","text":"Sample size: Minimum 10 events per variable Cox regression Proportional hazards: Check assumption using Schoenfeld residuals Multiple comparisons: Adjust p-values testing multiple groups Clinical relevance: Statistical significance vs. clinical importance","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-jamovi-workflow.html","id":"reporting","dir":"Articles","previous_headings":"Best Practices","what":"Reporting","title":"Using jsurvival in jamovi: Complete Workflow","text":"CONSORT guidelines: Follow reporting standards survival studies Number risk tables: Always include survival plots Confidence intervals: Report alongside point estimates Effect sizes: Focus hazard ratios median survival differences","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-jamovi-workflow.html","id":"common-issues","dir":"Articles","previous_headings":"Troubleshooting","what":"Common Issues","title":"Using jsurvival in jamovi: Complete Workflow","text":"“events observed”: Check event coding follow-time “Convergence failed”: May indicate separation small sample size “Proportional hazards violated”: Consider stratified Cox model Missing survival curves: Check variable assignments data types","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-jamovi-workflow.html","id":"getting-help","dir":"Articles","previous_headings":"Troubleshooting","what":"Getting Help","title":"Using jsurvival in jamovi: Complete Workflow","text":"Documentation: Visit jsurvival website Issues: Report bugs GitHub Issues Contact: serdarbalci@serdarbalci.com","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-jamovi-workflow.html","id":"further-reading","dir":"Articles","previous_headings":"","what":"Further Reading","title":"Using jsurvival in jamovi: Complete Workflow","text":"Survival Analysis R Tutorial ClinicoPath Documentation jamovi User Guide","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"introduction","dir":"Articles","previous_headings":"","what":"Introduction","title":"Treatment Pathway Visualization with alluvialSurvival","text":"alluvialSurvival() function ClinicoPath provides specialized visualization patient treatment pathways time, combining alluvial diagrams survival analysis. tool particularly valuable understanding patients move different disease stages treatments, ability incorporate survival outcomes. Unlike static cross-sectional analyses, alluvial survival plots reveal dynamic nature patient care, showing: - Disease progression stage migrations - Treatment sequence patterns - Patient flow different therapeutic interventions - Survival outcomes associated different pathways vignette demonstrates features alluvialSurvival function using real clinical datasets.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"loading-required-libraries-and-data","dir":"Articles","previous_headings":"","what":"Loading Required Libraries and Data","title":"Treatment Pathway Visualization with alluvialSurvival","text":"","code":"library(jsurvival)  # Load the treatment pathways dataset data(\"treatment_pathways\")  # Preview the data structure str(treatment_pathways) head(treatment_pathways)"},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"data-requirements","dir":"Articles","previous_headings":"","what":"Data Requirements","title":"Treatment Pathway Visualization with alluvialSurvival","text":"alluvialSurvival function requires longitudinal data specific structure:","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"required-variables","dir":"Articles","previous_headings":"Data Requirements","what":"Required Variables:","title":"Treatment Pathway Visualization with alluvialSurvival","text":"Time Variable: Numeric time points (e.g., months, visits) Stage Variable: Disease stage time point (factor) Treatment Variable: Treatment received time point (factor) Patient ID: Unique identifier tracking individual patients (factor)","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"optional-variables","dir":"Articles","previous_headings":"Data Requirements","what":"Optional Variables:","title":"Treatment Pathway Visualization with alluvialSurvival","text":"Survival Variable: Binary outcome variable (0 = alive, 1 = dead)","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"data-structure","dir":"Articles","previous_headings":"Data Requirements","what":"Data Structure:","title":"Treatment Pathway Visualization with alluvialSurvival","text":"Longitudinal format: One row per patient per time point Minimum requirements: ≥5 patients, ≥2 time points missing values time patient ID variables","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"simple-pathway-analysis","dir":"Articles","previous_headings":"Basic Treatment Pathway Visualization","what":"Simple Pathway Analysis","title":"Treatment Pathway Visualization with alluvialSurvival","text":"","code":"# Basic treatment pathway visualization alluvialSurvival(     data = treatment_pathways,     timeVar = \"Time\",     stageVar = \"Disease_Stage\",      treatmentVar = \"Treatment\",     patientId = \"ID\" )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"understanding-the-visualization","dir":"Articles","previous_headings":"Basic Treatment Pathway Visualization","what":"Understanding the Visualization","title":"Treatment Pathway Visualization with alluvialSurvival","text":"alluvial plot shows: - Vertical strata: Categories time point - Flows: Patient transitions categories - Width: Proportional number patients - Colors: Clinical color scheme default","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"color-schemes","dir":"Articles","previous_headings":"Parameter Customization","what":"Color Schemes","title":"Treatment Pathway Visualization with alluvialSurvival","text":"function provides two carefully designed color palettes:","code":"# Clinical color scheme (default) alluvialSurvival(     data = treatment_pathways,     timeVar = \"Time\",     stageVar = \"Disease_Stage\",     treatmentVar = \"Treatment\",      patientId = \"ID\",     colorScheme = \"clinical\" )  # Colorblind-safe palette alluvialSurvival(     data = treatment_pathways,     timeVar = \"Time\",     stageVar = \"Disease_Stage\",     treatmentVar = \"Treatment\",     patientId = \"ID\",      colorScheme = \"colorblind\" )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"percentage-axis","dir":"Articles","previous_headings":"Parameter Customization","what":"Percentage Axis","title":"Treatment Pathway Visualization with alluvialSurvival","text":"Add secondary axis showing percentages:","code":"# Show percentage of patients on right axis alluvialSurvival(     data = treatment_pathways,     timeVar = \"Time\",     stageVar = \"Disease_Stage\",     treatmentVar = \"Treatment\",     patientId = \"ID\",     showRightAxis = TRUE )"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"basic-survival-statistics","dir":"Articles","previous_headings":"Survival Analysis Integration","what":"Basic Survival Statistics","title":"Treatment Pathway Visualization with alluvialSurvival","text":"survival data available, function provides survival statistics:","code":"# Add survival variable for statistics alluvialSurvival(     data = treatment_pathways,     timeVar = \"Time\",      stageVar = \"Disease_Stage\",     treatmentVar = \"Treatment\",     patientId = \"ID\",     survivalVar = \"Survival_Status\" )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"survival-curves","dir":"Articles","previous_headings":"Survival Analysis Integration","what":"Survival Curves","title":"Treatment Pathway Visualization with alluvialSurvival","text":"Enable survival curve visualization: survival plots show: - Kaplan-Meier curves initial disease stage - Risk tables showing patients risk - P-values comparing survival curves - Confidence intervals survival estimates","code":"# Complete analysis with survival curves alluvialSurvival(     data = treatment_pathways,     timeVar = \"Time\",     stageVar = \"Disease_Stage\",      treatmentVar = \"Treatment\",     patientId = \"ID\",     survivalVar = \"Survival_Status\",     showSurvival = TRUE )"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"all-features-combined","dir":"Articles","previous_headings":"Comprehensive Analysis","what":"All Features Combined","title":"Treatment Pathway Visualization with alluvialSurvival","text":"","code":"# Complete treatment pathway analysis alluvialSurvival(     data = treatment_pathways,     timeVar = \"Time\",     stageVar = \"Disease_Stage\",     treatmentVar = \"Treatment\",      patientId = \"ID\",     survivalVar = \"Survival_Status\",     showRightAxis = TRUE,     colorScheme = \"colorblind\",     showSurvival = TRUE )"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"cancer-treatment-progression","dir":"Articles","previous_headings":"Advanced Examples","what":"Cancer Treatment Progression","title":"Treatment Pathway Visualization with alluvialSurvival","text":"","code":"# Focus on cancer stage progression alluvialSurvival(     data = treatment_pathways,     timeVar = \"Time\",     stageVar = \"Disease_Stage\",     treatmentVar = \"Treatment\",     patientId = \"ID\",     survivalVar = \"Survival_Status\",     colorScheme = \"clinical\" )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"treatment-sequence-analysis","dir":"Articles","previous_headings":"Advanced Examples","what":"Treatment Sequence Analysis","title":"Treatment Pathway Visualization with alluvialSurvival","text":"","code":"# Analyze treatment sequences with outcomes alluvialSurvival(     data = treatment_pathways,     timeVar = \"Time\",      stageVar = \"Disease_Stage\",     treatmentVar = \"Treatment\",     patientId = \"ID\",     survivalVar = \"Survival_Status\",     showRightAxis = TRUE,     showSurvival = TRUE )"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"reading-the-pathway-plot","dir":"Articles","previous_headings":"Clinical Interpretation","what":"Reading the Pathway Plot","title":"Treatment Pathway Visualization with alluvialSurvival","text":"Flow Thickness: Indicates number patients following pathway Stage Strata: Show disease stage distribution time point Treatment Strata: Show treatment distribution time point Transitions: Reveal progression patterns treatment responses","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"reading-the-survival-curves","dir":"Articles","previous_headings":"Clinical Interpretation","what":"Reading the Survival Curves","title":"Treatment Pathway Visualization with alluvialSurvival","text":"Initial Stage Analysis: Shows survival disease stage diagnosis Treatment Effect: Reveals survival differences final treatment Risk Tables: Provide numbers risk group time P-values: Test statistical significance survival differences","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"output-components","dir":"Articles","previous_headings":"","what":"Output Components","title":"Treatment Pathway Visualization with alluvialSurvival","text":"function generates multiple outputs:","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"main-pathway-plot","dir":"Articles","previous_headings":"Output Components","what":"1. Main Pathway Plot","title":"Treatment Pathway Visualization with alluvialSurvival","text":"Alluvial visualization patient flows Enhanced clinical color schemes Optional percentage axis","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"summary-statistics-table","dir":"Articles","previous_headings":"Output Components","what":"2. Summary Statistics Table","title":"Treatment Pathway Visualization with alluvialSurvival","text":"Patient counts time point Stage treatment distributions Transition summaries","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"survival-statistics-table-when-survival-data-provided","dir":"Articles","previous_headings":"Output Components","what":"3. Survival Statistics Table (when survival data provided)","title":"Treatment Pathway Visualization with alluvialSurvival","text":"Survival rates stage-treatment combinations Event counts patient numbers Statistical summaries","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"survival-curves-when-showsurvival-true","dir":"Articles","previous_headings":"Output Components","what":"4. Survival Curves (when showSurvival = TRUE)","title":"Treatment Pathway Visualization with alluvialSurvival","text":"Kaplan-Meier curves initial stage Risk tables numbers risk Log-rank test p-values","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"parameter-reference","dir":"Articles","previous_headings":"","what":"Parameter Reference","title":"Treatment Pathway Visualization with alluvialSurvival","text":"Complete parameter documentation:","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"data-validation","dir":"Articles","previous_headings":"","what":"Data Validation","title":"Treatment Pathway Visualization with alluvialSurvival","text":"function includes comprehensive data validation:","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"required-checks","dir":"Articles","previous_headings":"Data Validation","what":"Required Checks:","title":"Treatment Pathway Visualization with alluvialSurvival","text":"required variables present dataset Minimum 5 patients meaningful analysis Minimum 2 time points pathway analysis missing values time patient ID variables","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"survival-variable-validation","dir":"Articles","previous_headings":"Data Validation","what":"Survival Variable Validation:","title":"Treatment Pathway Visualization with alluvialSurvival","text":"Must binary (0/1) missing 0 = alive/censored, 1 = dead/event","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"error-messages","dir":"Articles","previous_headings":"Data Validation","what":"Error Messages:","title":"Treatment Pathway Visualization with alluvialSurvival","text":"Clear, specific error messages validation failures Guidance data preparation requirements","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"data-preparation","dir":"Articles","previous_headings":"Best Practices","what":"Data Preparation","title":"Treatment Pathway Visualization with alluvialSurvival","text":"Longitudinal Structure: Ensure one row per patient per time point Consistent Coding: Use consistent factor levels across time points Missing Data: Handle missing values appropriately analysis Time Points: Use meaningful time intervals (e.g., months, quarters)","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"visualization-guidelines","dir":"Articles","previous_headings":"Best Practices","what":"Visualization Guidelines","title":"Treatment Pathway Visualization with alluvialSurvival","text":"Color Scheme: Choose based audience (clinical vs. colorblind-safe) Sample Size: Function works best 20-500 patients Time Points: Optimal 3-6 time points Categories: Limit 3-6 categories per variable clarity","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"clinical-applications","dir":"Articles","previous_headings":"Best Practices","what":"Clinical Applications","title":"Treatment Pathway Visualization with alluvialSurvival","text":"Treatment Protocols: Evaluate standard vs. experimental pathways Disease Progression: Track stage migration patterns Outcome Analysis: Combine pathways survival outcomes Quality Improvement: Identify optimal treatment sequences","code":""},{"path":[]},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"data-must-contain-at-least-2-time-points","dir":"Articles","previous_headings":"Troubleshooting > Common Issues and Solutions:","what":"“Data must contain at least 2 time points”","title":"Treatment Pathway Visualization with alluvialSurvival","text":"Ensure longitudinal data structure Check time variable multiple unique values","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"data-must-contain-at-least-5-patients","dir":"Articles","previous_headings":"Troubleshooting > Common Issues and Solutions:","what":"“Data must contain at least 5 patients”","title":"Treatment Pathway Visualization with alluvialSurvival","text":"Increase sample size meaningful analysis Consider aggregating similar groups","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"survival-variable-must-be-binary-01","dir":"Articles","previous_headings":"Troubleshooting > Common Issues and Solutions:","what":"“Survival variable must be binary (0/1)”","title":"Treatment Pathway Visualization with alluvialSurvival","text":"Recode survival variable 0 (alive) 1 (dead) Handle missing values appropriately","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"time-variable-cannot-contain-missing-values","dir":"Articles","previous_headings":"Troubleshooting > Common Issues and Solutions:","what":"“Time variable cannot contain missing values”","title":"Treatment Pathway Visualization with alluvialSurvival","text":"Remove impute missing time values Ensure complete follow-data","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"multi-center-studies","dir":"Articles","previous_headings":"Advanced Use Cases","what":"Multi-Center Studies","title":"Treatment Pathway Visualization with alluvialSurvival","text":"","code":"# Analyze pathways across different centers # (assuming center variable exists) if (\"Center\" %in% names(treatment_pathways)) {     # Subset by center for comparison     center_data <- treatment_pathways[treatment_pathways$Center == \"A\", ]          alluvialSurvival(         data = center_data,         timeVar = \"Time\",         stageVar = \"Disease_Stage\",         treatmentVar = \"Treatment\",         patientId = \"ID\",         survivalVar = \"Survival_Status\",         showSurvival = TRUE     ) }"},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"subgroup-analysis","dir":"Articles","previous_headings":"Advanced Use Cases","what":"Subgroup Analysis","title":"Treatment Pathway Visualization with alluvialSurvival","text":"","code":"# Analyze by age groups or other demographics if (\"Age\" %in% names(treatment_pathways)) {     # Create age groups     treatment_pathways$AgeGroup <- cut(         treatment_pathways$Age,          breaks = c(0, 65, Inf),          labels = c(\"≤65\", \">65\")     )          # Analyze younger patients     young_patients <- treatment_pathways[treatment_pathways$AgeGroup == \"≤65\", ]          alluvialSurvival(         data = young_patients,         timeVar = \"Time\",         stageVar = \"Disease_Stage\",          treatmentVar = \"Treatment\",         patientId = \"ID\",         survivalVar = \"Survival_Status\",         colorScheme = \"colorblind\"     ) }"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"workflow-integration","dir":"Articles","previous_headings":"Integration with Other ClinicoPath Functions","what":"Workflow Integration","title":"Treatment Pathway Visualization with alluvialSurvival","text":"","code":"# 1. Start with descriptive analysis # (Use other ClinicoPath descriptive functions)  # 2. Perform pathway visualization alluvialSurvival(     data = treatment_pathways,     timeVar = \"Time\",     stageVar = \"Disease_Stage\",     treatmentVar = \"Treatment\",     patientId = \"ID\",     survivalVar = \"Survival_Status\" )  # 3. Follow with detailed survival analysis # (Use other ClinicoPath survival functions)"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"publication-ready-outputs","dir":"Articles","previous_headings":"Export and Reporting","what":"Publication-Ready Outputs","title":"Treatment Pathway Visualization with alluvialSurvival","text":"alluvialSurvival function generates publication-ready visualizations: - High-resolution plots suitable manuscripts - Professional clinical color schemes - Clear labeling legends - Statistical annotations","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"reproducible-analysis","dir":"Articles","previous_headings":"Export and Reporting","what":"Reproducible Analysis","title":"Treatment Pathway Visualization with alluvialSurvival","text":"","code":"# Set seed for reproducible examples set.seed(123)  # Document session info for reproducibility sessionInfo()"},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"conclusion","dir":"Articles","previous_headings":"","what":"Conclusion","title":"Treatment Pathway Visualization with alluvialSurvival","text":"alluvialSurvival() function provides powerful tool visualizing patient treatment pathways survival outcomes. Key advantages include: Comprehensive Visualization: Combines pathway analysis survival statistics Clinical Focus: Designed specifically medical research applications Robust Validation: Extensive data validation error handling Publication Ready: Professional visualization suitable manuscripts Flexible Analysis: Supports various clinical research scenarios function bridges gap descriptive pathway analysis survival statistics, providing insights patient flow patterns clinical outcomes.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"references","dir":"Articles","previous_headings":"","what":"References","title":"Treatment Pathway Visualization with alluvialSurvival","text":"Alluvial Diagrams Medical Research Survival Analysis Methods Clinical Studies Treatment Pathway Visualization Best Practices ClinicoPath Package Documentation","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/05-treatment-pathway-visualization.html","id":"session-information","dir":"Articles","previous_headings":"","what":"Session Information","title":"Treatment Pathway Visualization with alluvialSurvival","text":"","code":"sessionInfo()"},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-advanced-topics.html","id":"overview","dir":"Articles","previous_headings":"","what":"Overview","title":"Advanced Survival Analysis with jsurvival","text":"vignette covers advanced survival analysis techniques methodological considerations using jsurvival. addresses complex scenarios researchers commonly encounter clinical epidemiological studies.","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-advanced-topics.html","id":"checking-proportional-hazards-assumption","dir":"Articles","previous_headings":"Advanced Cox Regression Topics","what":"Checking Proportional Hazards Assumption","title":"Advanced Survival Analysis with jsurvival","text":"Cox proportional hazards model assumes hazard ratios remain constant time. Violation assumption can lead misleading results.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-advanced-topics.html","id":"visual-assessment","dir":"Articles","previous_headings":"Advanced Cox Regression Topics > Checking Proportional Hazards Assumption","what":"Visual Assessment","title":"Advanced Survival Analysis with jsurvival","text":"Visual Signs PH Violation: - Crossing survival curves - Changing hazard ratios time - Non-random patterns Schoenfeld residuals","code":"# Use survival analysis with extended follow-up time ph_check <- survival(   data = mydata,   elapsedtime = time_months,   outcome = death,   outcomeLevel = \"1\",   explanatory = treatment,   ph_cox = TRUE,   endplot = 120,  # Extended follow-up for visual inspection   sc = TRUE       # Schoenfeld residuals (if available) )"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-advanced-topics.html","id":"option-1-stratified-cox-model","dir":"Articles","previous_headings":"Advanced Cox Regression Topics > Checking Proportional Hazards Assumption > Solutions for PH Violations","what":"Option 1: Stratified Cox Model","title":"Advanced Survival Analysis with jsurvival","text":"","code":"# When PH assumption is violated for a categorical variable # Use stratification approach in multivariable analysis stratified_result <- multisurvival(   data = mydata,   elapsedtime = time_months,   outcome = death,   outcomeLevel = \"1\",   explanatory = c(treatment, age, sex),   # Note: Stratification would need to be implemented   # This is conceptual - actual implementation may vary )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-advanced-topics.html","id":"option-2-time-dependent-effects","dir":"Articles","previous_headings":"Advanced Cox Regression Topics > Checking Proportional Hazards Assumption > Solutions for PH Violations","what":"Option 2: Time-Dependent Effects","title":"Advanced Survival Analysis with jsurvival","text":"variables time-varying effects, consider: - Landmark analyses multiple time points - Piecewise exponential models - Flexible parametric models","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-advanced-topics.html","id":"forwardbackward-selection","dir":"Articles","previous_headings":"Advanced Cox Regression Topics > Model Selection and Variable Selection","what":"Forward/Backward Selection","title":"Advanced Survival Analysis with jsurvival","text":"","code":"# Start with univariate screening candidate_vars <- c(\"age\", \"sex\", \"stage\", \"grade\", \"biomarker\") univariate_results <- list()  for(var in candidate_vars) {   univariate_results[[var]] <- survival(     data = mydata,     elapsedtime = time_months,     outcome = death,     outcomeLevel = \"1\",     explanatory = !!sym(var),     ph_cox = TRUE   ) }  # Variables with p < 0.20 in univariate analysis # proceed to multivariable model significant_vars <- c(\"age\", \"stage\", \"biomarker\")  # Based on results  final_model <- multisurvival(   data = mydata,   elapsedtime = time_months,   outcome = death,   outcomeLevel = \"1\",   explanatory = significant_vars )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-advanced-topics.html","id":"model-validation","dir":"Articles","previous_headings":"Advanced Cox Regression Topics > Model Selection and Variable Selection","what":"Model Validation","title":"Advanced Survival Analysis with jsurvival","text":"","code":"# Internal validation using bootstrap or cross-validation # External validation in independent dataset  validation_result <- multisurvival(   data = validation_data,   elapsedtime = time_months,   outcome = death,   outcomeLevel = \"1\",   explanatory = final_model_variables )"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-advanced-topics.html","id":"complete-case-analysis","dir":"Articles","previous_headings":"Advanced Cox Regression Topics > Handling Missing Data","what":"Complete Case Analysis","title":"Advanced Survival Analysis with jsurvival","text":"","code":"# Default approach - uses only complete cases complete_result <- survival(   data = mydata,   elapsedtime = time_months,   outcome = death,   outcomeLevel = \"1\",   explanatory = treatment )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-advanced-topics.html","id":"multiple-imputation-approach","dir":"Articles","previous_headings":"Advanced Cox Regression Topics > Handling Missing Data","what":"Multiple Imputation Approach","title":"Advanced Survival Analysis with jsurvival","text":"","code":"# Conceptual approach for multiple imputation # 1. Create multiple imputed datasets # 2. Analyze each dataset separately # 3. Pool results using Rubin's rules  # Example workflow (implementation details may vary): imputed_results <- list() for(i in 1:5) {  # 5 imputed datasets   imputed_results[[i]] <- survival(     data = imputed_data[[i]],     elapsedtime = time_months,     outcome = death,     outcomeLevel = \"1\",     explanatory = treatment   ) }  # Pool results (conceptual) pooled_hr <- mean(sapply(imputed_results, function(x) x$hazard_ratio)) pooled_se <- sqrt(mean(sapply(imputed_results, function(x) x$se^2)) +                    (1 + 1/5) * var(sapply(imputed_results, function(x) x$hazard_ratio)))"},{"path":[]},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-advanced-topics.html","id":"multiple-cut-point-testing","dir":"Articles","previous_headings":"Cut-point Optimization > Methodological Considerations","what":"Multiple Cut-point Testing","title":"Advanced Survival Analysis with jsurvival","text":"","code":"# When testing multiple cut-points, adjust for multiple comparisons cutpoint_analysis <- survivalcont(   data = biomarker_data,   elapsedtime = time_months,   outcome = death,   outcomeLevel = \"1\",   contexpl = biomarker_value,   findcut = TRUE,   # Consider correction for multiple testing   padjustmethod = \"holm\" )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-advanced-topics.html","id":"cross-validation-of-cut-points","dir":"Articles","previous_headings":"Cut-point Optimization > Methodological Considerations","what":"Cross-Validation of Cut-points","title":"Advanced Survival Analysis with jsurvival","text":"","code":"# Split data into training and validation sets set.seed(123) train_idx <- sample(nrow(biomarker_data), nrow(biomarker_data) * 0.7) train_data <- biomarker_data[train_idx, ] test_data <- biomarker_data[-train_idx, ]  # Find cut-point in training data train_cutpoint <- survivalcont(   data = train_data,   elapsedtime = time_months,   outcome = death,   outcomeLevel = \"1\",   contexpl = biomarker_value,   findcut = TRUE )  # Apply cut-point to test data test_data$biomarker_high <- ifelse(test_data$biomarker_value >= optimal_cutpoint,                                     \"High\", \"Low\")  validation_result <- survival(   data = test_data,   elapsedtime = time_months,   outcome = death,   outcomeLevel = \"1\",   explanatory = biomarker_high )"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-advanced-topics.html","id":"tertiles-or-quartiles","dir":"Articles","previous_headings":"Cut-point Optimization > Alternative Approaches to Dichotomization","what":"Tertiles or Quartiles","title":"Advanced Survival Analysis with jsurvival","text":"","code":"# Instead of single cut-point, use tertiles biomarker_data$biomarker_tertile <- cut(biomarker_data$biomarker_value,                                         breaks = quantile(biomarker_data$biomarker_value,                                                          c(0, 1/3, 2/3, 1), na.rm = TRUE),                                         labels = c(\"Low\", \"Medium\", \"High\"),                                         include.lowest = TRUE)  tertile_analysis <- survival(   data = biomarker_data,   elapsedtime = time_months,   outcome = death,   outcomeLevel = \"1\",   explanatory = biomarker_tertile,   analysistype = \"overall\" )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-advanced-topics.html","id":"spline-analysis","dir":"Articles","previous_headings":"Cut-point Optimization > Alternative Approaches to Dichotomization","what":"Spline Analysis","title":"Advanced Survival Analysis with jsurvival","text":"","code":"# For truly continuous relationships # Consider restricted cubic splines or other flexible approaches # This would require additional implementation beyond basic jsurvival"},{"path":[]},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-advanced-topics.html","id":"multiple-landmark-points","dir":"Articles","previous_headings":"Time-Dependent Covariates > Landmark Analysis Implementation","what":"Multiple Landmark Points","title":"Advanced Survival Analysis with jsurvival","text":"","code":"# Analyze survival at different landmark times landmark_times <- c(6, 12, 24)  # months landmark_results <- list()  for(t in landmark_times) {   # Create landmark dataset   landmark_data <- subset(original_data,                           time_months > t | (time_months <= t & death == 0))      # Adjust survival times   landmark_data$time_from_landmark <- pmax(0, landmark_data$time_months - t)      # Analyze   landmark_results[[paste0(\"Month_\", t)]] <- survival(     data = landmark_data,     elapsedtime = time_from_landmark,     outcome = death,     outcomeLevel = \"1\",     explanatory = response_status,     uselandmark = TRUE,     landmark = t   ) }"},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-advanced-topics.html","id":"dynamic-prediction","dir":"Articles","previous_headings":"Time-Dependent Covariates > Landmark Analysis Implementation","what":"Dynamic Prediction","title":"Advanced Survival Analysis with jsurvival","text":"","code":"# Conditional survival probabilities # Probability of surviving additional 2 years given survival to 1 year  # Patients alive at 12 months alive_12m <- subset(mydata, time_months > 12 | (time_months <= 12 & death == 0)) alive_12m$time_conditional <- pmax(0, alive_12m$time_months - 12)  conditional_survival <- singlearm(   data = alive_12m,   elapsedtime = time_conditional,   outcome = death,   outcomeLevel = \"1\",   cutp = \"24\",  # Additional 2 years   timetypeoutput = \"months\" )"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-advanced-topics.html","id":"cause-specific-hazards","dir":"Articles","previous_headings":"Competing Risks Analysis","what":"Cause-Specific Hazards","title":"Advanced Survival Analysis with jsurvival","text":"","code":"# Separate analyses for different causes of death # Cancer-specific mortality cancer_death <- survival(   data = competing_data,   elapsedtime = time_months,   outcome = death_cancer,  # 1 = cancer death, 0 = alive or other death   outcomeLevel = \"1\",   explanatory = treatment,   ph_cox = TRUE )  # Other-cause mortality other_death <- survival(   data = competing_data,   elapsedtime = time_months,   outcome = death_other,   # 1 = other death, 0 = alive or cancer death   outcomeLevel = \"1\",   explanatory = treatment,   ph_cox = TRUE )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-advanced-topics.html","id":"subdistribution-hazards-fine-gray-model","dir":"Articles","previous_headings":"Competing Risks Analysis","what":"Subdistribution Hazards (Fine-Gray Model)","title":"Advanced Survival Analysis with jsurvival","text":"","code":"# Fine-Gray model for cumulative incidence # This approach treats competing events as censoring at the time they occur # but keeps subjects in the risk set  # Implementation would require specialized competing risks functions # Currently beyond basic jsurvival functionality"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-advanced-topics.html","id":"post-hoc-power-analysis","dir":"Articles","previous_headings":"Sample Size and Power Calculations","what":"Post-hoc Power Analysis","title":"Advanced Survival Analysis with jsurvival","text":"","code":"# Given observed data, calculate achieved power observed_events <- 120 observed_hr <- 0.75 alpha <- 0.05  # Use standard formulas or specialized software for power calculation # Example calculation (conceptual): log_hr <- log(observed_hr) se_log_hr <- 1.96 / abs(qnorm(alpha/2))  # Approximate from CI power <- pnorm(abs(log_hr)/se_log_hr - qnorm(1-alpha/2))"},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-advanced-topics.html","id":"required-sample-size","dir":"Articles","previous_headings":"Sample Size and Power Calculations","what":"Required Sample Size","title":"Advanced Survival Analysis with jsurvival","text":"","code":"# For planning future studies target_hr <- 0.70        # Clinically meaningful difference alpha <- 0.05            # Type I error power <- 0.80            # Desired power accrual_time <- 24       # months followup_time <- 36      # months median_survival <- 30    # months in control group  # Use specialized software or formulas for calculation # Required events ≈ 4 * (Z_α/2 + Z_β)² / (log(HR))²"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-advanced-topics.html","id":"individual-patient-data-meta-analysis","dir":"Articles","previous_headings":"Meta-Analysis of Survival Data","what":"Individual Patient Data Meta-Analysis","title":"Advanced Survival Analysis with jsurvival","text":"","code":"# Combine multiple datasets combined_data <- rbind(   transform(study1_data, study = \"Study1\"),   transform(study2_data, study = \"Study2\"),   transform(study3_data, study = \"Study3\") )  # Stratified analysis by study meta_result <- multisurvival(   data = combined_data,   elapsedtime = time_months,   outcome = death,   outcomeLevel = \"1\",   explanatory = c(treatment, age, sex, study)   # Consider stratification by study )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-advanced-topics.html","id":"fixed-effects-vs--random-effects","dir":"Articles","previous_headings":"Meta-Analysis of Survival Data","what":"Fixed Effects vs. Random Effects","title":"Advanced Survival Analysis with jsurvival","text":"","code":"# Fixed effects: assumes same treatment effect across studies fixed_effects <- survival(   data = combined_data,   elapsedtime = time_months,   outcome = death,   outcomeLevel = \"1\",   explanatory = treatment )  # Random effects: allows heterogeneity between studies # Would require specialized meta-analysis functions"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-advanced-topics.html","id":"data-quality-checks","dir":"Articles","previous_headings":"Quality Control and Validation","what":"Data Quality Checks","title":"Advanced Survival Analysis with jsurvival","text":"","code":"# Check for data inconsistencies data_checks <- list(   # Negative survival times   negative_times = sum(mydata$time_months < 0, na.rm = TRUE),      # Events after last follow-up   impossible_events = sum(mydata$death == 1 & mydata$time_months > max_followup),      # Missing key variables   missing_time = sum(is.na(mydata$time_months)),   missing_event = sum(is.na(mydata$death)),      # Extreme values   extreme_times = sum(mydata$time_months > 200, na.rm = TRUE)  # >16 years )  print(data_checks)"},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-advanced-topics.html","id":"model-diagnostics","dir":"Articles","previous_headings":"Quality Control and Validation","what":"Model Diagnostics","title":"Advanced Survival Analysis with jsurvival","text":"","code":"# Concordance index (C-index) # Measures discriminative ability of the model # Values >0.7 generally considered good  # Calibration assessment # Agreement between predicted and observed survival  # Model comparison using AIC/BIC # Lower values indicate better fit"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-advanced-topics.html","id":"effect-size-interpretation","dir":"Articles","previous_headings":"Reporting and Interpretation","what":"Effect Size Interpretation","title":"Advanced Survival Analysis with jsurvival","text":"","code":"# Hazard Ratio Interpretation: # HR = 0.50: 50% reduction in hazard (strong effect) # HR = 0.75: 25% reduction in hazard (moderate effect) # HR = 0.90: 10% reduction in hazard (small effect) # HR = 1.00: No effect # HR = 1.25: 25% increase in hazard (moderate harm) # HR = 2.00: 100% increase in hazard (strong harm)  # Number Needed to Treat (NNT) calculation survival_control <- 0.60  # 5-year survival in control survival_treatment <- 0.70  # 5-year survival in treatment absolute_benefit <- survival_treatment - survival_control nnt <- 1 / absolute_benefit  # Number needed to treat"},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-advanced-topics.html","id":"confidence-interval-interpretation","dir":"Articles","previous_headings":"Reporting and Interpretation","what":"Confidence Interval Interpretation","title":"Advanced Survival Analysis with jsurvival","text":"","code":"# HR = 0.75 (95% CI: 0.60-0.95) # Interpretation: # - Point estimate suggests 25% reduction in hazard # - We can be 95% confident the true HR is between 0.60 and 0.95 # - Since CI excludes 1.0, result is statistically significant # - Minimum plausible benefit is 5% (HR=0.95) # - Maximum plausible benefit is 40% (HR=0.60)"},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-advanced-topics.html","id":"conclusion","dir":"Articles","previous_headings":"","what":"Conclusion","title":"Advanced Survival Analysis with jsurvival","text":"Advanced survival analysis requires careful consideration : Model assumptions validation Missing data patterns appropriate handling Multiple comparisons adjustment strategies Clinical relevance beyond statistical significance Robust validation independent datasets Key principles advanced analysis: Pre-specify analysis plans avoid data dredging Validate findings independent cohorts possible Consider clinical context statistical decisions Report limitations assumptions clearly Collaborate statisticians complex analyses complex analyses beyond scope basic jsurvival functions, consider: - Specialized R packages (survival, survminer, rms, cmprsk) - Statistical software advanced survival capabilities - Consultation biostatisticians Additional resources: - Survival Analysis Handbook - Clinical Prediction Models - STROBE Guidelines observational studies","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"introduction-to-grouped-forest-plots","dir":"Articles","previous_headings":"","what":"Introduction to Grouped Forest Plots","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Grouped Hazard Forest Plot module provides powerful visualization method comparing treatment effects across different patient subgroups. analysis addresses critical need precision medicine clinical research performing separate Cox proportional hazards regression analyses subgroup presenting results unified forest plot. module developed address GitHub Issue #88: Create grouped forest plots showing treatment vs control variant.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"key-features","dir":"Articles","previous_headings":"Introduction to Grouped Forest Plots","what":"Key Features","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Subgroup-Specific Analysis: Separate Cox regression group Visual Comparison: Side--side hazard ratios forest plot format Statistical Testing: Individual p-values interaction tests Clinical Applications: Perfect biomarker studies, precision medicine, clinical trials Flexible Grouping: Support categorical grouping variable","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"precision-medicine","dir":"Articles","previous_headings":"Introduction to Grouped Forest Plots > Clinical Applications","what":"Precision Medicine","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Treatment efficacy genetic variants Biomarker-stratified therapy selection Molecular subtype analysis","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"clinical-trials","dir":"Articles","previous_headings":"Introduction to Grouped Forest Plots > Clinical Applications","what":"Clinical Trials","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Subgroup efficacy analysis Patient population identification Treatment interaction detection","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"biomarker-studies","dir":"Articles","previous_headings":"Introduction to Grouped Forest Plots > Clinical Applications","what":"Biomarker Studies","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Predictive biomarker evaluation Treatment-biomarker interactions Patient stratification strategies","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"required-data-structure","dir":"Articles","previous_headings":"Getting Started","what":"Required Data Structure","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"dataset contain: Time Variable: Continuous variable follow-duration Event Variable: Binary indicator (0=censored, 1=event) Treatment Variable: Factor variable treatment comparison Grouping Variable: Categorical variable defining subgroups","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"example-dataset","dir":"Articles","previous_headings":"Getting Started","what":"Example Dataset","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Let’s examine structure test data:","code":"library(jsurvival) library(dplyr) library(ggplot2)  # Load example data data(\"groupedforest_comprehensive_data\")  # Examine data structure str(groupedforest_comprehensive_data) # Preview the data head(groupedforest_comprehensive_data) %>%   knitr::kable(caption = \"Sample of Comprehensive Grouped Forest Data\")"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"simple-two-group-comparison","dir":"Articles","previous_headings":"Basic Grouped Forest Analysis","what":"Simple Two-Group Comparison","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Let’s start basic analysis comparing treatment effects biomarker-positive biomarker-negative patients:","code":"# Basic grouped forest plot by biomarker status result_biomarker <- groupedforest(   data = groupedforest_comprehensive_data,   time_var = \"survival_months\",   event_var = \"death_event\",   treatment_var = \"treatment\",   grouping_var = \"biomarker_status\",   show_statistics = TRUE,   show_overall = TRUE )  # The result object contains the analysis class(result_biomarker)"},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"tumor-stage-stratification","dir":"Articles","previous_headings":"Basic Grouped Forest Analysis","what":"Tumor Stage Stratification","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Compare treatment effects early advanced tumor stages:","code":"# Grouped analysis by tumor stage result_stage <- groupedforest(   data = groupedforest_comprehensive_data,   time_var = \"survival_months\",   event_var = \"death_event\",   treatment_var = \"treatment\",   grouping_var = \"tumor_stage\",   confidence_level = 0.95,   sort_by_hr = TRUE,   plot_title = \"Treatment Effects by Tumor Stage\" )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"gender-based-subgroup-analysis","dir":"Articles","previous_headings":"Basic Grouped Forest Analysis","what":"Gender-Based Subgroup Analysis","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Evaluate treatment effects across gender groups:","code":"# Analysis by gender result_gender <- groupedforest(   data = groupedforest_comprehensive_data,   time_var = \"survival_months\",   event_var = \"death_event\",   treatment_var = \"treatment\",   grouping_var = \"gender\",   show_counts = TRUE,   plot_theme = \"clinical\" )"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"covariate-adjustment","dir":"Articles","previous_headings":"Advanced Analysis Features","what":"Covariate Adjustment","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Include covariates adjust confounding factors:","code":"# Analysis with covariate adjustment result_adjusted <- groupedforest(   data = groupedforest_comprehensive_data,   time_var = \"survival_months\",   event_var = \"death_event\",   treatment_var = \"treatment\",   grouping_var = \"biomarker_status\",   covariates = c(\"age\", \"performance_status\"),   reference_treatment = \"Control\",   show_statistics = TRUE )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"interaction-testing","dir":"Articles","previous_headings":"Advanced Analysis Features","what":"Interaction Testing","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Test treatment--subgroup interactions:","code":"# Test for interaction effects result_interaction <- groupedforest(   data = groupedforest_comprehensive_data,   time_var = \"survival_months\",   event_var = \"death_event\",   treatment_var = \"treatment\",   grouping_var = \"tumor_stage\",   interaction_test = TRUE,   show_overall = TRUE )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"custom-display-options","dir":"Articles","previous_headings":"Advanced Analysis Features","what":"Custom Display Options","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Customize appearance range forest plot:","code":"# Custom forest plot settings result_custom <- groupedforest(   data = groupedforest_comprehensive_data,   time_var = \"survival_months\",   event_var = \"death_event\",   treatment_var = \"treatment\",   grouping_var = \"biomarker_status\",   plot_title = \"Biomarker-Stratified Treatment Analysis\",   plot_theme = \"publication\",   hr_range = \"wide\",   sort_by_hr = TRUE,   confidence_level = 0.95 )"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"multi-subgroup-dataset","dir":"Articles","previous_headings":"Multiple Subgroup Analysis","what":"Multi-Subgroup Dataset","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Let’s work dataset containing multiple molecular subtypes:","code":"# Load multi-subgroup data data(\"groupedforest_multi_subgroups\")  # Examine the subgroups table(groupedforest_multi_subgroups$molecular_subtype)"},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"molecular-subtype-analysis","dir":"Articles","previous_headings":"Multiple Subgroup Analysis","what":"Molecular Subtype Analysis","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Analyze treatment effects across molecular subtypes:","code":"# Molecular subtype forest plot result_molecular <- groupedforest(   data = groupedforest_multi_subgroups,   time_var = \"time_to_event\",   event_var = \"event_occurred\",   treatment_var = \"intervention\",   grouping_var = \"molecular_subtype\",   covariates = \"patient_age\",   show_statistics = TRUE,   show_counts = TRUE )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"risk-category-stratification","dir":"Articles","previous_headings":"Multiple Subgroup Analysis","what":"Risk Category Stratification","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Compare treatment effects across risk categories:","code":"# Risk category analysis result_risk <- groupedforest(   data = groupedforest_multi_subgroups,   time_var = \"time_to_event\",   event_var = \"event_occurred\",   treatment_var = \"intervention\",   grouping_var = \"risk_category\",   interaction_test = TRUE,   plot_theme = \"minimal\" )"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"genomic-variant-analysis","dir":"Articles","previous_headings":"Precision Medicine Applications","what":"Genomic Variant Analysis","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Demonstrate precision medicine applications genomic data:","code":"# Load precision medicine dataset data(\"groupedforest_precision_medicine\")  # Examine genomic variants table(groupedforest_precision_medicine$genomic_variant) # Genomic variant forest plot result_genomic <- groupedforest(   data = groupedforest_precision_medicine,   time_var = \"progression_free_months\",   event_var = \"progression_event\",   treatment_var = \"therapy_type\",   grouping_var = \"genomic_variant\",   reference_treatment = \"Chemotherapy\",   plot_title = \"Precision Therapy by Genomic Variant\" )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"expression-level-stratification","dir":"Articles","previous_headings":"Precision Medicine Applications","what":"Expression Level Stratification","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Analyze treatment effects biomarker expression levels:","code":"# Expression level analysis result_expression <- groupedforest(   data = groupedforest_precision_medicine,   time_var = \"progression_free_months\",   event_var = \"progression_event\",   treatment_var = \"therapy_type\",   grouping_var = \"expression_level\",   covariates = c(\"age_at_diagnosis\", \"tumor_size\"),   show_overall = TRUE )"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"biomarker-level-analysis","dir":"Articles","previous_headings":"Biomarker Stratification Studies","what":"Biomarker Level Analysis","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Work biomarker stratification data:","code":"# Load biomarker data data(\"groupedforest_biomarker_data\")  # Examine biomarker levels table(groupedforest_biomarker_data$biomarker_level) # Biomarker level forest plot result_biomarker_level <- groupedforest(   data = groupedforest_biomarker_data,   time_var = \"overall_survival_months\",   event_var = \"death_indicator\",   treatment_var = \"treatment_arm\",   grouping_var = \"biomarker_level\",   plot_title = \"Biomarker-Targeted Therapy by Expression Level\",   hr_range = \"custom\",   custom_hr_min = 0.2,   custom_hr_max = 5.0 )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"pathway-status-analysis","dir":"Articles","previous_headings":"Biomarker Stratification Studies","what":"Pathway Status Analysis","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Analyze treatment effects pathway activation status:","code":"# Pathway status analysis result_pathway <- groupedforest(   data = groupedforest_biomarker_data,   time_var = \"overall_survival_months\",   event_var = \"death_indicator\",   treatment_var = \"treatment_arm\",   grouping_var = \"pathway_status\",   plot_theme = \"publication\",   show_counts = TRUE )"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"multi-factor-clinical-trial","dir":"Articles","previous_headings":"Clinical Trial Applications","what":"Multi-Factor Clinical Trial","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Demonstrate complex clinical trial analysis:","code":"# Load clinical trial data data(\"groupedforest_interaction_data\")  # Examine trial characteristics table(groupedforest_interaction_data$genetic_profile) table(groupedforest_interaction_data$disease_severity) # Genetic profile analysis result_clinical <- groupedforest(   data = groupedforest_interaction_data,   time_var = \"event_free_survival\",   event_var = \"event_status\",   treatment_var = \"randomized_treatment\",   grouping_var = \"genetic_profile\",   interaction_test = TRUE,   export_data = TRUE,   plot_title = \"Clinical Trial: Treatment by Genetic Profile\" )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"disease-severity-stratification","dir":"Articles","previous_headings":"Clinical Trial Applications","what":"Disease Severity Stratification","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Analyze treatment effects across disease severity levels:","code":"# Disease severity analysis result_severity <- groupedforest(   data = groupedforest_interaction_data,   time_var = \"event_free_survival\",   event_var = \"event_status\",   treatment_var = \"randomized_treatment\",   grouping_var = \"disease_severity\",   covariates = c(\"age_years\", \"baseline_severity_score\"),   confidence_level = 0.90 )"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"plot-themes","dir":"Articles","previous_headings":"Customization and Visualization Options","what":"Plot Themes","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Demonstrate different plot themes:","code":"# Load simple dataset for theme demonstration data(\"groupedforest_simple_data\")  # Clinical theme (default) result_theme_clinical <- groupedforest(   data = groupedforest_simple_data,   time_var = \"time\",   event_var = \"event\",   treatment_var = \"treatment\",   grouping_var = \"subgroup\",   plot_theme = \"clinical\",   plot_title = \"Clinical Theme\" )  # Publication theme result_theme_pub <- groupedforest(   data = groupedforest_simple_data,   time_var = \"time\",   event_var = \"event\",   treatment_var = \"treatment\",   grouping_var = \"subgroup\",   plot_theme = \"publication\",   plot_title = \"Publication Theme\" )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"hazard-ratio-ranges","dir":"Articles","previous_headings":"Customization and Visualization Options","what":"Hazard Ratio Ranges","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Demonstrate different HR range options:","code":"# Wide range result_wide <- groupedforest(   data = groupedforest_simple_data,   time_var = \"time\",   event_var = \"event\",   treatment_var = \"treatment\",   grouping_var = \"subgroup\",   hr_range = \"wide\",   plot_title = \"Wide HR Range (0.1-10)\" )  # Narrow range result_narrow <- groupedforest(   data = groupedforest_simple_data,   time_var = \"time\",   event_var = \"event\",   treatment_var = \"treatment\",   grouping_var = \"subgroup\",   hr_range = \"narrow\",   plot_title = \"Narrow HR Range (0.5-2)\" )"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"sample-size-and-power","dir":"Articles","previous_headings":"Statistical Considerations","what":"Sample Size and Power","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Understanding impact subgroup sample sizes:","code":"# Examine sample sizes by subgroup groupedforest_comprehensive_data %>%   group_by(biomarker_status, treatment) %>%   summarise(     n = n(),     events = sum(death_event),     event_rate = round(mean(death_event), 3),     .groups = 'drop'   ) %>%   knitr::kable(caption = \"Sample Sizes and Event Rates by Subgroup\")"},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"confidence-intervals","dir":"Articles","previous_headings":"Statistical Considerations","what":"Confidence Intervals","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Demonstrate different confidence levels:","code":"# Different confidence levels conf_levels <- c(0.80, 0.90, 0.95, 0.99)  for (conf_level in conf_levels) {   result <- groupedforest(     data = groupedforest_simple_data,     time_var = \"time\",     event_var = \"event\",      treatment_var = \"treatment\",     grouping_var = \"subgroup\",     confidence_level = conf_level,     plot_title = paste0(conf_level * 100, \"% Confidence Intervals\")   ) }"},{"path":[]},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"key-elements","dir":"Articles","previous_headings":"Interpretation Guidelines > Reading Forest Plots","what":"Key Elements:","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Vertical line HR = 1: treatment effect Points left (HR < 1): Treatment reduces hazard (beneficial) Points right (HR > 1): Treatment increases hazard (harmful) Horizontal lines: Confidence intervals Wider intervals: Less precise estimates (smaller sample sizes)","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"statistical-significance","dir":"Articles","previous_headings":"Interpretation Guidelines > Reading Forest Plots","what":"Statistical Significance:","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Confidence interval excludes 1: Statistically significant effect Confidence interval includes 1: Non-significant effect P-values: Individual subgroup significance tests","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"treatment-heterogeneity","dir":"Articles","previous_headings":"Interpretation Guidelines > Clinical Interpretation","what":"Treatment Heterogeneity:","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Consistent effects: Similar HRs across subgroups Treatment interactions: Varying effects subgroups Precision medicine opportunities: Subgroups differential benefit","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"clinical-decision-making","dir":"Articles","previous_headings":"Interpretation Guidelines > Clinical Interpretation","what":"Clinical Decision Making:","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Patient selection: Identify subgroups likely benefit Treatment recommendation: Consider subgroup-specific effects Future research: Hypothesis generation subsequent studies","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"interaction-testing-1","dir":"Articles","previous_headings":"Advanced Statistical Methods","what":"Interaction Testing","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Understanding treatment--subgroup interactions:","code":"# Comprehensive interaction analysis result_full_interaction <- groupedforest(   data = groupedforest_comprehensive_data,   time_var = \"survival_months\",   event_var = \"death_event\",   treatment_var = \"treatment\",   grouping_var = \"biomarker_status\",   interaction_test = TRUE,   covariates = c(\"age\", \"performance_status\"),   show_overall = TRUE,   show_statistics = TRUE )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"multiple-comparisons","dir":"Articles","previous_headings":"Advanced Statistical Methods","what":"Multiple Comparisons","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Considerations multiple subgroup testing:","code":"# Multiple subgroup analysis result_multiple <- groupedforest(   data = groupedforest_multi_subgroups,   time_var = \"time_to_event\",   event_var = \"event_occurred\",   treatment_var = \"intervention\",   grouping_var = \"molecular_subtype\",  # 4 subgroups = multiple comparisons   show_statistics = TRUE,   plot_title = \"Multiple Subgroup Analysis (Consider Adjustment)\" )"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"regulatory-submissions","dir":"Articles","previous_headings":"Clinical Research Applications","what":"Regulatory Submissions","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Guidelines regulatory use:","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"best-practices","dir":"Articles","previous_headings":"Clinical Research Applications > Regulatory Submissions","what":"Best Practices:","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Pre-specified analyses: Define subgroups data analysis Clinical rationale: Justify subgroup selections Statistical plan: Document analysis methodology Interaction testing: Formally test treatment interactions Multiple comparisons: Consider adjustment methods","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"reporting-standards","dir":"Articles","previous_headings":"Clinical Research Applications > Publication Guidelines","what":"Reporting Standards:","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"CONSORT guidelines: Subgroup analysis reporting Transparency: Report analyzed subgroups Effect sizes: Include confidence intervals Clinical significance: Interpret beyond statistical significance","code":""},{"path":[]},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"minimum-sample-sizes","dir":"Articles","previous_headings":"Troubleshooting and Common Issues > Data Requirements","what":"Minimum Sample Sizes:","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Per subgroup: least 10-15 events recommended Treatment arms: Balanced representation preferred Event rates: Sufficient events Cox regression","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"data-quality","dir":"Articles","previous_headings":"Troubleshooting and Common Issues > Data Requirements","what":"Data Quality:","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"","code":"# Check data quality check_data_quality <- function(data, time_var, event_var, treatment_var, grouping_var) {   cat(\"Data Quality Checks:\\n\")   cat(\"Total sample size:\", nrow(data), \"\\n\")   cat(\"Complete cases:\", sum(complete.cases(data[, c(time_var, event_var, treatment_var, grouping_var)])), \"\\n\")   cat(\"Event rate:\", round(mean(data[[event_var]], na.rm = TRUE), 3), \"\\n\")      # Subgroup sizes   cat(\"\\nSubgroup sizes:\\n\")   print(table(data[[grouping_var]], data[[treatment_var]]))      # Event rates by subgroup   cat(\"\\nEvent rates by subgroup:\\n\")   event_rates <- data %>%     group_by(.data[[grouping_var]], .data[[treatment_var]]) %>%     summarise(event_rate = round(mean(.data[[event_var]], na.rm = TRUE), 3), .groups = 'drop')   print(event_rates) }  check_data_quality(   groupedforest_comprehensive_data,   \"survival_months\",   \"death_event\",    \"treatment\",   \"biomarker_status\" )"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"solutions","dir":"Articles","previous_headings":"Troubleshooting and Common Issues > Common Error Messages","what":"Solutions:","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"“valid Cox regression results”: Check subgroup sample sizes “Insufficient events”: Verify event rates per subgroup “Model convergence failed”: Consider removing small subgroups “Missing data”: Address missing values key variables","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"summary","dir":"Articles","previous_headings":"","what":"Summary","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Grouped Hazard Forest Plot module provides comprehensive solution subgroup analysis survival studies. Key benefits include:","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"clinical-value","dir":"Articles","previous_headings":"Summary","what":"Clinical Value:","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Precision Medicine: Identify patients likely benefit Treatment Personalization: Guide individual treatment decisions Research Planning: Inform future study designs","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"statistical-rigor","dir":"Articles","previous_headings":"Summary","what":"Statistical Rigor:","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Formal Testing: Cox regression subgroup Interaction Analysis: Test differential treatment effects Visualization: Clear presentation complex results","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"practical-applications","dir":"Articles","previous_headings":"Summary","what":"Practical Applications:","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Biomarker Studies: Evaluate predictive markers Clinical Trials: Subgroup efficacy analysis Drug Development: Support regulatory submissions module addresses critical need systematic subgroup analysis clinical research, providing statistical rigor practical clinical insights precision medicine applications.","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"statistical-methods","dir":"Articles","previous_headings":"References and Further Reading","what":"Statistical Methods:","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Cox Proportional Hazards Models Forest Plot Methodology Subgroup Analysis Guidelines Treatment-Biomarker Interactions","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"clinical-applications-1","dir":"Articles","previous_headings":"References and Further Reading","what":"Clinical Applications:","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"Precision Medicine Frameworks Biomarker Validation Studies Clinical Trial Design Regulatory Guidelines","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/08-groupedforest-comprehensive.html","id":"software-implementation","dir":"Articles","previous_headings":"References and Further Reading","what":"Software Implementation:","title":"Grouped Hazard Forest Plots for Subgroup Analysis","text":"survival R package ggplot2 visualization jamovi integration ClinicoPath module ecosystem","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"what-is-lasso-cox-regression","dir":"Articles","previous_headings":"Introduction to Lasso-Cox Regression","what":"What is Lasso-Cox Regression?","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"Lasso-Cox regression combines Cox proportional hazards model L1 regularization (Lasso penalty) perform automatic variable selection survival analysis. technique particularly valuable : many potential predictors (high-dimensional data) number variables approaches exceeds sample size want identify important prognostic factors need prevent overfitting survival models","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"key-advantages","dir":"Articles","previous_headings":"Introduction to Lasso-Cox Regression > What is Lasso-Cox Regression?","what":"Key Advantages","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"Automatic Variable Selection: Shrinks coefficients less important variables exactly zero Handles High-Dimensional Data: Works even p ≥ n (variables observations) Prevents Overfitting: Regularization improves model generalizability Clinical Interpretability: Produces sparse models selected key variables Cross-Validation: Optimal tuning parameter selection CV","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"ideal-scenarios","dir":"Articles","previous_headings":"Introduction to Lasso-Cox Regression > When to Use Lasso-Cox Regression","what":"Ideal Scenarios","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"Genomic/Biomarker Studies: Gene expression, proteomics, metabolomics data Large Clinical Datasets: Many potential prognostic factors screen Predictive Modeling: Building parsimonious prognostic models Exploratory Analysis: Identifying key variables large candidate sets","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"prerequisites","dir":"Articles","previous_headings":"Introduction to Lasso-Cox Regression > When to Use Lasso-Cox Regression","what":"Prerequisites","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"Survival Outcome: Time--event data censoring Multiple Predictors: least 2 variables (typically many ) Adequate Events: least 5-10 events reliable estimation Perfect Separation: Variables shouldn’t perfectly predict outcomes","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"the-lasso-cox-model","dir":"Articles","previous_headings":"Statistical Background","what":"The Lasso-Cox Model","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"Lasso-Cox regression minimizes penalized partial log-likelihood: ℓ(β)−λ∑j=1p|βj|\\ell(\\beta) - \\lambda \\sum_{j=1}^p |\\beta_j| : - ℓ(β)\\ell(\\beta) Cox partial log-likelihood - λ\\lambda regularization parameter (tuning parameter) - ∑j=1p|βj|\\sum_{j=1}^p |\\beta_j| L1 penalty (Lasso)","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"key-parameters","dir":"Articles","previous_headings":"Statistical Background > The Lasso-Cox Model","what":"Key Parameters","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"lambda.min: Minimizes cross-validation error lambda.1se: Uses 1-standard-error rule (parsimonious) Typically 5-10 folds Balances model fit vs. complexity","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"concordance-index-c-index","dir":"Articles","previous_headings":"Statistical Background > Performance Metrics","what":"Concordance Index (C-index)","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"Measures discriminative ability Range: 0.5 (random) 1.0 (perfect) < 0.6: Poor discrimination 0.6-0.7: Fair discrimination 0.7-0.8: Good discrimination 0.8: Excellent discrimination","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"risk-stratification","dir":"Articles","previous_headings":"Statistical Background > Performance Metrics","what":"Risk Stratification","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"Log-rank Test: Tests survival differences risk groups Hazard Ratio: Compares high vs. low risk groups Survival Curves: Visual assessment risk group separation","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"example-1-lung-cancer-prognostic-model","dir":"Articles","previous_headings":"Clinical Examples","what":"Example 1: Lung Cancer Prognostic Model","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"’ll analyze lung cancer dataset identify key prognostic factors clinical variables.","code":"# Load example data (would be provided in package) # For this example, we'll simulate realistic lung cancer data set.seed(123) n <- 180 lung_data <- data.frame(   # Survival outcome   follow_up_months = round(rexp(n, rate = 0.05) + runif(n, 0, 12), 1),   progression = factor(rbinom(n, 1, 0.6), levels = c(0, 1), labels = c(\"No\", \"Yes\")),      # Clinical variables   age = round(rnorm(n, 65, 10)),   gender = factor(sample(c(\"Male\", \"Female\"), n, replace = TRUE, prob = c(0.6, 0.4))),   stage = factor(sample(c(\"I\", \"II\", \"III\", \"IV\"), n, replace = TRUE,                          prob = c(0.2, 0.3, 0.3, 0.2))),   histology = factor(sample(c(\"Adenocarcinoma\", \"Squamous\", \"Other\"), n, replace = TRUE,                             prob = c(0.5, 0.3, 0.2))),   smoking_status = factor(sample(c(\"Never\", \"Former\", \"Current\"), n, replace = TRUE,                                  prob = c(0.2, 0.5, 0.3))),   tumor_size_cm = round(rnorm(n, 4.5, 2.0), 1),   ecog_ps = factor(sample(0:2, n, replace = TRUE, prob = c(0.4, 0.4, 0.2))),      # Laboratory values   hemoglobin = round(rnorm(n, 12.5, 2.0), 1),   wbc_count = round(rnorm(n, 8.5, 3.0), 1),   creatinine = round(rnorm(n, 1.1, 0.3), 2) )  # Display basic characteristics str(lung_data)"},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"running-lasso-cox-analysis","dir":"Articles","previous_headings":"Clinical Examples > Example 1: Lung Cancer Prognostic Model","what":"Running Lasso-Cox Analysis","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"","code":"# In jamovi, you would select: # Analyses → ClinicoPath Survival → Lasso-Cox Regression  # Programmatically (if running in R): lung_result <- lassocox(   data = lung_data,   elapsedtime = \"follow_up_months\",   outcome = \"progression\",   outcomeLevel = \"Yes\",   explanatory = c(\"age\", \"gender\", \"stage\", \"histology\", \"smoking_status\",                    \"tumor_size_cm\", \"ecog_ps\", \"hemoglobin\", \"wbc_count\", \"creatinine\"),   lambda = \"lambda.1se\",  # Use 1-SE rule for more parsimonious model   nfolds = 10,            # 10-fold cross-validation   standardize = TRUE      # Standardize variables )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"expected-results-interpretation","dir":"Articles","previous_headings":"Clinical Examples > Example 1: Lung Cancer Prognostic Model","what":"Expected Results Interpretation","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"Total variables: 10 Selected variables: 3-5 (lambda.1se) Selection proportion: 30-50% stage: Strong prognostic factor (HR > 1) ecog_ps: Performance status effect age: Age-related risk tumor_size_cm: Tumor burden effect C-index: 0.65-0.75 (fair good discrimination) Log-rank p-value: < 0.05 (significant stratification) Hazard ratio: 2.0-3.0 (moderate strong risk stratification)","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"example-2-high-dimensional-genomic-study","dir":"Articles","previous_headings":"Clinical Examples","what":"Example 2: High-Dimensional Genomic Study","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"example demonstrates Lasso-Cox high-dimensional genomic data p >> n.","code":"# Simulate high-dimensional genomic data set.seed(456) n_patients <- 100 n_genes <- 500  # Create genomic dataset genomic_data <- data.frame(   # Survival outcome   survival_months = round(rweibull(n_patients, shape = 1.5, scale = 24), 1),   death = factor(rbinom(n_patients, 1, 0.4), levels = c(0, 1), labels = c(\"No\", \"Yes\")),      # Clinical variables   age = round(rnorm(n_patients, 60, 12)),   stage = factor(sample(1:3, n_patients, replace = TRUE, prob = c(0.4, 0.4, 0.2)),                  levels = 1:3, labels = c(\"Early\", \"Intermediate\", \"Advanced\")) )  # Add gene expression data (standardized) gene_matrix <- matrix(rnorm(n_patients * n_genes), nrow = n_patients, ncol = n_genes) colnames(gene_matrix) <- paste0(\"GENE_\", sprintf(\"%03d\", 1:n_genes))  # Combine clinical and genomic data genomic_data <- cbind(genomic_data, gene_matrix)  cat(\"Dataset dimensions:\", nrow(genomic_data), \"patients ×\", ncol(genomic_data), \"variables\") cat(\"\\nNumber of genes:\", n_genes) cat(\"\\nEvents:\", sum(genomic_data$death == \"Yes\"), \"deaths\")"},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"high-dimensional-analysis-setup","dir":"Articles","previous_headings":"Clinical Examples > Example 2: High-Dimensional Genomic Study","what":"High-Dimensional Analysis Setup","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"","code":"# For high-dimensional data, consider: genomic_result <- lassocox(   data = genomic_data,   elapsedtime = \"survival_months\",   outcome = \"death\",   outcomeLevel = \"Yes\",   explanatory = c(\"age\", \"stage\", paste0(\"GENE_\", sprintf(\"%03d\", 1:n_genes))),   lambda = \"lambda.1se\",  # Prefer 1-SE rule for high-dimensional data   nfolds = 5,             # Reduce folds for small samples   standardize = TRUE      # Essential for genomic data )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"expected-high-dimensional-results","dir":"Articles","previous_headings":"Clinical Examples > Example 2: High-Dimensional Genomic Study","what":"Expected High-Dimensional Results","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"502 variables, typically 5-15 selected Selection proportion: 1-3% Identifies sparse prognostic signature Usually includes key clinical variables (age, stage) Selects high-impact genes Creates interpretable prognostic model","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"example-3-cardiovascular-risk-prediction","dir":"Articles","previous_headings":"Clinical Examples","what":"Example 3: Cardiovascular Risk Prediction","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"Analyzing cardiovascular risk factors correlated predictors.","code":"# Simulate cardiovascular dataset set.seed(789) n_subjects <- 200  cvd_data <- data.frame(   # Outcome   time_to_event_years = round(rexp(n_subjects, rate = 0.08), 1),   cv_event = factor(rbinom(n_subjects, 1, 0.3), levels = c(0, 1),                      labels = c(\"No Event\", \"Event\")),      # Demographics   age = round(rnorm(n_subjects, 62, 15)),   gender = factor(sample(c(\"Male\", \"Female\"), n_subjects, replace = TRUE)),      # Clinical measurements (correlated variables)   bmi = round(rnorm(n_subjects, 28, 6), 1),   systolic_bp = round(rnorm(n_subjects, 135, 25)),   diastolic_bp = round(rnorm(n_subjects, 82, 15)),   total_cholesterol = round(rnorm(n_subjects, 210, 40)),   hdl_cholesterol = round(rnorm(n_subjects, 45, 12)),   ldl_cholesterol = round(rnorm(n_subjects, 125, 35)),      # Medical history   diabetes = factor(sample(c(\"No\", \"Yes\"), n_subjects, replace = TRUE, prob = c(0.7, 0.3))),   hypertension = factor(sample(c(\"No\", \"Yes\"), n_subjects, replace = TRUE, prob = c(0.5, 0.5))),   smoking = factor(sample(c(\"Never\", \"Former\", \"Current\"), n_subjects, replace = TRUE,                           prob = c(0.5, 0.3, 0.2))),      # Medications   statin_use = factor(sample(c(\"No\", \"Yes\"), n_subjects, replace = TRUE, prob = c(0.4, 0.6))) )  str(cvd_data)"},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"cardiovascular-analysis","dir":"Articles","previous_headings":"Clinical Examples > Example 3: Cardiovascular Risk Prediction","what":"Cardiovascular Analysis","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"","code":"cvd_result <- lassocox(   data = cvd_data,   elapsedtime = \"time_to_event_years\",   outcome = \"cv_event\",   outcomeLevel = \"Event\",   explanatory = c(\"age\", \"gender\", \"bmi\", \"systolic_bp\", \"diastolic_bp\",                   \"total_cholesterol\", \"hdl_cholesterol\", \"ldl_cholesterol\",                   \"diabetes\", \"hypertension\", \"smoking\", \"statin_use\"),   lambda = \"lambda.min\",  # Use lambda.min for established risk factors   nfolds = 10 )"},{"path":[]},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"model-summary-table","dir":"Articles","previous_headings":"Interpreting Results > Understanding the Output Tables","what":"1. Model Summary Table","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"Total Variables: Number candidate predictors Selected Variables: Variables non-zero coefficients Selection Proportion: Percentage variables retained Optimal Lambda: Selected regularization parameter Sample Size & Events: Data characteristics","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"coefficients-table","dir":"Articles","previous_headings":"Interpreting Results > Understanding the Output Tables","what":"2. Coefficients Table","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"Variable: Selected predictor names Coefficient: Log hazard ratio (β) Hazard Ratio: exp(β), interpretable effect size Importance: Absolute coefficient value (variable importance)","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"performance-table","dir":"Articles","previous_headings":"Interpreting Results > Understanding the Output Tables","what":"3. Performance Table","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"C-index: Discriminative ability measure Log-rank p-value: Risk stratification significance Hazard Ratio: High vs. low risk group comparison","code":""},{"path":[]},{"path":[]},{"path":[]},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"cross-validation-plot","dir":"Articles","previous_headings":"Interpreting Results > Visualization Interpretation","what":"1. Cross-Validation Plot","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"X-axis: Log lambda values Y-axis: Cross-validation error Blue (lambda.min): Minimum CV error Green (lambda.1se): 1-SE rule (parsimonious)","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"coefficient-plot","dir":"Articles","previous_headings":"Interpreting Results > Visualization Interpretation","what":"2. Coefficient Plot","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"Red bars: Risk factors (positive coefficients) Blue bars: Protective factors (negative coefficients) Bar length: Coefficient magnitude (effect size)","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"survival-curves","dir":"Articles","previous_headings":"Interpreting Results > Visualization Interpretation","what":"3. Survival Curves","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"Separation: Better separation indicates stronger risk stratification P-value: Log-rank test significance Risk tables: Numbers risk time","code":""},{"path":[]},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"genomic-profiling","dir":"Articles","previous_headings":"Clinical Applications > 1. Biomarker Discovery","what":"Genomic Profiling","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"","code":"# Typical biomarker discovery workflow biomarker_analysis <- lassocox(   data = genomic_data,   elapsedtime = \"survival_time\",   outcome = \"progression\",   outcomeLevel = \"Yes\",   explanatory = gene_variables,  # Hundreds of genes   lambda = \"lambda.1se\",         # Prefer sparse models   standardize = TRUE            # Essential for genomic data )  # Expected outcome: 3-10 key genes selected from hundreds"},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"clinical-applications-1","dir":"Articles","previous_headings":"Clinical Applications > 1. Biomarker Discovery","what":"Clinical Applications:","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"Cancer Prognosis: Identify prognostic gene signatures Drug Development: Biomarker-driven patient stratification Personalized Medicine: Tailored treatment selection","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"multi-variable-risk-models","dir":"Articles","previous_headings":"Clinical Applications > 2. Clinical Risk Prediction","what":"Multi-variable Risk Models","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"","code":"# Clinical risk model development risk_model <- lassocox(   data = clinical_data,   elapsedtime = \"follow_up_time\",   outcome = \"death\",   outcomeLevel = \"Yes\",   explanatory = clinical_variables,  # 10-50 clinical factors   lambda = \"lambda.min\",            # Retain more clinical variables   nfolds = 10 )  # Creates parsimonious clinical risk score"},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"applications","dir":"Articles","previous_headings":"Clinical Applications > 2. Clinical Risk Prediction","what":"Applications:","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"ICU Prognosis: Predict mortality critical care Surgical Risk: Pre-operative risk stratification Chronic Disease: Long-term outcome prediction","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"precision-medicine","dir":"Articles","previous_headings":"Clinical Applications > 3. Treatment Response Prediction","what":"Precision Medicine","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"","code":"# Treatment response prediction treatment_model <- lassocox(   data = treatment_data,   elapsedtime = \"time_to_progression\",   outcome = \"progression\",   outcomeLevel = \"Yes\",   explanatory = c(baseline_factors, biomarkers),   lambda = \"lambda.1se\" )  # Identifies predictors of treatment response"},{"path":[]},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"cross-validation-strategy","dir":"Articles","previous_headings":"Advanced Topics > Model Validation","what":"Cross-Validation Strategy","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"Internal Validation: Built-cross-validation λ selection External Validation: Test independent dataset Bootstrap Validation: Assess model stability Temporal Validation: Validate recent data","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"validation-metrics","dir":"Articles","previous_headings":"Advanced Topics > Model Validation","what":"Validation Metrics","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"","code":"# Key validation approaches: # 1. Split-sample validation train_data <- sample_frac(full_data, 0.7) test_data <- anti_join(full_data, train_data)  # 2. Time-based validation early_cohort <- filter(full_data, enrollment_year <= 2015) recent_cohort <- filter(full_data, enrollment_year > 2015)  # 3. Multi-center validation center_A <- filter(full_data, center == \"A\") other_centers <- filter(full_data, center != \"A\")"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"preprocessing-strategies","dir":"Articles","previous_headings":"Advanced Topics > Dealing with Missing Data","what":"Preprocessing Strategies","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"Complete Case Analysis: Default approach Multiple Imputation: missing random data Indicator Variables: missing random Domain Knowledge: Clinical expertise imputation","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"missing-data-patterns","dir":"Articles","previous_headings":"Advanced Topics > Dealing with Missing Data","what":"Missing Data Patterns","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"","code":"# Check missing data patterns library(VIM) missing_pattern <- aggr(clinical_data, col = c('navyblue', 'red'),                          numbers = TRUE, sortVars = TRUE)  # Handle missing data before Lasso-Cox # Option 1: Multiple imputation library(mice) imputed_data <- mice(clinical_data, m = 5, method = 'pmm') complete_data <- complete(imputed_data)  # Option 2: Domain-specific imputation clinical_data$biomarker[is.na(clinical_data$biomarker)] <- median(clinical_data$biomarker, na.rm = TRUE)"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"variable-transformation","dir":"Articles","previous_headings":"Advanced Topics > Feature Engineering","what":"Variable Transformation","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"","code":"# Log transformation for skewed variables clinical_data$log_biomarker <- log(clinical_data$biomarker + 1)  # Polynomial terms for non-linear effects clinical_data$age_squared <- clinical_data$age^2  # Interaction terms clinical_data$age_stage <- clinical_data$age * as.numeric(clinical_data$stage)  # Binning continuous variables clinical_data$age_group <- cut(clinical_data$age,                                breaks = c(0, 50, 65, 80, 100),                               labels = c(\"Young\", \"Middle\", \"Elderly\", \"Very Elderly\"))"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"no-variables-selected","dir":"Articles","previous_headings":"Troubleshooting Common Issues","what":"1. No Variables Selected","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"Problem: Lasso selects zero variables (λ large) Solutions:","code":"# Try lambda.min instead of lambda.1se result <- lassocox(..., lambda = \"lambda.min\")  # Reduce regularization strength manually result <- lassocox(..., alpha = 0.5)  # Elastic net (if supported)  # Check for high correlation among predictors cor_matrix <- cor(predictors, use = \"complete.obs\") high_cor <- which(abs(cor_matrix) > 0.9 & cor_matrix != 1, arr.ind = TRUE)"},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"too-many-variables-selected","dir":"Articles","previous_headings":"Troubleshooting Common Issues","what":"2. Too Many Variables Selected","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"Problem: Model selects many variables (underfitting) Solutions:","code":"# Use lambda.1se for more regularization result <- lassocox(..., lambda = \"lambda.1se\")  # Increase number of CV folds result <- lassocox(..., nfolds = 10)  # Pre-filter variables by univariate significance univariate_p <- sapply(predictors, function(x) {   cox_fit <- coxph(Surv(time, event) ~ x)   summary(cox_fit)$coefficients[, \"Pr(>|z|)\"] }) significant_vars <- names(univariate_p)[univariate_p < 0.1]"},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"poor-model-performance","dir":"Articles","previous_headings":"Troubleshooting Common Issues","what":"3. Poor Model Performance","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"Problem: Low C-index poor risk stratification Solutions:","code":"# Check data quality summary(survival_data) plot(survfit(Surv(time, event) ~ 1))  # Overall survival curve  # Ensure adequate events table(survival_data$event)  # Need at least 5-10 events per variable  # Consider interaction terms clinical_data$age_stage_interaction <- clinical_data$age * as.numeric(clinical_data$stage)  # Try different time scales clinical_data$log_time <- log(clinical_data$time + 1)"},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"convergence-issues","dir":"Articles","previous_headings":"Troubleshooting Common Issues","what":"4. Convergence Issues","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"Problem: Algorithm doesn’t converge Solutions:","code":"# Standardize variables result <- lassocox(..., standardize = TRUE)  # Remove extreme outliers Q1 <- quantile(continuous_var, 0.25, na.rm = TRUE) Q3 <- quantile(continuous_var, 0.75, na.rm = TRUE) IQR <- Q3 - Q1 outliers <- which(continuous_var < (Q1 - 1.5*IQR) | continuous_var > (Q3 + 1.5*IQR))  # Check for perfect separation table(survival_data$event, survival_data$categorical_predictor)"},{"path":[]},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"sample-size-planning","dir":"Articles","previous_headings":"Best Practices > Study Design Considerations","what":"Sample Size Planning","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"Events per Variable: Aim 5-10 events per candidate variable Total Sample Size: Consider expected censoring rate Effect Size: Larger effects require smaller samples Multiple Testing: Account variable selection process","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"variable-selection","dir":"Articles","previous_headings":"Best Practices > Study Design Considerations","what":"Variable Selection","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"","code":"# Pre-selection strategies: # 1. Clinical relevance clinical_vars <- c(\"age\", \"stage\", \"grade\", \"treatment\")  # 2. Univariate screening (liberal p-value) univariate_screen <- function(data, time_var, event_var, predictors, p_threshold = 0.2) {   significant_vars <- c()   for (var in predictors) {     formula <- as.formula(paste(\"Surv(\", time_var, \",\", event_var, \") ~\", var))     cox_fit <- coxph(formula, data = data)     p_value <- summary(cox_fit)$coefficients[, \"Pr(>|z|)\"]     if (p_value < p_threshold) {       significant_vars <- c(significant_vars, var)     }   }   return(significant_vars) }  # 3. Correlation filtering remove_high_correlation <- function(data, threshold = 0.9) {   cor_matrix <- cor(data, use = \"complete.obs\")   high_cor <- findCorrelation(cor_matrix, cutoff = threshold)   return(names(data)[-high_cor]) }"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"essential-elements-for-publication","dir":"Articles","previous_headings":"Best Practices > Reporting Standards","what":"Essential Elements for Publication","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"Cross-validation procedure (k-folds) Lambda selection method (min vs. 1se) Standardization approach Missing data handling Number variables considered selected Cross-validation performance Final model coefficients hazard ratios Discrimination metrics (C-index) Risk stratification results Cross-validation plot Coefficient plot Survival curves risk groups Model performance summary","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"reproducibility-checklist","dir":"Articles","previous_headings":"Best Practices > Reporting Standards","what":"Reproducibility Checklist","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"","code":"# Reproducibility essentials: set.seed(123)  # For consistent CV folds  # Document software versions sessionInfo()  # Save model objects for future use save(lasso_model, file = \"lasso_cox_model.RData\")  # Provide clear variable definitions variable_dictionary <- data.frame(   Variable = names(clinical_data),   Description = c(\"Patient age in years\", \"Tumor stage\", ...),   Type = c(\"Continuous\", \"Categorical\", ...),   Units = c(\"Years\", \"I-IV\", ...) )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"conclusion","dir":"Articles","previous_headings":"","what":"Conclusion","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"Lasso-Cox regression powerful tool variable selection survival analysis, particularly valuable : High-dimensional data traditional methods fail Biomarker discovery genomic proteomic studies Clinical risk modeling many potential predictors Exploratory analysis identify key prognostic factors","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"key-takeaways","dir":"Articles","previous_headings":"Conclusion","what":"Key Takeaways","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"Choose appropriate λ: lambda.1se sparsity, lambda.min performance Validate externally: Internal CV sufficient clinical use Consider clinical context: Statistical significance ≠ clinical relevance Report transparently: Include analysis decisions limitations","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/09-lassocox-comprehensive.html","id":"future-directions","dir":"Articles","previous_headings":"Conclusion","what":"Future Directions","title":"Lasso-Cox Regression for Variable Selection in Survival Analysis","text":"Elastic Net Extensions: Combining L1 L2 penalties Time-varying Effects: Allowing coefficients change time Competing Risks: Extending multiple event types Machine Learning Integration: Combining ML approaches lassocox function ClinicoPath provides user-friendly interface performing sophisticated analyses, making advanced survival modeling accessible clinical researchers biostatisticians. information ClinicoPath survival analysis tools, visit package documentation tutorials.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/1-stagemigration-comprehensive.html","id":"introduction","dir":"Articles","previous_headings":"","what":"Introduction","title":"Advanced TNM Stage Migration Analysis: A Comprehensive Guide","text":"stagemigration function ClinicoPath provides state---art statistical methods validating TNM staging system improvements. comprehensive guide demonstrates use advanced features robust staging validation pathology research.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/1-stagemigration-comprehensive.html","id":"what-is-stage-migration","dir":"Articles","previous_headings":"Introduction","what":"What is Stage Migration Analysis?","title":"Advanced TNM Stage Migration Analysis: A Comprehensive Guide","text":"Stage migration analysis, also known Rogers phenomenon, occurs patients reclassified one staging system another. analysis helps pathologists clinicians evaluate whether new staging system provides better prognostic discrimination existing systems.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/1-stagemigration-comprehensive.html","id":"key-applications","dir":"Articles","previous_headings":"Introduction > What is Stage Migration Analysis?","what":"Key Applications","title":"Advanced TNM Stage Migration Analysis: A Comprehensive Guide","text":"TNM Edition Transitions: Validating AJCC 7th 8th edition changes Biomarker Integration: Adding molecular markers traditional staging Institution-Specific Modifications: Customizing staging local populations Multi-Institutional Harmonization: Standardizing staging across centers","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/1-stagemigration-comprehensive.html","id":"clinical-significance","dir":"Articles","previous_headings":"Introduction","what":"Clinical Significance","title":"Advanced TNM Stage Migration Analysis: A Comprehensive Guide","text":"Proper staging validation crucial : Treatment Planning: Staging guides therapeutic decisions Prognosis: Patients families need accurate survival estimates Clinical Trials: Enrollment stratification depend accurate staging Healthcare Resources: Staging influences follow-intensity costs","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/1-stagemigration-comprehensive.html","id":"installation","dir":"Articles","previous_headings":"Getting Started","what":"Installation and Setup","title":"Advanced TNM Stage Migration Analysis: A Comprehensive Guide","text":"","code":"# Install ClinicoPath if not already installed # install.packages(\"ClinicoPath\")  # Load required libraries library(jsurvival) library(dplyr) library(ggplot2) library(survival)"},{"path":"https://www.serdarbalci.com/jsurvival/articles/1-stagemigration-comprehensive.html","id":"sample-data","dir":"Articles","previous_headings":"Getting Started","what":"Sample Data Overview","title":"Advanced TNM Stage Migration Analysis: A Comprehensive Guide","text":"package includes comprehensive test datasets different cancer types:","code":"# Load lung cancer staging data load(\"stagemigration_lung_cancer.rda\")  # Examine the data structure head(lung_cancer_data) str(lung_cancer_data)  # Check staging distribution table(lung_cancer_data$old_stage, lung_cancer_data$new_stage)"},{"path":"https://www.serdarbalci.com/jsurvival/articles/1-stagemigration-comprehensive.html","id":"data-requirements","dir":"Articles","previous_headings":"Getting Started > Sample Data Overview","what":"Data Requirements","title":"Advanced TNM Stage Migration Analysis: A Comprehensive Guide","text":"dataset include: Old staging variable: Original staging system (e.g., TNM 7th edition) New staging variable: Proposed staging system (e.g., TNM 8th edition) Survival time: Time event censoring (months recommended) Event indicator: Death event occurrence (1 = event, 0 = censored) Patient characteristics: Age, sex, histology, performance status, etc.","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/1-stagemigration-comprehensive.html","id":"simple-comparison","dir":"Articles","previous_headings":"Basic Stage Migration Analysis","what":"Simple Comparison","title":"Advanced TNM Stage Migration Analysis: A Comprehensive Guide","text":"Start basic analysis understand migration patterns:","code":"# Basic stage migration analysis basic_result <- stagemigration(   data = lung_cancer_data,   oldStage = \"old_stage\",   newStage = \"new_stage\",   survivalTime = \"survival_time\",   event = \"event\",   eventLevel = \"1\",   analysisType = \"basic\" )  # View migration matrix print(basic_result$results$migrationMatrix)  # View stage-specific survival statistics print(basic_result$results$stageSummary)"},{"path":"https://www.serdarbalci.com/jsurvival/articles/1-stagemigration-comprehensive.html","id":"migration-patterns","dir":"Articles","previous_headings":"Basic Stage Migration Analysis","what":"Understanding Migration Patterns","title":"Advanced TNM Stage Migration Analysis: A Comprehensive Guide","text":"migration matrix shows patients move staging systems:","code":"# Calculate migration statistics migration_stats <- lung_cancer_data %>%   mutate(     migration_type = case_when(       old_stage == new_stage ~ \"No Change\",       as.numeric(old_stage) < as.numeric(new_stage) ~ \"Upstaging\",       as.numeric(old_stage) > as.numeric(new_stage) ~ \"Downstaging\"     )   ) %>%   count(migration_type) %>%   mutate(percentage = round(n / sum(n) * 100, 1))  print(migration_stats)"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/1-stagemigration-comprehensive.html","id":"comprehensive-statistical","dir":"Articles","previous_headings":"Standard Validation Analysis","what":"Comprehensive Statistical Assessment","title":"Advanced TNM Stage Migration Analysis: A Comprehensive Guide","text":"publication-quality staging validation, use standard analysis:","code":"# Standard staging validation standard_result <- stagemigration(   data = lung_cancer_data,   oldStage = \"old_stage\",   newStage = \"new_stage\",   survivalTime = \"survival_time\",   event = \"event\",   eventLevel = \"1\",   analysisType = \"standard\",      # Advanced metrics   calculateNRI = TRUE,   calculateIDI = TRUE,   performROCAnalysis = TRUE,   performDCA = TRUE,      # Validation   performBootstrap = TRUE,   bootstrapReps = 1000,      # Cancer-specific guidance   cancerType = \"lung\",      # Visualization   showMigrationHeatmap = TRUE,   showROCComparison = TRUE,   showForestPlot = TRUE )  # View key results print(standard_result$results$concordanceComparison) print(standard_result$results$nriResults) print(standard_result$results$clinicalInterpretation)"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/1-stagemigration-comprehensive.html","id":"c-index","dir":"Articles","previous_headings":"Standard Validation Analysis > Key Metrics Explained","what":"Harrell’s C-Index","title":"Advanced TNM Stage Migration Analysis: A Comprehensive Guide","text":"C-index measures discriminative ability: Range: 0.5 (discrimination) 1.0 (perfect discrimination) Clinical Significance: Improvement ≥ 0.02 meaningful Interpretation: Higher values indicate better prognostic separation","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/1-stagemigration-comprehensive.html","id":"nri","dir":"Articles","previous_headings":"Standard Validation Analysis > Key Metrics Explained","what":"Net Reclassification Improvement (NRI)","title":"Advanced TNM Stage Migration Analysis: A Comprehensive Guide","text":"NRI quantifies improvement risk classification:","code":"# Interpret NRI results nri_results <- standard_result$results$nriResults$asDF  # NRI > 0.20 (20%) is considered clinically significant # NRI > 0.60 (60%) is considered substantial improvement for (i in 1:nrow(nri_results)) {   time_point <- nri_results$TimePoint[i]   nri_value <- nri_results$NRI[i]      interpretation <- case_when(     nri_value > 0.60 ~ \"Substantial improvement\",     nri_value > 0.20 ~ \"Clinically significant improvement\",     nri_value > 0.10 ~ \"Modest improvement\",     nri_value > 0.00 ~ \"Minimal improvement\",     TRUE ~ \"No improvement or worsening\"   )      cat(sprintf(\"Time %s months: NRI = %.3f (%s)\\n\",                time_point, nri_value, interpretation)) }"},{"path":"https://www.serdarbalci.com/jsurvival/articles/1-stagemigration-comprehensive.html","id":"idi","dir":"Articles","previous_headings":"Standard Validation Analysis > Key Metrics Explained","what":"Integrated Discrimination Improvement (IDI)","title":"Advanced TNM Stage Migration Analysis: A Comprehensive Guide","text":"IDI measures improvement predicted probabilities:","code":"# Interpret IDI results idi_results <- standard_result$results$idiResults$asDF  # IDI > 0.02 is considered clinically meaningful # IDI > 0.05 is considered substantial idi_value <- idi_results$IDI[1]  idi_interpretation <- case_when(   idi_value > 0.05 ~ \"Substantial improvement in risk prediction\",   idi_value > 0.02 ~ \"Clinically meaningful improvement\",   idi_value > 0.01 ~ \"Modest improvement\",   idi_value > 0.00 ~ \"Minimal improvement\",   TRUE ~ \"No improvement\" )  cat(sprintf(\"IDI = %.4f (%s)\\n\", idi_value, idi_interpretation))"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/1-stagemigration-comprehensive.html","id":"decision-curve-analysis","dir":"Articles","previous_headings":"Advanced Analysis Features","what":"Decision Curve Analysis","title":"Advanced TNM Stage Migration Analysis: A Comprehensive Guide","text":"DCA evaluates clinical utility across decision thresholds:","code":"# Analysis with Decision Curve Analysis dca_result <- stagemigration(   data = lung_cancer_data,   oldStage = \"old_stage\",   newStage = \"new_stage\",   survivalTime = \"survival_time\",   event = \"event\",   eventLevel = \"1\",   analysisType = \"comprehensive\",      # Decision Curve Analysis   performDCA = TRUE,   performCalibration = TRUE,      # Clinical thresholds   clinicalSignificanceThreshold = 0.02,   nriClinicalThreshold = 0.20,      # Cancer-specific settings   cancerType = \"lung\",      # Comprehensive outputs   showDecisionCurves = TRUE,   showCalibrationPlots = TRUE,   showClinicalInterpretation = TRUE,   generateExecutiveSummary = TRUE )  # View Decision Curve results print(dca_result$results$dcaResults)  # View clinical interpretation print(dca_result$results$clinicalInterpretation)"},{"path":"https://www.serdarbalci.com/jsurvival/articles/1-stagemigration-comprehensive.html","id":"bootstrap-validation","dir":"Articles","previous_headings":"Advanced Analysis Features","what":"Bootstrap Validation","title":"Advanced TNM Stage Migration Analysis: A Comprehensive Guide","text":"Internal validation optimism correction:","code":"# Comprehensive analysis with bootstrap validation bootstrap_result <- stagemigration(   data = lung_cancer_data,   oldStage = \"old_stage\",   newStage = \"new_stage\",   survivalTime = \"survival_time\",   event = \"event\",   eventLevel = \"1\",   analysisType = \"comprehensive\",      # Bootstrap validation   performBootstrap = TRUE,   bootstrapReps = 2000,   useOptimismCorrection = TRUE,      # Cross-validation   performCrossValidation = TRUE,   cvFolds = 5,      # All advanced methods   calculateNRI = TRUE,   calculateIDI = TRUE,   performROCAnalysis = TRUE,   performDCA = TRUE,      # Model testing   performLikelihoodTests = TRUE,   calculatePseudoR2 = TRUE,   performHomogeneityTests = TRUE,   performTrendTests = TRUE,      # Cancer-specific   cancerType = \"lung\" )  # View bootstrap results print(bootstrap_result$results$bootstrapResults)  # View optimism-corrected performance bootstrap_summary <- bootstrap_result$results$bootstrapResults$asDF corrected_cindex <- bootstrap_summary$Corrected[bootstrap_summary$Metric == \"C-Index\"] cat(sprintf(\"Optimism-corrected C-index improvement: %.4f\\n\", corrected_cindex))"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/1-stagemigration-comprehensive.html","id":"lung-cancer-staging","dir":"Articles","previous_headings":"Cancer-Specific Analysis","what":"Lung Cancer Staging","title":"Advanced TNM Stage Migration Analysis: A Comprehensive Guide","text":"","code":"# Lung cancer specific analysis lung_result <- stagemigration(   data = lung_cancer_data,   oldStage = \"old_stage\",   newStage = \"new_stage\",   survivalTime = \"survival_time\",   event = \"event\",   eventLevel = \"1\",   analysisType = \"publication\",      # Lung cancer specific settings   cancerType = \"lung\",      # Time points relevant to lung cancer   nriTimePoints = \"6, 12, 24, 36, 60\",   rocTimePoints = \"6, 12, 24, 36, 60\",      # Comprehensive analysis   calculateNRI = TRUE,   calculateIDI = TRUE,   performROCAnalysis = TRUE,   performDCA = TRUE,   performBootstrap = TRUE,   bootstrapReps = 1000,      # Publication ready outputs   showClinicalInterpretation = TRUE,   generateExecutiveSummary = TRUE,   showStatisticalSummary = TRUE,   showMethodologyNotes = TRUE,   includeEffectSizes = TRUE )  # View lung cancer specific guidance print(lung_result$results$clinicalInterpretation)"},{"path":"https://www.serdarbalci.com/jsurvival/articles/1-stagemigration-comprehensive.html","id":"breast-cancer-staging","dir":"Articles","previous_headings":"Cancer-Specific Analysis","what":"Breast Cancer Staging","title":"Advanced TNM Stage Migration Analysis: A Comprehensive Guide","text":"","code":"# Load breast cancer data load(\"stagemigration_breast_cancer.rda\")  # Breast cancer specific analysis breast_result <- stagemigration(   data = breast_cancer_data,   oldStage = \"old_stage\",   newStage = \"new_stage\",   survivalTime = \"survival_time\",   event = \"event\",   eventLevel = \"1\",   analysisType = \"comprehensive\",      # Breast cancer specific settings   cancerType = \"breast\",      # Breast cancer relevant time points (longer follow-up)   nriTimePoints = \"12, 24, 60, 120\",   rocTimePoints = \"12, 24, 60, 120\",      # Clinical significance thresholds (more conservative for breast cancer)   clinicalSignificanceThreshold = 0.015,   nriClinicalThreshold = 0.15,      # Comprehensive methods   calculateNRI = TRUE,   calculateIDI = TRUE,   performROCAnalysis = TRUE,   performDCA = TRUE,   performBootstrap = TRUE,   bootstrapReps = 1000,      # Visualization   showMigrationHeatmap = TRUE,   showROCComparison = TRUE,   showCalibrationPlots = TRUE,   showDecisionCurves = TRUE,   showForestPlot = TRUE )  # Compare breast cancer specific recommendations print(breast_result$results$clinicalInterpretation)"},{"path":"https://www.serdarbalci.com/jsurvival/articles/1-stagemigration-comprehensive.html","id":"colorectal-cancer-staging","dir":"Articles","previous_headings":"Cancer-Specific Analysis","what":"Colorectal Cancer Staging","title":"Advanced TNM Stage Migration Analysis: A Comprehensive Guide","text":"","code":"# Load colorectal cancer data load(\"stagemigration_colorectal_cancer.rda\")  # Colorectal cancer specific analysis colorectal_result <- stagemigration(   data = colorectal_cancer_data,   oldStage = \"old_stage\",   newStage = \"new_stage\",   survivalTime = \"survival_time\",   event = \"event\",   eventLevel = \"1\",   analysisType = \"comprehensive\",      # Colorectal cancer specific settings   cancerType = \"colorectal\",      # Colorectal cancer time points   nriTimePoints = \"12, 24, 36, 60\",   rocTimePoints = \"12, 24, 36, 60\",      # Standard thresholds   clinicalSignificanceThreshold = 0.02,   nriClinicalThreshold = 0.20,      # Full analysis   calculateNRI = TRUE,   calculateIDI = TRUE,   performROCAnalysis = TRUE,   performDCA = TRUE,   performBootstrap = TRUE,   bootstrapReps = 1000,      # Advanced tests   performLikelihoodTests = TRUE,   calculatePseudoR2 = TRUE,   performHomogeneityTests = TRUE,   performTrendTests = TRUE,   showWillRogersAnalysis = TRUE,      # Comprehensive outputs   showClinicalInterpretation = TRUE,   generateExecutiveSummary = TRUE )  # View colorectal cancer specific results print(colorectal_result$results$clinicalInterpretation)"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/1-stagemigration-comprehensive.html","id":"statistical-vs-clinical","dir":"Articles","previous_headings":"Interpreting Results","what":"Statistical Significance vs Clinical Importance","title":"Advanced TNM Stage Migration Analysis: A Comprehensive Guide","text":"","code":"# Framework for interpreting staging validation results interpret_staging_validation <- function(result, cancer_type = \"general\") {      # Extract key metrics   concordance <- result$results$concordanceComparison$asDF   nri <- result$results$nriResults$asDF   clinical_interp <- result$results$clinicalInterpretation$asDF      # C-index interpretation   c_index_old <- concordance$C_Index[concordance$Model == \"Old Staging\"]   c_index_new <- concordance$C_Index[concordance$Model == \"New Staging\"]   c_index_diff <- c_index_new - c_index_old      # NRI interpretation (using 24-month if available)   nri_24 <- nri$NRI[nri$TimePoint == \"24\"]   if (length(nri_24) == 0) nri_24 <- nri$NRI[1]      # Clinical decision framework   cat(\"=== STAGING VALIDATION INTERPRETATION ===\\n\\n\")      # C-index assessment   cat(\"1. DISCRIMINATION (C-INDEX):\\n\")   cat(sprintf(\"   Old staging C-index: %.3f\\n\", c_index_old))   cat(sprintf(\"   New staging C-index: %.3f\\n\", c_index_new))   cat(sprintf(\"   Improvement: %.4f\\n\", c_index_diff))      if (c_index_diff >= 0.02) {     cat(\"   ✓ CLINICALLY SIGNIFICANT improvement\\n\")   } else if (c_index_diff > 0.01) {     cat(\"   ⚠ MODEST improvement (borderline significance)\\n\")   } else if (c_index_diff > 0.005) {     cat(\"   ⚠ MINIMAL improvement\\n\")   } else {     cat(\"   ✗ NO meaningful improvement\\n\")   }      cat(\"\\n2. RECLASSIFICATION (NRI):\\n\")   cat(sprintf(\"   24-month NRI: %.3f\\n\", nri_24))      if (nri_24 > 0.20) {     cat(\"   ✓ CLINICALLY SIGNIFICANT reclassification improvement\\n\")   } else if (nri_24 > 0.10) {     cat(\"   ⚠ MODEST reclassification improvement\\n\")   } else if (nri_24 > 0.05) {     cat(\"   ⚠ MINIMAL reclassification improvement\\n\")   } else {     cat(\"   ✗ NO meaningful reclassification improvement\\n\")   }      # Overall recommendation   cat(\"\\n3. OVERALL RECOMMENDATION:\\n\")      if (c_index_diff >= 0.02 && nri_24 > 0.20) {     cat(\"   ✓ STRONGLY RECOMMEND adopting new staging system\\n\")     cat(\"   • Both discrimination and reclassification show significant improvement\\n\")     cat(\"   • Clinical benefit is well-established\\n\")   } else if (c_index_diff >= 0.015 || nri_24 > 0.15) {     cat(\"   ⚠ CONSIDER adopting new staging system\\n\")     cat(\"   • Moderate improvement shown\\n\")     cat(\"   • Additional validation recommended\\n\")   } else {     cat(\"   ✗ INSUFFICIENT evidence for adoption\\n\")     cat(\"   • Improvements are below clinical significance thresholds\\n\")     cat(\"   • Consider larger sample size or different approach\\n\")   }      cat(\"\\n4. IMPLEMENTATION CONSIDERATIONS:\\n\")   cat(\"   • Training requirements for new staging system\\n\")   cat(\"   • Cost-benefit analysis of system change\\n\")   cat(\"   • Integration with existing clinical workflows\\n\")   cat(\"   • External validation in independent cohorts\\n\")      return(invisible(list(     c_index_improvement = c_index_diff,     nri_improvement = nri_24,     recommendation = ifelse(c_index_diff >= 0.02 && nri_24 > 0.20, \"Adopt\",                             ifelse(c_index_diff >= 0.015 || nri_24 > 0.15, \"Consider\", \"Insufficient\"))   ))) }  # Apply interpretation framework interpretation <- interpret_staging_validation(lung_result, \"lung\")"},{"path":"https://www.serdarbalci.com/jsurvival/articles/1-stagemigration-comprehensive.html","id":"sample-size-considerations","dir":"Articles","previous_headings":"Interpreting Results","what":"Sample Size Considerations","title":"Advanced TNM Stage Migration Analysis: A Comprehensive Guide","text":"","code":"# Analyze different sample sizes sample_sizes <- c(100, 200, 500, 1000)  sample_size_results <- list()  for (n in sample_sizes) {      # Create subsample   subsample <- lung_cancer_data %>%      slice_sample(n = n) %>%     mutate(event = as.numeric(event))      # Run analysis   result <- stagemigration(     data = subsample,     oldStage = \"old_stage\",     newStage = \"new_stage\",     survivalTime = \"survival_time\",     event = \"event\",     eventLevel = \"1\",     analysisType = \"standard\",     calculateNRI = TRUE,     calculateIDI = TRUE,     cancerType = \"lung\",     performBootstrap = FALSE  # Skip for speed   )      # Extract key metrics   concordance <- result$results$concordanceComparison$asDF   c_index_diff <- concordance$C_Index[concordance$Model == \"New Staging\"] -                    concordance$C_Index[concordance$Model == \"Old Staging\"]      nri_result <- result$results$nriResults$asDF   nri_24 <- nri_result$NRI[nri_result$TimePoint == \"24\"]   if (length(nri_24) == 0) nri_24 <- nri_result$NRI[1]      sample_size_results[[as.character(n)]] <- list(     n = n,     c_index_improvement = c_index_diff,     nri_improvement = nri_24,     events = sum(subsample$event),     event_rate = mean(subsample$event)   ) }  # Summarize sample size effects sample_size_summary <- do.call(rbind, lapply(sample_size_results, function(x) {   data.frame(     SampleSize = x$n,     Events = x$events,     EventRate = round(x$event_rate, 3),     CIndexImprovement = round(x$c_index_improvement, 4),     NRIImprovement = round(x$nri_improvement, 3)   ) }))  print(sample_size_summary)  # Recommendations for sample size cat(\"\\n=== SAMPLE SIZE RECOMMENDATIONS ===\\n\") cat(\"• Minimum 200 patients for basic analysis\\n\") cat(\"• Minimum 500 patients for reliable NRI/IDI estimation\\n\") cat(\"• Minimum 1000 patients for comprehensive validation\\n\") cat(\"• At least 100 events for stable results\\n\") cat(\"• Consider power analysis for specific effect sizes\\n\")"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/1-stagemigration-comprehensive.html","id":"complete-workflow","dir":"Articles","previous_headings":"Publication-Ready Analysis","what":"Complete Workflow for Manuscript","title":"Advanced TNM Stage Migration Analysis: A Comprehensive Guide","text":"","code":"# Complete publication-ready analysis publication_result <- stagemigration(   data = lung_cancer_data,   oldStage = \"old_stage\",   newStage = \"new_stage\",   survivalTime = \"survival_time\",   event = \"event\",   eventLevel = \"1\",   analysisType = \"publication\",      # Complete statistical analysis   calculateNRI = TRUE,   calculateIDI = TRUE,   performROCAnalysis = TRUE,   performDCA = TRUE,   performCalibration = TRUE,      # Validation   performBootstrap = TRUE,   bootstrapReps = 2000,   useOptimismCorrection = TRUE,   performCrossValidation = TRUE,   cvFolds = 10,      # Model comparison   performLikelihoodTests = TRUE,   calculatePseudoR2 = TRUE,   performHomogeneityTests = TRUE,   performTrendTests = TRUE,   showWillRogersAnalysis = TRUE,      # Clinical assessment   clinicalSignificanceThreshold = 0.02,   nriClinicalThreshold = 0.20,   cancerType = \"lung\",      # Time points   nriTimePoints = \"6, 12, 18, 24, 36, 60\",   rocTimePoints = \"6, 12, 18, 24, 36, 60\",      # Comprehensive outputs   showClinicalInterpretation = TRUE,   generateExecutiveSummary = TRUE,   showStatisticalSummary = TRUE,   showMethodologyNotes = TRUE,   includeEffectSizes = TRUE,      # Visualizations   showMigrationHeatmap = TRUE,   showROCComparison = TRUE,   showCalibrationPlots = TRUE,   showDecisionCurves = TRUE,   showForestPlot = TRUE,      # Confidence intervals   showConfidenceIntervals = TRUE,   confidenceLevel = 0.95 )  # Generate manuscript tables cat(\"=== TABLE 1: PATIENT CHARACTERISTICS ===\\n\") # This would typically be generated separately with tableone or similar  cat(\"\\n=== TABLE 2: STAGING MIGRATION MATRIX ===\\n\") print(publication_result$results$migrationMatrix)  cat(\"\\n=== TABLE 3: DISCRIMINATION COMPARISON ===\\n\") print(publication_result$results$concordanceComparison)  cat(\"\\n=== TABLE 4: RECLASSIFICATION METRICS ===\\n\") print(publication_result$results$nriResults)  cat(\"\\n=== TABLE 5: CLINICAL INTERPRETATION ===\\n\") print(publication_result$results$clinicalInterpretation)  cat(\"\\n=== EXECUTIVE SUMMARY ===\\n\") # Extract executive summary if available if (\"executiveSummary\" %in% names(publication_result$results)) {   print(publication_result$results$executiveSummary) }"},{"path":"https://www.serdarbalci.com/jsurvival/articles/1-stagemigration-comprehensive.html","id":"statistical-reporting-template","dir":"Articles","previous_headings":"Publication-Ready Analysis","what":"Statistical Reporting Template","title":"Advanced TNM Stage Migration Analysis: A Comprehensive Guide","text":"","code":"# Template for statistical reporting generate_methods_text <- function(result, cancer_type) {      cat(\"=== METHODS SECTION TEXT ===\\n\\n\")      cat(\"Statistical Analysis:\\n\")   cat(\"Stage migration analysis was performed using the ClinicoPath package in R. \")   cat(\"We compared the discriminative ability of the original and new staging systems \")   cat(\"using Harrell's C-index with 95% confidence intervals. Net Reclassification \")   cat(\"Improvement (NRI) was calculated at 6, 12, 24, 36, and 60 months to quantify \")   cat(\"improvement in risk classification. Integrated Discrimination Improvement (IDI) \")   cat(\"was used to assess overall improvement in predicted survival probabilities.\\n\\n\")      cat(\"Time-dependent receiver operating characteristic (ROC) analysis was performed \")   cat(\"to evaluate discriminative ability over time. Decision curve analysis (DCA) \")   cat(\"was used to assess the clinical utility of each staging system across different \")   cat(\"decision thresholds. Bootstrap validation with 2000 repetitions was performed \")   cat(\"to assess internal validity and apply optimism correction.\\n\\n\")      cat(\"Clinical significance was defined as C-index improvement ≥0.02 and NRI >20%. \")   cat(\"Likelihood ratio tests were used to compare nested models. All statistical \")   cat(\"tests were two-sided with significance level α=0.05.\\n\\n\")      cat(\"=== RESULTS SECTION TEXT ===\\n\\n\")      # Extract key results   concordance <- result$results$concordanceComparison$asDF   nri <- result$results$nriResults$asDF      c_index_old <- concordance$C_Index[concordance$Model == \"Old Staging\"]   c_index_new <- concordance$C_Index[concordance$Model == \"New Staging\"]   c_index_diff <- c_index_new - c_index_old      nri_24 <- nri$NRI[nri$TimePoint == \"24\"]   if (length(nri_24) == 0) nri_24 <- nri$NRI[1]      cat(sprintf(\"The original staging system achieved a C-index of %.3f (95%% CI: %.3f-%.3f), \",               c_index_old,                concordance$CI_Lower[concordance$Model == \"Old Staging\"],               concordance$CI_Upper[concordance$Model == \"Old Staging\"]))      cat(sprintf(\"while the new staging system achieved a C-index of %.3f (95%% CI: %.3f-%.3f), \",               c_index_new,               concordance$CI_Lower[concordance$Model == \"New Staging\"],               concordance$CI_Upper[concordance$Model == \"New Staging\"]))      cat(sprintf(\"representing an improvement of %.4f (p<0.001).\\n\\n\", c_index_diff))      cat(sprintf(\"The 24-month Net Reclassification Improvement was %.3f (95%% CI: %.3f-%.3f), \",               nri_24,               nri$NRI_CI_Lower[nri$TimePoint == \"24\"],               nri$NRI_CI_Upper[nri$TimePoint == \"24\"]))      if (nri_24 > 0.20) {     cat(\"indicating clinically significant improvement in risk classification.\\n\\n\")   } else {     cat(\"indicating modest improvement in risk classification.\\n\\n\")   }      cat(\"Bootstrap validation with optimism correction confirmed the stability of these results.\\n\\n\")      return(invisible(NULL)) }  # Generate methods and results text generate_methods_text(publication_result, \"lung\")"},{"path":[]},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/1-stagemigration-comprehensive.html","id":"small-sample-sizes","dir":"Articles","previous_headings":"Troubleshooting and Best Practices > Common Issues and Solutions","what":"Small Sample Sizes","title":"Advanced TNM Stage Migration Analysis: A Comprehensive Guide","text":"","code":"# Load small sample data load(\"stagemigration_small_sample.rda\")  # Analyze small sample with appropriate methods small_sample_result <- stagemigration(   data = small_sample_data,   oldStage = \"old_stage\",   newStage = \"new_stage\",   survivalTime = \"survival_time\",   event = \"event\",   eventLevel = \"1\",   analysisType = \"basic\",  # Use basic analysis for small samples      # Reduce bootstrap repetitions   performBootstrap = TRUE,   bootstrapReps = 500,      # Skip computationally intensive methods   performCrossValidation = FALSE,   performDCA = FALSE,      # Use wider confidence intervals   confidenceLevel = 0.90,      # Appropriate clinical thresholds   clinicalSignificanceThreshold = 0.03,  # More conservative   nriClinicalThreshold = 0.25 )  # Check sample size adequacy n_patients <- nrow(small_sample_data) n_events <- sum(small_sample_data$event) event_rate <- mean(small_sample_data$event)  cat(sprintf(\"Sample size: %d patients, %d events (%.1f%%)\\n\",              n_patients, n_events, event_rate * 100))  if (n_patients < 200) {   cat(\"WARNING: Small sample size may limit reliability of results\\n\") }  if (n_events < 50) {   cat(\"WARNING: Low event count may affect statistical power\\n\") }"},{"path":"https://www.serdarbalci.com/jsurvival/articles/1-stagemigration-comprehensive.html","id":"missing-data","dir":"Articles","previous_headings":"Troubleshooting and Best Practices > Common Issues and Solutions","what":"Handling Missing Data","title":"Advanced TNM Stage Migration Analysis: A Comprehensive Guide","text":"","code":"# Check for missing data check_missing_data <- function(data) {   missing_summary <- data %>%     summarise_all(~sum(is.na(.))) %>%     gather(variable, missing_count) %>%     mutate(missing_percent = round(missing_count / nrow(data) * 100, 1)) %>%     filter(missing_count > 0) %>%     arrange(desc(missing_count))      if (nrow(missing_summary) > 0) {     cat(\"Missing data detected:\\n\")     print(missing_summary)          # Recommendations     cat(\"\\nRecommendations:\\n\")     cat(\"• Consider multiple imputation for <10% missing\\n\")     cat(\"• Use complete case analysis for >10% missing\\n\")     cat(\"• Assess missingness pattern (MCAR, MAR, MNAR)\\n\")   } else {     cat(\"No missing data detected\\n\")   }      return(missing_summary) }  # Check example data missing_summary <- check_missing_data(lung_cancer_data)"},{"path":"https://www.serdarbalci.com/jsurvival/articles/1-stagemigration-comprehensive.html","id":"problematic-migration","dir":"Articles","previous_headings":"Troubleshooting and Best Practices > Common Issues and Solutions","what":"Problematic Migration Patterns","title":"Advanced TNM Stage Migration Analysis: A Comprehensive Guide","text":"","code":"# Load problematic data load(\"stagemigration_problematic.rda\")  # Analyze problematic migration patterns problematic_result <- stagemigration(   data = problematic_data,   oldStage = \"old_stage\",   newStage = \"new_stage\",   survivalTime = \"survival_time\",   event = \"event\",   eventLevel = \"1\",   analysisType = \"basic\",      # Conservative settings   confidenceLevel = 0.90,   clinicalSignificanceThreshold = 0.03,   nriClinicalThreshold = 0.30,      # Focus on basic metrics   calculateNRI = TRUE,   performBootstrap = FALSE,   showClinicalInterpretation = TRUE )  # Analyze migration patterns migration_analysis <- problematic_data %>%   count(old_stage, new_stage) %>%   group_by(old_stage) %>%   mutate(     total_in_old_stage = sum(n),     migration_rate = n / total_in_old_stage,     migration_type = case_when(       old_stage == new_stage ~ \"No Change\",       as.numeric(old_stage) < as.numeric(new_stage) ~ \"Upstaging\",       as.numeric(old_stage) > as.numeric(new_stage) ~ \"Downstaging\"     )   )  print(migration_analysis)  # Identify problematic patterns problematic_patterns <- migration_analysis %>%   filter(migration_rate > 0.5, migration_type != \"No Change\")  if (nrow(problematic_patterns) > 0) {   cat(\"WARNING: Problematic migration patterns detected:\\n\")   print(problematic_patterns)   cat(\"\\nConsider:\\n\")   cat(\"• Reviewing staging criteria\\n\")   cat(\"• Checking for systematic biases\\n\")   cat(\"• Validating in independent cohort\\n\") }"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/1-stagemigration-comprehensive.html","id":"data-preparation-best-practices","dir":"Articles","previous_headings":"Troubleshooting and Best Practices > Best Practices Summary","what":"Data Preparation","title":"Advanced TNM Stage Migration Analysis: A Comprehensive Guide","text":"Minimum 200 patients basic analysis Minimum 500 patients reliable advanced metrics least 100 events stable results Verify staging consistency Check missing data patterns Validate event definitions Use clinically relevant time points Consider cancer-specific survival patterns Include short-term long-term outcomes","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/1-stagemigration-comprehensive.html","id":"statistical-analysis-best-practices","dir":"Articles","previous_headings":"Troubleshooting and Best Practices > Best Practices Summary","what":"Statistical Analysis","title":"Advanced TNM Stage Migration Analysis: A Comprehensive Guide","text":"Use basic analysis small samples Use standard analysis validation studies Use comprehensive analysis publications Always perform bootstrap validation Use optimism correction Consider cross-validation large samples Define thresholds analysis Use cancer-specific thresholds available Consider statistical clinical significance","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/1-stagemigration-comprehensive.html","id":"interpretation-best-practices","dir":"Articles","previous_headings":"Troubleshooting and Best Practices > Best Practices Summary","what":"Interpretation","title":"Advanced TNM Stage Migration Analysis: A Comprehensive Guide","text":"Consider cancer type stage distribution Assess practical implementation challenges Evaluate cost-benefit implications Validate independent cohorts Consider different populations Assess generalizability Follow statistical reporting guidelines Include confidence intervals Provide clinical interpretation","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/1-stagemigration-comprehensive.html","id":"conclusion","dir":"Articles","previous_headings":"","what":"Conclusion","title":"Advanced TNM Stage Migration Analysis: A Comprehensive Guide","text":"enhanced stagemigration function provides comprehensive tools validating TNM staging improvements. Key features include:","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/1-stagemigration-comprehensive.html","id":"advanced-statistical-methods","dir":"Articles","previous_headings":"Conclusion","what":"Advanced Statistical Methods","title":"Advanced TNM Stage Migration Analysis: A Comprehensive Guide","text":"Harrell’s C-index bootstrap confidence intervals Net Reclassification Improvement (NRI) risk classification assessment Integrated Discrimination Improvement (IDI) prediction accuracy Time-dependent ROC analysis temporal discrimination Decision Curve Analysis clinical utility assessment","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/1-stagemigration-comprehensive.html","id":"clinical-decision-support","dir":"Articles","previous_headings":"Conclusion","what":"Clinical Decision Support","title":"Advanced TNM Stage Migration Analysis: A Comprehensive Guide","text":"Cancer-specific guidance appropriate thresholds Clinical significance assessment beyond statistical significance Implementation recommendations based evidence quality Effect size interpretation practical impact","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/1-stagemigration-comprehensive.html","id":"robust-validation","dir":"Articles","previous_headings":"Conclusion","what":"Robust Validation","title":"Advanced TNM Stage Migration Analysis: A Comprehensive Guide","text":"Bootstrap validation optimism correction Cross-validation independent assessment Stability testing across different scenarios Sensitivity analysis threshold selection","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/1-stagemigration-comprehensive.html","id":"publication-support","dir":"Articles","previous_headings":"Conclusion","what":"Publication Support","title":"Advanced TNM Stage Migration Analysis: A Comprehensive Guide","text":"Comprehensive reporting methodology notes Statistical summary tables manuscripts Executive summaries stakeholders Visualization outputs presentations analysis helps pathologists make evidence-based decisions staging system adoption, ensuring new systems provide meaningful improvements patient care clinical outcomes. additional support examples, refer ClinicoPath documentation package vignettes covering specific cancer types advanced use cases. vignette demonstrates comprehensive capabilities stagemigration function ClinicoPath. latest features updates, visit ClinicoPath GitHub repository.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/11-data-preparation.html","id":"overview","dir":"Articles","previous_headings":"","what":"Overview","title":"Data Preparation for Survival Analysis","text":"Proper data preparation crucial reliable survival analysis. vignette provides comprehensive guidance preparing data use jsurvival, covering common data issues solutions.","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/11-data-preparation.html","id":"required-variables","dir":"Articles","previous_headings":"Essential Data Components","what":"Required Variables","title":"Data Preparation for Survival Analysis","text":"Every survival analysis requires minimum: Time variable: Time study entry event censoring Event indicator: Binary variable indicating whether event occurred","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/11-data-preparation.html","id":"optional-variables","dir":"Articles","previous_headings":"Essential Data Components","what":"Optional Variables","title":"Data Preparation for Survival Analysis","text":"Grouping factors: comparing survival groups Continuous predictors: cut-point analysis multivariable models Date variables: calculating time intervals Stratification variables: adjusted analyses","code":""},{"path":[]},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/11-data-preparation.html","id":"using-built-in-time-interval-calculator","dir":"Articles","previous_headings":"Time Variable Preparation > Calculating Time from Dates","what":"Using Built-in Time Interval Calculator","title":"Data Preparation for Survival Analysis","text":"jsurvival module includes time interval calculator:","code":"# In jamovi: Survival → Data Preparation → Time Interval Calculator # Assign: # - Start Date: Study entry date (e.g., diagnosis_date) # - End Date: Event/censoring date (e.g., death_date or last_followup_date) # - Output Unit: months or years  # This creates a new variable with calculated time intervals"},{"path":"https://www.serdarbalci.com/jsurvival/articles/11-data-preparation.html","id":"manual-calculation-in-r","dir":"Articles","previous_headings":"Time Variable Preparation > Calculating Time from Dates","what":"Manual Calculation in R","title":"Data Preparation for Survival Analysis","text":"","code":"library(lubridate)  # Example data with dates clinical_data <- data.frame(   patient_id = 1:100,   diagnosis_date = as.Date(\"2020-01-01\") + sample(0:365, 100, replace = TRUE),   death_date = as.Date(\"2020-01-01\") + sample(200:1000, 100, replace = TRUE),   last_followup_date = as.Date(\"2023-12-31\") )  # Calculate time to death or censoring clinical_data$death_occurred <- !is.na(clinical_data$death_date) clinical_data$event_date <- ifelse(clinical_data$death_occurred,                                    clinical_data$death_date,                                    clinical_data$last_followup_date) clinical_data$event_date <- as.Date(clinical_data$event_date, origin = \"1970-01-01\")  # Time in months clinical_data$time_months <- as.numeric(   difftime(clinical_data$event_date, clinical_data$diagnosis_date, units = \"days\") ) / 30.44  # Average days per month  # Time in years clinical_data$time_years <- as.numeric(   difftime(clinical_data$event_date, clinical_data$diagnosis_date, units = \"days\") ) / 365.25  # Accounting for leap years"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/11-data-preparation.html","id":"left-truncation","dir":"Articles","previous_headings":"Time Variable Preparation > Handling Time Zero Issues","what":"Left Truncation","title":"Data Preparation for Survival Analysis","text":"","code":"# Patients entering study at different times # Example: analyzing from landmark time (e.g., 3 months post-diagnosis)  # Include only patients who survived to landmark landmark_time <- 3  # months eligible_data <- subset(clinical_data, time_months >= landmark_time)  # Adjust time origin to landmark eligible_data$time_from_landmark <- eligible_data$time_months - landmark_time"},{"path":"https://www.serdarbalci.com/jsurvival/articles/11-data-preparation.html","id":"negative-time-values","dir":"Articles","previous_headings":"Time Variable Preparation > Handling Time Zero Issues","what":"Negative Time Values","title":"Data Preparation for Survival Analysis","text":"","code":"# Check for and handle negative times negative_times <- clinical_data$time_months < 0 if(any(negative_times, na.rm = TRUE)) {   print(paste(\"Found\", sum(negative_times, na.rm = TRUE), \"negative time values\"))      # Options:   # 1. Exclude these patients   clinical_data <- clinical_data[!negative_times | is.na(negative_times), ]      # 2. Set to small positive value   # clinical_data$time_months[negative_times] <- 0.001      # 3. Investigate data entry errors   # View(clinical_data[negative_times, ]) }"},{"path":[]},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/11-data-preparation.html","id":"death-as-event","dir":"Articles","previous_headings":"Event Indicator Preparation > Creating Binary Event Variables","what":"Death as Event","title":"Data Preparation for Survival Analysis","text":"","code":"# From death status variable clinical_data$death_binary <- ifelse(clinical_data$vital_status == \"Dead\", 1, 0)  # From death date clinical_data$death_binary <- ifelse(is.na(clinical_data$death_date), 0, 1)  # Verify coding table(clinical_data$death_binary, clinical_data$vital_status, useNA = \"always\")"},{"path":"https://www.serdarbalci.com/jsurvival/articles/11-data-preparation.html","id":"other-events","dir":"Articles","previous_headings":"Event Indicator Preparation > Creating Binary Event Variables","what":"Other Events","title":"Data Preparation for Survival Analysis","text":"","code":"# Disease progression clinical_data$progression <- ifelse(clinical_data$progression_status == \"Progressive Disease\", 1, 0)  # Recurrence clinical_data$recurrence <- ifelse(!is.na(clinical_data$recurrence_date), 1, 0)  # Composite endpoint (death or progression, whichever comes first) clinical_data$death_or_progression <- pmax(clinical_data$death_binary,                                            clinical_data$progression,                                            na.rm = TRUE)"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/11-data-preparation.html","id":"competing-risks-setup","dir":"Articles","previous_headings":"Event Indicator Preparation > Multiple Event Types","what":"Competing Risks Setup","title":"Data Preparation for Survival Analysis","text":"","code":"# Create separate indicators for different event types clinical_data$death_cancer <- ifelse(clinical_data$death_cause == \"Cancer\", 1, 0) clinical_data$death_other <- ifelse(clinical_data$death_cause == \"Other\" |                                     clinical_data$death_cause == \"Cardiovascular\", 1, 0)  # For patients still alive, both should be 0 alive_patients <- clinical_data$vital_status == \"Alive\" clinical_data$death_cancer[alive_patients] <- 0 clinical_data$death_other[alive_patients] <- 0  # Verify: sum should equal total deaths table(clinical_data$death_cancer + clinical_data$death_other,        clinical_data$vital_status)"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/11-data-preparation.html","id":"consistency-checks","dir":"Articles","previous_headings":"Data Quality Checks","what":"Consistency Checks","title":"Data Preparation for Survival Analysis","text":"","code":"# Function to perform comprehensive data quality checks check_survival_data <- function(data, time_var, event_var) {      checks <- list()      # 1. Missing values   checks$missing_time <- sum(is.na(data[[time_var]]))   checks$missing_event <- sum(is.na(data[[event_var]]))      # 2. Negative or zero times   checks$negative_times <- sum(data[[time_var]] <= 0, na.rm = TRUE)      # 3. Event indicator values   event_values <- unique(data[[event_var]])   checks$valid_events <- all(event_values %in% c(0, 1, NA))   checks$event_table <- table(data[[event_var]], useNA = \"always\")      # 4. Extreme values   checks$extreme_times <- list(     max_time = max(data[[time_var]], na.rm = TRUE),     min_time = min(data[[time_var]], na.rm = TRUE),     outliers = sum(data[[time_var]] > quantile(data[[time_var]], 0.99, na.rm = TRUE), na.rm = TRUE)   )      # 5. Event rate   checks$event_rate <- mean(data[[event_var]], na.rm = TRUE)      return(checks) }  # Run checks data_quality <- check_survival_data(clinical_data, \"time_months\", \"death_binary\") print(data_quality)"},{"path":"https://www.serdarbalci.com/jsurvival/articles/11-data-preparation.html","id":"outlier-detection","dir":"Articles","previous_headings":"Data Quality Checks","what":"Outlier Detection","title":"Data Preparation for Survival Analysis","text":"","code":"# Identify potential outliers in survival times Q1 <- quantile(clinical_data$time_months, 0.25, na.rm = TRUE) Q3 <- quantile(clinical_data$time_months, 0.75, na.rm = TRUE) IQR <- Q3 - Q1  # Define outliers using 1.5 * IQR rule lower_bound <- Q1 - 1.5 * IQR upper_bound <- Q3 + 1.5 * IQR  outliers <- clinical_data$time_months < lower_bound | clinical_data$time_months > upper_bound print(paste(\"Found\", sum(outliers, na.rm = TRUE), \"potential outliers\"))  # Review outliers if(sum(outliers, na.rm = TRUE) > 0) {   outlier_data <- clinical_data[outliers & !is.na(outliers),                                 c(\"patient_id\", \"time_months\", \"death_binary\")]   print(outlier_data) }"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/11-data-preparation.html","id":"missing-data-patterns","dir":"Articles","previous_headings":"Handling Missing Data","what":"Missing Data Patterns","title":"Data Preparation for Survival Analysis","text":"","code":"# Assess missing data patterns library(VIM)  # Visualization and Imputation of Missing values  # Create missingness indicator clinical_data$time_missing <- is.na(clinical_data$time_months) clinical_data$event_missing <- is.na(clinical_data$death_binary)  # Missing data summary missing_summary <- clinical_data %>%   summarise(     n_total = n(),     time_missing = sum(time_missing),     event_missing = sum(event_missing),     both_missing = sum(time_missing & event_missing),     complete_cases = sum(!time_missing & !event_missing)   )  print(missing_summary)"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/11-data-preparation.html","id":"complete-case-analysis","dir":"Articles","previous_headings":"Handling Missing Data > Strategies for Missing Data","what":"Complete Case Analysis","title":"Data Preparation for Survival Analysis","text":"","code":"# Use only patients with complete survival data complete_data <- clinical_data[!is.na(clinical_data$time_months) &                                !is.na(clinical_data$death_binary), ]  print(paste(\"Complete cases:\", nrow(complete_data), \"of\", nrow(clinical_data)))"},{"path":"https://www.serdarbalci.com/jsurvival/articles/11-data-preparation.html","id":"administrative-censoring","dir":"Articles","previous_headings":"Handling Missing Data > Strategies for Missing Data","what":"Administrative Censoring","title":"Data Preparation for Survival Analysis","text":"","code":"# For missing death dates, censor at last known follow-up clinical_data$time_months_imputed <- clinical_data$time_months clinical_data$death_binary_imputed <- clinical_data$death_binary  # If death status missing but last follow-up available, assume alive missing_death <- is.na(clinical_data$death_binary) & !is.na(clinical_data$last_followup_date) if(any(missing_death)) {   clinical_data$death_binary_imputed[missing_death] <- 0   clinical_data$time_months_imputed[missing_death] <-      as.numeric(difftime(clinical_data$last_followup_date[missing_death],                        clinical_data$diagnosis_date[missing_death],                         units = \"days\")) / 30.44 }"},{"path":[]},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/11-data-preparation.html","id":"factor-ordering","dir":"Articles","previous_headings":"Explanatory Variable Preparation > Categorical Variables","what":"Factor Ordering","title":"Data Preparation for Survival Analysis","text":"","code":"# Ensure proper ordering for categorical variables clinical_data$tumor_grade <- factor(clinical_data$tumor_grade,                                     levels = c(\"Grade 1\", \"Grade 2\", \"Grade 3\", \"Grade 4\"),                                    ordered = TRUE)  clinical_data$stage <- factor(clinical_data$stage,                              levels = c(\"Stage I\", \"Stage II\", \"Stage III\", \"Stage IV\"),                              ordered = TRUE)  # For unordered factors, set reference level clinical_data$treatment <- factor(clinical_data$treatment) clinical_data$treatment <- relevel(clinical_data$treatment, ref = \"Standard\")"},{"path":"https://www.serdarbalci.com/jsurvival/articles/11-data-preparation.html","id":"handling-rare-categories","dir":"Articles","previous_headings":"Explanatory Variable Preparation > Categorical Variables","what":"Handling Rare Categories","title":"Data Preparation for Survival Analysis","text":"","code":"# Combine rare categories to ensure adequate sample sizes table(clinical_data$histology)  # Combine categories with <10 patients rare_histologies <- names(table(clinical_data$histology))[table(clinical_data$histology) < 10] clinical_data$histology_grouped <- as.character(clinical_data$histology) clinical_data$histology_grouped[clinical_data$histology_grouped %in% rare_histologies] <- \"Other\" clinical_data$histology_grouped <- factor(clinical_data$histology_grouped)  table(clinical_data$histology_grouped)"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/11-data-preparation.html","id":"age-preparation","dir":"Articles","previous_headings":"Explanatory Variable Preparation > Continuous Variables","what":"Age Preparation","title":"Data Preparation for Survival Analysis","text":"","code":"# Check age distribution summary(clinical_data$age_at_diagnosis)  # Create age groups if needed clinical_data$age_group <- cut(clinical_data$age_at_diagnosis,                               breaks = c(0, 50, 65, 80, Inf),                               labels = c(\"≤50\", \"51-65\", \"66-80\", \">80\"),                               include.lowest = TRUE)  # Age as decades clinical_data$age_decades <- floor(clinical_data$age_at_diagnosis / 10) * 10"},{"path":"https://www.serdarbalci.com/jsurvival/articles/11-data-preparation.html","id":"biomarker-preparation","dir":"Articles","previous_headings":"Explanatory Variable Preparation > Continuous Variables","what":"Biomarker Preparation","title":"Data Preparation for Survival Analysis","text":"","code":"# Log transformation for skewed biomarkers clinical_data$log_biomarker <- log10(clinical_data$biomarker_value + 1)  # Standardization (z-score) clinical_data$biomarker_zscore <- scale(clinical_data$biomarker_value)[,1]  # Handle extreme values biomarker_99th <- quantile(clinical_data$biomarker_value, 0.99, na.rm = TRUE) clinical_data$biomarker_winsorized <- pmin(clinical_data$biomarker_value, biomarker_99th)"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/11-data-preparation.html","id":"cross-validation-with-source-data","dir":"Articles","previous_headings":"Data Validation","what":"Cross-Validation with Source Data","title":"Data Preparation for Survival Analysis","text":"","code":"# Compare calculated times with expected ranges validation_checks <- function(data) {   issues <- list()      # Check if all events occurred before end of study   study_end <- as.Date(\"2023-12-31\")   late_events <- data$event_date > study_end & data$death_binary == 1   issues$late_events <- sum(late_events, na.rm = TRUE)      # Check if follow-up times are reasonable   unreasonable_followup <- data$time_months > 240  # > 20 years   issues$long_followup <- sum(unreasonable_followup, na.rm = TRUE)      # Check for impossible age at events   impossible_age <- data$age_at_diagnosis < 0 | data$age_at_diagnosis > 120   issues$impossible_age <- sum(impossible_age, na.rm = TRUE)      return(issues) }  validation_results <- validation_checks(clinical_data) print(validation_results)"},{"path":"https://www.serdarbalci.com/jsurvival/articles/11-data-preparation.html","id":"final-dataset-preparation","dir":"Articles","previous_headings":"Data Validation","what":"Final Dataset Preparation","title":"Data Preparation for Survival Analysis","text":"","code":"# Create final analysis dataset analysis_data <- clinical_data %>%   # Include only complete cases for primary analysis   filter(!is.na(time_months), !is.na(death_binary)) %>%   # Remove patients with negative or zero follow-up time   filter(time_months > 0) %>%   # Remove patients with missing key covariates   filter(!is.na(age_at_diagnosis), !is.na(stage)) %>%   # Select relevant variables   select(     patient_id,     time_months,     death_binary,     age_at_diagnosis,     age_group,     sex,     stage,     tumor_grade,     treatment,     biomarker_value,     histology_grouped   )  # Final data summary cat(\"Final analysis dataset:\\n\") cat(\"N =\", nrow(analysis_data), \"\\n\") cat(\"Events =\", sum(analysis_data$death_binary), \"\\n\") cat(\"Event rate =\", round(mean(analysis_data$death_binary) * 100, 1), \"%\\n\") cat(\"Median follow-up =\", round(median(analysis_data$time_months), 1), \"months\\n\")"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/11-data-preparation.html","id":"csv-export","dir":"Articles","previous_headings":"Export for jamovi","what":"CSV Export","title":"Data Preparation for Survival Analysis","text":"","code":"# Export cleaned data for use in jamovi write.csv(analysis_data, \"survival_analysis_data.csv\", row.names = FALSE)  # Include data dictionary data_dictionary <- data.frame(   variable = names(analysis_data),   description = c(     \"Patient identifier\",     \"Time from diagnosis to death or censoring (months)\",     \"Death indicator (1=death, 0=alive/censored)\",     \"Age at diagnosis (years)\",     \"Age group categories\",     \"Patient sex\",     \"Cancer stage\",     \"Tumor grade\",     \"Treatment received\",     \"Biomarker value\",     \"Histology type (grouped)\"   ),   type = c(     \"Identifier\",     \"Continuous\",     \"Binary\",     \"Continuous\",      \"Categorical\",     \"Categorical\",     \"Ordinal\",     \"Ordinal\",     \"Categorical\",     \"Continuous\",     \"Categorical\"   ) )  write.csv(data_dictionary, \"data_dictionary.csv\", row.names = FALSE)"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/11-data-preparation.html","id":"pre-analysis-checklist","dir":"Articles","previous_headings":"Quality Assurance Checklist","what":"Pre-Analysis Checklist","title":"Data Preparation for Survival Analysis","text":"proceeding survival analysis, verify: Time variable contains negative zero values Event indicator properly coded (0/1 /Yes) Missing data patterns assessed addressed Categorical variables appropriate reference levels Continuous variables checked outliers Data types correct (numeric, factor, date) Sample size adequate (rule thumb: 10 events per variable) Follow-time sufficient meaningful analysis","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/11-data-preparation.html","id":"common-data-preparation-mistakes","dir":"Articles","previous_headings":"Quality Assurance Checklist","what":"Common Data Preparation Mistakes","title":"Data Preparation for Survival Analysis","text":"Incorrect time calculation: Using calendar time instead time study entry Wrong event coding: Mixing 0 1 events censoring Including impossible values: Negative times, events last follow-Ignoring competing risks: Treating deaths event type Improper handling missing data: Excluding many patients without justification checking assumptions: Ignoring data distribution outliers","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/11-data-preparation.html","id":"conclusion","dir":"Articles","previous_headings":"","what":"Conclusion","title":"Data Preparation for Survival Analysis","text":"Proper data preparation essential reliable survival analysis results. Key principles include: Careful time calculation appropriate handling dates time zero Consistent event coding validation source data Comprehensive quality checks identify resolve data issues Appropriate handling missing data based missingness patterns Proper preparation explanatory variables attention clinical meaning Taking time thorough data preparation ensure reliable interpretable survival analysis results jsurvival.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/14-comparing-survival.html","id":"introduction","dir":"Articles","previous_headings":"","what":"Introduction","title":"jSurvival 14: Comparing Survival Outcomes Between Groups","text":"Comparing survival outcomes different groups fundamental aspect clinical research oncology studies. comparingsurvival function jSurvival provides comprehensive tools performing group-wise survival comparisons using Kaplan-Meier estimation log-rank tests, enhanced visualization capabilities. Learning Objectives: Master group-wise survival comparisons using Kaplan-Meier methods Interpret log-rank test results statistical significance Create publication-ready survival curves group stratification Understand hazard ratios median survival differences Apply proper statistical methodology survival group comparisons Identify survival differences clinically meaningful","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/14-comparing-survival.html","id":"module-overview","dir":"Articles","previous_headings":"Introduction","what":"Module Overview","title":"jSurvival 14: Comparing Survival Outcomes Between Groups","text":"comparingsurvival function provides:","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/14-comparing-survival.html","id":"statistical-methods","dir":"Articles","previous_headings":"Introduction > Module Overview","what":"1. Statistical Methods","title":"jSurvival 14: Comparing Survival Outcomes Between Groups","text":"Kaplan-Meier Estimation: Non-parametric survival curves group Log-rank Test: Statistical comparison survival distributions Hazard Ratio Estimation: Measure relative risk groups Confidence Intervals: Uncertainty quantification survival estimates","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/14-comparing-survival.html","id":"visualization-features","dir":"Articles","previous_headings":"Introduction > Module Overview","what":"2. Visualization Features","title":"jSurvival 14: Comparing Survival Outcomes Between Groups","text":"Survival Curves: Group-stratified Kaplan-Meier plots Risk Tables: Number risk specified time points Confidence Bands: Visual representation estimation uncertainty Statistical Annotations: P-values test statistics plots","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/14-comparing-survival.html","id":"clinical-applications","dir":"Articles","previous_headings":"Introduction > Module Overview","what":"3. Clinical Applications","title":"jSurvival 14: Comparing Survival Outcomes Between Groups","text":"Treatment Comparisons: Compare therapeutic interventions Biomarker Stratification: Evaluate prognostic markers Risk Group Analysis: Compare different risk categories Subgroup Analysis: Examine specific patient populations","code":"library(jsurvival) library(survival) library(dplyr)"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/14-comparing-survival.html","id":"sample-data-overview","dir":"Articles","previous_headings":"Getting Started","what":"Sample Data Overview","title":"jSurvival 14: Comparing Survival Outcomes Between Groups","text":"’ll use comprehensive clinical datasets demonstrate survival comparisons across different scenarios.","code":"# Load clinical survival data data(ihc_molecular_comprehensive)  # Dataset overview cat(\"Dataset dimensions:\", nrow(ihc_molecular_comprehensive), \"×\", ncol(ihc_molecular_comprehensive), \"\\n\")  # Key survival variables survival_vars <- c(\"Overall_Survival_Months\", \"Death_Event\", \"PFS_Months\", \"Progression_Event\") cat(\"Survival variables:\", paste(survival_vars, collapse = \", \"), \"\\n\")  # Grouping variables for comparison grouping_vars <- c(\"EGFR_Mutation\", \"Grade\", \"MSI_Status\", \"HER2_IHC\") cat(\"Grouping variables:\", paste(grouping_vars, collapse = \", \"), \"\\n\")  # Basic survival statistics by key groups survival_by_egfr <- ihc_molecular_comprehensive %>%   group_by(EGFR_Mutation) %>%   summarise(     n = n(),     events = sum(Death_Event),     event_rate = round(mean(Death_Event) * 100, 1),     median_survival = median(Overall_Survival_Months),     .groups = 'drop'   )  cat(\"\\nSurvival by EGFR Mutation Status:\\n\") print(survival_by_egfr)"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/14-comparing-survival.html","id":"basic-survival-comparison","dir":"Articles","previous_headings":"Core Functionality","what":"1. Basic Survival Comparison","title":"jSurvival 14: Comparing Survival Outcomes Between Groups","text":"Fundamental two-group survival comparison.","code":"# Basic Survival Comparison Example # In jamovi: jsurvival > Comparing Survival  cat(\"Basic Survival Comparison: EGFR Mutation Status\\n\") cat(\"===============================================\\n\\n\")  if(requireNamespace(\"survival\", quietly = TRUE)) {   library(survival)      # Create survival object   surv_obj <- Surv(ihc_molecular_comprehensive$Overall_Survival_Months,                    ihc_molecular_comprehensive$Death_Event)      # Kaplan-Meier analysis by EGFR status   km_egfr <- survfit(surv_obj ~ EGFR_Mutation, data = ihc_molecular_comprehensive)      cat(\"Survival Summary by EGFR Status:\\n\")   summary_table <- summary(km_egfr, times = c(12, 24, 36, 48, 60))$table   print(summary_table)      # Extract median survival times   median_survivals <- summary(km_egfr)$table[, \"median\"]   names(median_survivals) <- c(\"EGFR Negative\", \"EGFR Positive\")      cat(\"\\nMedian Survival Times:\\n\")   for(i in 1:length(median_survivals)) {     cat(names(median_survivals)[i], \":\", median_survivals[i], \"months\\n\")   }      # Calculate survival difference   survival_diff <- abs(diff(median_survivals))   cat(\"Difference in median survival:\", round(survival_diff, 1), \"months\\n\")      # Log-rank test   logrank_test <- survdiff(surv_obj ~ EGFR_Mutation, data = ihc_molecular_comprehensive)   chi_square <- logrank_test$chisq   p_value <- 1 - pchisq(chi_square, 1)      cat(\"\\nLog-rank Test Results:\\n\")   cat(\"Chi-square statistic:\", round(chi_square, 3), \"\\n\")   cat(\"P-value:\", round(p_value, 4), \"\\n\")   cat(\"Degrees of freedom: 1\\n\")      # Statistical interpretation   if(p_value < 0.001) {     cat(\"Interpretation: Highly significant difference (p < 0.001)\\n\")   } else if(p_value < 0.01) {     cat(\"Interpretation: Highly significant difference (p < 0.01)\\n\")   } else if(p_value < 0.05) {     cat(\"Interpretation: Significant difference (p < 0.05)\\n\")   } else {     cat(\"Interpretation: No significant difference (p ≥ 0.05)\\n\")   }      # Effect size (hazard ratio approximation)   cox_simple <- coxph(surv_obj ~ EGFR_Mutation, data = ihc_molecular_comprehensive)   hr <- exp(cox_simple$coefficients)   hr_ci <- exp(confint(cox_simple))      cat(\"\\nHazard Ratio Analysis:\\n\")   cat(\"Hazard Ratio:\", round(hr, 2), \"\\n\")   cat(\"95% Confidence Interval:\", round(hr_ci[1], 2), \"-\", round(hr_ci[2], 2), \"\\n\")      if(hr > 1) {     cat(\"Interpretation: EGFR positive patients have\", round(hr, 2), \"times higher hazard of death\\n\")   } else {     cat(\"Interpretation: EGFR positive patients have\", round(1/hr, 2), \"times lower hazard of death\\n\")   } }"},{"path":"https://www.serdarbalci.com/jsurvival/articles/14-comparing-survival.html","id":"multi-group-comparison","dir":"Articles","previous_headings":"Core Functionality","what":"2. Multi-Group Comparison","title":"jSurvival 14: Comparing Survival Outcomes Between Groups","text":"Compare survival across multiple groups simultaneously.","code":"# Multi-Group Survival Comparison # Comparing across tumor grades  cat(\"\\nMulti-Group Survival Comparison: Tumor Grade\\n\") cat(\"===========================================\\n\\n\")  if(requireNamespace(\"survival\", quietly = TRUE)) {   # Survival by tumor grade (3 groups)   km_grade <- survfit(surv_obj ~ Grade, data = ihc_molecular_comprehensive)      cat(\"Survival Summary by Tumor Grade:\\n\")   grade_summary <- summary(km_grade, times = c(12, 24, 36, 48, 60))$table   print(grade_summary)      # Median survival by grade   grade_medians <- summary(km_grade)$table[, \"median\"]   grade_names <- paste(\"Grade\", 1:length(grade_medians))   names(grade_medians) <- grade_names      cat(\"\\nMedian Survival by Grade:\\n\")   for(i in 1:length(grade_medians)) {     cat(names(grade_medians)[i], \":\", grade_medians[i], \"months\\n\")   }      # Overall log-rank test   logrank_grade <- survdiff(surv_obj ~ Grade, data = ihc_molecular_comprehensive)   chi_square_grade <- logrank_grade$chisq   df_grade <- length(unique(ihc_molecular_comprehensive$Grade)) - 1   p_value_grade <- 1 - pchisq(chi_square_grade, df_grade)      cat(\"\\nOverall Log-rank Test:\\n\")   cat(\"Chi-square statistic:\", round(chi_square_grade, 3), \"\\n\")   cat(\"Degrees of freedom:\", df_grade, \"\\n\")   cat(\"P-value:\", round(p_value_grade, 4), \"\\n\")      # Pairwise comparisons (if overall test is significant)   if(p_value_grade < 0.05) {     cat(\"\\nPairwise Comparisons:\\n\")     grades <- unique(ihc_molecular_comprehensive$Grade)     grades <- grades[!is.na(grades)]          for(i in 1:(length(grades)-1)) {       for(j in (i+1):length(grades)) {         grade_subset <- ihc_molecular_comprehensive[ihc_molecular_comprehensive$Grade %in% c(grades[i], grades[j]), ]         if(nrow(grade_subset) > 0) {           surv_subset <- Surv(grade_subset$Overall_Survival_Months, grade_subset$Death_Event)           logrank_pair <- survdiff(surv_subset ~ Grade, data = grade_subset)           p_pair <- 1 - pchisq(logrank_pair$chisq, 1)                      cat(paste0(\"Grade \", grades[i], \" vs Grade \", grades[j], \": p = \", round(p_pair, 4), \"\\n\"))         }       }     }   }      # Clinical significance assessment   max_diff <- max(grade_medians, na.rm = TRUE) - min(grade_medians, na.rm = TRUE)   cat(\"\\nClinical Significance:\\n\")   cat(\"Range of median survivals:\", round(max_diff, 1), \"months\\n\")      if(max_diff >= 12) {     cat(\"Interpretation: Clinically meaningful difference (≥12 months)\\n\")   } else if(max_diff >= 6) {     cat(\"Interpretation: Moderate clinical difference (6-12 months)\\n\")   } else {     cat(\"Interpretation: Limited clinical difference (<6 months)\\n\")   } }"},{"path":"https://www.serdarbalci.com/jsurvival/articles/14-comparing-survival.html","id":"biomarker-stratification-analysis","dir":"Articles","previous_headings":"Core Functionality","what":"3. Biomarker Stratification Analysis","title":"jSurvival 14: Comparing Survival Outcomes Between Groups","text":"Evaluate survival differences molecular biomarkers.","code":"# Biomarker-Based Survival Stratification cat(\"\\nBiomarker Stratification Analysis\\n\") cat(\"=================================\\n\\n\")  # Multiple biomarker analysis biomarkers <- list(   \"MSI_Status\" = \"Microsatellite Instability\",   \"HER2_IHC\" = \"HER2 Expression\",   \"EGFR_Mutation\" = \"EGFR Mutation Status\" )  biomarker_results <- list()  for(biomarker in names(biomarkers)) {   cat(paste0(\"Analysis: \", biomarkers[[biomarker]], \" (\", biomarker, \")\\n\"))   cat(paste0(rep(\"-\", nchar(biomarkers[[biomarker]]) + nchar(biomarker) + 12), collapse = \"\"), \"\\n\")      # Filter out missing values   complete_data <- ihc_molecular_comprehensive[!is.na(ihc_molecular_comprehensive[[biomarker]]), ]      if(nrow(complete_data) > 0) {     # Survival analysis     surv_bio <- Surv(complete_data$Overall_Survival_Months, complete_data$Death_Event)     formula_str <- paste(\"surv_bio ~\", biomarker)     km_bio <- survfit(as.formula(formula_str), data = complete_data)          # Summary statistics     bio_summary <- summary(km_bio)$table     print(bio_summary)          # Log-rank test     logrank_bio <- survdiff(as.formula(formula_str), data = complete_data)     p_bio <- 1 - pchisq(logrank_bio$chisq, nrow(bio_summary) - 1)          cat(\"Log-rank test p-value:\", round(p_bio, 4), \"\\n\")          # Cox regression for hazard ratio     cox_bio <- coxph(as.formula(formula_str), data = complete_data)     hr_bio <- exp(cox_bio$coefficients)          if(length(hr_bio) == 1) {  # Binary biomarker       hr_ci_bio <- exp(confint(cox_bio))       cat(\"Hazard Ratio:\", round(hr_bio, 2), \"(95% CI:\", round(hr_ci_bio[1], 2), \"-\", round(hr_ci_bio[2], 2), \")\\n\")     }          # Store results     biomarker_results[[biomarker]] <- list(       p_value = p_bio,       significant = p_bio < 0.05,       summary = bio_summary     )          # Interpretation     if(p_bio < 0.001) {       cat(\"Result: Highly significant prognostic biomarker (p < 0.001)\\n\")     } else if(p_bio < 0.01) {       cat(\"Result: Highly significant prognostic biomarker (p < 0.01)\\n\")     } else if(p_bio < 0.05) {       cat(\"Result: Significant prognostic biomarker (p < 0.05)\\n\")     } else {       cat(\"Result: Not a significant prognostic biomarker (p ≥ 0.05)\\n\")     }   } else {     cat(\"Insufficient data for analysis\\n\")     biomarker_results[[biomarker]] <- list(p_value = NA, significant = FALSE)   }      cat(\"\\n\") }  # Summary of biomarker findings cat(\"Biomarker Analysis Summary:\\n\") cat(\"===========================\\n\") significant_biomarkers <- names(biomarker_results)[sapply(biomarker_results, function(x) x$significant)] if(length(significant_biomarkers) > 0) {   cat(\"Significant prognostic biomarkers:\\n\")   for(bio in significant_biomarkers) {     p_val <- biomarker_results[[bio]]$p_value     cat(paste0(\"- \", biomarkers[[bio]], \" (p = \", round(p_val, 4), \")\\n\"))   } } else {   cat(\"No significant prognostic biomarkers identified\\n\") }"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/14-comparing-survival.html","id":"time-to-progression-analysis","dir":"Articles","previous_headings":"Advanced Applications","what":"4. Time-to-Progression Analysis","title":"jSurvival 14: Comparing Survival Outcomes Between Groups","text":"Compare progression-free survival groups.","code":"# Time-to-Progression Comparison cat(\"\\nProgression-Free Survival Analysis\\n\") cat(\"==================================\\n\\n\")  if(requireNamespace(\"survival\", quietly = TRUE)) {   # Create PFS survival object   pfs_surv <- Surv(ihc_molecular_comprehensive$PFS_Months,                    ihc_molecular_comprehensive$Progression_Event)      # PFS by treatment-relevant biomarker (e.g., EGFR)   km_pfs <- survfit(pfs_surv ~ EGFR_Mutation, data = ihc_molecular_comprehensive)      cat(\"Progression-Free Survival by EGFR Status:\\n\")   pfs_summary <- summary(km_pfs, times = c(6, 12, 18, 24, 30))$table   print(pfs_summary)      # Median PFS   pfs_medians <- summary(km_pfs)$table[, \"median\"]   cat(\"\\nMedian PFS Times:\\n\")   cat(\"EGFR Negative:\", pfs_medians[1], \"months\\n\")   cat(\"EGFR Positive:\", pfs_medians[2], \"months\\n\")      # Statistical test   logrank_pfs <- survdiff(pfs_surv ~ EGFR_Mutation, data = ihc_molecular_comprehensive)   p_pfs <- 1 - pchisq(logrank_pfs$chisq, 1)      cat(\"\\nLog-rank Test for PFS:\\n\")   cat(\"P-value:\", round(p_pfs, 4), \"\\n\")      # Compare OS vs PFS findings   os_p <- biomarker_results[[\"EGFR_Mutation\"]]$p_value   cat(\"\\nOS vs PFS Comparison:\\n\")   cat(\"Overall Survival p-value:\", round(os_p, 4), \"\\n\")   cat(\"Progression-Free Survival p-value:\", round(p_pfs, 4), \"\\n\")      if(os_p < 0.05 && p_pfs < 0.05) {     cat(\"Interpretation: EGFR status affects both OS and PFS\\n\")   } else if(p_pfs < 0.05) {     cat(\"Interpretation: EGFR status primarily affects PFS\\n\")   } else if(os_p < 0.05) {     cat(\"Interpretation: EGFR status primarily affects OS\\n\")   } else {     cat(\"Interpretation: EGFR status does not significantly affect survival outcomes\\n\")   } }"},{"path":"https://www.serdarbalci.com/jsurvival/articles/14-comparing-survival.html","id":"subgroup-analysis","dir":"Articles","previous_headings":"Advanced Applications","what":"5. Subgroup Analysis","title":"jSurvival 14: Comparing Survival Outcomes Between Groups","text":"Examine survival differences within specific patient subgroups.","code":"# Subgroup Survival Analysis cat(\"\\nSubgroup Analysis: High-Grade Tumors\\n\") cat(\"===================================\\n\\n\")  # Focus on high-grade tumors (Grade 3) high_grade <- ihc_molecular_comprehensive[ihc_molecular_comprehensive$Grade == 3, ]  if(nrow(high_grade) > 20) {  # Ensure adequate sample size   cat(\"High-grade tumor cohort size:\", nrow(high_grade), \"patients\\n\")      # Survival in high-grade tumors by EGFR status   surv_hg <- Surv(high_grade$Overall_Survival_Months, high_grade$Death_Event)   km_hg <- survfit(surv_hg ~ EGFR_Mutation, data = high_grade)      cat(\"\\nSurvival in High-Grade Tumors by EGFR Status:\\n\")   hg_summary <- summary(km_hg, times = c(12, 24, 36))$table   print(hg_summary)      # Statistical test in subgroup   logrank_hg <- survdiff(surv_hg ~ EGFR_Mutation, data = high_grade)   p_hg <- 1 - pchisq(logrank_hg$chisq, 1)      cat(\"Log-rank test p-value in high-grade subgroup:\", round(p_hg, 4), \"\\n\")      # Compare to overall population   overall_p <- biomarker_results[[\"EGFR_Mutation\"]]$p_value   cat(\"\\nSubgroup vs Overall Population:\\n\")   cat(\"Overall population p-value:\", round(overall_p, 4), \"\\n\")   cat(\"High-grade subgroup p-value:\", round(p_hg, 4), \"\\n\")      if(p_hg < 0.05 && overall_p >= 0.05) {     cat(\"Interpretation: EGFR effect is significant only in high-grade tumors\\n\")   } else if(p_hg >= 0.05 && overall_p < 0.05) {     cat(\"Interpretation: EGFR effect is diluted in high-grade subgroup\\n\")   } else if(p_hg < overall_p) {     cat(\"Interpretation: EGFR effect is stronger in high-grade tumors\\n\")   } else {     cat(\"Interpretation: EGFR effect is consistent across grades\\n\")   } } else {   cat(\"Insufficient sample size for subgroup analysis\\n\") }"},{"path":"https://www.serdarbalci.com/jsurvival/articles/14-comparing-survival.html","id":"risk-based-stratification","dir":"Articles","previous_headings":"Advanced Applications","what":"6. Risk-Based Stratification","title":"jSurvival 14: Comparing Survival Outcomes Between Groups","text":"Create risk groups compare survival outcomes.","code":"# Risk-Based Survival Stratification cat(\"\\nRisk-Based Survival Stratification\\n\") cat(\"==================================\\n\\n\")  # Create composite risk score risk_data <- ihc_molecular_comprehensive %>%   mutate(     # Risk factors (higher = worse prognosis)     age_risk = ifelse(Age > 65, 1, 0),     grade_risk = ifelse(Grade == 3, 1, 0),     egfr_risk = ifelse(EGFR_Mutation == \"Positive\", 1, 0),          # Protective factors (higher = better prognosis)     msi_protective = ifelse(MSI_Status == \"MSI-High\", 1, 0),          # Composite risk score (0-3, higher = worse)     risk_score = age_risk + grade_risk + egfr_risk - msi_protective   ) %>%   mutate(     # Risk groups     risk_group = case_when(       risk_score <= 0 ~ \"Low Risk\",       risk_score == 1 ~ \"Intermediate Risk\",        risk_score >= 2 ~ \"High Risk\"     ),     risk_group = factor(risk_group, levels = c(\"Low Risk\", \"Intermediate Risk\", \"High Risk\"))   )  # Risk group distribution cat(\"Risk Group Distribution:\\n\") risk_dist <- table(risk_data$risk_group) print(risk_dist) cat(\"Percentages:\", round(prop.table(risk_dist) * 100, 1), \"%\\n\")  # Survival by risk group if(requireNamespace(\"survival\", quietly = TRUE)) {   surv_risk <- Surv(risk_data$Overall_Survival_Months, risk_data$Death_Event)   km_risk <- survfit(surv_risk ~ risk_group, data = risk_data)      cat(\"\\nSurvival by Risk Group:\\n\")   risk_summary <- summary(km_risk, times = c(12, 24, 36, 48))$table   print(risk_summary)      # Risk group medians   risk_medians <- summary(km_risk)$table[, \"median\"]   cat(\"\\nMedian Survival by Risk Group:\\n\")   for(i in 1:length(risk_medians)) {     cat(levels(risk_data$risk_group)[i], \":\", risk_medians[i], \"months\\n\")   }      # Statistical test for risk stratification   logrank_risk <- survdiff(surv_risk ~ risk_group, data = risk_data)   chi_sq_risk <- logrank_risk$chisq   df_risk <- length(levels(risk_data$risk_group)) - 1   p_risk <- 1 - pchisq(chi_sq_risk, df_risk)      cat(\"\\nRisk Stratification Test:\\n\")   cat(\"Chi-square:\", round(chi_sq_risk, 3), \"\\n\")   cat(\"P-value:\", round(p_risk, 4), \"\\n\")      # Trend test   risk_numeric <- as.numeric(risk_data$risk_group)   cox_trend <- coxph(surv_risk ~ risk_numeric, data = risk_data)   trend_p <- summary(cox_trend)$coefficients[, \"Pr(>|z|)\"]   hr_trend <- exp(cox_trend$coefficients)      cat(\"\\nTrend Analysis:\\n\")   cat(\"Hazard ratio per risk level:\", round(hr_trend, 2), \"\\n\")   cat(\"Trend test p-value:\", round(trend_p, 4), \"\\n\")      # Model performance   c_index <- summary(cox_trend)$concordance[1]   cat(\"Concordance index:\", round(c_index, 3), \"\\n\")      if(c_index >= 0.7) {     cat(\"Risk model performance: Excellent (C-index ≥ 0.7)\\n\")   } else if(c_index >= 0.6) {     cat(\"Risk model performance: Good (C-index 0.6-0.7)\\n\")   } else {     cat(\"Risk model performance: Poor (C-index < 0.6)\\n\")   } }"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/14-comparing-survival.html","id":"power-and-sample-size","dir":"Articles","previous_headings":"Statistical Considerations","what":"Power and Sample Size","title":"jSurvival 14: Comparing Survival Outcomes Between Groups","text":"Important considerations survival comparisons.","code":"# Sample Size and Power Considerations cat(\"Sample Size and Power Analysis\\n\") cat(\"==============================\\n\\n\")  # Current study characteristics total_n <- nrow(ihc_molecular_comprehensive) events <- sum(ihc_molecular_comprehensive$Death_Event) event_rate <- mean(ihc_molecular_comprehensive$Death_Event)  cat(\"Current Study Characteristics:\\n\") cat(\"Total sample size:\", total_n, \"\\n\") cat(\"Total events:\", events, \"\\n\") cat(\"Overall event rate:\", round(event_rate * 100, 1), \"%\\n\")  # Group sizes for major comparisons egfr_groups <- table(ihc_molecular_comprehensive$EGFR_Mutation) cat(\"\\nEGFR Group Sizes:\\n\") print(egfr_groups)  # Events per group egfr_events <- ihc_molecular_comprehensive %>%   group_by(EGFR_Mutation) %>%   summarise(     n = n(),     events = sum(Death_Event),     event_rate = round(mean(Death_Event) * 100, 1),     .groups = 'drop'   )  cat(\"\\nEvents by EGFR Status:\\n\") print(egfr_events)  # Power estimation guidelines min_events_per_group <- 10 adequate_events <- all(egfr_events$events >= min_events_per_group)  cat(\"\\nPower Assessment:\\n\") cat(\"Minimum events per group recommended:\", min_events_per_group, \"\\n\") cat(\"Adequate events per group:\", adequate_events, \"\\n\")  if(adequate_events) {   cat(\"Conclusion: Adequate power for primary comparisons\\n\") } else {   cat(\"Conclusion: Limited power - consider pooling groups or longer follow-up\\n\") }  # Effect size detectability median_diff_detectable <- sqrt(4 / min(egfr_events$events)) * 12  # Rough approximation cat(\"Approximately detectable median survival difference:\", round(median_diff_detectable, 1), \"months\\n\")"},{"path":"https://www.serdarbalci.com/jsurvival/articles/14-comparing-survival.html","id":"multiple-comparisons","dir":"Articles","previous_headings":"Statistical Considerations","what":"Multiple Comparisons","title":"jSurvival 14: Comparing Survival Outcomes Between Groups","text":"Addressing multiple testing survival comparisons.","code":"# Multiple Comparisons Adjustment cat(\"\\nMultiple Comparisons Consideration\\n\") cat(\"=================================\\n\\n\")  # Collect all p-values from biomarker analyses all_p_values <- sapply(biomarker_results, function(x) x$p_value) all_p_values <- all_p_values[!is.na(all_p_values)]  cat(\"Raw P-values from Biomarker Analyses:\\n\") for(i in 1:length(all_p_values)) {   cat(names(all_p_values)[i], \":\", round(all_p_values[i], 4), \"\\n\") }  # Bonferroni correction bonferroni_alpha <- 0.05 / length(all_p_values) bonferroni_significant <- all_p_values < bonferroni_alpha  cat(\"\\nBonferroni Correction:\\n\") cat(\"Adjusted alpha level:\", round(bonferroni_alpha, 4), \"\\n\") cat(\"Significant after Bonferroni correction:\\n\") if(any(bonferroni_significant)) {   for(i in which(bonferroni_significant)) {     cat(names(all_p_values)[i], \": p =\", round(all_p_values[i], 4), \"< α =\", round(bonferroni_alpha, 4), \"\\n\")   } } else {   cat(\"None remain significant after correction\\n\") }  # False Discovery Rate (FDR) control if(requireNamespace(\"stats\", quietly = TRUE)) {   fdr_adjusted <- p.adjust(all_p_values, method = \"fdr\")   fdr_significant <- fdr_adjusted < 0.05      cat(\"\\nFalse Discovery Rate (FDR) Adjustment:\\n\")   for(i in 1:length(all_p_values)) {     cat(names(all_p_values)[i], \": raw p =\", round(all_p_values[i], 4),          \", FDR p =\", round(fdr_adjusted[i], 4), \"\\n\")   }      cat(\"\\nSignificant after FDR correction:\\n\")   if(any(fdr_significant)) {     for(i in which(fdr_significant)) {       cat(names(all_p_values)[i], \": FDR p =\", round(fdr_adjusted[i], 4), \"< 0.05\\n\")     }   } else {     cat(\"None remain significant after FDR correction\\n\")   } }  # Recommendation cat(\"\\nRecommendation:\\n\") if(length(all_p_values) <= 3) {   cat(\"With\", length(all_p_values), \"comparisons, multiple testing adjustment may not be necessary\\n\") } else if(any(fdr_significant)) {   cat(\"Use FDR-adjusted p-values for interpretation\\n\") } else if(any(bonferroni_significant)) {   cat(\"Conservative Bonferroni correction identifies significant findings\\n\") } else {   cat(\"Consider exploratory interpretation due to multiple testing\\n\") }"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/14-comparing-survival.html","id":"clinical-significance","dir":"Articles","previous_headings":"Best Practices and Interpretation","what":"Clinical Significance","title":"jSurvival 14: Comparing Survival Outcomes Between Groups","text":"Guidelines interpreting survival differences.","code":"# Clinical Significance Assessment cat(\"Clinical Significance Guidelines\\n\") cat(\"===============================\\n\\n\")  # Establish clinical significance thresholds clinically_meaningful_months <- 6  # Minimum meaningful difference highly_meaningful_months <- 12     # Highly meaningful difference  cat(\"Clinical Significance Thresholds:\\n\") cat(\"Meaningful difference: ≥\", clinically_meaningful_months, \"months\\n\") cat(\"Highly meaningful difference: ≥\", highly_meaningful_months, \"months\\n\\n\")  # Assess each comparison cat(\"Clinical Significance Assessment:\\n\") cat(\"=================================\\n\")  # EGFR comparison example if(\"EGFR_Mutation\" %in% names(biomarker_results) && biomarker_results[[\"EGFR_Mutation\"]]$significant) {   egfr_medians <- summary(survfit(Surv(Overall_Survival_Months, Death_Event) ~ EGFR_Mutation,                                   data = ihc_molecular_comprehensive))$table[, \"median\"]   egfr_diff <- abs(diff(egfr_medians))      cat(\"EGFR Mutation Status:\\n\")   cat(\"Median survival difference:\", round(egfr_diff, 1), \"months\\n\")   cat(\"Statistical significance: Yes (p < 0.05)\\n\")      if(egfr_diff >= highly_meaningful_months) {     cat(\"Clinical significance: Highly meaningful (≥12 months)\\n\")   } else if(egfr_diff >= clinically_meaningful_months) {     cat(\"Clinical significance: Meaningful (6-12 months)\\n\")   } else {     cat(\"Clinical significance: Limited (<6 months)\\n\")   }      # Additional considerations   cat(\"Additional considerations:\\n\")   if(egfr_diff >= clinically_meaningful_months) {     cat(\"- Difference likely to be noticeable to patients and families\\n\")     cat(\"- May influence treatment decisions\\n\")     cat(\"- Consider for biomarker-guided therapy\\n\")   } else {     cat(\"- Difference may be too small to be clinically relevant\\n\")     cat(\"- Statistical significance may not translate to clinical utility\\n\")     cat(\"- Consider as prognostic information only\\n\")   } }  # General interpretation framework cat(\"\\nGeneral Interpretation Framework:\\n\") cat(\"- Statistical significance indicates reliable difference\\n\") cat(\"- Clinical significance requires meaningful survival benefit\\n\") cat(\"- Consider both statistical and clinical significance together\\n\") cat(\"- Account for confidence intervals and uncertainty\\n\") cat(\"- Evaluate biological plausibility of findings\\n\")"},{"path":"https://www.serdarbalci.com/jsurvival/articles/14-comparing-survival.html","id":"reporting-guidelines","dir":"Articles","previous_headings":"Best Practices and Interpretation","what":"Reporting Guidelines","title":"jSurvival 14: Comparing Survival Outcomes Between Groups","text":"Comprehensive reporting survival comparisons.","code":"# Reporting Guidelines for Survival Comparisons cat(\"Reporting Guidelines\\n\") cat(\"===================\\n\\n\")  cat(\"Essential Elements to Report:\\n\") cat(\"1. Study Population:\\n\") cat(\"   - Total sample size:\", nrow(ihc_molecular_comprehensive), \"\\n\") cat(\"   - Follow-up characteristics\\n\") cat(\"   - Censoring pattern\\n\\n\")  cat(\"2. Descriptive Statistics:\\n\") cat(\"   - Group sizes and event rates\\n\") cat(\"   - Median follow-up time\\n\") cat(\"   - Median survival times with confidence intervals\\n\\n\")  cat(\"3. Statistical Tests:\\n\") cat(\"   - Log-rank test statistics and p-values\\n\") cat(\"   - Hazard ratios with 95% confidence intervals\\n\") cat(\"   - Multiple comparison adjustments (if applicable)\\n\\n\")  cat(\"4. Visualization:\\n\") cat(\"   - Kaplan-Meier survival curves\\n\") cat(\"   - Number at risk tables\\n\") cat(\"   - Confidence bands (optional)\\n\\n\")  cat(\"5. Clinical Interpretation:\\n\") cat(\"   - Clinical significance assessment\\n\") cat(\"   - Biological plausibility\\n\") cat(\"   - Limitations and potential biases\\n\\n\")  # Example results summary cat(\"Example Results Summary:\\n\") cat(\"========================\\n\") cat(\"Among\", nrow(ihc_molecular_comprehensive), \"patients with comprehensive molecular profiling,\") cat(\"survival comparisons were performed for key biomarkers.\\n\")  significant_findings <- sum(sapply(biomarker_results, function(x) x$significant)) cat(\"Of\", length(biomarker_results), \"biomarkers evaluated,\", significant_findings,      \"showed statistically significant survival differences.\\n\")  if(significant_findings > 0) {   cat(\"These findings suggest potential prognostic value for molecular stratification\")   cat(\"in this patient population.\\n\") } else {   cat(\"No significant prognostic biomarkers were identified in this analysis.\\n\") }"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/14-comparing-survival.html","id":"using-comparingsurvival-in-jamovi","dir":"Articles","previous_headings":"Integration with jamovi","what":"Using comparingsurvival in jamovi","title":"jSurvival 14: Comparing Survival Outcomes Between Groups","text":"Step--step guide jamovi users.","code":"# jamovi Integration Guide cat(\"Using comparingsurvival in jamovi\\n\") cat(\"=================================\\n\\n\")  cat(\"Step-by-Step Instructions:\\n\") cat(\"1. Data Preparation:\\n\") cat(\"   - Ensure survival time variable (continuous)\\n\") cat(\"   - Event indicator variable (0/1 or logical)\\n\") cat(\"   - Grouping variable (categorical)\\n\\n\")  cat(\"2. Access the Function:\\n\") cat(\"   - Navigate to: jSurvival → Comparing Survival\\n\") cat(\"   - Or use: Analyses → ClinicoPath → jSurvival → Comparing Survival\\n\\n\")  cat(\"3. Variable Assignment:\\n\") cat(\"   - Time Variable: Select survival time column\\n\") cat(\"   - Event Variable: Select event indicator\\n\") cat(\"   - Groups: Select grouping variable\\n\\n\")  cat(\"4. Output Options:\\n\") cat(\"   - Survival curves: Check for Kaplan-Meier plots\\n\") cat(\"   - Statistics: Check for detailed statistical output\\n\") cat(\"   - Risk tables: Check for number at risk tables\\n\\n\")  cat(\"5. Interpretation:\\n\") cat(\"   - Review log-rank test p-value\\n\") cat(\"   - Examine survival curves visually\\n\") cat(\"   - Check median survival differences\\n\") cat(\"   - Consider clinical significance\\n\\n\")  # Common variable formats cat(\"Common Variable Formats:\\n\") cat(\"- Time: months, days, years (numeric)\\n\") cat(\"- Event: 1=event, 0=censored (or TRUE/FALSE)\\n\") cat(\"- Groups: factor levels (e.g., 'Control', 'Treatment')\\n\\n\")  cat(\"Troubleshooting:\\n\") cat(\"- Ensure no missing values in key variables\\n\") cat(\"- Check that event rates are reasonable (>5% per group)\\n\") cat(\"- Verify adequate sample sizes per group\\n\") cat(\"- Confirm proper variable types\\n\")"},{"path":"https://www.serdarbalci.com/jsurvival/articles/14-comparing-survival.html","id":"conclusion","dir":"Articles","previous_headings":"","what":"Conclusion","title":"jSurvival 14: Comparing Survival Outcomes Between Groups","text":"comparingsurvival function provides comprehensive tools group-wise survival comparisons, basic two-group analyses complex multi-biomarker evaluations. Proper application requires attention statistical methodology clinical interpretation.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/14-comparing-survival.html","id":"key-takeaways","dir":"Articles","previous_headings":"Conclusion","what":"Key Takeaways","title":"jSurvival 14: Comparing Survival Outcomes Between Groups","text":"Statistical Rigor: Use appropriate methods (Kaplan-Meier, log-rank tests) Clinical Relevance: Consider statistical clinical significance Multiple Comparisons: Adjust multiple testing appropriate Sample Size: Ensure adequate power meaningful comparisons Interpretation: Balance statistical findings biological plausibility","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/14-comparing-survival.html","id":"next-steps","dir":"Articles","previous_headings":"Conclusion","what":"Next Steps","title":"jSurvival 14: Comparing Survival Outcomes Between Groups","text":"Explore advanced survival modeling Cox regression Consider competing risks analysis complex outcomes Integrate findings ClinicoPath modules Develop prognostic models based significant biomarkers vignette demonstrates comprehensive survival comparison methodology using comparingsurvival function. Apply principles clinical datasets robust survival analysis.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/15-competing-survival.html","id":"introduction","dir":"Articles","previous_headings":"","what":"Introduction","title":"jSurvival 15: Competing Survival Analysis","text":"Competing survival analysis essential patients can experience multiple types events prevent occurrence primary event interest. competingsurvival function jSurvival provides comprehensive tools analyzing overall survival, cause-specific survival, competing risks scenarios using advanced statistical methods. Learning Objectives: Understand differences overall, cause-specific, competing risks survival analysis Master application Fine-Gray subdistribution hazard models Interpret cumulative incidence functions competing risks scenarios Apply competing survival methods real-world clinical datasets Create publication-ready competing risks plots tables Understand use type survival analysis","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/15-competing-survival.html","id":"module-overview","dir":"Articles","previous_headings":"Introduction","what":"Module Overview","title":"jSurvival 15: Competing Survival Analysis","text":"competingsurvival function provides three complementary analysis approaches:","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/15-competing-survival.html","id":"overall-survival-analysis","dir":"Articles","previous_headings":"Introduction > Module Overview","what":"1. Overall Survival Analysis","title":"jSurvival 15: Competing Survival Analysis","text":"Purpose: Analyze -cause mortality regardless specific cause Event Definition: death (disease-related causes) vs. alive Use Cases: Primary endpoint many clinical trials, population health studies Statistical Method: Standard Kaplan-Meier Cox regression","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/15-competing-survival.html","id":"cause-specific-survival-analysis","dir":"Articles","previous_headings":"Introduction > Module Overview","what":"2. Cause-Specific Survival Analysis","title":"jSurvival 15: Competing Survival Analysis","text":"Purpose: Focus exclusively disease-specific deaths Event Definition: Disease death vs. censored (including deaths) Use Cases: causes death considered nuisance events Limitation: May overestimate survival competing risks substantial","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/15-competing-survival.html","id":"competing-risks-analysis","dir":"Articles","previous_headings":"Introduction > Module Overview","what":"3. Competing Risks Analysis","title":"jSurvival 15: Competing Survival Analysis","text":"Purpose: Account multiple competing events simultaneously Event Definition: Disease death vs. death vs. alive outcomes Statistical Method: Fine-Gray subdistribution hazard model cumulative incidence functions Advantage: Provides realistic probability estimates accounting competition","code":"library(jsurvival) library(survival) library(dplyr)"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/15-competing-survival.html","id":"sample-data-overview","dir":"Articles","previous_headings":"Getting Started","what":"Sample Data Overview","title":"jSurvival 15: Competing Survival Analysis","text":"’ll use comprehensive competing survival dataset designed specifically analysis type.","code":"# Load competing survival data data(competing_survival_data)  # Dataset overview cat(\"Dataset dimensions:\", nrow(competing_survival_data), \"×\", ncol(competing_survival_data), \"\\n\")  # Key survival variables survival_vars <- c(\"Overall_Time\", \"Outcome\") cat(\"Survival variables:\", paste(survival_vars, collapse = \", \"), \"\\n\")  # Explanatory variables for stratification explanatory_vars <- c(\"Treatment\", \"Tumor_Stage\", \"EGFR_Status\", \"Grade\") cat(\"Explanatory variables:\", paste(explanatory_vars, collapse = \", \"), \"\\n\")  # Outcome distribution outcome_summary <- competing_survival_data %>%   group_by(Outcome) %>%   summarise(     n = n(),     percentage = round(n() / nrow(competing_survival_data) * 100, 1),     median_time = round(median(Overall_Time), 1),     .groups = 'drop'   )  cat(\"\\nOutcome Distribution:\\n\") print(outcome_summary)  # Treatment group summary treatment_outcome <- competing_survival_data %>%   group_by(Treatment, Outcome) %>%   summarise(n = n(), .groups = 'drop') %>%   tidyr::pivot_wider(names_from = Outcome, values_from = n, values_fill = 0)  cat(\"\\nTreatment by Outcome:\\n\") print(treatment_outcome)"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/15-competing-survival.html","id":"overall-survival-analysis-1","dir":"Articles","previous_headings":"Core Competing Survival Analysis","what":"1. Overall Survival Analysis","title":"jSurvival 15: Competing Survival Analysis","text":"Analyze -cause mortality treating death event.","code":"# Overall Survival Analysis Example # In jamovi: jsurvival > Competing Survival > Analysis Type: Overall  cat(\"Overall Survival Analysis\\n\") cat(\"========================\\n\\n\")  if(requireNamespace(\"survival\", quietly = TRUE) &&     requireNamespace(\"finalfit\", quietly = TRUE)) {      # Create overall survival indicator   os_data <- competing_survival_data %>%     mutate(       death_overall = ifelse(Outcome %in% c(\"Dead_of_Disease\", \"Dead_of_Other\"), 1, 0)     )      # Kaplan-Meier analysis by treatment   surv_obj <- Surv(os_data$Overall_Time, os_data$death_overall)   km_overall <- survfit(surv_obj ~ Treatment, data = os_data)      cat(\"Overall Survival Summary by Treatment:\\n\")   os_summary <- summary(km_overall, times = c(6, 12, 24, 36))$table   print(os_summary)      # Log-rank test   logrank_test <- survdiff(surv_obj ~ Treatment, data = os_data)   p_value <- 1 - pchisq(logrank_test$chisq, 1)      cat(\"\\nLog-rank Test Results:\\n\")   cat(\"Chi-square statistic:\", round(logrank_test$chisq, 3), \"\\n\")   cat(\"P-value:\", round(p_value, 4), \"\\n\")      if(p_value < 0.05) {     cat(\"Conclusion: Significant difference in overall survival by treatment\\n\")   } else {     cat(\"Conclusion: No significant difference in overall survival by treatment\\n\")   }      # Cox regression for hazard ratio   cox_model <- coxph(surv_obj ~ Treatment, data = os_data)   hr <- exp(cox_model$coefficients)   hr_ci <- exp(confint(cox_model))      cat(\"\\nHazard Ratio Analysis:\\n\")   cat(\"Hazard Ratio:\", round(hr, 2), \"\\n\")   cat(\"95% Confidence Interval:\", round(hr_ci[1], 2), \"-\", round(hr_ci[2], 2), \"\\n\")      treatment_levels <- levels(os_data$Treatment)   cat(\"Interpretation:\", treatment_levels[2], \"vs\", treatment_levels[1], \"\\n\") }"},{"path":"https://www.serdarbalci.com/jsurvival/articles/15-competing-survival.html","id":"cause-specific-survival-analysis-1","dir":"Articles","previous_headings":"Core Competing Survival Analysis","what":"2. Cause-Specific Survival Analysis","title":"jSurvival 15: Competing Survival Analysis","text":"Focus exclusively disease-specific deaths, treating deaths censored.","code":"# Cause-Specific Survival Analysis Example # In jamovi: jsurvival > Competing Survival > Analysis Type: Cause Specific  cat(\"\\nCause-Specific Survival Analysis\\n\") cat(\"=================================\\n\\n\")  if(requireNamespace(\"survival\", quietly = TRUE) &&     requireNamespace(\"finalfit\", quietly = TRUE)) {      # Create cause-specific survival indicator   css_data <- competing_survival_data %>%     mutate(       death_disease = ifelse(Outcome == \"Dead_of_Disease\", 1, 0)     )      # Kaplan-Meier analysis for disease-specific survival   surv_css <- Surv(css_data$Overall_Time, css_data$death_disease)   km_css <- survfit(surv_css ~ Treatment, data = css_data)      cat(\"Cause-Specific Survival Summary by Treatment:\\n\")   css_summary <- summary(km_css, times = c(6, 12, 24, 36))$table   print(css_summary)      # Log-rank test for cause-specific survival   logrank_css <- survdiff(surv_css ~ Treatment, data = css_data)   p_css <- 1 - pchisq(logrank_css$chisq, 1)      cat(\"\\nCause-Specific Log-rank Test:\\n\")   cat(\"Chi-square statistic:\", round(logrank_css$chisq, 3), \"\\n\")   cat(\"P-value:\", round(p_css, 4), \"\\n\")      # Cox regression for cause-specific hazard ratio   cox_css <- coxph(surv_css ~ Treatment, data = css_data)   hr_css <- exp(cox_css$coefficients)   hr_ci_css <- exp(confint(cox_css))      cat(\"\\nCause-Specific Hazard Ratio:\\n\")   cat(\"Hazard Ratio:\", round(hr_css, 2), \"\\n\")   cat(\"95% Confidence Interval:\", round(hr_ci_css[1], 2), \"-\", round(hr_ci_css[2], 2), \"\\n\")      # Compare with overall survival   cat(\"\\nComparison with Overall Survival:\\n\")   cat(\"Disease-specific deaths:\", sum(css_data$death_disease), \"of\", nrow(css_data),        \"(\", round(mean(css_data$death_disease) * 100, 1), \"%)\\n\")      other_deaths <- sum(competing_survival_data$Outcome == \"Dead_of_Other\")   cat(\"Other deaths:\", other_deaths, \"(\",        round(other_deaths / nrow(css_data) * 100, 1), \"%)\\n\")      if(other_deaths / nrow(css_data) > 0.1) {     cat(\"Note: Substantial competing mortality present - consider competing risks analysis\\n\")   } }"},{"path":"https://www.serdarbalci.com/jsurvival/articles/15-competing-survival.html","id":"competing-risks-analysis-1","dir":"Articles","previous_headings":"Core Competing Survival Analysis","what":"3. Competing Risks Analysis","title":"jSurvival 15: Competing Survival Analysis","text":"Account multiple competing events using Fine-Gray subdistribution hazard models.","code":"# Competing Risks Analysis Example   # In jamovi: jsurvival > Competing Survival > Analysis Type: Competing Risk  cat(\"\\nCompeting Risks Analysis\\n\") cat(\"=======================\\n\\n\")  if(requireNamespace(\"survival\", quietly = TRUE) &&     requireNamespace(\"finalfit\", quietly = TRUE) &&    requireNamespace(\"cmprsk\", quietly = TRUE)) {      # Create competing risks status variable   crr_data <- competing_survival_data %>%     mutate(       status_crr = case_when(         Outcome %in% c(\"Alive_w_Disease\", \"Alive_wo_Disease\") ~ 0,  # censored         Outcome == \"Dead_of_Disease\" ~ 1,                          # disease death         Outcome == \"Dead_of_Other\" ~ 2,                            # competing death         TRUE ~ 0       ),       Treatment_numeric = as.numeric(Treatment) - 1  # for cmprsk     )      cat(\"Competing Events Summary:\\n\")   event_summary <- crr_data %>%     group_by(status_crr) %>%     summarise(       n = n(),       percentage = round(n() / nrow(crr_data) * 100, 1),       .groups = 'drop'     ) %>%     mutate(       event_type = case_when(         status_crr == 0 ~ \"Censored/Alive\",         status_crr == 1 ~ \"Disease Death\",          status_crr == 2 ~ \"Other Death\"       )     )   print(event_summary[, c(\"event_type\", \"n\", \"percentage\")])      # Fine-Gray competing risks regression   library(cmprsk)   cuminc_result <- cuminc(     ftime = crr_data$Overall_Time,     fstatus = crr_data$status_crr,     group = crr_data$Treatment   )      cat(\"\\nCumulative Incidence Function Results:\\n\")      # Extract cumulative incidence estimates at key time points   time_points <- c(12, 24, 36)      for (tp in time_points) {     cat(paste0(\"\\nAt \", tp, \" months:\\n\"))          # Find closest time point in results     for (i in 1:length(cuminc_result)) {       group_name <- names(cuminc_result)[i]       times <- cuminc_result[[i]]$time       est <- cuminc_result[[i]]$est              closest_idx <- which.min(abs(times - tp))       if (length(closest_idx) > 0) {         cat(paste0(group_name, \": \", round(est[closest_idx] * 100, 1), \"%\\n\"))       }     }   }      # Fine-Gray regression for treatment effect   crr_fit <- crr(     ftime = crr_data$Overall_Time,     fstatus = crr_data$status_crr,      cov1 = crr_data$Treatment_numeric,     failcode = 1  # disease death   )      cat(\"\\nFine-Gray Regression Results (Disease Death):\\n\")   cat(\"Subdistribution Hazard Ratio:\", round(exp(crr_fit$coef), 2), \"\\n\")   cat(\"95% Confidence Interval:\", round(exp(crr_fit$coef - 1.96*sqrt(crr_fit$var)), 2),        \"-\", round(exp(crr_fit$coef + 1.96*sqrt(crr_fit$var)), 2), \"\\n\")   cat(\"P-value:\", round(2 * (1 - pnorm(abs(crr_fit$coef / sqrt(crr_fit$var)))), 4), \"\\n\")      # Clinical interpretation   cat(\"\\nClinical Interpretation:\\n\")   if (exp(crr_fit$coef) > 1) {     cat(\"Experimental therapy associated with higher subdistribution hazard of disease death\\n\")   } else {     cat(\"Experimental therapy associated with lower subdistribution hazard of disease death\\n\")   } }"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/15-competing-survival.html","id":"stratified-analysis-by-disease-stage","dir":"Articles","previous_headings":"Advanced Applications","what":"4. Stratified Analysis by Disease Stage","title":"jSurvival 15: Competing Survival Analysis","text":"Evaluate competing survival patterns across different disease stages.","code":"# Stratified Competing Risks Analysis by Tumor Stage cat(\"\\nStratified Analysis by Tumor Stage\\n\") cat(\"==================================\\n\\n\")  # Stage distribution stage_dist <- competing_survival_data %>%   group_by(Tumor_Stage) %>%   summarise(     n = n(),     disease_deaths = sum(Outcome == \"Dead_of_Disease\"),     other_deaths = sum(Outcome == \"Dead_of_Other\"),     alive = sum(Outcome %in% c(\"Alive_w_Disease\", \"Alive_wo_Disease\")),     .groups = 'drop'   ) %>%   mutate(     disease_death_rate = round(disease_deaths / n * 100, 1),     other_death_rate = round(other_deaths / n * 100, 1)   )  cat(\"Disease and Other Death Rates by Stage:\\n\") print(stage_dist[, c(\"Tumor_Stage\", \"n\", \"disease_death_rate\", \"other_death_rate\")])  # Competing risks analysis by stage if(requireNamespace(\"cmprsk\", quietly = TRUE)) {   stage_data <- competing_survival_data %>%     mutate(       status_crr = case_when(         Outcome %in% c(\"Alive_w_Disease\", \"Alive_wo_Disease\") ~ 0,         Outcome == \"Dead_of_Disease\" ~ 1,         Outcome == \"Dead_of_Other\" ~ 2,         TRUE ~ 0       )     )      # Cumulative incidence by stage   stage_cuminc <- cuminc(     ftime = stage_data$Overall_Time,     fstatus = stage_data$status_crr,     group = stage_data$Tumor_Stage   )      cat(\"\\nCumulative Incidence at 24 months by Stage:\\n\")   for (i in 1:length(stage_cuminc)) {     group_name <- names(stage_cuminc)[i]     times <- stage_cuminc[[i]]$time     est <- stage_cuminc[[i]]$est          # Find 24-month estimate     closest_24m <- which.min(abs(times - 24))     if (length(closest_24m) > 0) {       cat(paste0(group_name, \": \", round(est[closest_24m] * 100, 1), \"%\\n\"))     }   }      # Trend analysis across stages   stage_numeric <- as.numeric(factor(stage_data$Tumor_Stage,                                      levels = c(\"I\", \"II\", \"III\", \"IV\")))      stage_crr <- crr(     ftime = stage_data$Overall_Time,     fstatus = stage_data$status_crr,     cov1 = stage_numeric,     failcode = 1   )      cat(\"\\nTrend Analysis Across Stages (per stage increase):\\n\")   cat(\"Subdistribution HR:\", round(exp(stage_crr$coef), 2), \"\\n\")   cat(\"95% CI:\", round(exp(stage_crr$coef - 1.96*sqrt(stage_crr$var)), 2),        \"-\", round(exp(stage_crr$coef + 1.96*sqrt(stage_crr$var)), 2), \"\\n\")      trend_p <- 2 * (1 - pnorm(abs(stage_crr$coef / sqrt(stage_crr$var))))   cat(\"P for trend:\", round(trend_p, 4), \"\\n\")      if (trend_p < 0.05) {     cat(\"Conclusion: Significant trend of increasing disease death risk with advancing stage\\n\")   } }"},{"path":"https://www.serdarbalci.com/jsurvival/articles/15-competing-survival.html","id":"biomarker-based-competing-risks-analysis","dir":"Articles","previous_headings":"Advanced Applications","what":"5. Biomarker-Based Competing Risks Analysis","title":"jSurvival 15: Competing Survival Analysis","text":"Evaluate prognostic biomarkers context competing risks.","code":"# Biomarker Analysis in Competing Risks Context cat(\"\\nBiomarker Analysis: EGFR Status\\n\") cat(\"===============================\\n\\n\")  # EGFR status distribution egfr_summary <- competing_survival_data %>%   group_by(EGFR_Status, Outcome) %>%   summarise(n = n(), .groups = 'drop') %>%   group_by(EGFR_Status) %>%   mutate(     total = sum(n),     percentage = round(n / total * 100, 1)   )  cat(\"Outcome Distribution by EGFR Status:\\n\") print(egfr_summary[, c(\"EGFR_Status\", \"Outcome\", \"n\", \"percentage\")])  # Competing risks analysis by EGFR status if(requireNamespace(\"cmprsk\", quietly = TRUE)) {   egfr_data <- competing_survival_data %>%     mutate(       status_crr = case_when(         Outcome %in% c(\"Alive_w_Disease\", \"Alive_wo_Disease\") ~ 0,         Outcome == \"Dead_of_Disease\" ~ 1,         Outcome == \"Dead_of_Other\" ~ 2,         TRUE ~ 0       ),       EGFR_numeric = ifelse(EGFR_Status == \"Positive\", 1, 0)     )      # Cumulative incidence by EGFR status   egfr_cuminc <- cuminc(     ftime = egfr_data$Overall_Time,     fstatus = egfr_data$status_crr,     group = egfr_data$EGFR_Status   )      cat(\"\\nCumulative Incidence Comparison (EGFR Positive vs Negative):\\n\")      time_points <- c(12, 24, 36)   for (tp in time_points) {     cat(paste0(\"\\nAt \", tp, \" months:\\n\"))          for (i in 1:length(egfr_cuminc)) {       group_name <- names(egfr_cuminc)[i]       times <- egfr_cuminc[[i]]$time       est <- egfr_cuminc[[i]]$est              closest_idx <- which.min(abs(times - tp))       if (length(closest_idx) > 0) {         cat(paste0(\"  \", group_name, \": \", round(est[closest_idx] * 100, 1), \"%\\n\"))       }     }   }      # Fine-Gray regression for EGFR effect   egfr_crr <- crr(     ftime = egfr_data$Overall_Time,     fstatus = egfr_data$status_crr,     cov1 = egfr_data$EGFR_numeric,     failcode = 1   )      cat(\"\\nEGFR Status Effect on Disease Death (Positive vs Negative):\\n\")   cat(\"Subdistribution HR:\", round(exp(egfr_crr$coef), 2), \"\\n\")   cat(\"95% CI:\", round(exp(egfr_crr$coef - 1.96*sqrt(egfr_crr$var)), 2),        \"-\", round(exp(egfr_crr$coef + 1.96*sqrt(egfr_crr$var)), 2), \"\\n\")      egfr_p <- 2 * (1 - pnorm(abs(egfr_crr$coef / sqrt(egfr_crr$var))))   cat(\"P-value:\", round(egfr_p, 4), \"\\n\")      if (egfr_p < 0.05) {     if (exp(egfr_crr$coef) > 1) {       cat(\"Interpretation: EGFR-positive tumors have significantly higher disease death risk\\n\")     } else {       cat(\"Interpretation: EGFR-positive tumors have significantly lower disease death risk\\n\")     }   } else {     cat(\"Interpretation: No significant association between EGFR status and disease death risk\\n\")   } }"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/15-competing-survival.html","id":"model-assumptions-and-validation","dir":"Articles","previous_headings":"Statistical Considerations","what":"Model Assumptions and Validation","title":"jSurvival 15: Competing Survival Analysis","text":"Important considerations competing risks analysis.","code":"# Statistical Assumptions and Model Validation cat(\"Statistical Considerations for Competing Risks Analysis\\n\") cat(\"======================================================\\n\\n\")  # Sample size considerations total_events <- sum(competing_survival_data$Outcome %in% c(\"Dead_of_Disease\", \"Dead_of_Other\")) disease_events <- sum(competing_survival_data$Outcome == \"Dead_of_Disease\") other_events <- sum(competing_survival_data$Outcome == \"Dead_of_Other\")  cat(\"Sample Size Assessment:\\n\") cat(\"Total patients:\", nrow(competing_survival_data), \"\\n\") cat(\"Total events:\", total_events, \"(\", round(total_events/nrow(competing_survival_data)*100, 1), \"%)\\n\") cat(\"Disease deaths:\", disease_events, \"(\", round(disease_events/nrow(competing_survival_data)*100, 1), \"%)\\n\") cat(\"Other deaths:\", other_events, \"(\", round(other_events/nrow(competing_survival_data)*100, 1), \"%)\\n\")  # Power considerations min_events_per_group <- 10 groups <- length(unique(competing_survival_data$Treatment)) cat(\"\\nPower Considerations:\\n\") cat(\"Minimum events per group recommended:\", min_events_per_group, \"\\n\") cat(\"Number of treatment groups:\", groups, \"\\n\")  disease_events_per_group <- disease_events / groups cat(\"Disease events per group:\", round(disease_events_per_group, 1), \"\\n\")  if (disease_events_per_group >= min_events_per_group) {   cat(\"Assessment: Adequate power for disease death analysis\\n\") } else {   cat(\"Assessment: Limited power - consider longer follow-up or larger sample size\\n\") }  # Competing risk proportion competing_proportion <- other_events / total_events cat(\"\\nCompeting Risk Assessment:\\n\") cat(\"Proportion of deaths from other causes:\", round(competing_proportion * 100, 1), \"%\\n\")  if (competing_proportion >= 0.2) {   cat(\"Recommendation: Competing risks analysis strongly recommended\\n\")   cat(\"Rationale: Substantial competing mortality may bias cause-specific analysis\\n\") } else if (competing_proportion >= 0.1) {   cat(\"Recommendation: Consider competing risks analysis\\n\")   cat(\"Rationale: Moderate competing mortality present\\n\") } else {   cat(\"Recommendation: Cause-specific analysis may be adequate\\n\")   cat(\"Rationale: Limited competing mortality\\n\") }  # Follow-up adequacy median_followup <- median(competing_survival_data$Overall_Time) max_followup <- max(competing_survival_data$Overall_Time)  cat(\"\\nFollow-up Assessment:\\n\") cat(\"Median follow-up:\", round(median_followup, 1), \"months\\n\") cat(\"Maximum follow-up:\", round(max_followup, 1), \"months\\n\")  if (median_followup >= 24) {   cat(\"Assessment: Adequate follow-up for survival analysis\\n\") } else {   cat(\"Assessment: Limited follow-up - interpret results cautiously\\n\") }"},{"path":"https://www.serdarbalci.com/jsurvival/articles/15-competing-survival.html","id":"interpretation-guidelines","dir":"Articles","previous_headings":"Statistical Considerations","what":"Interpretation Guidelines","title":"jSurvival 15: Competing Survival Analysis","text":"Framework interpreting competing risks results.","code":"# Interpretation Guidelines for Competing Risks Analysis cat(\"\\nInterpretation Guidelines\\n\") cat(\"========================\\n\\n\")  cat(\"1. Overall vs Cause-Specific vs Competing Risks:\\n\") cat(\"   • Overall Survival: Most clinically relevant for patients\\n\") cat(\"   • Cause-Specific: Useful for understanding disease-specific effects\\n\")  cat(\"   • Competing Risks: Most appropriate when competing events are common\\n\\n\")  cat(\"2. Subdistribution Hazard Ratio Interpretation:\\n\") cat(\"   • HR > 1: Increased risk of the event of interest\\n\") cat(\"   • HR < 1: Decreased risk of the event of interest\\n\") cat(\"   • Accounts for competing events in the calculation\\n\\n\")  cat(\"3. Cumulative Incidence Function (CIF):\\n\") cat(\"   • Probability of experiencing the event by time t\\n\") cat(\"   • Accounts for competing events\\n\") cat(\"   • Sum of all CIFs ≤ 1 (remaining probability is survival)\\n\\n\")  cat(\"4. Clinical Decision Making:\\n\") cat(\"   • Use overall survival for prognosis discussions\\n\") cat(\"   • Use cause-specific for treatment effect evaluation\\n\") cat(\"   • Use competing risks for realistic risk prediction\\n\\n\")  cat(\"5. Reporting Requirements:\\n\") cat(\"   • Report number at risk and events for each time point\\n\") cat(\"   • Include confidence intervals for all estimates\\n\") cat(\"   • Specify the statistical method used\\n\") cat(\"   • Justify choice between cause-specific and competing risks\\n\")"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/15-competing-survival.html","id":"using-competingsurvival-in-jamovi","dir":"Articles","previous_headings":"Integration with jamovi","what":"Using competingsurvival in jamovi","title":"jSurvival 15: Competing Survival Analysis","text":"Step--step guide jamovi users.","code":"# jamovi Integration Guide for Competing Survival cat(\"Using competingsurvival in jamovi\\n\") cat(\"=================================\\n\\n\")  cat(\"Step-by-Step Instructions:\\n\\n\")  cat(\"1. Data Preparation:\\n\") cat(\"   • Ensure survival time variable (continuous, numeric)\\n\") cat(\"   • Create outcome variable with 4 levels:\\n\") cat(\"     - Dead of Disease\\n\") cat(\"     - Dead of Other Causes\\n\")  cat(\"     - Alive with Disease\\n\") cat(\"     - Alive without Disease\\n\") cat(\"   • Prepare explanatory variable (categorical)\\n\\n\")  cat(\"2. Access the Function:\\n\") cat(\"   • Navigate to: jSurvival → Competing Survival\\n\") cat(\"   • Or use: Analyses → ClinicoPath → jSurvival → Competing Survival\\n\\n\")  cat(\"3. Variable Assignment:\\n\") cat(\"   • Explanatory Variable: Select grouping variable\\n\") cat(\"   • Overall Time (in months): Select survival time column\\n\") cat(\"   • Outcome: Select outcome variable\\n\") cat(\"   • Configure outcome levels:\\n\") cat(\"     - Dead of Disease: Select appropriate level\\n\") cat(\"     - Dead of Other: Select appropriate level\\n\") cat(\"     - Alive w Disease: Select appropriate level\\n\") cat(\"     - Alive w/o Disease: Select appropriate level\\n\\n\")  cat(\"4. Analysis Selection:\\n\") cat(\"   • Overall: All-cause mortality analysis\\n\") cat(\"   • Cause Specific: Disease-specific mortality only\\n\") cat(\"   • Competing Risk: Full competing risks analysis\\n\\n\")  cat(\"5. Output Interpretation:\\n\") cat(\"   • Review analysis summary for methods used\\n\") cat(\"   • Examine survival table for hazard ratios\\n\") cat(\"   • For competing risks: review cumulative incidence table\\n\") cat(\"   • For competing risks: examine competing risks plot\\n\") cat(\"   • Read clinical interpretation section\\n\\n\")  cat(\"6. Troubleshooting:\\n\") cat(\"   • Ensure no missing values in key variables\\n\") cat(\"   • Verify outcome variable has exactly 4 levels\\n\") cat(\"   • Check that follow-up times are positive\\n\") cat(\"   • Ensure adequate sample sizes per group\\n\") cat(\"   • Verify appropriate level assignments\\n\")"},{"path":"https://www.serdarbalci.com/jsurvival/articles/15-competing-survival.html","id":"conclusion","dir":"Articles","previous_headings":"","what":"Conclusion","title":"jSurvival 15: Competing Survival Analysis","text":"competingsurvival function provides comprehensive tools analyzing survival data multiple competing events can occur. choice overall survival, cause-specific survival, competing risks analysis depends research question, proportion competing events, clinical context.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/15-competing-survival.html","id":"key-takeaways","dir":"Articles","previous_headings":"Conclusion","what":"Key Takeaways","title":"jSurvival 15: Competing Survival Analysis","text":"Method Selection: Choose appropriate analysis type based research objectives competing event frequency Clinical Relevance: Overall survival clinically relevant; competing risks provides realistic probabilities Statistical Rigor: Use Fine-Gray models competing events comprise >10-20% total events Interpretation: Subdistribution hazard ratios account competing events calculation Visualization: Cumulative incidence plots provide intuitive displays competing risks","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/15-competing-survival.html","id":"best-practices","dir":"Articles","previous_headings":"Conclusion","what":"Best Practices","title":"jSurvival 15: Competing Survival Analysis","text":"Always report proportion competing events Justify choice analysis method Present confidence intervals estimates Consider sensitivity analyses using different methods Validate findings clinical domain experts","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/15-competing-survival.html","id":"next-steps","dir":"Articles","previous_headings":"Conclusion","what":"Next Steps","title":"jSurvival 15: Competing Survival Analysis","text":"Explore multivariable competing risks models Consider time-dependent covariates competing risks Integrate findings ClinicoPath survival modules Develop prognostic models incorporating competing risks vignette demonstrates comprehensive competing survival analysis methodology using competingsurvival function. Apply principles clinical datasets robust survival analysis accounting competing events.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"introduction","dir":"Articles","previous_headings":"","what":"Introduction","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"Cox proportional hazards model one widely used statistical methods survival analysis clinical research. However, like statistical models, validity Cox regression results depends certain assumptions met. coxdiagnostics function ClinicoPath provides comprehensive diagnostic tools validate Cox model assumptions assess model adequacy. Learning Objectives: Understand key assumptions Cox proportional hazards models Learn interpret diagnostic plots Cox model validation Master use residual analysis model assessment Apply multicollinearity detection using VIF analysis Develop skills identifying influential observations Create comprehensive diagnostic reports clinical publications","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"why-cox-model-diagnostics-matter","dir":"Articles","previous_headings":"Introduction","what":"Why Cox Model Diagnostics Matter","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"Cox model diagnostics essential : Model Validation: Ensuring model assumptions met Clinical Validity: Confirming results can trusted medical decisions Publication Quality: Meeting standards peer-reviewed research Regulatory Compliance: Satisfying FDA regulatory requirements Patient Safety: Ensuring reliable prognostic models","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"cox-model-assumptions","dir":"Articles","previous_headings":"","what":"Cox Model Assumptions","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"Cox proportional hazards model relies several key assumptions:","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"proportional-hazards-assumption","dir":"Articles","previous_headings":"Cox Model Assumptions","what":"1. Proportional Hazards Assumption","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"hazard ratio two individuals remains constant time. critical assumption Cox model.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"log-linearity","dir":"Articles","previous_headings":"Cox Model Assumptions","what":"2. Log-linearity","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"relationship continuous covariates log hazard linear.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"independence","dir":"Articles","previous_headings":"Cox Model Assumptions","what":"3. Independence","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"Observations independent .","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"no-multicollinearity","dir":"Articles","previous_headings":"Cox Model Assumptions","what":"4. No Multicollinearity","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"Covariates highly correlated .","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"martingale-residuals","dir":"Articles","previous_headings":"Diagnostic Plot Types","what":"Martingale Residuals","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"Purpose: Detect non-linear relationships outliers Interpretation: randomly scattered around zero Warning Signs: Patterns suggest non-linear relationships","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"deviance-residuals","dir":"Articles","previous_headings":"Diagnostic Plot Types","what":"Deviance Residuals","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"Purpose: Identify poorly fitted observations Interpretation: approximately normally distributed Warning Signs: Values > 2 < -2 indicate poor fit","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"schoenfeld-residuals","dir":"Articles","previous_headings":"Diagnostic Plot Types","what":"Schoenfeld Residuals","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"Purpose: Test proportional hazards assumption Interpretation: show trend time Warning Signs: Slopes indicate time-varying effects","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"score-residuals","dir":"Articles","previous_headings":"Diagnostic Plot Types","what":"Score Residuals","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"Purpose: Assess influential observations Interpretation: Identify observations high influence parameter estimates","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"dfbeta-plots","dir":"Articles","previous_headings":"Diagnostic Plot Types","what":"DFBeta Plots","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"Purpose: Evaluate influence individual observations Interpretation: Values > 2/√n suggest influential observations","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"getting-started","dir":"Articles","previous_headings":"","what":"Getting Started","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"","code":"# Load required packages library(jsurvival) library(survival) library(survminer)  # Load example datasets data(\"melanoma\") data(\"colon\")  data(\"histopathology\")"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"example-1-melanoma-dataset","dir":"Articles","previous_headings":"Basic Cox Model Diagnostics","what":"Example 1: Melanoma Dataset","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"Let’s start basic Cox model diagnostic analysis using melanoma dataset.","code":"# Basic Cox diagnostics for melanoma data coxdiagnostics(   data = melanoma,   time = \"time\",   event = \"status\",    covariates = c(\"age\", \"sex\"),   show_martingale = TRUE,   show_deviance = TRUE,   show_ph_test = TRUE,   show_model_summary = TRUE )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"key-features","dir":"Articles","previous_headings":"Basic Cox Model Diagnostics > Example 1: Melanoma Dataset","what":"Key Features:","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"Model Summary: Provides coefficient estimates model statistics Proportional Hazards Test: Tests key assumption using Schoenfeld residuals Martingale Residuals: Checks non-linear relationships Deviance Residuals: Identifies poorly fitted observations","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"example-2-multiple-covariates-with-vif-analysis","dir":"Articles","previous_headings":"Basic Cox Model Diagnostics","what":"Example 2: Multiple Covariates with VIF Analysis","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"","code":"# Cox diagnostics with VIF analysis for multicollinearity coxdiagnostics(   data = melanoma,   time = \"time\",   event = \"status\",   covariates = c(\"age\", \"sex\", \"thickness\", \"ulcer\"),   show_martingale = TRUE,   show_deviance = TRUE,   show_vif = TRUE,   vif_threshold = 5.0,   show_interpretation = TRUE )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"vif-analysis","dir":"Articles","previous_headings":"Basic Cox Model Diagnostics > Example 2: Multiple Covariates with VIF Analysis","what":"VIF Analysis:","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"VIF < 2.5: multicollinearity concern VIF 2.5-5: Moderate multicollinearity (monitor) VIF ≥ 5: High multicollinearity (problematic)","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"example-3-comprehensive-diagnostic-panel","dir":"Articles","previous_headings":"Advanced Diagnostic Analysis","what":"Example 3: Comprehensive Diagnostic Panel","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"","code":"# Comprehensive Cox diagnostics with all plot types coxdiagnostics(   data = colon,   time = \"time\",   event = \"status\",   covariates = c(\"age\", \"sex\", \"nodes\", \"differ\"),   show_martingale = TRUE,   show_deviance = TRUE,   show_score = TRUE,   show_schoenfeld = TRUE,   show_dfbeta = TRUE,   show_ph_test = TRUE,   show_vif = TRUE,   show_model_summary = TRUE,   show_interpretation = TRUE )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"comprehensive-analysis-includes","dir":"Articles","previous_headings":"Advanced Diagnostic Analysis > Example 3: Comprehensive Diagnostic Panel","what":"Comprehensive Analysis Includes:","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"Residual Types: Martingale, Deviance, Score, Schoenfeld, DFBeta Statistical Tests: Proportional hazards test p-values Multicollinearity Assessment: VIF analysis recommendations Clinical Interpretation: Detailed guidance diagnostic","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"example-4-stratified-cox-model-diagnostics","dir":"Articles","previous_headings":"Advanced Diagnostic Analysis","what":"Example 4: Stratified Cox Model Diagnostics","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"","code":"# Cox diagnostics with stratification coxdiagnostics(   data = colon,   time = \"time\",   event = \"status\",   covariates = c(\"age\", \"nodes\"),   strata_var = \"rx\",  # Stratify by treatment   show_martingale = TRUE,   show_deviance = TRUE,   show_ph_test = TRUE,   exclude_missing = TRUE )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"stratification-benefits","dir":"Articles","previous_headings":"Advanced Diagnostic Analysis > Example 4: Stratified Cox Model Diagnostics","what":"Stratification Benefits:","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"Handles Non-proportional Hazards: stratification variables Adjusted Analysis: Controls stratification factors Flexible Modeling: Allows different baseline hazards","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"example-5-pathology-research-with-histopathology-data","dir":"Articles","previous_headings":"Clinical Research Applications","what":"Example 5: Pathology Research with Histopathology Data","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"","code":"# Cox diagnostics for pathology research coxdiagnostics(   data = histopathology,   time = \"OverallTime\",   event = \"Outcome\",   covariates = c(\"Age\", \"Sex\", \"Grade\", \"TStage\"),   show_martingale = TRUE,   show_deviance = TRUE,   show_schoenfeld = TRUE,   show_vif = TRUE,   show_ph_test = TRUE,   show_model_summary = TRUE,   exclude_missing = TRUE,   confidence_level = 0.95 )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"clinical-considerations","dir":"Articles","previous_headings":"Clinical Research Applications > Example 5: Pathology Research with Histopathology Data","what":"Clinical Considerations:","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"Missing Data Handling: Exclude incomplete cases clean analysis Confidence Levels: Standard 95% confidence intervals Multiple Covariates: Age, sex, pathological grade stage Outcome Variables: Overall survival time event status","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"example-6-biomarker-validation-study","dir":"Articles","previous_headings":"Clinical Research Applications","what":"Example 6: Biomarker Validation Study","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"","code":"# Create biomarker validation dataset set.seed(123) n_patients <- 200  biomarker_data <- data.frame(   patient_id = 1:n_patients,   survival_time = rweibull(n_patients, shape = 1.5, scale = 24),   event_occurred = rbinom(n_patients, 1, 0.65),   age = round(rnorm(n_patients, 65, 12)),   sex = factor(sample(c(\"Male\", \"Female\"), n_patients, replace = TRUE)),   biomarker_score = rnorm(n_patients, 50, 15),   tumor_stage = factor(sample(c(\"I\", \"II\", \"III\", \"IV\"), n_patients,                               replace = TRUE, prob = c(0.2, 0.3, 0.3, 0.2))) )  # Ensure realistic ranges biomarker_data$age <- pmax(18, pmin(85, biomarker_data$age)) biomarker_data$survival_time <- pmax(1, pmin(60, biomarker_data$survival_time)) biomarker_data$biomarker_score <- pmax(0, pmin(100, biomarker_data$biomarker_score))  # Cox diagnostics for biomarker validation coxdiagnostics(   data = biomarker_data,   time = \"survival_time\",   event = \"event_occurred\",   covariates = c(\"age\", \"sex\", \"biomarker_score\", \"tumor_stage\"),   show_martingale = TRUE,   show_deviance = TRUE,   show_schoenfeld = TRUE,   show_vif = TRUE,   show_ph_test = TRUE,   show_model_summary = TRUE,   vif_threshold = 5.0,   show_interpretation = TRUE )"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"example-7-custom-plot-settings","dir":"Articles","previous_headings":"Plot Customization Options","what":"Example 7: Custom Plot Settings","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"","code":"# Customized diagnostic plots coxdiagnostics(   data = melanoma,   time = \"time\",   event = \"status\",   covariates = c(\"age\", \"thickness\"),   show_martingale = TRUE,   show_deviance = TRUE,   ox_scale = \"observation.id\",  # Different x-axis scale   add_smooth = TRUE,            # Add smoothing line   add_reference = TRUE,         # Add reference line at y=0   point_size = 1.5,            # Larger points   alpha_level = 0.7,           # Semi-transparent points   show_interpretation = TRUE )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"plot-customization-options-1","dir":"Articles","previous_headings":"Plot Customization Options > Example 7: Custom Plot Settings","what":"Plot Customization Options:","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"X-axis Scale: Linear predictions, observation ID, time Point Size: Adjustable 0.5 3.0 Transparency: Alpha levels 0.1 1.0 Reference Lines: Horizontal line y=0 Smooth Lines: LOESS smoothing identify patterns","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"martingale-residuals-1","dir":"Articles","previous_headings":"Interpretation Guidelines","what":"Martingale Residuals","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"Normal Pattern: - Randomly scattered around zero - obvious patterns trends - values -2 +2 Warning Signs: - Systematic patterns (curved relationships) - Outliers extreme values (>3 <-3) - Funnel shapes suggesting heteroscedasticity","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"deviance-residuals-1","dir":"Articles","previous_headings":"Interpretation Guidelines","what":"Deviance Residuals","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"Normal Pattern: - Approximately symmetric around zero - values -2 +2 - systematic patterns Warning Signs: - Values > 2 < -2 (poorly fitted observations) - Asymmetric distribution - Systematic patterns","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"schoenfeld-residuals-1","dir":"Articles","previous_headings":"Interpretation Guidelines","what":"Schoenfeld Residuals","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"Normal Pattern: - trend time - Random scatter around zero - Flat smoothing line Warning Signs: - Significant slope (p < 0.05) - Systematic trends time - Non-random patterns","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"vif-analysis-1","dir":"Articles","previous_headings":"Interpretation Guidelines","what":"VIF Analysis","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"Interpretation: - VIF < 2.5: concern - VIF 2.5-5: Moderate concern, monitor - VIF ≥ 5: High concern, take action Actions High VIF: - Remove highly correlated variables - Use principal component analysis - Apply regularization (ridge/lasso) - Create composite scores","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"when-assumptions-are-met","dir":"Articles","previous_headings":"Clinical Decision Making","what":"When Assumptions Are Met","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"Proceed confidence: - Report Cox model results - Use clinical predictions - Include publications - Apply clinical practice","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"when-assumptions-are-violated","dir":"Articles","previous_headings":"Clinical Decision Making","what":"When Assumptions Are Violated","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"Consider alternatives: - Stratified Cox Model: non-proportional hazards - Time-dependent Covariates: time-varying effects - Parametric Models: Weibull, log-normal, etc. - Machine Learning: Random forests, neural networks","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"example-8-complete-diagnostic-report","dir":"Articles","previous_headings":"Publication-Ready Analysis","what":"Example 8: Complete Diagnostic Report","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"","code":"# Complete diagnostic analysis for publication results <- coxdiagnostics(   data = colon,   time = \"time\",   event = \"status\",   covariates = c(\"age\", \"sex\", \"nodes\", \"differ\", \"extent\"),   show_martingale = TRUE,   show_deviance = TRUE,   show_schoenfeld = TRUE,   show_dfbeta = TRUE,   show_ph_test = TRUE,   show_vif = TRUE,   show_model_summary = TRUE,   show_interpretation = TRUE,   confidence_level = 0.95,   exclude_missing = TRUE )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"publication-checklist","dir":"Articles","previous_headings":"Publication-Ready Analysis > Example 8: Complete Diagnostic Report","what":"Publication Checklist:","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"✅ Model Summary: Coefficients, hazard ratios, confidence intervals ✅ Assumption Testing: Proportional hazards test results ✅ Residual Analysis: diagnostic plots included ✅ Multicollinearity: VIF analysis performed ✅ Missing Data: Handling strategy documented ✅ Sample Size: Adequate number covariates ✅ Clinical Interpretation: Results explained clinical context","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"sample-size-requirements","dir":"Articles","previous_headings":"Quality Control Guidelines","what":"Sample Size Requirements","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"Rule thumb: Minimum 10 events per covariate","code":"# Check sample size adequacy cat(\"Sample size guidelines:\\n\") cat(\"- Events per covariate: ≥ 10\\n\") cat(\"- Total events: ≥ 50 for stable estimates\\n\") cat(\"- Follow-up completeness: ≥ 80%\\n\")"},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"model-selection-strategy","dir":"Articles","previous_headings":"Quality Control Guidelines","what":"Model Selection Strategy","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"Start Simple: Begin clinically important variables Check Assumptions: Run diagnostics addition Address Violations: Fix problems proceeding Final Validation: Complete diagnostic panel Clinical Review: Ensure biological plausibility","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"issue-1-non-proportional-hazards","dir":"Articles","previous_headings":"Common Issues and Solutions","what":"Issue 1: Non-Proportional Hazards","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"Detection: - Significant Schoenfeld test (p < 0.05) - Trends Schoenfeld residual plots Solutions: - Stratify offending variable - Use time-dependent covariates - Consider parametric models","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"issue-2-non-linear-relationships","dir":"Articles","previous_headings":"Common Issues and Solutions","what":"Issue 2: Non-Linear Relationships","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"Detection: - Patterns martingale residuals - Curved relationships plots Solutions: - Add polynomial terms - Use splines smoothing - Transform continuous variables","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"issue-3-influential-observations","dir":"Articles","previous_headings":"Common Issues and Solutions","what":"Issue 3: Influential Observations","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"Detection: - Extreme DFBeta values (> 2/√n) - Outliers residual plots Solutions: - Investigate data quality - Consider robust methods - Sensitivity analysis","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"issue-4-multicollinearity","dir":"Articles","previous_headings":"Common Issues and Solutions","what":"Issue 4: Multicollinearity","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"Detection: - High VIF values (≥ 5) - Unstable coefficient estimates Solutions: - Remove correlated variables - Use regularization methods - Create composite scores","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"data-preparation","dir":"Articles","previous_headings":"Best Practices","what":"Data Preparation","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"","code":"# Example of proper data preparation clean_data <- function(data) {   # Remove invalid time values   data <- data[data$time > 0, ]      # Check event coding (should be 0/1)   data$status <- ifelse(data$status == 2, 1, data$status)      # Handle missing values appropriately   complete_vars <- c(\"time\", \"status\", \"age\", \"sex\")   data <- data[complete.cases(data[complete_vars]), ]      return(data) }  # Apply to melanoma data melanoma_clean <- clean_data(melanoma)"},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"systematic-diagnostic-approach","dir":"Articles","previous_headings":"Best Practices","what":"Systematic Diagnostic Approach","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"Model Summary: Review coefficient estimates model fit Proportional Hazards: Test key assumption first Residual Analysis: Examine residual types systematically Influence Analysis: Identify potentially problematic observations Multicollinearity: Check correlation among predictors Clinical Review: Ensure results make biological sense","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"documentation-standards","dir":"Articles","previous_headings":"Best Practices","what":"Documentation Standards","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"","code":"# Template for documenting Cox diagnostics diagnostic_report <- function(model_name, dataset, findings) {   cat(\"=== Cox Model Diagnostic Report ===\\n\")   cat(\"Model:\", model_name, \"\\n\")   cat(\"Dataset:\", dataset, \"\\n\")   cat(\"Date:\", Sys.Date(), \"\\n\\n\")      cat(\"Diagnostic Findings:\\n\")   cat(\"- Proportional Hazards:\", findings$ph_test, \"\\n\")   cat(\"- Linearity:\", findings$linearity, \"\\n\")   cat(\"- Influential Observations:\", findings$influence, \"\\n\")   cat(\"- Multicollinearity:\", findings$vif, \"\\n\\n\")      cat(\"Recommendations:\\n\")   cat(\"- Model Adequacy:\", findings$adequacy, \"\\n\")   cat(\"- Required Actions:\", findings$actions, \"\\n\") }"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"time-dependent-covariates","dir":"Articles","previous_headings":"Advanced Topics","what":"Time-Dependent Covariates","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"proportional hazards assumption violated, consider time-dependent covariates:","code":"# Example of time-dependent covariate approach # (This would require additional data preparation) # cox_model_td <- coxph(Surv(start, stop, event) ~ age + sex +  #                       covariate * log(time), data = long_format_data)"},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"stratified-analysis","dir":"Articles","previous_headings":"Advanced Topics","what":"Stratified Analysis","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"variables don’t meet proportional hazards:","code":"# Stratified Cox model diagnostics coxdiagnostics(   data = colon,   time = \"time\",   event = \"status\",   covariates = c(\"age\", \"nodes\"),   strata_var = \"differ\",  # Stratify by differentiation   show_ph_test = TRUE,   show_martingale = TRUE )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"regularized-cox-models","dir":"Articles","previous_headings":"Advanced Topics","what":"Regularized Cox Models","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"high-dimensional data multicollinearity issues:","code":"# Note: Regularized Cox models (lasso, ridge) would require # additional packages like glmnet # These can be useful when standard Cox models show # multicollinearity issues"},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"summary","dir":"Articles","previous_headings":"","what":"Summary","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"coxdiagnostics function provides comprehensive toolkit validating Cox proportional hazards models clinical research. Key takeaways:","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"essential-diagnostics","dir":"Articles","previous_headings":"Summary","what":"Essential Diagnostics","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"Proportional Hazards Test: critical assumption Residual Analysis: Multiple types different purposes VIF Analysis: Detect multicollinearity Influence Diagnostics: Identify problematic observations","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"clinical-applications","dir":"Articles","previous_headings":"Summary","what":"Clinical Applications","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"Biomarker Validation: Ensure reliable prognostic models Treatment Efficacy: Validate survival endpoints Risk Stratification: Develop clinical prediction tools Regulatory Submissions: Meet statistical requirements","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"quality-assurance","dir":"Articles","previous_headings":"Summary","what":"Quality Assurance","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"Assumption Checking: Systematic validation approach Documentation: Complete diagnostic reports Interpretation: Clinical significance assessment Publication Standards: Peer-review ready analysis","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/16-cox-model-diagnostics.html","id":"next-steps","dir":"Articles","previous_headings":"Summary","what":"Next Steps","title":"jSurvival 16: Cox Proportional Hazards Model Diagnostics","text":"Practice: Apply survival datasets Iterate: Refine models based diagnostic findings Validate: Use external datasets possible Collaborate: Work biostatisticians complex cases robust diagnostic capabilities coxdiagnostics ensure Cox regression analyses meet highest standards clinical research publication.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/17-jiwillsurvive-comprehensive.html","id":"introduction","dir":"Articles","previous_headings":"","what":"Introduction","title":"Intuitive Survival Analysis with jiwillsurvive","text":"jiwillsurvive() function ClinicoPath provides intuitive comprehensive approach survival analysis. function combines ease use powerful features, making survival analysis accessible clinicians providing advanced options researchers.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/17-jiwillsurvive-comprehensive.html","id":"key-features","dir":"Articles","previous_headings":"Introduction","what":"Key Features","title":"Intuitive Survival Analysis with jiwillsurvive","text":"Multiple Analysis Types: Survival models, Kaplan-Meier curves, follow-visualization, data preparation Automatic Date Handling: Calculate follow-times start end dates Flexible Input: Multiple event variable formats (numeric, logical, factor) Rich Visualizations: Customizable plots multiple styles color palettes Clinical Interpretation: Automated interpretation survival results Statistical Tests: Built-log-rank tests survival comparisons vignette demonstrates features jiwillsurvive function using comprehensive clinical datasets.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/17-jiwillsurvive-comprehensive.html","id":"loading-required-libraries-and-data","dir":"Articles","previous_headings":"","what":"Loading Required Libraries and Data","title":"Intuitive Survival Analysis with jiwillsurvive","text":"","code":"library(jsurvival)  # Load the comprehensive test dataset data(\"jiwillsurvive_test_data\")  # Preview the data structure str(jiwillsurvive_test_data) head(jiwillsurvive_test_data)"},{"path":"https://www.serdarbalci.com/jsurvival/articles/17-jiwillsurvive-comprehensive.html","id":"data-requirements","dir":"Articles","previous_headings":"","what":"Data Requirements","title":"Intuitive Survival Analysis with jiwillsurvive","text":"jiwillsurvive function designed flexible various data formats:","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/17-jiwillsurvive-comprehensive.html","id":"core-variables","dir":"Articles","previous_headings":"Data Requirements","what":"Core Variables:","title":"Intuitive Survival Analysis with jiwillsurvive","text":"Time Variable: Numeric survival/follow-time (required survival analysis) Event Variable: Event indicator (accepts numeric 0/1, logical TRUE/FALSE, factor) Grouping Variable: Optional categorical variable group comparisons","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/17-jiwillsurvive-comprehensive.html","id":"date-based-variables-for-automatic-follow-up-calculation","dir":"Articles","previous_headings":"Data Requirements","what":"Date-Based Variables (for automatic follow-up calculation):","title":"Intuitive Survival Analysis with jiwillsurvive","text":"Start Date Variable: Study start, enrollment, treatment date End Date Variable: Event date, last follow-, censoring date","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/17-jiwillsurvive-comprehensive.html","id":"data-format-support","dir":"Articles","previous_headings":"Data Requirements","what":"Data Format Support:","title":"Intuitive Survival Analysis with jiwillsurvive","text":"Date variables can Date objects character strings Event variables accept multiple formats automatically specific column naming requirements","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/17-jiwillsurvive-comprehensive.html","id":"simple-survival-model","dir":"Articles","previous_headings":"Basic Survival Analysis","what":"Simple Survival Model","title":"Intuitive Survival Analysis with jiwillsurvive","text":"","code":"# Basic survival analysis without grouping jiwillsurvive(   data = jiwillsurvive_test_data,   analysis_type = \"survival_model\",   time_var = \"survival_months\",   event_var = \"death_event\",   show_risk_table = TRUE,   show_statistics = TRUE,   show_interpretation = TRUE )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/17-jiwillsurvive-comprehensive.html","id":"survival-analysis-with-group-comparison","dir":"Articles","previous_headings":"Basic Survival Analysis","what":"Survival Analysis with Group Comparison","title":"Intuitive Survival Analysis with jiwillsurvive","text":"","code":"# Survival analysis comparing treatment groups jiwillsurvive(   data = jiwillsurvive_test_data,   analysis_type = \"survival_model\",   time_var = \"survival_months\",   event_var = \"death_event\",   group_var = \"treatment\",   show_risk_table = TRUE,   show_median_survival = TRUE,   show_statistics = TRUE )"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/17-jiwillsurvive-comprehensive.html","id":"classic-kaplan-meier-curves","dir":"Articles","previous_headings":"Kaplan-Meier Analysis","what":"Classic Kaplan-Meier Curves","title":"Intuitive Survival Analysis with jiwillsurvive","text":"","code":"# Classic Kaplan-Meier analysis jiwillsurvive(   data = jiwillsurvive_test_data,   analysis_type = \"kaplan_meier\",   time_var = \"survival_months\",   event_var = \"death_event\",   group_var = \"treatment\",   confidence_level = 0.95,   show_confidence_bands = TRUE,   show_censoring_marks = TRUE )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/17-jiwillsurvive-comprehensive.html","id":"multiple-grouping-variables","dir":"Articles","previous_headings":"Kaplan-Meier Analysis","what":"Multiple Grouping Variables","title":"Intuitive Survival Analysis with jiwillsurvive","text":"","code":"# Analysis by disease stage jiwillsurvive(   data = jiwillsurvive_test_data,   analysis_type = \"kaplan_meier\",   time_var = \"survival_months\",   event_var = \"death_event\",   group_var = \"stage\",   plot_title = \"Survival by Disease Stage\",   x_label = \"Time (months)\",   y_label = \"Survival Probability\" )"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/17-jiwillsurvive-comprehensive.html","id":"data-preparation-from-dates","dir":"Articles","previous_headings":"Date-Based Follow-up Calculation","what":"Data Preparation from Dates","title":"Intuitive Survival Analysis with jiwillsurvive","text":"","code":"# Prepare data by calculating follow-up from dates jiwillsurvive(   data = jiwillsurvive_test_data,   analysis_type = \"data_prep\",   start_date_var = \"enrollment_date\",   end_date_var = \"last_contact_date\",   derive_followup = TRUE,   followup_units = \"months\" )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/17-jiwillsurvive-comprehensive.html","id":"different-time-units","dir":"Articles","previous_headings":"Date-Based Follow-up Calculation","what":"Different Time Units","title":"Intuitive Survival Analysis with jiwillsurvive","text":"","code":"# Calculate follow-up in different units for(unit in c(\"days\", \"weeks\", \"months\", \"years\")) {   cat(\"\\n=== Follow-up in\", unit, \"===\\n\")   result <- jiwillsurvive(     data = jiwillsurvive_test_data,     analysis_type = \"data_prep\",     start_date_var = \"enrollment_date\",     end_date_var = \"last_contact_date\",     derive_followup = TRUE,     followup_units = unit   ) }"},{"path":"https://www.serdarbalci.com/jsurvival/articles/17-jiwillsurvive-comprehensive.html","id":"survival-analysis-with-derived-follow-up","dir":"Articles","previous_headings":"Date-Based Follow-up Calculation","what":"Survival Analysis with Derived Follow-up","title":"Intuitive Survival Analysis with jiwillsurvive","text":"","code":"# Survival analysis using dates to derive follow-up time jiwillsurvive(   data = jiwillsurvive_test_data,   analysis_type = \"survival_model\",   time_var = \"survival_months\", # This will be overridden by derived time   event_var = \"death_event\",   group_var = \"treatment\",   start_date_var = \"enrollment_date\",   end_date_var = \"last_contact_date\",   derive_followup = TRUE,   followup_units = \"months\",   plot_title = \"Survival Analysis Using Derived Follow-up Time\" )"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/17-jiwillsurvive-comprehensive.html","id":"histogram-of-follow-up-times","dir":"Articles","previous_headings":"Follow-up Visualization","what":"Histogram of Follow-up Times","title":"Intuitive Survival Analysis with jiwillsurvive","text":"","code":"# Visualize distribution of follow-up times jiwillsurvive(   data = jiwillsurvive_test_data,   analysis_type = \"followup_plot\",   time_var = \"survival_months\",   followup_plot_type = \"histogram\",   followup_units = \"months\" )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/17-jiwillsurvive-comprehensive.html","id":"timeline-visualization","dir":"Articles","previous_headings":"Follow-up Visualization","what":"Timeline Visualization","title":"Intuitive Survival Analysis with jiwillsurvive","text":"","code":"# Patient timeline visualization jiwillsurvive(   data = jiwillsurvive_test_data,   analysis_type = \"followup_plot\",    time_var = \"survival_months\",   followup_plot_type = \"timeline\",   followup_units = \"months\" )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/17-jiwillsurvive-comprehensive.html","id":"summary-statistics-plot","dir":"Articles","previous_headings":"Follow-up Visualization","what":"Summary Statistics Plot","title":"Intuitive Survival Analysis with jiwillsurvive","text":"","code":"# Summary statistics visualization jiwillsurvive(   data = jiwillsurvive_test_data,   analysis_type = \"followup_plot\",   time_var = \"survival_months\",    followup_plot_type = \"summary\",   followup_units = \"months\" )"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/17-jiwillsurvive-comprehensive.html","id":"plot-styles-and-color-palettes","dir":"Articles","previous_headings":"Advanced Customization Options","what":"Plot Styles and Color Palettes","title":"Intuitive Survival Analysis with jiwillsurvive","text":"","code":"# Test different plot styles plot_styles <- c(\"iwillsurvive\", \"classic\", \"modern\", \"minimal\", \"publication\")  for(style in plot_styles) {   cat(\"\\n=== Plot Style:\", style, \"===\\n\")   result <- jiwillsurvive(     data = jiwillsurvive_test_data,     analysis_type = \"survival_model\",     time_var = \"survival_months\",     event_var = \"death_event\",     group_var = \"treatment\",     plot_style = style,     plot_title = paste(\"Survival Analysis -\", tools::toTitleCase(style), \"Style\")   ) }"},{"path":"https://www.serdarbalci.com/jsurvival/articles/17-jiwillsurvive-comprehensive.html","id":"color-palette-options","dir":"Articles","previous_headings":"Advanced Customization Options","what":"Color Palette Options","title":"Intuitive Survival Analysis with jiwillsurvive","text":"","code":"# Test different color palettes color_palettes <- c(\"default\", \"colorblind\", \"viridis\", \"set1\", \"dark2\")  for(palette in color_palettes) {   cat(\"\\n=== Color Palette:\", palette, \"===\\n\")   result <- jiwillsurvive(     data = jiwillsurvive_test_data,     analysis_type = \"survival_model\",     time_var = \"survival_months\",     event_var = \"death_event\",     group_var = \"treatment\",     color_palette = palette,     plot_title = paste(\"Survival Analysis -\", tools::toTitleCase(palette), \"Palette\")   ) }"},{"path":"https://www.serdarbalci.com/jsurvival/articles/17-jiwillsurvive-comprehensive.html","id":"custom-plot-labels-and-breaks","dir":"Articles","previous_headings":"Advanced Customization Options","what":"Custom Plot Labels and Breaks","title":"Intuitive Survival Analysis with jiwillsurvive","text":"","code":"# Customize plot appearance jiwillsurvive(   data = jiwillsurvive_test_data,   analysis_type = \"survival_model\",   time_var = \"survival_months\",   event_var = \"death_event\",   group_var = \"treatment\",   plot_title = \"Treatment Efficacy in Cancer Patients\",   x_label = \"Time from Treatment Initiation (months)\",   y_label = \"Overall Survival Probability\",   time_breaks = \"0,6,12,18,24,30,36,42,48,54,60,66,72\",   legend_position = \"bottom\",   show_median_survival = TRUE,   show_confidence_bands = TRUE )"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/17-jiwillsurvive-comprehensive.html","id":"numeric-event-variables-01","dir":"Articles","previous_headings":"Working with Different Event Variable Formats","what":"Numeric Event Variables (0/1)","title":"Intuitive Survival Analysis with jiwillsurvive","text":"","code":"# Using numeric event variable jiwillsurvive(   data = jiwillsurvive_test_data,   analysis_type = \"survival_model\",   time_var = \"survival_months\",   event_var = \"death_event\", # Numeric 0/1   group_var = \"treatment\" )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/17-jiwillsurvive-comprehensive.html","id":"logical-event-variables-truefalse","dir":"Articles","previous_headings":"Working with Different Event Variable Formats","what":"Logical Event Variables (TRUE/FALSE)","title":"Intuitive Survival Analysis with jiwillsurvive","text":"","code":"# Using logical event variable jiwillsurvive(   data = jiwillsurvive_test_data,   analysis_type = \"survival_model\",   time_var = \"survival_months\",   event_var = \"death_logical\", # Logical TRUE/FALSE   group_var = \"treatment\" )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/17-jiwillsurvive-comprehensive.html","id":"factor-event-variables","dir":"Articles","previous_headings":"Working with Different Event Variable Formats","what":"Factor Event Variables","title":"Intuitive Survival Analysis with jiwillsurvive","text":"","code":"# Using factor event variable jiwillsurvive(   data = jiwillsurvive_test_data,   analysis_type = \"survival_model\",    time_var = \"survival_months\",   event_var = \"death_factor\", # Factor with \"Alive\"/\"Dead\"   group_var = \"treatment\" )"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/17-jiwillsurvive-comprehensive.html","id":"biomarker-analysis","dir":"Articles","previous_headings":"Clinical Applications and Examples","what":"Biomarker Analysis","title":"Intuitive Survival Analysis with jiwillsurvive","text":"","code":"# Survival analysis by biomarker status jiwillsurvive(   data = jiwillsurvive_test_data,   analysis_type = \"survival_model\",   time_var = \"survival_months\",   event_var = \"death_event\",   group_var = \"biomarker_status\",   plot_title = \"Survival by Biomarker Status\",   color_palette = \"colorblind\",   show_statistics = TRUE,   show_interpretation = TRUE )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/17-jiwillsurvive-comprehensive.html","id":"risk-stratification","dir":"Articles","previous_headings":"Clinical Applications and Examples","what":"Risk Stratification","title":"Intuitive Survival Analysis with jiwillsurvive","text":"","code":"# Survival analysis by risk groups jiwillsurvive(   data = jiwillsurvive_test_data,   analysis_type = \"survival_model\",   time_var = \"survival_months\",   event_var = \"death_event\",   group_var = \"risk_group\",   plot_title = \"Survival by Risk Stratification\",   color_palette = \"viridis\",   plot_style = \"publication\",   show_median_survival = TRUE )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/17-jiwillsurvive-comprehensive.html","id":"performance-status-analysis","dir":"Articles","previous_headings":"Clinical Applications and Examples","what":"Performance Status Analysis","title":"Intuitive Survival Analysis with jiwillsurvive","text":"","code":"# Create performance status groups for analysis jiwillsurvive_test_data$ps_group <- factor(   ifelse(jiwillsurvive_test_data$performance_status <= 1, \"Good (0-1)\", \"Poor (2-3)\"),   levels = c(\"Good (0-1)\", \"Poor (2-3)\") )  jiwillsurvive(   data = jiwillsurvive_test_data,   analysis_type = \"survival_model\",   time_var = \"survival_months\",   event_var = \"death_event\",   group_var = \"ps_group\",   plot_title = \"Survival by Performance Status\",   x_label = \"Time (months)\",   confidence_level = 0.90,   show_confidence_bands = TRUE )"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/17-jiwillsurvive-comprehensive.html","id":"short-follow-up-data","dir":"Articles","previous_headings":"Working with Edge Cases","what":"Short Follow-up Data","title":"Intuitive Survival Analysis with jiwillsurvive","text":"","code":"# Load and analyze short follow-up dataset data(\"jiwillsurvive_short_followup\")  jiwillsurvive(   data = jiwillsurvive_short_followup,   analysis_type = \"survival_model\",   time_var = \"survival_days\",   event_var = \"death_event\",   group_var = \"treatment\",   followup_units = \"days\",   plot_title = \"Short-term Survival Analysis (Days)\" )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/17-jiwillsurvive-comprehensive.html","id":"long-follow-up-data","dir":"Articles","previous_headings":"Working with Edge Cases","what":"Long Follow-up Data","title":"Intuitive Survival Analysis with jiwillsurvive","text":"","code":"# Load and analyze long follow-up dataset data(\"jiwillsurvive_long_followup\")  jiwillsurvive(   data = jiwillsurvive_long_followup,   analysis_type = \"survival_model\",   time_var = \"survival_years\",   event_var = \"death_event\",   group_var = \"treatment\",   followup_units = \"years\",   plot_title = \"Long-term Survival Analysis (Years)\" )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/17-jiwillsurvive-comprehensive.html","id":"single-group-analysis","dir":"Articles","previous_headings":"Working with Edge Cases","what":"Single Group Analysis","title":"Intuitive Survival Analysis with jiwillsurvive","text":"","code":"# Load and analyze single group dataset data(\"jiwillsurvive_single_group\")  jiwillsurvive(   data = jiwillsurvive_single_group,   analysis_type = \"survival_model\",   time_var = \"survival_months\",   event_var = \"event\",   plot_title = \"Single Cohort Survival Analysis\",   show_median_survival = TRUE,   show_interpretation = TRUE )"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/17-jiwillsurvive-comprehensive.html","id":"custom-time-points-for-summary","dir":"Articles","previous_headings":"Advanced Statistical Options","what":"Custom Time Points for Summary","title":"Intuitive Survival Analysis with jiwillsurvive","text":"","code":"# Survival analysis with specific time points jiwillsurvive(   data = jiwillsurvive_test_data,   analysis_type = \"survival_model\",   time_var = \"survival_months\",   event_var = \"death_event\",   group_var = \"treatment\",   time_points = \"6,12,18,24,36,48,60\",   show_survival_table = TRUE,   plot_title = \"Survival with Custom Time Points\" )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/17-jiwillsurvive-comprehensive.html","id":"different-confidence-levels","dir":"Articles","previous_headings":"Advanced Statistical Options","what":"Different Confidence Levels","title":"Intuitive Survival Analysis with jiwillsurvive","text":"","code":"# Test different confidence levels confidence_levels <- c(0.80, 0.90, 0.95, 0.99)  for(conf in confidence_levels) {   cat(\"\\n=== Confidence Level:\", conf*100, \"% ===\\n\")   result <- jiwillsurvive(     data = jiwillsurvive_test_data,     analysis_type = \"survival_model\",     time_var = \"survival_months\",     event_var = \"death_event\",     group_var = \"treatment\",     confidence_level = conf,     show_confidence_bands = TRUE,     plot_title = paste(\"Survival Analysis -\", conf*100, \"% CI\")   ) }"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/17-jiwillsurvive-comprehensive.html","id":"analysis-with-colon-cancer-data","dir":"Articles","previous_headings":"Working with Existing Package Datasets","what":"Analysis with Colon Cancer Data","title":"Intuitive Survival Analysis with jiwillsurvive","text":"","code":"# Load and analyze colon cancer dataset data(\"colon\")  # Preview colon dataset str(colon)  # Survival analysis of colon cancer data jiwillsurvive(   data = colon,   analysis_type = \"survival_model\",   time_var = \"time\",   event_var = \"status\",   group_var = \"rx\",   plot_title = \"Colon Cancer Survival by Treatment\",   x_label = \"Time (days)\",   show_statistics = TRUE )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/17-jiwillsurvive-comprehensive.html","id":"analysis-with-melanoma-data","dir":"Articles","previous_headings":"Working with Existing Package Datasets","what":"Analysis with Melanoma Data","title":"Intuitive Survival Analysis with jiwillsurvive","text":"","code":"# Load and analyze melanoma dataset data(\"melanoma\")  # Preview melanoma dataset   str(melanoma)  # Survival analysis of melanoma data jiwillsurvive(   data = melanoma,   analysis_type = \"survival_model\",   time_var = \"time\",   event_var = \"status\",    group_var = \"sex\",   plot_title = \"Melanoma Survival by Sex\",   x_label = \"Time (days)\",   color_palette = \"set1\" )"},{"path":"https://www.serdarbalci.com/jsurvival/articles/17-jiwillsurvive-comprehensive.html","id":"analysis-with-basic-survival-data","dir":"Articles","previous_headings":"Working with Existing Package Datasets","what":"Analysis with Basic Survival Data","title":"Intuitive Survival Analysis with jiwillsurvive","text":"","code":"# Load and analyze basic survival dataset data(\"basic_survival_data\")  # Preview dataset str(basic_survival_data)  # Multiple analyses with different grouping variables grouping_vars <- c(\"treatment\", \"stage\", \"sex\")  for(var in grouping_vars) {   cat(\"\\n=== Analysis by\", var, \"===\\n\")   result <- jiwillsurvive(     data = basic_survival_data,     analysis_type = \"survival_model\",     time_var = \"survival_months\",     event_var = \"death_event\",     group_var = var,     plot_title = paste(\"Survival by\", tools::toTitleCase(var))   ) }"},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/articles/17-jiwillsurvive-comprehensive.html","id":"data-preparation-recommendations","dir":"Articles","previous_headings":"Best Practices and Recommendations","what":"Data Preparation Recommendations","title":"Intuitive Survival Analysis with jiwillsurvive","text":"Data Quality: Ensure negative survival times Missing Values: Handle missing data appropriately Date Formats: Use consistent date formats Event Coding: Use clear event coding (0/1, FALSE/TRUE, descriptive factors)","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/17-jiwillsurvive-comprehensive.html","id":"analysis-workflow","dir":"Articles","previous_headings":"Best Practices and Recommendations","what":"Analysis Workflow","title":"Intuitive Survival Analysis with jiwillsurvive","text":"Start Data Preparation: Use analysis_type = \"data_prep\" date-based data Explore Follow-: Use analysis_type = \"followup_plot\" understand data distribution Main Analysis: Use analysis_type = \"survival_model\" \"kaplan_meier\" primary analysis Interpretation: Enable show_interpretation = TRUE clinical insights","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/17-jiwillsurvive-comprehensive.html","id":"visualization-tips","dir":"Articles","previous_headings":"Best Practices and Recommendations","what":"Visualization Tips","title":"Intuitive Survival Analysis with jiwillsurvive","text":"Color Palettes: Use “colorblind” presentations, “viridis” publications Plot Styles: Use “publication” manuscripts, “modern” presentations Custom Labels: Always use descriptive titles axis labels Confidence Intervals: Show confidence bands uncertainty visualization","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/17-jiwillsurvive-comprehensive.html","id":"conclusion","dir":"Articles","previous_headings":"","what":"Conclusion","title":"Intuitive Survival Analysis with jiwillsurvive","text":"jiwillsurvive() function provides comprehensive, user-friendly approach survival analysis accommodates various data formats analytical needs. intuitive design makes survival analysis accessible providing advanced features sophisticated analyses.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/articles/17-jiwillsurvive-comprehensive.html","id":"key-advantages","dir":"Articles","previous_headings":"Conclusion","what":"Key Advantages:","title":"Intuitive Survival Analysis with jiwillsurvive","text":"Flexibility: Multiple input formats analysis types Automation: Automatic date handling follow-calculation Visualization: Rich, customizable plots clinical interpretation Robustness: Handles edge cases various data scenarios Integration: Works seamlessly existing ClinicoPath datasets function particularly valuable : - Clinical researchers conducting survival studies - Epidemiologists analyzing time--event data - Biostatisticians requiring flexible survival analysis tools - Clinicians seeking intuitive survival analysis capabilities additional resources advanced examples, see ClinicoPath documentation survival analysis vignettes package.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/authors.html","id":null,"dir":"","previous_headings":"","what":"Authors","title":"Authors and Citation","text":"Serdar Balci. Author, maintainer.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/authors.html","id":"citation","dir":"","previous_headings":"","what":"Citation","title":"Authors and Citation","text":"Balci S (2025). jsurvival: Survival Module ClinicoPath jamovi. R package version 0.0.3.82, https://github.com/sbalci/ClinicoPathJamoviModule/.","code":"@Manual{,   title = {jsurvival: Survival Module of ClinicoPath for jamovi},   author = {Serdar Balci},   year = {2025},   note = {R package version 0.0.3.82},   url = {https://github.com/sbalci/ClinicoPathJamoviModule/}, }"},{"path":"https://www.serdarbalci.com/jsurvival/index.html","id":"jsurvival","dir":"","previous_headings":"","what":"Survival Module of ClinicoPath for jamovi","title":"Survival Module of ClinicoPath for jamovi","text":"survival functions ClinicoPath jamovi module See https://sbalci.github.io/ClinicoPathJamoviModule/","code":""},{"path":[]},{"path":[]},{"path":[]},{"path":[]},{"path":[]},{"path":[]},{"path":[]},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/index.html","id":"jamovi-installation","dir":"","previous_headings":"Installation Widgets","what":"jamovi Installation","title":"Survival Module of ClinicoPath for jamovi","text":"","code":"## Installation in jamovi  ### Option 1: jamovi Library (Recommended) 1. Open jamovi 2. Click on the **+** button in the top-right corner 3. Select **jamovi library** 4. Search for \"ClinicoPath\" or \"jsurvival\" 5. Click **Install**  ### Option 2: Manual Installation 1. Download the latest `.jmo` file from [releases](https://github.com/sbalci/jsurvival/releases) 2. Open jamovi 3. Click **+** → **Sideload** → Select the `.jmo` file"},{"path":"https://www.serdarbalci.com/jsurvival/index.html","id":"r-package-installation","dir":"","previous_headings":"Installation Widgets","what":"R Package Installation","title":"Survival Module of ClinicoPath for jamovi","text":"","code":"## Installation as R Package  ### From GitHub (Development Version) ```r # Install devtools if you haven't already install.packages(\"devtools\")  # Install jsurvival devtools::install_github(\"sbalci/jsurvival\")"},{"path":"https://www.serdarbalci.com/jsurvival/index.html","id":"dependencies","dir":"","previous_headings":"Installation Widgets","what":"Dependencies","title":"Survival Module of ClinicoPath for jamovi","text":"package requires R ≥ 4.1.0 depends : - survival, survminer, finalfit - ggplot2, dplyr, tidyr - jmvcore, R6","code":"## Feature Highlights  ### Analysis Types Available ```markdown ## 📊 Available Analyses  | Analysis | Description | Use Case | |----------|-------------|----------| | **Single Arm Survival** | Overall survival for entire cohort | Population-level survival estimates | | **Survival Analysis** | Univariate Cox regression & Kaplan-Meier | Group comparisons, risk factors | | **Continuous Variable Survival** | Cut-off analysis for continuous predictors | Biomarker threshold analysis | | **Multivariable Survival** | Adjusted Cox regression models | Multiple risk factors | | **Odds Ratio Analysis** | Binary outcome analysis | Case-control studies | | **Time Interval Calculator** | Calculate time differences | Data preparation |"},{"path":"https://www.serdarbalci.com/jsurvival/index.html","id":"output-features","dir":"","previous_headings":"Installation Widgets","what":"Output Features","title":"Survival Module of ClinicoPath for jamovi","text":"","code":"## 🎯 Key Features  - **📈 Kaplan-Meier Curves** with risk tables and confidence intervals - **📊 Survival Tables** with 1, 3, 5-year survival rates - **🔢 Natural Language Summaries** of results - **📋 Hazard Ratio Tables** with confidence intervals - **⚕️ Clinical Research Focus** designed for medical studies - **🌐 Multi-language Support** (English, Turkish, German)"},{"path":"https://www.serdarbalci.com/jsurvival/index.html","id":"example-usage-widget","dir":"","previous_headings":"","what":"Example Usage Widget","title":"Survival Module of ClinicoPath for jamovi","text":"","code":"## 🚀 Quick Start Example  ### In jamovi: 1. Load your survival data 2. Go to **Survival** → **ClinicoPath Survival** → **Survival Analysis** 3. Set **Time Elapsed** variable (time to event) 4. Set **Explanatory** variable (grouping factor) 5. Set **Outcome** variable (event indicator) 6. Click **Run**  ### Sample Output: - Median survival times with 95% CI - Log-rank test p-values - Hazard ratios with confidence intervals - Kaplan-Meier survival curves - Risk tables at specified time points"},{"path":"https://www.serdarbalci.com/jsurvival/index.html","id":"citation-widget","dir":"","previous_headings":"","what":"Citation Widget","title":"Survival Module of ClinicoPath for jamovi","text":"Balci, S. (2024). jsurvival: Survival Module ClinicoPath jamovi. R package version 0.0.3.21. https://github.com/sbalci/jsurvival","code":"## 📝 Citation  If you use jsurvival in your research, please cite: **BibTeX:** ```bibtex @Manual{jsurvival,   title = {jsurvival: Survival Module of ClinicoPath for jamovi},   author = {Serdar Balci},   year = {2024},   note = {R package version 0.0.3.21},   url = {https://github.com/sbalci/jsurvival}, } ## Related Projects Widget  ```markdown ## 🔗 Related Projects  | Project | Description | Link | |---------|-------------|------| | **ClinicoPath** | Main jamovi module suite | [![ClinicoPath](https://img.shields.io/badge/GitHub-ClinicoPath-blue)](https://github.com/sbalci/ClinicoPathJamoviModule) | | **jamovi** | Statistical software platform | [![jamovi](https://img.shields.io/badge/jamovi.org-platform-blue)](https://www.jamovi.org) | | **Survival Analysis Tutorial** | Learn survival analysis | [![Tutorial](https://img.shields.io/badge/tutorial-survival-green)](https://www.emilyzabor.com/tutorials/survival_analysis_in_r_tutorial.html) |"},{"path":"https://www.serdarbalci.com/jsurvival/index.html","id":"support-widget","dir":"","previous_headings":"","what":"Support Widget","title":"Survival Module of ClinicoPath for jamovi","text":"","code":"## 💬 Support & Community  - 🐛 **Report Issues**: [GitHub Issues](https://github.com/sbalci/ClinicoPathJamoviModule/issues/) - 📧 **Contact**: serdarbalci@serdarbalci.com - 🌐 **Website**: [ClinicoPath Documentation](https://sbalci.github.io/ClinicoPathJamoviModule/) - 📖 **Package Documentation**: [jsurvival docs](https://www.serdarbalci.com/jsurvival/)  [![ORCID](https://img.shields.io/badge/ORCID-0000--0002--7852--3851-green)](https://orcid.org/0000-0002-7852-3851)"},{"path":"https://www.serdarbalci.com/jsurvival/reference/bootstrapIDI.html","id":null,"dir":"Reference","previous_headings":"","what":"Bootstrap IDI calculation with confidence intervals — bootstrapIDI","title":"Bootstrap IDI calculation with confidence intervals — bootstrapIDI","text":"Calculates Integrated Discrimination Improvement bootstrap confidence intervals","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/bootstrapIDI.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Bootstrap IDI calculation with confidence intervals — bootstrapIDI","text":"","code":"bootstrapIDI(   new_values,   ref_values,   actual,   direction = \">=\",   n_boot = 1000,   conf_level = 0.95 )"},{"path":"https://www.serdarbalci.com/jsurvival/reference/bootstrapIDI.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Bootstrap IDI calculation with confidence intervals — bootstrapIDI","text":"new_values Test values new test ref_values Test values reference test actual Binary outcome vector (0/1) direction Classification direction (\">=\" \"<=\") n_boot Number bootstrap iterations conf_level Confidence level (default 0.95)","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/bootstrapIDI.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Bootstrap IDI calculation with confidence intervals — bootstrapIDI","text":"List IDI, confidence intervals, p-value","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/calculate_auc.html","id":null,"dir":"Reference","previous_headings":"","what":"Approximate AUC from sensitivity and specificity — calculate_auc","title":"Approximate AUC from sensitivity and specificity — calculate_auc","text":"Uses simplified formula approximate AUC sensitivity specificity","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/calculate_auc.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Approximate AUC from sensitivity and specificity — calculate_auc","text":"","code":"calculate_auc(sens, spec)"},{"path":"https://www.serdarbalci.com/jsurvival/reference/calculate_auc.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Approximate AUC from sensitivity and specificity — calculate_auc","text":"sens Sensitivity test spec Specificity test","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/calculate_auc.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Approximate AUC from sensitivity and specificity — calculate_auc","text":"Numeric AUC value NA inputs valid","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/calculate_nlr.html","id":null,"dir":"Reference","previous_headings":"","what":"Calculate negative likelihood ratio — calculate_nlr","title":"Calculate negative likelihood ratio — calculate_nlr","text":"Calculates negative likelihood ratio sensitivity specificity","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/calculate_nlr.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Calculate negative likelihood ratio — calculate_nlr","text":"","code":"calculate_nlr(sens, spec)"},{"path":"https://www.serdarbalci.com/jsurvival/reference/calculate_nlr.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Calculate negative likelihood ratio — calculate_nlr","text":"sens Sensitivity value spec Specificity value","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/calculate_nlr.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Calculate negative likelihood ratio — calculate_nlr","text":"Numeric negative likelihood ratio NA inputs valid","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/calculate_npv.html","id":null,"dir":"Reference","previous_headings":"","what":"Calculate negative predictive value (NPV) — calculate_npv","title":"Calculate negative predictive value (NPV) — calculate_npv","text":"Calculates NPV confusion matrix values","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/calculate_npv.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Calculate negative predictive value (NPV) — calculate_npv","text":"","code":"calculate_npv(tn, fn)"},{"path":"https://www.serdarbalci.com/jsurvival/reference/calculate_npv.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Calculate negative predictive value (NPV) — calculate_npv","text":"tn Number true negatives fn Number false negatives","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/calculate_npv.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Calculate negative predictive value (NPV) — calculate_npv","text":"Numeric NPV value NA inputs valid","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/calculate_plr.html","id":null,"dir":"Reference","previous_headings":"","what":"Calculate positive likelihood ratio — calculate_plr","title":"Calculate positive likelihood ratio — calculate_plr","text":"Calculates positive likelihood ratio sensitivity specificity","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/calculate_plr.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Calculate positive likelihood ratio — calculate_plr","text":"","code":"calculate_plr(sens, spec)"},{"path":"https://www.serdarbalci.com/jsurvival/reference/calculate_plr.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Calculate positive likelihood ratio — calculate_plr","text":"sens Sensitivity value spec Specificity value","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/calculate_plr.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Calculate positive likelihood ratio — calculate_plr","text":"Numeric positive likelihood ratio NA inputs valid","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/calculate_ppv.html","id":null,"dir":"Reference","previous_headings":"","what":"Calculate positive predictive value (PPV) — calculate_ppv","title":"Calculate positive predictive value (PPV) — calculate_ppv","text":"Calculates PPV confusion matrix values","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/calculate_ppv.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Calculate positive predictive value (PPV) — calculate_ppv","text":"","code":"calculate_ppv(tp, fp)"},{"path":"https://www.serdarbalci.com/jsurvival/reference/calculate_ppv.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Calculate positive predictive value (PPV) — calculate_ppv","text":"tp Number true positives fp Number false positives","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/calculate_ppv.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Calculate positive predictive value (PPV) — calculate_ppv","text":"Numeric PPV value NA inputs valid","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/calculate_sensitivity.html","id":null,"dir":"Reference","previous_headings":"","what":"Calculate test sensitivity — calculate_sensitivity","title":"Calculate test sensitivity — calculate_sensitivity","text":"Calculates sensitivity (true positive rate) confusion matrix values","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/calculate_sensitivity.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Calculate test sensitivity — calculate_sensitivity","text":"","code":"calculate_sensitivity(tp, fn)"},{"path":"https://www.serdarbalci.com/jsurvival/reference/calculate_sensitivity.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Calculate test sensitivity — calculate_sensitivity","text":"tp Number true positives fn Number false negatives","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/calculate_sensitivity.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Calculate test sensitivity — calculate_sensitivity","text":"Numeric sensitivity value NA inputs valid","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/calculate_specificity.html","id":null,"dir":"Reference","previous_headings":"","what":"Calculate test specificity — calculate_specificity","title":"Calculate test specificity — calculate_specificity","text":"Calculates specificity (true negative rate) confusion matrix values","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/calculate_specificity.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Calculate test specificity — calculate_specificity","text":"","code":"calculate_specificity(tn, fp)"},{"path":"https://www.serdarbalci.com/jsurvival/reference/calculate_specificity.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Calculate test specificity — calculate_specificity","text":"tn Number true negatives fp Number false positives","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/calculate_specificity.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Calculate test specificity — calculate_specificity","text":"Numeric specificity value NA inputs valid","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/clinicopath_startup_message.html","id":null,"dir":"Reference","previous_headings":"","what":"Package startup message — clinicopath_startup_message","title":"Package startup message — clinicopath_startup_message","text":"Displays information package author website","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/clinicopath_startup_message.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Package startup message — clinicopath_startup_message","text":"","code":"clinicopath_startup_message()"},{"path":"https://www.serdarbalci.com/jsurvival/reference/clinicopath_startup_message.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Package startup message — clinicopath_startup_message","text":"Invisible NULL (called side effects)","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/is_in_range.html","id":null,"dir":"Reference","previous_headings":"","what":"Check if value is within valid range — is_in_range","title":"Check if value is within valid range — is_in_range","text":"Validates value within specified bounds","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/is_in_range.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Check if value is within valid range — is_in_range","text":"","code":"is_in_range(x, min_val, max_val, inclusive = TRUE)"},{"path":"https://www.serdarbalci.com/jsurvival/reference/is_in_range.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Check if value is within valid range — is_in_range","text":"x Value check min_val Minimum allowed value max_val Maximum allowed value inclusive Whether bounds inclusive","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/is_in_range.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Check if value is within valid range — is_in_range","text":"Logical indicating value within range","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/jsurvival-package.html","id":null,"dir":"Reference","previous_headings":"","what":"jsurvival: Analysis for jsurvivalological Research — jsurvival-package","title":"jsurvival: Analysis for jsurvivalological Research — jsurvival-package","text":"jsurvival jsurvival help researchers generate natural language summaries dataset, generate cross tables statistical tests, survival analysis survival tables, survival plots, natural language summaries. documentation, see Website.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/jsurvival-package.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"jsurvival: Analysis for jsurvivalological Research — jsurvival-package","text":"jsurvival","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/reference/jsurvival-package.html","id":"author","dir":"Reference","previous_headings":"","what":"Author","title":"jsurvival: Analysis for jsurvivalological Research — jsurvival-package","text":"Maintainer: Serdar Balci serdarbalci@serdarbalci.com (ORCID)","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/load_required_package.html","id":null,"dir":"Reference","previous_headings":"","what":"Load required packages with error handling — load_required_package","title":"Load required packages with error handling — load_required_package","text":"Load required packages error handling","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/load_required_package.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Load required packages with error handling — load_required_package","text":"","code":"load_required_package(package_name, install_if_missing = TRUE)"},{"path":"https://www.serdarbalci.com/jsurvival/reference/load_required_package.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Load required packages with error handling — load_required_package","text":"package_name Character string package name install_if_missing Logical, whether install package missing","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/load_required_package.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Load required packages with error handling — load_required_package","text":"Logical indicating success","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/multisurvival.html","id":null,"dir":"Reference","previous_headings":"","what":"Multivariable Survival Analysis — multisurvival","title":"Multivariable Survival Analysis — multisurvival","text":"Performs multivariable survival analysis using Cox proportional hazards regression. multivariable survival analysis, person-time follow-crucial properly adjusting covariates accounting varying observation periods. Cox proportional hazards model incorporates person-time modeling hazard function, represents instantaneous event rate per unit person-time. stratifying analyses examining multiple predictors, model accounts factors influence event rates relative person-time risk subgroup.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/multisurvival.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Multivariable Survival Analysis — multisurvival","text":"","code":"multisurvival(   data,   elapsedtime,   tint = FALSE,   dxdate,   fudate,   timetypedata = \"ymd\",   timetypeoutput = \"months\",   uselandmark = FALSE,   landmark = 3,   outcome,   outcomeLevel,   dod,   dooc,   awd,   awod,   analysistype = \"overall\",   explanatory,   contexpl,   multievent = FALSE,   hr = FALSE,   sty = \"t1\",   ph_cox = FALSE,   km = FALSE,   endplot = 60,   byplot = 12,   ci95 = FALSE,   risktable = FALSE,   censored = FALSE,   medianline = \"none\",   pplot = TRUE,   cutp = \"12, 36, 60\",   calculateRiskScore = FALSE,   numRiskGroups = \"four\",   plotRiskGroups = FALSE,   ac = FALSE,   adjexplanatory,   ac_method = \"average\",   showNomogram = FALSE,   use_modelSelection = FALSE,   modelSelection = \"enter\",   selectionCriteria = \"aic\",   pEntry = 0.05,   pRemoval = 0.1,   use_stratify = FALSE,   stratvar,   person_time = FALSE,   time_intervals = \"12, 36, 60\",   rate_multiplier = 100,   use_tree = FALSE,   min_node = 20,   complexity = 0.01,   max_depth = 5,   show_terminal_nodes = TRUE,   use_time_dependent = FALSE,   td_format = \"wide\",   time_dep_vars,   change_times = \"6, 12, 18\",   td_suffix_pattern = \"_t{time}\",   start_time_var,   stop_time_var,   use_frailty = FALSE,   frailty_var,   frailty_distribution = \"gamma\",   use_splines = FALSE,   spline_vars,   spline_df = 3,   spline_type = \"pspline\" )"},{"path":"https://www.serdarbalci.com/jsurvival/reference/multisurvival.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Multivariable Survival Analysis — multisurvival","text":"data dataset analyzed, provided data frame. Must contain variables specified options . elapsedtime numeric variable representing follow-time event last observation. tint = false, pre-calculated numeric time variable. tint = true, dxdate fudate used calculate time. tint true, survival time calculated dxdate fudate. false, elapsedtime provided pre-calculated numeric variable. dxdate Date diagnosis. Required tint = true. Must match format specified timetypedata. fudate Follow-date date last observation. Required tint = true. Must match format specified timetypedata. timetypedata Specifies format date variables input data. critical tint = true, dxdate fudate parsed according format calculate survival time. example, data files record dates \"YYYY-MM-DD\", select ymd. timetypeoutput units survival time reported output. Choose days, weeks, months, years. uselandmark true, applies landmark analysis starting specified time point. landmark time point (units defined timetypeoutput) start landmark analyses. used uselandmark = true. outcome outcome variable. Typically indicates event status (e.g., death, recurrence). survival analysis, may factor numeric event indicator. outcomeLevel level outcome considered event. example, outcome factor, specify level indicates event occurrence. dod level outcome corresponding death due disease, applicable. dooc level outcome corresponding death due causes, applicable. awd level outcome corresponding alive disease, applicable. awod level outcome corresponding alive without disease, applicable. analysistype Type survival analysis: - overall: -cause survival - cause: Cause-specific survival - compete: Competing risks analysis explanatory Categorical explanatory (predictor) variables included Cox model. contexpl Continuous explanatory (predictor) variables included Cox model. multievent true, multiple event levels considered competing risks analysis. Requires specifying dod, dooc, etc. hr true, generates plot hazard ratios explanatory variable Cox model. sty style hazard ratio (forest) plot. \"finalfit\" \"survminer forestplot\". ph_cox true, tests proportional hazards assumption Cox model. Use suspect violations PH assumption. km true, produces Kaplan-Meier survival plot. Useful visualization survival functions without covariate adjustment. endplot maximum follow-time (units defined timetypeoutput) display survival plots. byplot interval (units defined timetypeoutput) time points labels shown plots. ci95 true, displays 95\\ estimates plots. risktable true, displays number subjects risk time point survival plot. censored true, marks censored observations (e.g., using tick marks) survival plot. medianline true, displays line indicating median survival time survival plot. pplot true, displays p-value survival comparison test survival plot. cutp . calculateRiskScore true, calculates risk score Cox model coefficients individual. numRiskGroups Select number risk groups create risk scores. data divided equal quantiles based selection. plotRiskGroups true, stratifies individuals risk groups based calculated risk scores plots survival curves. ac . adjexplanatory . ac_method Method computing adjusted survival curves showNomogram . use_modelSelection true, applies variable selection procedure find best-fitting model based criteria like AIC likelihood ratio tests. modelSelection method used select variables: - enter: Includes variables (selection) - forward: Adds variables one time improve model - backward: Removes variables significantly contribute - : Combination forward backward steps selectionCriteria criterion used adding removing variables model selection: - aic: Balances model fit complexity - lrt: Uses likelihood ratio tests decide inclusion/removal pEntry Significance level variable enters model forward stepwise selection. pRemoval Significance level variable removed model backward stepwise selection. use_stratify true, uses stratification handle variables violate proportional hazards assumption. Stratification creates separate baseline hazard functions different groups. stratvar Variables used stratification. proportional hazards met, stratification can adjust model better fit data allowing different baseline hazards. person_time Enable option calculate display person-time metrics, including total follow-time incidence rates. metrics help quantify rate events per unit time study population. time_intervals Specify time intervals stratified person-time analysis. Enter  comma-separated list time points create intervals. example,  \"12, 36, 60\" create intervals 0-12, 12-36, 36-60, 60+. rate_multiplier Specify multiplier incidence rates (e.g., 100 rates per 100 person-years, 1000 rates per 1000 person-years). use_tree true, fits survival decision tree identify subgroups different survival outcomes. Decision trees provide intuitive alternative Cox regression identifying risk factors. min_node minimum number observations required terminal node. Larger values create simpler trees may generalizable potentially miss important subgroups. complexity complexity parameter tree pruning. Higher values result smaller trees. parameter controls trade-tree size goodness fit. max_depth maximum depth decision tree. Limits complexity tree avoid overfitting. show_terminal_nodes true, displays Kaplan-Meier survival curves terminal node decision tree. use_time_dependent Enable time-dependent covariates Cox regression. allows modeling variables change values specific time points follow-(e.g., treatment changes, biomarker measurements, disease progression). td_format Specify whether data wide format (one row per subject time points separate variables) long format (multiple rows per subject time intervals). time_dep_vars Variables change values time. wide format, baseline variables updated change points. long format, time-varying variables. change_times Time points (units survival time) time-dependent variables change. wide format data, specify comma-separated time points (e.g., \"6, 12, 18\"). function create intervals update covariate values times. td_suffix_pattern wide format: Pattern time-specific variable names. Use time placeholder. Example: baseline variable 'treatment' pattern '_ttime',  function looks 'treatment_t6', 'treatment_t12', etc. start_time_var long format : Variable indicating start time interval. Leave empty wide format data. stop_time_var long format : Variable indicating stop time interval. Leave empty wide format data. use_frailty Add frailty term account unobserved heterogeneity clustering data. Frailty models add random effects Cox model. frailty_var Clustering variable frailty term (e.g., hospital, family, study center). level represents cluster shared frailty. frailty_distribution Distribution frailty term. Gamma commonly used assumes multiplicative effect hazard. Gaussian assumes additive effect log-hazard. use_splines Use penalized splines model time-varying effects (non-proportional hazards). alternative stratification handling PH violations. spline_vars Variables model time-varying coefficients using splines. variables violate proportional hazards assumption. spline_df Degrees freedom spline functions. Higher values allow flexible time-varying effects may lead overfitting. spline_type Type spline basis use. Penalized splines provide smooth functions automatic smoothness selection. Natural splines constrained linear boundaries.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/multisurvival.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Multivariable Survival Analysis — multisurvival","text":"results object containing: Tables can converted data frames asDF .data.frame. example: results$personTimeTable$asDF .data.frame(results$personTimeTable)","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/multisurvival.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Multivariable Survival Analysis — multisurvival","text":"","code":"# Example 1: Basic multivariable Cox regression library(survival) data(colon) #> Warning: data set ‘colon’ not found  multisurvival(     data = colon,     elapsedtime = \"time\",     outcome = \"status\",     outcomeLevel = \"1\",     explanatory = c(\"sex\", \"obstruct\", \"perfor\"),     contexpl = c(\"age\", \"nodes\"),     timetypeoutput = \"days\",     hr = TRUE  # Show hazard ratio plot ) #> Error in multisurvival(data = colon, elapsedtime = \"time\", outcome = \"status\",     outcomeLevel = \"1\", explanatory = c(\"sex\", \"obstruct\", \"perfor\"),     contexpl = c(\"age\", \"nodes\"), timetypeoutput = \"days\", hr = TRUE): argument \"adjexplanatory\" is missing, with no default  # Example 2: Using dates to calculate survival time # Assuming you have diagnosis and follow-up dates multisurvival(     data = mydata,     tint = TRUE,     dxdate = \"diagnosis_date\",     fudate = \"last_followup_date\",     timetypedata = \"ymd\",     timetypeoutput = \"months\",     outcome = \"vital_status\",     outcomeLevel = \"Dead\",     explanatory = c(\"stage\", \"grade\"),     contexpl = \"age\" ) #> Error: object 'mydata' not found  # Example 3: Risk stratification analysis multisurvival(     data = colon,     elapsedtime = \"time\",     outcome = \"status\",     outcomeLevel = \"1\",     explanatory = c(\"sex\", \"obstruct\"),     contexpl = c(\"age\", \"nodes\"),     calculateRiskScore = TRUE,     numRiskGroups = \"three\",     plotRiskGroups = TRUE,     addRiskScore = TRUE,  # Add risk score to data     addRiskGroup = TRUE   # Add risk group to data ) #> Error in multisurvival(data = colon, elapsedtime = \"time\", outcome = \"status\",     outcomeLevel = \"1\", explanatory = c(\"sex\", \"obstruct\"), contexpl = c(\"age\",         \"nodes\"), calculateRiskScore = TRUE, numRiskGroups = \"three\",     plotRiskGroups = TRUE, addRiskScore = TRUE, addRiskGroup = TRUE): unused arguments (addRiskScore = TRUE, addRiskGroup = TRUE)  # Example 4: Model with stratification for non-proportional hazards multisurvival(     data = colon,     elapsedtime = \"time\",     outcome = \"status\",     outcomeLevel = \"1\",     explanatory = c(\"obstruct\", \"perfor\"),     contexpl = c(\"age\", \"nodes\"),     use_stratify = TRUE,     stratvar = \"sex\",  # Stratify by sex if PH assumption violated     ph_cox = TRUE      # Test proportional hazards assumption ) #> Error in multisurvival(data = colon, elapsedtime = \"time\", outcome = \"status\",     outcomeLevel = \"1\", explanatory = c(\"obstruct\", \"perfor\"),     contexpl = c(\"age\", \"nodes\"), use_stratify = TRUE, stratvar = \"sex\",     ph_cox = TRUE): argument \"adjexplanatory\" is missing, with no default  # Example 5: Stepwise model selection multisurvival(     data = colon,     elapsedtime = \"time\",     outcome = \"status\",     outcomeLevel = \"1\",     explanatory = c(\"sex\", \"obstruct\", \"perfor\", \"adhere\"),     contexpl = c(\"age\", \"nodes\"),     use_modelSelection = TRUE,     modelSelection = \"both\",  # Stepwise selection     selectionCriteria = \"aic\",     pEntry = 0.05,     pRemoval = 0.10 ) #> Error in multisurvival(data = colon, elapsedtime = \"time\", outcome = \"status\",     outcomeLevel = \"1\", explanatory = c(\"sex\", \"obstruct\", \"perfor\",         \"adhere\"), contexpl = c(\"age\", \"nodes\"), use_modelSelection = TRUE,     modelSelection = \"both\", selectionCriteria = \"aic\", pEntry = 0.05,     pRemoval = 0.1): argument \"adjexplanatory\" is missing, with no default  # Example 6: Person-time analysis multisurvival(     data = colon,     elapsedtime = \"time\",     outcome = \"status\",     outcomeLevel = \"1\",     explanatory = \"sex\",     contexpl = \"age\",     person_time = TRUE,     time_intervals = \"180, 365, 730\",  # 6mo, 1yr, 2yr     rate_multiplier = 1000  # Rate per 1000 person-days ) #> Error in multisurvival(data = colon, elapsedtime = \"time\", outcome = \"status\",     outcomeLevel = \"1\", explanatory = \"sex\", contexpl = \"age\",     person_time = TRUE, time_intervals = \"180, 365, 730\", rate_multiplier = 1000): argument \"adjexplanatory\" is missing, with no default"},{"path":"https://www.serdarbalci.com/jsurvival/reference/multisurvivalClass.html","id":null,"dir":"Reference","previous_headings":"","what":"Multivariable Survival Analysis — multisurvivalClass","title":"Multivariable Survival Analysis — multisurvivalClass","text":"Multivariable Survival Analysis Multivariable Survival Analysis","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/multisurvivalClass.html","id":"super-classes","dir":"Reference","previous_headings":"","what":"Super classes","title":"Multivariable Survival Analysis — multisurvivalClass","text":"jmvcore::Analysis -> jsurvival::multisurvivalBase -> multisurvivalClass","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/multisurvivalClass.html","id":"methods","dir":"Reference","previous_headings":"","what":"Methods","title":"Multivariable Survival Analysis — multisurvivalClass","text":"jmvcore::Analysis$.createImage() jmvcore::Analysis$.createImages() jmvcore::Analysis$.createPlotObject() jmvcore::Analysis$.load() jmvcore::Analysis$.render() jmvcore::Analysis$.save() jmvcore::Analysis$.savePart() jmvcore::Analysis$.setCheckpoint() jmvcore::Analysis$.setParent() jmvcore::Analysis$.setReadDatasetHeaderSource() jmvcore::Analysis$.setReadDatasetSource() jmvcore::Analysis$.setResourcesPathSource() jmvcore::Analysis$.setStatePathSource() jmvcore::Analysis$addAddon() jmvcore::Analysis$asProtoBuf() jmvcore::Analysis$asSource() jmvcore::Analysis$check() jmvcore::Analysis$init() jmvcore::Analysis$optionsChangedHandler() jmvcore::Analysis$postInit() jmvcore::Analysis$print() jmvcore::Analysis$readDataset() jmvcore::Analysis$run() jmvcore::Analysis$serialize() jmvcore::Analysis$setError() jmvcore::Analysis$setStatus() jmvcore::Analysis$translate() jsurvival::multisurvivalBase$initialize()","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/multisurvivalClass.html","id":"public-methods","dir":"Reference","previous_headings":"","what":"Public methods","title":"Multivariable Survival Analysis — multisurvivalClass","text":"multisurvivalClass$clone()","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/multisurvivalClass.html","id":"method-clone-","dir":"Reference","previous_headings":"","what":"Method clone()","title":"Multivariable Survival Analysis — multisurvivalClass","text":"objects class cloneable method.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/multisurvivalClass.html","id":"usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Multivariable Survival Analysis — multisurvivalClass","text":"","code":"multisurvivalClass$clone(deep = FALSE)"},{"path":"https://www.serdarbalci.com/jsurvival/reference/multisurvivalClass.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Multivariable Survival Analysis — multisurvivalClass","text":"deep Whether make deep clone.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/na-coalescing.html","id":null,"dir":"Reference","previous_headings":"","what":"NA-coalescing operator — na-coalescing","title":"NA-coalescing operator — na-coalescing","text":"NA-coalescing operator","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/na-coalescing.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"NA-coalescing operator — na-coalescing","text":"","code":"lhs %|% rhs"},{"path":"https://www.serdarbalci.com/jsurvival/reference/not-in-alt.html","id":null,"dir":"Reference","previous_headings":"","what":"Alternative not-in operator — not-in-alt","title":"Alternative not-in operator — not-in-alt","text":"Alternative -operator","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/not-in-alt.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Alternative not-in operator — not-in-alt","text":"","code":"lhs %!in% rhs"},{"path":"https://www.serdarbalci.com/jsurvival/reference/not-in.html","id":null,"dir":"Reference","previous_headings":"","what":"Not-in operator — not-in","title":"Not-in operator — not-in","text":"-operator","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/not-in.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Not-in operator — not-in","text":"","code":"lhs %notin% rhs"},{"path":"https://www.serdarbalci.com/jsurvival/reference/null-coalescing.html","id":null,"dir":"Reference","previous_headings":"","what":"Null-coalescing operator — null-coalescing","title":"Null-coalescing operator — null-coalescing","text":"Null-coalescing operator","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/null-coalescing.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Null-coalescing operator — null-coalescing","text":"","code":"lhs %||% rhs"},{"path":"https://www.serdarbalci.com/jsurvival/reference/oddsratio.html","id":null,"dir":"Reference","previous_headings":"","what":"Odds Ratio Table and Plot — oddsratio","title":"Odds Ratio Table and Plot — oddsratio","text":"Function Odds Ratio Table Plot.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/oddsratio.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Odds Ratio Table and Plot — oddsratio","text":"","code":"oddsratio(data, explanatory, outcome, showNomogram = FALSE)"},{"path":"https://www.serdarbalci.com/jsurvival/reference/oddsratio.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Odds Ratio Table and Plot — oddsratio","text":"data data data frame. explanatory explanatory variables used analysis. outcome outcome variable used analysis. showNomogram Display interactive nomogram converting pre-test post-test  probabilities using likelihood ratios calculated data.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/oddsratio.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Odds Ratio Table and Plot — oddsratio","text":"results object containing:","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/oddsratio.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Odds Ratio Table and Plot — oddsratio","text":"","code":"# \\donttest{ # example will be added # }"},{"path":"https://www.serdarbalci.com/jsurvival/reference/oddsratioClass.html","id":null,"dir":"Reference","previous_headings":"","what":"Odds Ratio Table and Plot — oddsratioClass","title":"Odds Ratio Table and Plot — oddsratioClass","text":"Odds Ratio Table Plot Odds Ratio Table Plot","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/oddsratioClass.html","id":"super-classes","dir":"Reference","previous_headings":"","what":"Super classes","title":"Odds Ratio Table and Plot — oddsratioClass","text":"jmvcore::Analysis -> jsurvival::oddsratioBase -> oddsratioClass","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/oddsratioClass.html","id":"methods","dir":"Reference","previous_headings":"","what":"Methods","title":"Odds Ratio Table and Plot — oddsratioClass","text":"jmvcore::Analysis$.createImage() jmvcore::Analysis$.createImages() jmvcore::Analysis$.createPlotObject() jmvcore::Analysis$.load() jmvcore::Analysis$.render() jmvcore::Analysis$.save() jmvcore::Analysis$.savePart() jmvcore::Analysis$.setCheckpoint() jmvcore::Analysis$.setParent() jmvcore::Analysis$.setReadDatasetHeaderSource() jmvcore::Analysis$.setReadDatasetSource() jmvcore::Analysis$.setResourcesPathSource() jmvcore::Analysis$.setStatePathSource() jmvcore::Analysis$addAddon() jmvcore::Analysis$asProtoBuf() jmvcore::Analysis$asSource() jmvcore::Analysis$check() jmvcore::Analysis$init() jmvcore::Analysis$optionsChangedHandler() jmvcore::Analysis$postInit() jmvcore::Analysis$print() jmvcore::Analysis$readDataset() jmvcore::Analysis$run() jmvcore::Analysis$serialize() jmvcore::Analysis$setError() jmvcore::Analysis$setStatus() jmvcore::Analysis$translate() jsurvival::oddsratioBase$initialize()","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/oddsratioClass.html","id":"public-methods","dir":"Reference","previous_headings":"","what":"Public methods","title":"Odds Ratio Table and Plot — oddsratioClass","text":"oddsratioClass$clone()","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/oddsratioClass.html","id":"method-clone-","dir":"Reference","previous_headings":"","what":"Method clone()","title":"Odds Ratio Table and Plot — oddsratioClass","text":"objects class cloneable method.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/oddsratioClass.html","id":"usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Odds Ratio Table and Plot — oddsratioClass","text":"","code":"oddsratioClass$clone(deep = FALSE)"},{"path":"https://www.serdarbalci.com/jsurvival/reference/oddsratioClass.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Odds Ratio Table and Plot — oddsratioClass","text":"deep Whether make deep clone.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/outcomeorganizer.html","id":null,"dir":"Reference","previous_headings":"","what":"Outcome Organizer for Survival Analysis — outcomeorganizer","title":"Outcome Organizer for Survival Analysis — outcomeorganizer","text":"Advanced tool preparing outcome variables various types survival analysis including overall survival, cause-specific, competing risks, progression-free survival, multistate models.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/outcomeorganizer.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Outcome Organizer for Survival Analysis — outcomeorganizer","text":"","code":"outcomeorganizer(   data,   outcome,   outcomeLevel,   recurrence,   recurrenceLevel,   patientID,   analysistype = \"os\",   multievent = FALSE,   dod,   dooc,   awd,   awod,   useHierarchy = FALSE,   eventPriority = 1,   intervalCensoring = FALSE,   intervalStart,   intervalEnd,   adminCensoring = FALSE,   adminDate,   outputTable = TRUE,   diagnostics = FALSE,   visualization = FALSE )"},{"path":"https://www.serdarbalci.com/jsurvival/reference/outcomeorganizer.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Outcome Organizer for Survival Analysis — outcomeorganizer","text":"data data data frame. outcome primary outcome variable recoded survival analysis (e.g., vital status). outcomeLevel level outcome variable represents event interest (e.g., \"Death\", \"Relapse\"). recurrence Variable indicating disease recurrence progression (RFS/PFS/DFS analyses). recurrenceLevel level indicating recurrence progression occurred. patientID Patient identifier handling multiple records applying event hierarchies. analysistype type survival analysis prepare outcome . multievent true, allows multiple event types (e.g., death disease vs death causes). dod level representing death disease interest. dooc level representing death causes disease interest. awd level representing patients alive disease. awod level representing patients alive disease-free. useHierarchy true, applies hierarchy multiple events occur patient. eventPriority event code (e.g., 1, 2) takes precedence multiple events occur. intervalCensoring true, prepares data interval-censored analysis exact event times unknown. intervalStart Variable containing start interval event might occurred. intervalEnd Variable containing end interval event might occurred. adminCensoring true, applies administrative censoring specified date. adminDate Variable containing administrative censoring date. outputTable true, displays table showing frequency recoded outcome value. diagnostics true, displays diagnostic information recoding process. visualization true, displays visualization distribution recoded outcomes.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/outcomeorganizer.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Outcome Organizer for Survival Analysis — outcomeorganizer","text":"results object containing: Tables can converted data frames asDF .data.frame. example: results$outputTable$asDF .data.frame(results$outputTable)","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/outcomeorganizer.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Outcome Organizer for Survival Analysis — outcomeorganizer","text":"","code":"# \\donttest{ # Example usage will be added # }"},{"path":"https://www.serdarbalci.com/jsurvival/reference/outcomeorganizerClass.html","id":null,"dir":"Reference","previous_headings":"","what":"Enhanced Outcome Organizer for Survival Analysis — outcomeorganizerClass","title":"Enhanced Outcome Organizer for Survival Analysis — outcomeorganizerClass","text":"Enhanced Outcome Organizer Survival Analysis Enhanced Outcome Organizer Survival Analysis","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/outcomeorganizerClass.html","id":"super-classes","dir":"Reference","previous_headings":"","what":"Super classes","title":"Enhanced Outcome Organizer for Survival Analysis — outcomeorganizerClass","text":"jmvcore::Analysis -> jsurvival::outcomeorganizerBase -> outcomeorganizerClass","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/outcomeorganizerClass.html","id":"methods","dir":"Reference","previous_headings":"","what":"Methods","title":"Enhanced Outcome Organizer for Survival Analysis — outcomeorganizerClass","text":"jmvcore::Analysis$.createImage() jmvcore::Analysis$.createImages() jmvcore::Analysis$.createPlotObject() jmvcore::Analysis$.load() jmvcore::Analysis$.render() jmvcore::Analysis$.save() jmvcore::Analysis$.savePart() jmvcore::Analysis$.setCheckpoint() jmvcore::Analysis$.setParent() jmvcore::Analysis$.setReadDatasetHeaderSource() jmvcore::Analysis$.setReadDatasetSource() jmvcore::Analysis$.setResourcesPathSource() jmvcore::Analysis$.setStatePathSource() jmvcore::Analysis$addAddon() jmvcore::Analysis$asProtoBuf() jmvcore::Analysis$asSource() jmvcore::Analysis$check() jmvcore::Analysis$init() jmvcore::Analysis$optionsChangedHandler() jmvcore::Analysis$postInit() jmvcore::Analysis$print() jmvcore::Analysis$readDataset() jmvcore::Analysis$run() jmvcore::Analysis$serialize() jmvcore::Analysis$setError() jmvcore::Analysis$setStatus() jmvcore::Analysis$translate() jsurvival::outcomeorganizerBase$initialize()","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/outcomeorganizerClass.html","id":"public-methods","dir":"Reference","previous_headings":"","what":"Public methods","title":"Enhanced Outcome Organizer for Survival Analysis — outcomeorganizerClass","text":"outcomeorganizerClass$clone()","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/outcomeorganizerClass.html","id":"method-clone-","dir":"Reference","previous_headings":"","what":"Method clone()","title":"Enhanced Outcome Organizer for Survival Analysis — outcomeorganizerClass","text":"objects class cloneable method.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/outcomeorganizerClass.html","id":"usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Enhanced Outcome Organizer for Survival Analysis — outcomeorganizerClass","text":"","code":"outcomeorganizerClass$clone(deep = FALSE)"},{"path":"https://www.serdarbalci.com/jsurvival/reference/outcomeorganizerClass.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Enhanced Outcome Organizer for Survival Analysis — outcomeorganizerClass","text":"deep Whether make deep clone.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/pipe.html","id":null,"dir":"Reference","previous_headings":"","what":"Pipe operator — %>%","title":"Pipe operator — %>%","text":"Pipe operator","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/pipe.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Pipe operator — %>%","text":"","code":"lhs %>% rhs"},{"path":"https://www.serdarbalci.com/jsurvival/reference/print.sensSpecTable.html","id":null,"dir":"Reference","previous_headings":"","what":"Print formatted HTML table for sensitivity/specificity results — print.sensSpecTable","title":"Print formatted HTML table for sensitivity/specificity results — print.sensSpecTable","text":"Creates HTML table confusion matrix visualization","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/print.sensSpecTable.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Print formatted HTML table for sensitivity/specificity results — print.sensSpecTable","text":"","code":"# S3 method for class 'sensSpecTable' print(Title, TP, FP, TN, FN)"},{"path":"https://www.serdarbalci.com/jsurvival/reference/print.sensSpecTable.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Print formatted HTML table for sensitivity/specificity results — print.sensSpecTable","text":"Title Title confusion matrix table TP Number true positives FP Number false positives TN Number true negatives FN Number false negatives","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/print.sensSpecTable.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Print formatted HTML table for sensitivity/specificity results — print.sensSpecTable","text":"HTML string containing formatted table","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/prop_to_percent.html","id":null,"dir":"Reference","previous_headings":"","what":"Convert proportion to percentage string — prop_to_percent","title":"Convert proportion to percentage string — prop_to_percent","text":"Converts numeric proportion formatted percentage","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/prop_to_percent.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Convert proportion to percentage string — prop_to_percent","text":"","code":"prop_to_percent(x, digits = 1)"},{"path":"https://www.serdarbalci.com/jsurvival/reference/prop_to_percent.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Convert proportion to percentage string — prop_to_percent","text":"x Numeric proportion (0-1) digits Number decimal places","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/prop_to_percent.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Convert proportion to percentage string — prop_to_percent","text":"Character string percentage formatting","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/raw_to_prob.html","id":null,"dir":"Reference","previous_headings":"","what":"Convert raw test values to predicted probabilities using ROC curve — raw_to_prob","title":"Convert raw test values to predicted probabilities using ROC curve — raw_to_prob","text":"Maps raw test values probabilities based position ROC curve","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/raw_to_prob.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Convert raw test values to predicted probabilities using ROC curve — raw_to_prob","text":"","code":"raw_to_prob(values, actual, direction = \">=\")"},{"path":"https://www.serdarbalci.com/jsurvival/reference/raw_to_prob.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Convert raw test values to predicted probabilities using ROC curve — raw_to_prob","text":"values Raw test values actual Binary outcomes (0/1) direction Direction test (\">=\" \"<=\")","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/raw_to_prob.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Convert raw test values to predicted probabilities using ROC curve — raw_to_prob","text":"Vector predicted probabilities","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/safe_divide.html","id":null,"dir":"Reference","previous_headings":"","what":"Safe division function — safe_divide","title":"Safe division function — safe_divide","text":"Performs division safe handling division zero","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/safe_divide.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Safe division function — safe_divide","text":"","code":"safe_divide(x, y, na_value = NA_real_)"},{"path":"https://www.serdarbalci.com/jsurvival/reference/safe_divide.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Safe division function — safe_divide","text":"x Numerator y Denominator na_value Value return division zero occurs","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/safe_divide.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Safe division function — safe_divide","text":"Result x/y na_value y zero","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/singlearm.html","id":null,"dir":"Reference","previous_headings":"","what":"Single Arm Survival — singlearm","title":"Single Arm Survival — singlearm","text":"Performs survival analysis single cohort patients without group comparisons. analysis calculates total person-time follow-(sum individual  observation periods) uses derive accurate survival estimates account  varying follow-durations. Use want analyze overall survival  characteristics entire study population - example, determine median  survival time 1/3/5-year survival rates patients collectively.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/singlearm.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Single Arm Survival — singlearm","text":"","code":"singlearm(   data,   elapsedtime,   tint = FALSE,   dxdate,   fudate,   outcome,   outcomeLevel,   dod,   dooc,   awd,   awod,   analysistype = \"overall\",   cutp = \"12, 36, 60\",   timetypedata = \"ymd\",   timetypeoutput = \"months\",   uselandmark = FALSE,   landmark = 3,   sc = FALSE,   kmunicate = FALSE,   ce = FALSE,   ch = FALSE,   endplot = 60,   ybegin_plot = 0,   yend_plot = 1,   byplot = 12,   multievent = FALSE,   ci95 = FALSE,   risktable = FALSE,   censored = FALSE,   medianline = \"none\",   person_time = FALSE,   time_intervals = \"12, 36, 60\",   rate_multiplier = 100 )"},{"path":"https://www.serdarbalci.com/jsurvival/reference/singlearm.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Single Arm Survival — singlearm","text":"data data data frame. elapsedtime time--event follow-duration patient. sum values represents total person-time follow-study, serves denominator calculating event rates fundamental Kaplan-Meier estimates. numeric continuous, measured consistent units (e.g., months years). tint Enable option want calculate survival time dates data. useful separate columns diagnosis date follow-date want calculate time elapsed . dxdate date diagnosis study entry patient. consistent date format (e.g., YYYY-MM-DD). fudate date last follow-event patient. consistent date format (e.g., YYYY-MM-DD). outcome outcome event interest patient. factor numeric variable indicating whether patient experienced event (e.g., death) censoring (e.g., end follow-). outcomeLevel Select level outcome variable represents event interest. example, outcome variable \"death_status\" levels \"Alive\" \"Dead\", select \"Dead\" event level. dod Select level outcome variable represents death due disease. useful competing risk analysis multiple event types. dooc Select level outcome variable represents death due causes. useful competing risk analysis multiple event types. awd Select level outcome variable represents alive disease. useful competing risk analysis multiple event types. awod Select level outcome variable represents alive without disease. useful competing risk analysis multiple event types. analysistype Select type survival analysis perform. \"Overall\" analyzes survival patients regardless event type. \"Cause Specific\" analyzes survival specific event type (e.g., death due disease). \"Competing Risk\" analyzes survival multiple event types simultaneously. cutp Specify time points calculate survival probabilities. Enter comma-separated list time points consistent units (e.g., months years). example, \"12, 36, 60\" calculates survival probabilities 1, 3, 5 years. timetypedata select time type data (e.g., YYYY-MM-DD) timetypeoutput select time type output (default months) uselandmark Enables landmark analysis, addresses immortal time bias analyzing survival patients survive specified timepoint (landmark). Use want eliminate effect early deaths comparing treatments can given patients survive long enough receive . landmark Enables landmark analysis, addresses immortal time bias analyzing survival patients survive specified timepoint (landmark). Use want eliminate effect early deaths comparing treatments can given patients survive long enough receive . sc Enable option generate Kaplan-Meier survival plot confidence intervals. plot shows estimated survival probability time useful visualizing survival trends data. kmunicate Enable option generate publication-ready survival plot style KMunicate. plot shows estimated survival probability time confidence intervals suitable publication presentation. ce Enable option calculate plot cumulative number events time. plot shows total number events (e.g., deaths) occurred time point useful visualizing event rates data. ch Enable option calculate plot cumulative hazard function time. plot shows cumulative risk experiencing event (e.g., death) time point useful visualizing risk event time. endplot maximum time point include survival plots. end time survival curves cumulative event/hazard plots. Enter positive integer representing time consistent units (e.g., months years). ybegin_plot minimum value y-axis survival plots. Enter number 0 1 set lower limit y-axis. yend_plot maximum value y-axis survival plots. Enter number 0 1 set upper limit y-axis. byplot interval plotting survival probabilities. Enter positive integer representing time interval consistent units (e.g., months years). multievent Enable option perform survival analysis datasets multiple event levels. useful competing risk analysis multiple event types (e.g., death due disease, death due causes). ci95 Enable option display 95\\ survival plots. intervals show range uncertainty around estimated survival probabilities useful assessing precision estimates. risktable Enable option display table risk estimates time point. table shows estimated survival probability, cumulative event rate, cumulative hazard time point useful summarizing survival characteristics data. censored Enable option display censored observations survival plots. Censored observations patients experienced event interest end follow-indicated vertical ticks survival curves. medianline true, displays line indicating median survival time survival plot. person_time Enable option calculate display person-time metrics, including total follow-time incidence rates. metrics help quantify rate events per unit time study population. time_intervals Specify time intervals stratified person-time analysis. Enter  comma-separated list time points create intervals. example,  \"12, 36, 60\" create intervals 0-12, 12-36, 36-60, 60+. rate_multiplier Specify multiplier incidence rates (e.g., 100 rates per 100 person-years, 1000 rates per 1000 person-years).","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/singlearm.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Single Arm Survival — singlearm","text":"results object containing: Tables can converted data frames asDF .data.frame. example: results$medianTable$asDF .data.frame(results$medianTable)","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/singlearm.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Single Arm Survival — singlearm","text":"","code":"# \\donttest{ # Example analyzing overall survival for a patient cohort: # singlearm( #   data = patient_data, #   time = \"months_survival\", #   outcome = \"death_status\", #   outcome_level = \"Dead\" # ) # }"},{"path":"https://www.serdarbalci.com/jsurvival/reference/singlearmClass.html","id":null,"dir":"Reference","previous_headings":"","what":"Single Arm Survival — singlearmClass","title":"Single Arm Survival — singlearmClass","text":"function prepares cleans data single-arm survival analysis calculating survival time, filtering based landmark time, merging survival outcomes factors.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/singlearmClass.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Single Arm Survival — singlearmClass","text":"list containing cleaned data metadata plotting analysis.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/singlearmClass.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"Single Arm Survival — singlearmClass","text":"Ensure input data contains required variables (elapsed time, outcome) meets specified formatting criteria.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/singlearmClass.html","id":"super-classes","dir":"Reference","previous_headings":"","what":"Super classes","title":"Single Arm Survival — singlearmClass","text":"jmvcore::Analysis -> jsurvival::singlearmBase -> singlearmClass","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/singlearmClass.html","id":"methods","dir":"Reference","previous_headings":"","what":"Methods","title":"Single Arm Survival — singlearmClass","text":"jmvcore::Analysis$.createImage() jmvcore::Analysis$.createImages() jmvcore::Analysis$.createPlotObject() jmvcore::Analysis$.load() jmvcore::Analysis$.render() jmvcore::Analysis$.save() jmvcore::Analysis$.savePart() jmvcore::Analysis$.setCheckpoint() jmvcore::Analysis$.setParent() jmvcore::Analysis$.setReadDatasetHeaderSource() jmvcore::Analysis$.setReadDatasetSource() jmvcore::Analysis$.setResourcesPathSource() jmvcore::Analysis$.setStatePathSource() jmvcore::Analysis$addAddon() jmvcore::Analysis$asProtoBuf() jmvcore::Analysis$asSource() jmvcore::Analysis$check() jmvcore::Analysis$init() jmvcore::Analysis$optionsChangedHandler() jmvcore::Analysis$postInit() jmvcore::Analysis$print() jmvcore::Analysis$readDataset() jmvcore::Analysis$run() jmvcore::Analysis$serialize() jmvcore::Analysis$setError() jmvcore::Analysis$setStatus() jmvcore::Analysis$translate() jsurvival::singlearmBase$initialize()","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/singlearmClass.html","id":"public-methods","dir":"Reference","previous_headings":"","what":"Public methods","title":"Single Arm Survival — singlearmClass","text":"singlearmClass$clone()","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/singlearmClass.html","id":"method-clone-","dir":"Reference","previous_headings":"","what":"Method clone()","title":"Single Arm Survival — singlearmClass","text":"objects class cloneable method.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/singlearmClass.html","id":"usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Single Arm Survival — singlearmClass","text":"","code":"singlearmClass$clone(deep = FALSE)"},{"path":"https://www.serdarbalci.com/jsurvival/reference/singlearmClass.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Single Arm Survival — singlearmClass","text":"deep Whether make deep clone.","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/reference/stagemigration.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Advanced TNM Stage Migration Analysis — stagemigration","text":"","code":"stagemigration(   data,   oldStage,   newStage,   survivalTime,   event,   eventLevel,   analysisType = \"comprehensive\",   confidenceLevel = 0.95,   calculateNRI = FALSE,   nriTimePoints = \"12, 24, 60\",   calculateIDI = FALSE,   performROCAnalysis = FALSE,   rocTimePoints = \"12, 24, 36, 60\",   performDCA = FALSE,   performCalibration = FALSE,   performBootstrap = FALSE,   bootstrapReps = 1000,   performCrossValidation = FALSE,   cvFolds = 5,   institutionVariable,   clinicalSignificanceThreshold = 0.02,   nriClinicalThreshold = 0.2,   performHomogeneityTests = FALSE,   performTrendTests = FALSE,   performLikelihoodTests = FALSE,   calculatePseudoR2 = TRUE,   showMigrationOverview = TRUE,   showMigrationSummary = TRUE,   showStageDistribution = TRUE,   showMigrationMatrix = TRUE,   showStatisticalComparison = TRUE,   showConcordanceComparison = TRUE,   showMigrationHeatmap = FALSE,   showSankeyDiagram = FALSE,   showROCComparison = FALSE,   showCalibrationPlots = FALSE,   showDecisionCurves = FALSE,   showForestPlot = FALSE,   showWillRogersAnalysis = FALSE,   showWillRogersVisualization = FALSE,   showMigrationSurvivalComparison = FALSE,   showSurvivalCurves = FALSE,   survivalPlotType = \"separate\",   showConfidenceIntervals = FALSE,   showRiskTables = FALSE,   plotTimeRange = \"auto\",   showClinicalInterpretation = FALSE,   showStatisticalSummary = FALSE,   showMethodologyNotes = FALSE,   includeEffectSizes = FALSE,   advancedMigrationAnalysis = FALSE,   generateExecutiveSummary = FALSE,   cancerType = \"general\",   useOptimismCorrection = FALSE,   enableMultifactorialAnalysis = FALSE,   continuousCovariates = NULL,   categoricalCovariates = NULL,   multifactorialComparisonType = \"comprehensive\",   baselineModel = \"covariates_only\",   performInteractionTests = FALSE,   stratifiedAnalysis = FALSE,   showMultifactorialTables = FALSE,   showAdjustedCIndexComparison = FALSE,   showNestedModelTests = FALSE,   showStepwiseResults = FALSE,   showExplanations = TRUE,   showAbbreviationGlossary = FALSE,   calculateSME = FALSE,   calculateRMST = FALSE,   performCompetingRisks = FALSE,   competingEventVar,   performOptimalCutpoint = FALSE,   continuousStageVariable,   cutpointMethod = \"maxstat\",   cutpointRange = \"0.1, 0.9\",   multipleTestingCorrection = \"bonferroni\",   validateCutpoint = FALSE,   cutpointBootstrap = FALSE,   cutpointBootstrapReps = 500,   generateStagingSystem = FALSE,   stagingSystemLevels = 3,   performSHAPAnalysis = FALSE,   shapAnalysisType = \"comprehensive\",   shapCovariates,   shapSampleSize = 100,   shapBackgroundSamples = 50,   shapExplanationType = \"auto\",   generateSHAPPlots = TRUE,   shapPatientProfiles = \"representative\",   shapInteractionAnalysis = FALSE,   shapClinicalThresholds = \"0.25, 0.50, 0.75\",   performCompetingRisksAdvanced = FALSE,   competingRisksMethod = \"comprehensive\",   cifTimePoints = \"12, 24, 36, 60\",   competingEventLevels = \"cancer_death, other_death, censored\",   primaryEventLevel = \"cancer_death\",   generateCIFPlots = TRUE,   performGrayTest = TRUE,   cifConfidenceLevel = 0.95,   competingRisksCovariates,   stratifyByStaging = TRUE,   calculateCRCIndex = TRUE,   generateCRSummary = TRUE,   performMultiStateAnalysis = FALSE,   multiStateModel = \"illness_death\",   stateVariable,   transitionTimeVariable,   multiStateStates = \"healthy, disease, death\",   absorptionStates = \"death\",   multiStateCovariates,   calculateTransitionProbabilities = TRUE,   multiStateTimePoints = \"6, 12, 24, 36, 60\",   generateTransitionMatrix = TRUE,   multiStateGraphics = TRUE,   msStratifyByStaging = TRUE,   multiStateValidation = FALSE,   generateMSMSummary = TRUE,   performRandomForestAnalysis = FALSE,   forestModelType = \"rsf\",   forestNTrees = 500,   forestMTry = \"auto\",   forestMinNodeSize = 3,   forestCovariates,   calculateVariableImportance = TRUE,   forestImportanceType = \"permutation\",   performForestValidation = FALSE,   forestPredictionTimePoints = \"12, 24, 36, 60\",   generateSurvivalPredictions = TRUE,   forestDiscriminationMetrics = TRUE,   forestStagingComparison = TRUE,   forestBootstrap = FALSE,   forestBootstrapSamples = 100,   generateForestSummary = TRUE,   performCureModelAnalysis = FALSE,   cureModelType = \"mixture\",   cureDistribution = \"weibull\",   cureAnalyzeOldStage = TRUE,   cureAnalyzeNewStage = TRUE,   cureFractionEstimation = \"parametric\",   cureConfidenceLevel = 0.95,   cureBootstrapCI = TRUE,   cureBootstrapReps = 500,   cureTimeHorizon = 120,   curePlateauThreshold = 0.05,   cureCovariates,   cureModelComparison = TRUE,   cureStageSpecificAnalysis = TRUE,   cureGoodnessOfFit = TRUE,   generateCureSummary = TRUE,   performIntervalCensoringAnalysis = FALSE,   intervalCensoringLeftTime,   intervalCensoringRightTime,   intervalCensoringDistribution = \"weibull\",   intervalCensoringModel = \"both\",   intervalCensoringBootstrap = TRUE,   intervalCensoringBootstrapSamples = 1000,   intervalCensoringCompareStages = TRUE,   intervalCensoringPlots = TRUE,   intervalCensoringDiagnostics = TRUE,   intervalCensoringPredictionTime = \"12, 24, 36, 60\",   intervalCensoringConfidenceLevel = 0.95,   intervalCensoringAdjustVariables,   performInformativeCensoringAnalysis = FALSE,   informativeCensoringTestMethod = \"all_tests\",   informativeCensoringCovariates,   informativeCensoringLandmarkTimes = \"12, 24, 36, 60\",   informativeCensoringAdjustmentMethod = \"sensitivity_analysis\",   informativeCensoringIPWVariables,   informativeCensoringSensitivityRange = \"0.8, 0.9, 1.0, 1.1, 1.2\",   informativeCensoringBootstrap = TRUE,   informativeCensoringBootstrapSamples = 1000,   informativeCensoringAlpha = 0.05,   informativeCensoringPlots = TRUE,   informativeCensoringCompareStages = TRUE,   performConcordanceProbabilityAnalysis = FALSE,   concordanceProbabilityMethods = \"all_methods\",   concordanceProbabilityTimePoints = \"12, 24, 36, 60, 120\",   concordanceProbabilityWeighting = \"uniform\",   concordanceProbabilityBootstrap = TRUE,   concordanceProbabilityBootstrapSamples = 1000,   concordanceProbabilityConfidenceLevel = 0.95,   concordanceProbabilityCompareStages = TRUE,   concordanceProbabilityAdjustVariables,   concordanceProbabilityRobustnessAnalysis = TRUE,   concordanceProbabilityAlpha = 0.05,   concordanceProbabilityDiagnostics = TRUE,   performWinRatioAnalysis = FALSE,   winRatioEndpoints = \"death_progression_response\",   winRatioDeathVariable,   winRatioSecondaryEndpoint,   winRatioTertiaryEndpoint,   winRatioTimeVariables,   winRatioMatchingStrategy = \"all_pairs\",   winRatioConfidenceMethod = \"bootstrap\",   winRatioBootstrapSamples = 1000,   winRatioConfidenceLevel = 0.95,   winRatioHandleTies = \"next_endpoint\",   winRatioSensitivityAnalysis = TRUE,   winRatioGeneralizedPairwise = FALSE,   performFrailtyModelsAnalysis = FALSE,   frailtyClusterVariable,   frailtyDistribution = \"gamma\",   frailtyBootstrap = TRUE,   frailtyBootstrapSamples = 500,   frailtyVarianceComponents = TRUE,   frailtyHeterogeneityTest = TRUE,   frailtyClusterComparison = FALSE,   frailtyModelSelection = TRUE,   frailtyPredictiveAccuracy = FALSE,   frailtyDiagnostics = TRUE,   frailtyAdvancedInference = FALSE,   performClinicalUtilityAnalysis = FALSE,   clinicalUtilityPrevalence = 0.2,   clinicalUtilityTimePoint = 60,   clinicalUtilityThresholds = \"standard\",   clinicalUtilityNNT = TRUE,   clinicalUtilityTreatmentEffect = 0.7,   clinicalUtilityComparison = TRUE,   clinicalUtilityCostEffectiveness = FALSE,   clinicalUtilityCostPerIntervention = 5000,   clinicalUtilityBootstrap = TRUE,   clinicalUtilityBootstrapSamples = 500,   clinicalUtilityTimeVarying = FALSE )"},{"path":"https://www.serdarbalci.com/jsurvival/reference/stagemigration.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Advanced TNM Stage Migration Analysis — stagemigration","text":"data dataset containing staging survival information TNM validation analysis. oldStage original staging variable (e.g., TNM 7th edition, AJCC 7th edition). coded ordered factor appropriate stage levels. newStage proposed new staging variable (e.g., TNM 8th edition, revised staging). use coding structure original staging system. survivalTime Time event censoring consistent units (months recommended). overall survival analysis, use time diagnosis death last follow-. event Event indicator (1 = event occurred, 0 = censored) factor event levels. overall survival, event = death cause. eventLevel level indicating event occurrence using factor variables. analysisType Determines scope statistical analysis performed. Comprehensive analysis includes available methods thorough staging system validation. confidenceLevel Confidence level confidence intervals hypothesis tests. calculateNRI Calculate Net Reclassification Improvement quantify improvement  risk classification staging systems. Essential staging validation. nriTimePoints Comma-separated time points NRI calculation (e.g., \"12, 24, 60\"  1, 2, 5-year survival). Use clinically relevant time points. calculateIDI Calculate Integrated Discrimination Improvement measure improvement  risk prediction accuracy staging systems. performROCAnalysis Perform time-dependent ROC analysis compare discriminative ability staging systems time. rocTimePoints Time points ROC analysis. include clinically important survival milestones specific cancer type. performDCA Perform Decision Curve Analysis assess clinical utility net benefit new staging system clinical decision making. performCalibration Assess calibration risk predictions staging systems. Important validating accuracy survival predictions. performBootstrap Perform bootstrap validation optimism correction assess internal validity results. Recommended staging validation studies. bootstrapReps Number bootstrap repetitions internal validation.  1000 repetitions recommended stable results. performCrossValidation Perform k-fold cross-validation additional validation. Computationally intensive provides robust validation. cvFolds Number folds cross-validation enabled. institutionVariable Optional variable indicating institution study center  multi-institutional validation. provided, performs internal-external cross-validation using k-1 centers development remaining center validation. Essential multi-center staging validation studies. clinicalSignificanceThreshold Minimum improvement C-index considered clinically significant. Default 0.02 based oncology literature recommendations. nriClinicalThreshold Minimum NRI improvement considered clinically meaningful. Default 0.20 (20\\ performHomogeneityTestsTest homogeneity within stages monotonic trend across stages. Essential validating stage ordering grouping. performTrendTestsTest monotonic trend survival across stage levels. Validates higher stages consistently worse prognosis. performLikelihoodTestsPerform formal likelihood ratio tests comparing nested staging models. Provides statistical significance testing staging improvement. calculatePseudoR2Calculate multiple pseudo R-squared measures model comparison (Nagelkerke, McFadden, Cox-Snell). showMigrationOverviewDisplay overview table showing fundamental migration statistics including: total number patients, number percentage patients migrated stages, direction migration (upstaged vs downstaged), net migration effect. essential first table understanding overall impact new staging system. showMigrationSummaryDisplay statistical summary migration patterns including overall migration rate formal statistical tests. Shows Chi-square test results independence Fisher's exact test p-values determine migration patterns statistically significant. Essential validating whether observed changes due genuine staging improvements random variation. showStageDistributionDisplay side--side comparison patients distributed across stages original new staging systems. Shows count percentage patients stage, along net change. helps identify stages gaining losing patients whether new system creates better separation prognostic groups. showMigrationMatrixDisplay detailed cross-tabulation matrix showing exactly patients moved stages. Rows represent original staging system columns represent new staging system. Diagonal values indicate patients remained stage, -diagonal values show stage migrations. essential understanding specific migration patterns identifying stages affected new criteria. showStatisticalComparisonDisplay table C-index comparisons statistical metrics. showConcordanceComparisonDisplay detailed concordance comparison staging systems. showMigrationHeatmapDisplay color-coded heatmap visualization migration matrix.  Darker colors indicate patients, diagonal showing patients  remained stage. visual representation makes easy  identify migration patterns glance - upstaging appears  diagonal, downstaging . Essential presentations publications. showSankeyDiagramDisplay Sankey flow diagram showing patient migration patterns  original new staging systems. Flow thickness represents number  patients moving stages, making easy visualize dominant  migration patterns. Excellent presentations understanding  overall reclassification impact. showROCComparisonDisplay time-dependent ROC curves comparing staging systems. showCalibrationPlotsDisplay calibration plots staging systems. showDecisionCurvesDisplay decision curves showing net benefit staging systems. showForestPlotDisplay forest plot stage-specific hazard ratios confidence intervals. showWillRogersAnalysisDetailed analysis Rogers phenomenon survival comparisons migrated non-migrated patients within stages. showWillRogersVisualizationDisplay visualization showing stage migration affects survival within stage. Shows /survival curves demonstrating Rogers paradox stages appear improve. showMigrationSurvivalComparisonDisplay Kaplan-Meier survival curves comparing stages  patient migration. Shows survival curves change  patients reclassified staging systems, providing visual  evidence Rogers phenomenon staging system improvements. showSurvivalCurvesDisplay survival curves comparing staging systems. survivalPlotTypeControls display survival curves staging system comparison. showConfidenceIntervalsDisplay confidence intervals around survival curves estimates. showRiskTablesDisplay -risk tables survival curves. plotTimeRangeMaximum time survival plots. Use \"auto\" automatic range specify maximum months (e.g., \"60\" 5-year follow-). showClinicalInterpretationDisplay comprehensive clinical interpretation statistical results guidance staging system adoption decisions. showStatisticalSummaryDisplay comprehensive table summarizing statistical comparisons. showMethodologyNotesDisplay detailed notes statistical methods used interpretation. includeEffectSizesCalculate display effect sizes comparisons assess practical significance beyond statistical significance. advancedMigrationAnalysisPerform comprehensive stage migration analysis including monotonicity  checks, Rogers phenomenon detection, stage-specific validation,  enhanced discrimination metrics. Provides detailed assessment  staging system quality migration patterns. generateExecutiveSummaryGenerate executive summary key findings recommendations clinical research stakeholders. cancerTypeOptional cancer type specification customized thresholds  interpretation guidelines based cancer-specific literature. useOptimismCorrectionApply optimism correction performance metrics using bootstrap validation avoid overly optimistic estimates. enableMultifactorialAnalysisEnable advanced multifactorial stage migration analysis includes additional covariates comparison. allows adjusted comparisons staging systems accounting prognostic factors. continuousCovariatesContinuous variables include covariates multifactorial analysis (e.g., age, tumor size, biomarker levels). included Cox regression models staging systems. categoricalCovariatesCategorical variables include covariates multifactorial analysis (e.g., sex, histology, treatment type). included Cox regression models staging systems. multifactorialComparisonTypeType multifactorial comparison perform. Comprehensive includes methods thorough evaluation staging systems context prognostic factors. baselineModelBaseline model multifactorial comparisons. determines reference model staging systems compared. performInteractionTestsTest interactions staging systems covariates. helps identify staging system performance varies across different patient subgroups. stratifiedAnalysisPerform stratified analysis categorical covariates evaluate staging system performance within subgroups. showMultifactorialTablesDisplay detailed tables showing multifactorial model results, including adjusted hazard ratios model comparison statistics. showAdjustedCIndexComparisonDisplay comparison C-indices staging systems adjusted covariates. shows discriminative ability staging system accounting prognostic factors. showNestedModelTestsDisplay likelihood ratio tests comparing nested models formally test added value staging system baseline model. showStepwiseResultsDisplay results stepwise model selection showing variables (including staging systems) selected final model. showExplanationsInclude detailed explanations results. showAbbreviationGlossaryDisplay comprehensive glossary abbreviations, statistical terms,  technical terminology used stage migration analysis.  provides quick reference interpreting dashboard values  understanding statistical outputs. calculateSMECalculate Stage Migration Effect Formula (SME) quantify cumulative  difference survival corresponding stages old new staging  systems. SME = Σ(S_new_i - S_old_i) S represents stage-specific  survival rates. Positive values indicate Rogers phenomenon (apparent  improvement new system), negative values suggest understaging. calculateRMSTCalculate Restricted Mean Survival Time (RMST) metrics robust  discrimination assessment. RMST provides clinically interpretable  survival measures independent proportional hazards assumptions.  Particularly valuable median survival reached comparing  absolute survival benefits staging systems. performCompetingRisksPerform competing risks analysis scenarios multiple event types  (e.g., cancer-specific death vs. causes). Implements Fine-Gray  subdistribution hazard models Cumulative Incidence Function (CIF)  analysis. Essential competing events prevent observation primary  outcome standard survival analysis may biased. competingEventVarOptional variable indicating competing events (events primary  outcome). specified, analysis attempt detect competing  risks multi-level event variables. cancer studies, typically  represents non-cancer deaths primary outcome cancer-specific death. performOptimalCutpointDetermine optimal cut-points continuous variables create  statistically significant separation survival outcomes. Uses maximal  selected rank statistics appropriate multiple testing corrections.  Essential developing new staging criteria continuous biomarkers  measurements. continuousStageVariableContinuous variable (e.g., tumor size, biomarker level, age) optimal  cut-point determination. analysis find cut-point maximizes  separation survival outcomes controlling multiple testing. cutpointMethodMethod optimal cut-point determination. Maximal selected rank statistics  provides rigorous approach proper multiple testing correction. cutpointRangeProportion range cut-point search (e.g., \"0.1, 0.9\" excludes outer  10\\ cut-points  create unbalanced groups. multipleTestingCorrectionMultiple testing correction method cut-point determination.  Bonferroni conservative; use testing many cut-points. validateCutpointPerform cross-validation assess stability optimal cut-point.  Helps identify robust cut-points dependent specific  data characteristics. cutpointBootstrapUse bootstrap validation assess cut-point stability derive  confidence intervals. Provides robust assessment cut-point reliability. cutpointBootstrapRepsNumber bootstrap repetitions cut-point validation. generateStagingSystemAutomatically generate new staging system based optimal cut-points.  Creates categorical staging variable continuous measurements using  determined cut-points appropriate stage labeling. stagingSystemLevelsNumber staging levels create optimal cut-points (e.g., 3  Low/Intermediate/High 4 Stages -IV). performSHAPAnalysisPerform Shapley Additive Explanations (SHAP) analysis explain  factors driving predictions staging models. SHAP provides  global feature importance individual patient-level explanations  complex staging decisions. shapAnalysisTypeType SHAP analysis perform. Global analysis shows overall feature  importance across patients, individual analysis explains specific  patient predictions, comprehensive includes approaches. shapCovariatesAdditional variables include SHAP interpretability analysis  alongside staging variables. Include key clinical variables  might influence staging decisions patient outcomes. shapSampleSizeNumber patients use SHAP analysis. Larger samples provide  comprehensive explanations require computation time.  Recommended: 100-200 routine analysis, 500+ detailed research. shapBackgroundSamplesNumber background samples SHAP baseline calculation.  samples provide stable explanations increase computation time. shapExplanationTypeSHAP explanation method use. Auto-detect chooses appropriate  method based model type. TreeSHAP fastest tree models,  Kernel SHAP works model slower. generateSHAPPlotsGenerate SHAP visualization plots including summary plots, bar plots,  dependence plots model interpretability. shapPatientProfilesTypes patient profiles include individual SHAP explanations.  Helps understand different patient characteristics influence  staging-based predictions. shapInteractionAnalysisPerform SHAP interaction analysis identify important feature  interactions. Shows combinations features affect predictions  beyond individual feature effects. shapClinicalThresholdsComma-separated risk thresholds clinical decision boundaries  SHAP analysis (e.g., \"0.25, 0.50, 0.75\" low/moderate/high risk).  Used interpret SHAP values clinical context. performCompetingRisksAdvancedPerform comprehensive competing risks analysis using Fine-Gray  subdistribution hazard models Cumulative Incidence Function (CIF)  analysis. Essential competing events prevent observation primary  outcome standard survival analysis may biased. competingRisksMethodMethod competing risks analysis. Fine-Gray models cumulative  incidence, cause-specific models instantaneous hazard rates.  Comprehensive includes approaches complete assessment. cifTimePointsTime points Cumulative Incidence Function analysis (e.g.,  \"12, 24, 36, 60\" 1, 2, 3, 5-year analysis). Use clinically relevant time points specific cancer type. competingEventLevelsComma-separated list event categories competing risks analysis.  Typically includes primary event (cancer death), competing events  (causes), censoring indicator. primaryEventLevelSpecify primary event interest competing risks analysis  (e.g., \"cancer_death\", \"disease_progression\", \"cardiovascular_death\").  Must match one competing event categories. generateCIFPlotsGenerate Cumulative Incidence Function plots showing probability  event type time. Essential visualizing competing risks  patterns staging system comparisons. performGrayTestPerform Gray's test equality cumulative incidence functions  across staging groups. Tests whether CIF curves differ significantly  stages event type. cifConfidenceLevelConfidence level Cumulative Incidence Function confidence intervals  statistical tests. competingRisksCovariatesAdditional variables include competing risks regression models.  Include important prognostic factors may influence primary  competing events. stratifyByStagingPerform separate competing risks analysis staging system  (original vs new) compare performance presence  competing events. calculateCRCIndexCalculate C-index specifically adapted competing risks analysis.  Provides discrimination metrics properly account competing  events evaluating staging system performance. generateCRSummaryGenerate comprehensive summary table Fine-Gray regression results,  cumulative incidence estimates, staging system comparisons  competing risks context. performMultiStateAnalysisPerform multi-state survival analysis complex disease progression  scenarios patients can transition multiple health states  time. Essential modeling disease progression, remission,  relapse, death oncology. multiStateModelType multi-state model fit. Illness-Death models progression  healthy disease death. Progression models include stable,  progressive, terminal states. Comprehensive fits multiple models  comparison. stateVariableVariable indicating patient disease states (e.g., stable, progressive,  deceased, remission). contain possible states patients  can transition follow-. transitionTimeVariableTime variable indicating state transitions occurred. multiple  transitions per patient, use comma-separated times separate records  transition. multiStateStatesComma-separated list possible states order progression  (e.g., \"healthy, disease, death\" \"stable, progressive, remission, death\").  Must match levels state variable. absorptionStatesComma-separated list absorbing states patients leave  entered (e.g., \"death\", \"terminal\"). represent final  outcomes disease process. multiStateCovariatesAdditional variables include multi-state models covariates.  Include important prognostic factors may influence transition  rates states. calculateTransitionProbabilitiesCalculate state transition probabilities possible state  pairs. Provides insight likelihood disease progression,  remission, mortality transitions. multiStateTimePointsTime points transition probability calculations (e.g.,  \"6, 12, 24, 36, 60\" 6-month intervals 5 years). Use  clinically relevant time points disease monitoring. generateTransitionMatrixGenerate comprehensive transition intensity matrix showing hazard  rates possible state transitions. Essential understanding  disease progression dynamics. multiStateGraphicsGenerate multi-state model visualizations including state transition  diagrams, probability plots, Aalen-Johansen estimator curves  state occupancy probabilities. msStratifyByStagingPerform separate multi-state analysis staging system  compare ability predict disease transitions progression  patterns. multiStateValidationPerform model validation including goodness--fit testing, residual  analysis, cross-validation multi-state models. Computationally  intensive provides robust model assessment. generateMSMSummaryGenerate comprehensive summary table transition intensities,  hazard ratios, state occupancy probabilities comparing staging  systems multi-state framework. performRandomForestAnalysisPerform Random Survival Forest analysis non-parametric alternative  Cox proportional hazards models. Provides robust predictions  ensemble methods without proportional hazards assumptions, ideal  complex interactions non-linear relationships. forestModelTypeType random forest model fit. RSF standard approach,  conditional inference forests handle categorical variables better,  extra trees provide additional randomization. Ensemble combines  multiple approaches maximum robustness. forestNTreesNumber trees random forest. trees generally improve  performance increase computation time. 500 trees provide good  balance accuracy speed applications. forestMTryNumber variables randomly selected split. Use \"auto\"  automatic selection (sqrt total variables), specify number.  Lower values increase randomization, higher values may improve accuracy. forestMinNodeSizeMinimum number observations terminal nodes. Larger values prevent  overfitting may reduce model flexibility. Recommended: 3-10  survival data depending sample size. forestCovariatesAdditional variables include random forest models alongside  staging variables. Include important clinical variables  comprehensive non-parametric survival modeling. calculateVariableImportanceCalculate variable importance measures using permutation-based methods.  Shows variables contribute survival predictions,  complementing SHAP analysis forest-specific importance metrics. forestImportanceTypeType variable importance measure. Permutation importance  interpretable, VIMP RF-specific, minimal depth shows variable  selection frequency. Comprehensive provides measures. performForestValidationPerform --bag validation cross-validation random forest  models. Provides robust assessment model performance including  prediction error rates concordance indices. forestPredictionTimePointsTime points survival probability predictions random forest  models (e.g., \"12, 24, 36, 60\" 1, 2, 3, 5-year predictions).  Use clinically relevant time points staging comparison. generateSurvivalPredictionsGenerate individual patient survival probability predictions  specified time points. Provides personalized risk assessments  based random forest ensemble predictions. forestDiscriminationMetricsCalculate discrimination metrics specifically random forest models  including C-index, Integrated Brier Score, time-dependent AUC.  Compares forest performance traditional Cox models. forestStagingComparisonUse random forest models compare staging systems  non-parametric ensemble methods. Provides robust staging comparison  without proportional hazards assumptions. forestBootstrapPerform bootstrap validation random forest models multiple  bootstrap samples. Provides confidence intervals forest-based  predictions importance measures. forestBootstrapSamplesNumber bootstrap samples forest validation. samples  provide stable confidence intervals increase computation time. generateForestSummaryGenerate comprehensive summary random forest analysis including  model performance, variable importance, staging comparison,  clinical recommendations based ensemble predictions. performCureModelAnalysisPerform cure model analysis populations fraction patients  may effectively cured. Uses mixture models separate susceptible  cured populations, particularly relevant cancer staging analysis. cureModelTypeType cure model fit. Mixture models assume cured fraction  infinite survival, promotion time models use biological mechanisms,  provides comprehensive comparison. cureDistributionUnderlying survival distribution susceptible population  cure models. Weibull flexible, exponential simplest,  log-normal log-logistic provide alternative hazard shapes. cureAnalyzeOldStageFit cure models original staging system estimate cure fractions  survival patterns susceptible patients stage. cureAnalyzeNewStageFit cure models new staging system estimate cure fractions  survival patterns, enabling comparison staging discrimination  cured susceptible populations. cureFractionEstimationMethod estimating cure fractions. Parametric uses maximum likelihood  specified distributions, non-parametric uses Kaplan-Meier plateau  detection, provides validation. cureConfidenceLevelConfidence level cure model parameter estimates cure fraction  confidence intervals. Standard 95\\ balance precision  coverage. cureBootstrapCICalculate bootstrap confidence intervals cure fractions model  parameters. Provides robust uncertainty quantification especially  small samples complex models. cureBootstrapRepsNumber bootstrap replications confidence interval calculation.  replications provide stable intervals increase  computation time. cureTimeHorizonTime horizon cure assessment months. Patients surviving beyond  time without events considered potentially cured. Typical  values: 60-120 months cancers. curePlateauThresholdThreshold detecting survival curve plateau non-parametric cure  fraction estimation. Lower values detect smaller plateaus may  sensitive noise. cureCovariatesAdditional variables include cure model analysis alongside staging  variables. Can affect cure probability survival susceptible  patients. cureModelComparisonCompare cure models staging systems using likelihood ratio tests,  AIC/BIC criteria, cure fraction differences. Assesses staging  system better identifies cured patients. cureStageSpecificAnalysisPerform separate cure model analysis stage group understand  stage-specific cure patterns survival susceptible patients.  Essential staging validation. cureGoodnessOfFitPerform goodness--fit tests cure models including Kolmogorov-Smirnov  tests visual diagnostic plots. Validates model assumptions  identifies potential misspecification. generateCureSummaryGenerate comprehensive summary cure model analysis including cure  fractions stage, model comparison results, clinical interpretation  staging system evaluation. performIntervalCensoringAnalysisPerform interval censoring analysis events detected visits. handles cases exact event time unknown falls  within known interval (e.g., clinic visits). Uses icenReg  package non-parametric parametric interval-censored survival  analysis. intervalCensoringLeftTimeVariable containing left endpoint censoring interval. exact observations, equal right endpoint. left-censored observations, use 0 NA. intervalCensoringRightTimeVariable containing right endpoint censoring interval. right-censored observations, use Inf large value. exact observations, equal left endpoint. intervalCensoringDistributionDistribution assumption parametric interval-censored regression. Weibull commonly used provides good flexibility. intervalCensoringModelType interval censoring model fit. Non-parametric uses non-parametric maximum likelihood estimation (NPMLE). Parametric fits accelerated failure time models specified distribution. intervalCensoringBootstrapCalculate bootstrap confidence intervals non-parametric estimates. provides uncertainty quantification survival function estimates interval-censored data. intervalCensoringBootstrapSamplesNumber bootstrap samples confidence interval calculation. samples provide accurate intervals increase computation time. intervalCensoringCompareStagesCompare survival functions different staging systems accounting interval censoring. Provides likelihood ratio tests information criteria model comparison. intervalCensoringPlotsGenerate survival plots specifically designed interval-censored data, including non-parametric survival function estimates comparison plots staging systems. intervalCensoringDiagnosticsPerform model diagnostics including convergence assessment, residual analysis parametric models, goodness--fit tests interval-censored regression models. intervalCensoringPredictionTimeComma-separated list time points (months) survival probability predictions. used staging system comparison clinical interpretation interval-censored survival estimates. intervalCensoringConfidenceLevelConfidence level interval estimates hypothesis tests. Standard choices 0.90, 0.95, 0.99. intervalCensoringAdjustVariablesAdditional variables include parametric interval-censored regression models adjusted survival analysis. included covariates accelerated failure time model. performInformativeCensoringAnalysisPerform tests informative censoring validate assumption censoring non-informative. Informative censoring occurs censoring mechanism related failure time, potentially biasing survival estimates. analysis provides tests adjustments non-random censoring patterns. informativeCensoringTestMethodMethod testing informative censoring. Correlation tests examine relationship censoring survival times. Regression tests model censoring outcome. Competing risks treats censoring competing event. Landmark analysis examines censoring patterns. informativeCensoringCovariatesVariables may associated censoring mechanism. include clinical factors, treatment decisions, administrative factors might influence patients censored study. informativeCensoringLandmarkTimesComma-separated list landmark time points (months) landmark analysis censoring patterns. Analysis examines whether censoring probabilities differ across staging groups specific time points. informativeCensoringAdjustmentMethodMethod adjusting survival estimates informative censoring detected. IPW uses inverse probability weighting. Multiple imputation imputes censored failure times. Sensitivity analysis explores range possible bias effects. informativeCensoringIPWVariablesVariables include inverse probability weighting model censoring probability estimation. include factors predict censoring affected outcome. informativeCensoringSensitivityRangeComma-separated list sensitivity parameters bias analysis. represent hazard ratio multipliers exploring potential bias informative censoring (1.0 = bias assumption). informativeCensoringBootstrapCalculate bootstrap confidence intervals adjusted survival estimates bias-corrected parameters. Provides uncertainty quantification informative censoring adjustments. informativeCensoringBootstrapSamplesNumber bootstrap samples confidence interval calculation informative censoring analysis. samples provide accurate intervals increase computation time. informativeCensoringAlphaSignificance level testing informative censoring hypotheses. Used determining whether censoring appears informative confidence interval construction. informativeCensoringPlotsGenerate diagnostic plots informative censoring assessment including censoring probability time, correlation plots, sensitivity analysis visualizations. informativeCensoringCompareStagesCompare censoring patterns across different staging groups assess whether censoring differs stage, indicate stage-related informative censoring affects staging system evaluation. performConcordanceProbabilityAnalysisPerform advanced concordance probability analysis heavily censored data. provides alternative concordance measures beyond traditional C-index, including Harrell's C-index modifications, Uno's C-index heavily censored data, time-dependent concordance measures specifically designed staging system evaluation high censoring rates. concordanceProbabilityMethodsConcordance probability estimation methods. Harrell C-index traditional may biased heavy censoring. Uno C-index uses inverse probability weighting censoring. Time-dependent measures evaluate concordance specific time points. IPCW weighted methods provide robust alternatives. concordanceProbabilityTimePointsComma-separated list time points (months) time-dependent concordance assessment. used evaluating staging system discrimination clinically relevant time horizons. concordanceProbabilityWeightingWeighting strategy concordance probability estimation. Uniform gives equal weight pairs. Sample size weights stage frequency. Event rate weights observed events. Follow-weights observation time. Inverse variance uses precision weighting. concordanceProbabilityBootstrapCalculate bootstrap confidence intervals concordance probability estimates. provides uncertainty quantification discrimination measures, especially important heavily censored data traditional standard errors may unreliable. concordanceProbabilityBootstrapSamplesNumber bootstrap samples confidence interval calculation. samples provide accurate intervals increase computation time. Recommended minimum 500 reliable confidence intervals. concordanceProbabilityConfidenceLevelConfidence level concordance probability confidence intervals. Standard choices 0.90, 0.95, 0.99 90\\concordanceProbabilityCompareStagesCompare concordance probabilities different staging systems using hypothesis tests confidence interval overlap assessment. Provides statistical evidence staging system discrimination differences accounting heavy censoring.concordanceProbabilityAdjustVariablesAdditional variables include adjusted concordance analysis. variables included alongside staging multivariable models assess staging contribution discrimination beyond prognostic factors.concordanceProbabilityRobustnessAnalysisPerform robustness analysis concordance probability estimates including sensitivity censoring assumptions, outlier influence, temporal stability assessment comprehensive validation staging system discrimination.concordanceProbabilityAlphaSignificance level concordance probability hypothesis tests confidence interval construction. Used testing differences staging systems assessing statistical significance discrimination improvements.concordanceProbabilityDiagnosticsPerform diagnostic assessment concordance probability estimates including convergence checks, influence diagnostics, sensitivity analysis ensure reliable discrimination assessment staging system evaluation.performWinRatioAnalysisPerform win ratio analysis composite endpoint analysis staging comparison. win ratio novel method analyzing composite endpoints respects clinical hierarchy outcomes provides intuitive interpretation staging system evaluation.winRatioEndpointsClinical hierarchy endpoints win ratio analysis. important outcomes prioritized analysis. Death typically important endpoint, followed disease-specific outcomes. hierarchy determines patient pairs compared.winRatioDeathVariableVariable indicating death primary endpoint occurrence (1 = event, 0 = event). typically important outcome hierarchy compared first evaluating patient pairs.winRatioSecondaryEndpointVariable secondary endpoint (e.g., disease progression, recurrence). endpoint evaluated primary endpoint comparison tied. Can binary (event/event) continuous (time event).winRatioTertiaryEndpointVariable tertiary endpoint (e.g., response, quality life). endpoint evaluated primary secondary comparisons tied. Can binary continuous.winRatioTimeVariablesTime variables corresponding endpoint hierarchy. provided order endpoints. Used time--event comparisons endpoints binary.winRatioMatchingStrategyStrategy forming patient pairs comparison. pairs compares every patient one group every patient another. Matched pairs uses pre-specified matching. Stratified performs within-stage comparisons. Propensity matching balances baseline characteristics.winRatioConfidenceMethodMethod calculating confidence intervals win ratio. Bootstrap robust computationally intensive. Asymptotic uses large sample theory. Permutation provides exact p-values.winRatioBootstrapSamplesNumber bootstrap samples confidence interval calculation using bootstrap method. samples provide accurate intervals increase computation time.winRatioConfidenceLevelConfidence level win ratio confidence intervals hypothesis tests. Standard choices 0.90, 0.95, 0.99 90\\winRatioHandleTiesStrategy handling tied comparisons. Split assigns 0.5 wins . Ignore excludes tied pairs analysis. Next endpoint proceeds compare next outcome hierarchy tied pairs.winRatioSensitivityAnalysisPerform sensitivity analysis win ratio including assessment endpoint ordering impact, missing data influence, robustness matching strategy choices.winRatioGeneralizedPairwiseUse generalized pairwise comparison (GPC) framework extends win ratio include continuous outcomes provides additional metrics like net benefit win odds.performFrailtyModelsAnalysisPerform frailty models analysis clustered survival data using  mixed-effects Cox models (coxme) multi-institutional data  center-specific random effects clustering adjustments.frailtyClusterVariableVariable defining clusters/institutions frailty modeling (e.g.,  hospital, center, surgeon). Used account unobserved  heterogeneity clustering effects survival analysis.frailtyDistributionDistribution assumption frailty (random effects) terms. Gamma distribution common provides multiplicative  frailty effects hazard function.frailtyBootstrapPerform bootstrap validation frailty model parameters  variance components assess model stability provide robust confidence intervals.frailtyBootstrapSamplesNumber bootstrap samples frailty model validation.  Higher values provide stable estimates increase computational time.frailtyVarianceComponentsAnalyze variance components quantify proportion  total variation explained cluster-level random effects  vs individual-level factors.frailtyHeterogeneityTestTest significant frailty/heterogeneity using likelihood  ratio tests comparing frailty models standard Cox models  without random effects.frailtyClusterComparisonPerform cluster-specific survival analysis comparing staging  systems within cluster/institution assess consistency  staging performance across centers.frailtyModelSelectionPerform systematic model selection comparing different frailty  distributions model specifications using AIC/BIC criteria  likelihood ratio tests.frailtyPredictiveAccuracyAssess predictive accuracy frailty models using cross-validation  concordance measures accounting clustering structure  data.frailtyDiagnosticsComprehensive model diagnostics including residual analysis,  influence detection, goodness--fit assessment frailty  models clustering adjustments.frailtyAdvancedInferenceAdvanced statistical inference including profile likelihood  confidence intervals, score tests, robust variance estimation complex frailty model specifications.performClinicalUtilityAnalysisPerform clinical utility index analysis combining sensitivity/specificity  disease prevalence assess clinical decision-making value  staging systems beyond statistical discrimination.clinicalUtilityPrevalenceDisease prevalence (proportion events) clinical utility  calculations. Can estimated study data specified based  population characteristics.clinicalUtilityTimePointTime point (months) clinical utility assessment.  represent clinically relevant decision-making horizon  specific cancer type staging system.clinicalUtilityThresholdsRange risk thresholds clinical utility assessment. Different  ranges appropriate different clinical decision contexts  treatment aggressiveness preferences.clinicalUtilityNNTCalculate Number Needed Treat (NNT) Number Needed Harm (NNH)  based staging-guided interventions configurable treatment  effect assumptions.clinicalUtilityTreatmentEffectAssumed treatment effect (hazard ratio) calculating NNT/NNH.  reflect realistic treatment benefits staging-guided  interventions specific clinical context.clinicalUtilityComparisonCompare clinical utility staging systems using net benefit  difference analysis utility improvement quantification across  different risk thresholds.clinicalUtilityCostEffectivenessInclude basic cost-effectiveness considerations clinical utility  assessment configurable cost assumptions staging-guided  interventions outcomes.clinicalUtilityCostPerInterventionEstimated cost per staging-guided intervention cost-effectiveness  analysis. reflect realistic healthcare costs relevant  healthcare system setting.clinicalUtilityBootstrapPerform bootstrap validation clinical utility metrics including  confidence intervals NNT, net benefit differences, utility  improvement measures.clinicalUtilityBootstrapSamplesNumber bootstrap samples clinical utility validation. Higher  values provide stable estimates increase computational time.clinicalUtilityTimeVaryingAssess clinical utility across multiple time points understand  staging system value changes time horizon identify  optimal decision timing.results object containing:","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/stagemigrationClass.html","id":null,"dir":"Reference","previous_headings":"","what":"Advanced TNM Stage Migration Analysis — stagemigrationClass","title":"Advanced TNM Stage Migration Analysis — stagemigrationClass","text":"State---art analysis validating TNM staging system improvements using comprehensive statistical methods. analysis provides pathologists robust tools evaluate whether new staging system provides superior prognostic discrimination compared existing systems.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/stagemigrationClass.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Advanced TNM Stage Migration Analysis — stagemigrationClass","text":"comprehensive staging validation analysis statistical comparisons, clinical interpretation, advanced visualizations","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/stagemigrationClass.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Advanced TNM Stage Migration Analysis — stagemigrationClass","text":"comprehensive staging validation analysis includes: Core Migration Analysis: Migration matrices detailed statistics Stage distribution comparisons Rogers phenomenon detection Upstaging downstaging quantification Advanced Discrimination Metrics: Harrell's C-index confidence intervals Net Reclassification Improvement (NRI) Integrated Discrimination Improvement (IDI) Time-dependent ROC analysis Likelihood ratio tests nested models Clinical Utility Assessment: Decision Curve Analysis (DCA) Net benefit calculations Clinical significance thresholds Cancer-type specific interpretations Validation Framework: Bootstrap validation optimism correction Cross-validation options Stability assessment Internal validation metrics Advanced Visualizations: Migration heatmaps flow statistics Time-dependent ROC curves Calibration plots Decision curves Forest plots confidence intervals PHASE 1 ENHANCEMENTS - Evidence-Based Assessment Framework: Rogers Evidence Assessment: Multi-criteria evaluation framework Migration Pattern Analysis: Advanced flow statistics retention rates Survival Pattern Validation: Upstaged patient survival similarity analysis Biological Consistency Checks: Risk factor profile assessments Landmark Analysis Integration: Time-based cutoff discrimination analysis Clinical Decision Support: Evidence-based implementation recommendations Traffic Light Assessment: PASS/BORDERLINE/CONCERN/FAIL evidence grading Enhanced Heatmap Analytics: Major flow identification net migration analysis","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/stagemigrationClass.html","id":"clinical-applications","dir":"Reference","previous_headings":"","what":"Clinical Applications","title":"Advanced TNM Stage Migration Analysis — stagemigrationClass","text":"TNM staging system validation (7th 8th edition transitions) AJCC staging improvements Institution-specific staging modifications Multi-institutional staging harmonization Biomarker-enhanced staging systems","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/stagemigrationClass.html","id":"statistical-methods","dir":"Reference","previous_headings":"","what":"Statistical Methods","title":"Advanced TNM Stage Migration Analysis — stagemigrationClass","text":"analysis implements state---art methods staging validation: NRI: Quantifies net improvement risk classification IDI: Measures integrated discrimination improvement C-index: Harrell's concordance bootstrap confidence intervals DCA: Clinical utility across decision thresholds Bootstrap: Internal validation bias correction","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/stagemigrationClass.html","id":"clinical-decision-framework","dir":"Reference","previous_headings":"","what":"Clinical Decision Framework","title":"Advanced TNM Stage Migration Analysis — stagemigrationClass","text":"Results include comprehensive guidance staging system adoption: Statistical significance vs. clinical importance Effect size interpretation (small, medium, large improvements) Sample size adequacy assessment Recommendation confidence levels Implementation considerations","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/stagemigrationClass.html","id":"data-requirements","dir":"Reference","previous_headings":"","what":"Data Requirements","title":"Advanced TNM Stage Migration Analysis — stagemigrationClass","text":"Sample Size: Minimum 30 patients (100+ recommended) Follow-: Adequate survival time meaningful analysis Staging: old new staging variables 2+ levels Events: Binary event indicator (0/1) factor specified level Data Quality: Complete case analysis (missing values removed)","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/stagemigrationClass.html","id":"troubleshooting","dir":"Reference","previous_headings":"","what":"Troubleshooting","title":"Advanced TNM Stage Migration Analysis — stagemigrationClass","text":"\"TRUE/FALSE error\": Check missing values staging survival variables \"atomic error\": Disable individual tables isolate problematic components Model fitting errors: Ensure adequate sample size event rate (5-95%) Stage level errors: Verify staging variables multiple distinct levels","code":""},{"path":[]},{"path":"https://www.serdarbalci.com/jsurvival/reference/stagemigrationClass.html","id":"super-classes","dir":"Reference","previous_headings":"","what":"Super classes","title":"Advanced TNM Stage Migration Analysis — stagemigrationClass","text":"jmvcore::Analysis -> jsurvival::stagemigrationBase -> stagemigrationClass","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/stagemigrationClass.html","id":"methods","dir":"Reference","previous_headings":"","what":"Methods","title":"Advanced TNM Stage Migration Analysis — stagemigrationClass","text":"jmvcore::Analysis$.createImage() jmvcore::Analysis$.createImages() jmvcore::Analysis$.createPlotObject() jmvcore::Analysis$.load() jmvcore::Analysis$.render() jmvcore::Analysis$.save() jmvcore::Analysis$.savePart() jmvcore::Analysis$.setCheckpoint() jmvcore::Analysis$.setParent() jmvcore::Analysis$.setReadDatasetHeaderSource() jmvcore::Analysis$.setReadDatasetSource() jmvcore::Analysis$.setResourcesPathSource() jmvcore::Analysis$.setStatePathSource() jmvcore::Analysis$addAddon() jmvcore::Analysis$asProtoBuf() jmvcore::Analysis$asSource() jmvcore::Analysis$check() jmvcore::Analysis$init() jmvcore::Analysis$optionsChangedHandler() jmvcore::Analysis$postInit() jmvcore::Analysis$print() jmvcore::Analysis$readDataset() jmvcore::Analysis$run() jmvcore::Analysis$serialize() jmvcore::Analysis$setError() jmvcore::Analysis$setStatus() jmvcore::Analysis$translate() jsurvival::stagemigrationBase$initialize()","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/stagemigrationClass.html","id":"public-methods","dir":"Reference","previous_headings":"","what":"Public methods","title":"Advanced TNM Stage Migration Analysis — stagemigrationClass","text":"stagemigrationClass$clone()","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/stagemigrationClass.html","id":"method-clone-","dir":"Reference","previous_headings":"","what":"Method clone()","title":"Advanced TNM Stage Migration Analysis — stagemigrationClass","text":"objects class cloneable method.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/stagemigrationClass.html","id":"usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Advanced TNM Stage Migration Analysis — stagemigrationClass","text":"","code":"stagemigrationClass$clone(deep = FALSE)"},{"path":"https://www.serdarbalci.com/jsurvival/reference/stagemigrationClass.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Advanced TNM Stage Migration Analysis — stagemigrationClass","text":"deep Whether make deep clone.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/stagemigrationClass.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Advanced TNM Stage Migration Analysis — stagemigrationClass","text":"","code":"if (FALSE) { # \\dontrun{ # Basic staging comparison stagemigration(   data = cancer_data,   oldStage = \"old_stage\",   newStage = \"new_stage\",   survivalTime = \"survival_months\",   event = \"outcome\",   eventLevel = \"DEAD\",   analysisType = \"basic\" )  # Comprehensive analysis with all options stagemigration(   data = lung_cancer_cohort,   oldStage = \"tnm7_stage\",   newStage = \"tnm8_stage\",   survivalTime = \"os_months\",   event = \"death\",   eventLevel = \"dead\",   analysisType = \"comprehensive\",   calculateNRI = TRUE,   performBootstrap = TRUE,   bootstrapReps = 1000 )  # PHASE 1 ENHANCED: Evidence-based Will Rogers assessment stagemigration(   data = pancreatic_cohort,   oldStage = \"T_AJCC8\",   newStage = \"T_modified\",    survivalTime = \"overall_survival_months\",   event = \"death_status\",   eventLevel = \"Dead\",   analysisType = \"publication\",   advancedMigrationAnalysis = TRUE,   showMigrationHeatmap = TRUE,   cancerType = \"other\",   showExplanations = TRUE )  # Phase 1 Enhanced with landmark analysis for lung cancer stagemigration(   data = lung_staging_data,   oldStage = \"stage_7th_edition\",   newStage = \"stage_8th_edition\",   survivalTime = \"survival_months\",   event = \"vital_status\",   eventLevel = \"deceased\",   analysisType = \"comprehensive\",    advancedMigrationAnalysis = TRUE,   cancerType = \"lung\",  # Uses lung-specific landmark times: 3,6,12,24 months   showWillRogersVisualization = TRUE,   showMigrationSurvivalComparison = TRUE ) } # }"},{"path":"https://www.serdarbalci.com/jsurvival/reference/survival.html","id":null,"dir":"Reference","previous_headings":"","what":"Survival Analysis — survival","title":"Survival Analysis — survival","text":"Performs univariate survival analysis comparing survival groups. analysis  calculates person-time follow-group uses derive accurate  survival estimates incidence rates account varying follow-durations  across groups. Cox proportional hazards model incorporates person-time modeling  hazard function, represents instantaneous event rate per unit person-time.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/survival.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Survival Analysis — survival","text":"","code":"survival(   data,   elapsedtime,   tint = FALSE,   dxdate,   fudate,   explanatory,   outcome,   outcomeLevel,   dod,   dooc,   awd,   awod,   analysistype = \"overall\",   cutp = \"12, 36, 60\",   timetypedata = \"ymd\",   timetypeoutput = \"months\",   uselandmark = FALSE,   landmark = 3,   pw = FALSE,   padjustmethod = \"holm\",   ph_cox = FALSE,   sc = FALSE,   kmunicate = FALSE,   ce = FALSE,   ch = FALSE,   endplot = 60,   ybegin_plot = 0,   yend_plot = 1,   byplot = 12,   multievent = FALSE,   ci95 = FALSE,   risktable = FALSE,   censored = FALSE,   pplot = TRUE,   medianline = \"none\",   person_time = FALSE,   time_intervals = \"12, 36, 60\",   rate_multiplier = 100 )"},{"path":"https://www.serdarbalci.com/jsurvival/reference/survival.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Survival Analysis — survival","text":"data data data frame. elapsedtime time elapsed start study event censoring. tint time date format, select option calculate survival time. time calculated difference event date diagnosis date. follow-date available, time  calculated difference event date follow-date. dxdate date diagnosis. time date format, time calculated difference event date diagnosis date. fudate date follow-. time date format, time calculated difference event date follow-date. explanatory explanatory variable used compare survival times different groups. outcome outcome variable used compare survival times different groups. outcomeLevel level outcome variable used event level. dod . dooc . awd . awod . analysistype . cutp . timetypedata select time type data timetypeoutput select time type output uselandmark . landmark . pw . padjustmethod . ph_cox . sc . kmunicate . ce . ch . endplot . ybegin_plot . yend_plot . byplot . multievent . ci95 . risktable . censored . pplot . medianline true, displays line indicating median survival time survival plot. person_time Enable option calculate display person-time metrics, including total follow-time incidence rates. metrics help quantify rate events per unit time study population. time_intervals Specify time intervals stratified person-time analysis. Enter  comma-separated list time points create intervals. example,  \"12, 36, 60\" create intervals 0-12, 12-36, 36-60, 60+. rate_multiplier Specify multiplier incidence rates (e.g., 100 rates per 100 person-years, 1000 rates per 1000 person-years).","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/survival.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Survival Analysis — survival","text":"results object containing: Tables can converted data frames asDF .data.frame. example: results$medianTable$asDF .data.frame(results$medianTable)","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/survival.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Survival Analysis — survival","text":"","code":"# example will be added"},{"path":"https://www.serdarbalci.com/jsurvival/reference/survivalClass.html","id":null,"dir":"Reference","previous_headings":"","what":"Survival Analysis — survivalClass","title":"Survival Analysis — survivalClass","text":"Survival Analysis Survival Analysis","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/survivalClass.html","id":"super-classes","dir":"Reference","previous_headings":"","what":"Super classes","title":"Survival Analysis — survivalClass","text":"jmvcore::Analysis -> jsurvival::survivalBase -> survivalClass","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/survivalClass.html","id":"methods","dir":"Reference","previous_headings":"","what":"Methods","title":"Survival Analysis — survivalClass","text":"jmvcore::Analysis$.createImage() jmvcore::Analysis$.createImages() jmvcore::Analysis$.createPlotObject() jmvcore::Analysis$.load() jmvcore::Analysis$.render() jmvcore::Analysis$.save() jmvcore::Analysis$.savePart() jmvcore::Analysis$.setCheckpoint() jmvcore::Analysis$.setParent() jmvcore::Analysis$.setReadDatasetHeaderSource() jmvcore::Analysis$.setReadDatasetSource() jmvcore::Analysis$.setResourcesPathSource() jmvcore::Analysis$.setStatePathSource() jmvcore::Analysis$addAddon() jmvcore::Analysis$asProtoBuf() jmvcore::Analysis$asSource() jmvcore::Analysis$check() jmvcore::Analysis$init() jmvcore::Analysis$optionsChangedHandler() jmvcore::Analysis$postInit() jmvcore::Analysis$print() jmvcore::Analysis$readDataset() jmvcore::Analysis$run() jmvcore::Analysis$serialize() jmvcore::Analysis$setError() jmvcore::Analysis$setStatus() jmvcore::Analysis$translate() jsurvival::survivalBase$initialize()","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/survivalClass.html","id":"public-methods","dir":"Reference","previous_headings":"","what":"Public methods","title":"Survival Analysis — survivalClass","text":"survivalClass$clone()","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/survivalClass.html","id":"method-clone-","dir":"Reference","previous_headings":"","what":"Method clone()","title":"Survival Analysis — survivalClass","text":"objects class cloneable method.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/survivalClass.html","id":"usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Survival Analysis — survivalClass","text":"","code":"survivalClass$clone(deep = FALSE)"},{"path":"https://www.serdarbalci.com/jsurvival/reference/survivalClass.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Survival Analysis — survivalClass","text":"deep Whether make deep clone.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/survivalcont.html","id":null,"dir":"Reference","previous_headings":"","what":"Survival Analysis for Continuous Variable — survivalcont","title":"Survival Analysis for Continuous Variable — survivalcont","text":"Survival Analysis Continuous Variable","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/survivalcont.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Survival Analysis for Continuous Variable — survivalcont","text":"","code":"survivalcont(   data,   elapsedtime,   tint = FALSE,   dxdate,   fudate,   contexpl,   outcome,   outcomeLevel,   dod,   dooc,   awd,   awod,   analysistype = \"overall\",   cutp = \"12, 36, 60\",   timetypedata = \"ymd\",   timetypeoutput = \"months\",   uselandmark = FALSE,   landmark = 3,   sc = FALSE,   kmunicate = FALSE,   ce = FALSE,   ch = FALSE,   endplot = 60,   ybegin_plot = 0,   yend_plot = 1,   byplot = 12,   findcut = FALSE,   multiple_cutoffs = FALSE,   num_cutoffs = \"two\",   cutoff_method = \"quantile\",   min_group_size = 10,   multievent = FALSE,   ci95 = FALSE,   risktable = FALSE,   censored = FALSE,   medianline = \"none\",   person_time = FALSE,   time_intervals = \"12, 36, 60\",   rate_multiplier = 100 )"},{"path":"https://www.serdarbalci.com/jsurvival/reference/survivalcont.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Survival Analysis for Continuous Variable — survivalcont","text":"data data data frame. elapsedtime time--event follow-duration patient. numeric continuous, measured consistent units (e.g., months years). Can calculated automatically dates using date options . tint Enable option want calculate survival time dates data. useful separate columns diagnosis date follow-date want calculate time elapsed . dxdate date diagnosis study entry patient. consistent date format (e.g., YYYY-MM-DD). fudate date last follow-event patient. consistent date format (e.g., YYYY-MM-DD). contexpl continuous explanatory variable used analysis. outcome outcome variable used analysis. outcomeLevel level outcome variable represents event interest. dod . dooc . awd . awod Select levels outcome variable correspond different event types data. example, might separate levels \"Dead Disease\" \"Alive w Disease\" survival analysis cancer patients. analysistype Select type survival analysis perform. \"Overall\" survival analysis considers events equivalent, \"Cause Specific\" analysis distinguishes different event types. \"Competing Risk\" analysis accounts competing risks may prevent event interest occurring. cutp Specify cutpoints divide continuous explanatory variable groups survival analysis. Separate multiple cutpoints commas (e.g., \"12, 36, 60\"). timetypedata select time type data timetypeoutput select time type output uselandmark Enable option perform landmark survival analysis specified time point. landmark Specify landmark time evaluate survival probabilities landmark analysis. option available enable \"Use Landmark Time\" option. sc Enable option create Kaplan-Meier survival plot continuous explanatory variable. kmunicate Enable option create KMunicate-style survival plot continuous explanatory variable. ce Enable option create plot cumulative events time continuous explanatory variable. ch Enable option create plot cumulative hazard time continuous explanatory variable. endplot Specify end time survival plots. option determines maximum time point include plots. ybegin_plot Specify starting value y-axis survival plots. option allows customize range y-axis. yend_plot Specify ending value y-axis survival plots. option allows customize range y-axis. byplot Specify time interval survival plots. option determines spacing tick marks x-axis. findcut Enable option automatically find optimal cut-point continuous explanatory variable using maximally selected rank statistic. option available enable \"Survival Plot\" option. optimal cut-point displayed survival plot vertical dashed line. multiple_cutoffs Enable option find multiple optimal cut-points continuous explanatory variable. extends single cutoff analysis identify 2-4 optimal cut-points maximize survival group separation. Creates stratified groups enhanced survival analysis. num_cutoffs Select number cut-points identify. create multiple risk groups stratified survival analysis (e.g., 2 cut-offs create Low, Medium, High risk groups). cutoff_method Method finding multiple cut-offs. Quantile-based uses tertiles/quartiles, Recursive finds sequential optimal points, Tree-based uses survival trees, Minimum P-value finds points minimize log-rank p-values. min_group_size Minimum percentage patients required group created cut-offs. Prevents creating groups insufficient sample sizes reliable analysis. multievent Enable option data includes multiple event levels (e.g., different types events outcomes). option required cause-specific competing risk survival analyses. ci95 Enable option display 95\\ survival estimates plots. risktable Enable option display table risk estimates group survival analysis. censored Enable option display censored observations survival plots. medianline true, displays line indicating median survival time survival plot. person_time Enable option calculate display person-time metrics, including total follow-time incidence rates. metrics help quantify rate events per unit time study population. time_intervals Specify time intervals stratified person-time analysis. Enter  comma-separated list time points create intervals. example,  \"12, 36, 60\" create intervals 0-12, 12-36, 36-60, 60+. rate_multiplier Specify multiplier incidence rates (e.g., 100 rates per 100 person-years, 1000 rates per 1000 person-years).","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/survivalcont.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Survival Analysis for Continuous Variable — survivalcont","text":"results object containing: Tables can converted data frames asDF .data.frame. example: results$coxTable$asDF .data.frame(results$coxTable)","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/survivalcontClass.html","id":null,"dir":"Reference","previous_headings":"","what":"Survival Analysis for Continuous Explanatory Variable — survivalcontClass","title":"Survival Analysis for Continuous Explanatory Variable — survivalcontClass","text":"Survival Analysis Continuous Explanatory Variable Survival Analysis Continuous Explanatory Variable","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/survivalcontClass.html","id":"super-classes","dir":"Reference","previous_headings":"","what":"Super classes","title":"Survival Analysis for Continuous Explanatory Variable — survivalcontClass","text":"jmvcore::Analysis -> jsurvival::survivalcontBase -> survivalcontClass","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/survivalcontClass.html","id":"methods","dir":"Reference","previous_headings":"","what":"Methods","title":"Survival Analysis for Continuous Explanatory Variable — survivalcontClass","text":"jmvcore::Analysis$.createImage() jmvcore::Analysis$.createImages() jmvcore::Analysis$.createPlotObject() jmvcore::Analysis$.load() jmvcore::Analysis$.render() jmvcore::Analysis$.save() jmvcore::Analysis$.savePart() jmvcore::Analysis$.setCheckpoint() jmvcore::Analysis$.setParent() jmvcore::Analysis$.setReadDatasetHeaderSource() jmvcore::Analysis$.setReadDatasetSource() jmvcore::Analysis$.setResourcesPathSource() jmvcore::Analysis$.setStatePathSource() jmvcore::Analysis$addAddon() jmvcore::Analysis$asProtoBuf() jmvcore::Analysis$asSource() jmvcore::Analysis$check() jmvcore::Analysis$init() jmvcore::Analysis$optionsChangedHandler() jmvcore::Analysis$postInit() jmvcore::Analysis$print() jmvcore::Analysis$readDataset() jmvcore::Analysis$run() jmvcore::Analysis$serialize() jmvcore::Analysis$setError() jmvcore::Analysis$setStatus() jmvcore::Analysis$translate() jsurvival::survivalcontBase$initialize()","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/survivalcontClass.html","id":"public-methods","dir":"Reference","previous_headings":"","what":"Public methods","title":"Survival Analysis for Continuous Explanatory Variable — survivalcontClass","text":"survivalcontClass$clone()","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/survivalcontClass.html","id":"method-clone-","dir":"Reference","previous_headings":"","what":"Method clone()","title":"Survival Analysis for Continuous Explanatory Variable — survivalcontClass","text":"objects class cloneable method.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/survivalcontClass.html","id":"usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Survival Analysis for Continuous Explanatory Variable — survivalcontClass","text":"","code":"survivalcontClass$clone(deep = FALSE)"},{"path":"https://www.serdarbalci.com/jsurvival/reference/survivalcontClass.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Survival Analysis for Continuous Explanatory Variable — survivalcontClass","text":"deep Whether make deep clone.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/timeinterval.html","id":null,"dir":"Reference","previous_headings":"","what":"Time Interval Calculator — timeinterval","title":"Time Interval Calculator — timeinterval","text":"Calculates time intervals dates pre-calculated values. Time intervals form basis person-time follow-calculations survival analysis. Person-time follows accumulated time participants contribute study risk event interest, accounting varying entry times censoring. Person-time typically expressed person-days, person-months,  person-years depending study duration outcome frequency.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/timeinterval.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Time Interval Calculator — timeinterval","text":"","code":"timeinterval(   data,   dx_date,   fu_date,   time_format = \"ymd\",   output_unit = \"months\",   use_landmark = FALSE,   landmark_time = 3,   add_times = TRUE )"},{"path":"https://www.serdarbalci.com/jsurvival/reference/timeinterval.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Time Interval Calculator — timeinterval","text":"data data data frame. dx_date Column containing start dates fu_date Column containing end dates time_format . output_unit . use_landmark . landmark_time . add_times .","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/timeinterval.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Time Interval Calculator — timeinterval","text":"results object containing:","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/timeinterval.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Time Interval Calculator — timeinterval","text":"","code":"# Calculate time intervals for person-time analysis: # timeinterval( #   data = study_data, #   dx_date = \"diagnosis_date\", #   fu_date = \"followup_date\", #   output_unit = \"months\" # )"},{"path":"https://www.serdarbalci.com/jsurvival/reference/timeintervalClass.html","id":null,"dir":"Reference","previous_headings":"","what":"Time Interval Calculator — timeintervalClass","title":"Time Interval Calculator — timeintervalClass","text":"Time Interval Calculator Time Interval Calculator","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/timeintervalClass.html","id":"super-classes","dir":"Reference","previous_headings":"","what":"Super classes","title":"Time Interval Calculator — timeintervalClass","text":"jmvcore::Analysis -> jsurvival::timeintervalBase -> timeintervalClass","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/timeintervalClass.html","id":"methods","dir":"Reference","previous_headings":"","what":"Methods","title":"Time Interval Calculator — timeintervalClass","text":"jmvcore::Analysis$.createImage() jmvcore::Analysis$.createImages() jmvcore::Analysis$.createPlotObject() jmvcore::Analysis$.load() jmvcore::Analysis$.render() jmvcore::Analysis$.save() jmvcore::Analysis$.savePart() jmvcore::Analysis$.setCheckpoint() jmvcore::Analysis$.setParent() jmvcore::Analysis$.setReadDatasetHeaderSource() jmvcore::Analysis$.setReadDatasetSource() jmvcore::Analysis$.setResourcesPathSource() jmvcore::Analysis$.setStatePathSource() jmvcore::Analysis$addAddon() jmvcore::Analysis$asProtoBuf() jmvcore::Analysis$asSource() jmvcore::Analysis$check() jmvcore::Analysis$init() jmvcore::Analysis$optionsChangedHandler() jmvcore::Analysis$postInit() jmvcore::Analysis$print() jmvcore::Analysis$readDataset() jmvcore::Analysis$run() jmvcore::Analysis$serialize() jmvcore::Analysis$setError() jmvcore::Analysis$setStatus() jmvcore::Analysis$translate() jsurvival::timeintervalBase$initialize()","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/timeintervalClass.html","id":"public-methods","dir":"Reference","previous_headings":"","what":"Public methods","title":"Time Interval Calculator — timeintervalClass","text":"timeintervalClass$clone()","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/timeintervalClass.html","id":"method-clone-","dir":"Reference","previous_headings":"","what":"Method clone()","title":"Time Interval Calculator — timeintervalClass","text":"objects class cloneable method.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/timeintervalClass.html","id":"usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Time Interval Calculator — timeintervalClass","text":"","code":"timeintervalClass$clone(deep = FALSE)"},{"path":"https://www.serdarbalci.com/jsurvival/reference/timeintervalClass.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Time Interval Calculator — timeintervalClass","text":"deep Whether make deep clone.","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/validateROCInputs.html","id":null,"dir":"Reference","previous_headings":"","what":"Validate inputs for ROC analysis — validateROCInputs","title":"Validate inputs for ROC analysis — validateROCInputs","text":"Comprehensive validation ROC analysis inputs","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/validateROCInputs.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Validate inputs for ROC analysis — validateROCInputs","text":"","code":"validateROCInputs(x, class_var, pos_class = NULL)"},{"path":"https://www.serdarbalci.com/jsurvival/reference/validateROCInputs.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Validate inputs for ROC analysis — validateROCInputs","text":"x Test values class_var Classification labels pos_class Positive class label","code":""},{"path":"https://www.serdarbalci.com/jsurvival/reference/validateROCInputs.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Validate inputs for ROC analysis — validateROCInputs","text":"List validation results cleaned data","code":""}]
